cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
129744,"2-methylcyclopentane-1,3-dione",212-153-2,765-69-5,Eye Irrit. 2B;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,3,H402:1;H412:1;H320:1;H319:2;H315:2;H335:2;H332:1;H302:1
129747,"potassium sodium 6,13-dichloro-3,10-bis{}{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate",414-100-0,154336-20-6,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
129748,"1,3,5-triazine-2,4,6-triamine monophosphate",243-601-5,20208-95-1,Not Classified,Notified C&L,21,Not classified:20;H319:1;H315:1;H335:1
129749,"Acetamide, N-[2-[2-(2-bromo-4,6-dinitrophenyl)diazenyl]-5-(diethylamino)-4-methoxyphenyl]-",617-504-7,83929-84-4,,Notified C&L,5,H317:3;Not classified:2
129753,Ethinamate,204-789-4,126-52-3,Acute Tox. 4,Notified C&L,39,H302:38;H301:1
129755,4-benzylpyridine,218-319-0,2116-65-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:44;H302:41;H335:43;H300:4;H312:1;H332:1
129757,Iodobenzene,209-719-6,591-50-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,53,H319:42;H302:52;H332:7;Not classified:4;H312:2;H301:1;H335:1;H315:1
129760,Calcium silicate,233-250-6,10101-39-0,Not Classified,Notified C&L,231,Not classified:173;H319:58;H335:58
129761,Disodium hydrogen [3-[[2-amino-5-hydroxy-6-[(2-hydroxy-5-nitro-3-sulphophenyl)azo]-7-sulpho-1-naphthyl]azo]-5-sulphosalicylato(6-)]chromate(3-),277-110-2,72939-58-3,Not Classified,Notified C&L,2039,Not classified:2039
129765,2-methoxy-4-(methoxymethyl)phenol,226-882-9,5533-03-9,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,224,H317:1;H302:1;Not classified:223
129766,(Z)-but-2-ene,209-673-7,590-18-1,Press. Gas;Flam. Gas 1,Harmonised C&L,0,H220:0;Not classified:0
129767,Tetrakis(4-methylphenyl) orthosilicate,240-763-9,16714-41-3,Aquatic Chronic 4,Notified C&L,38,H413:38
129768,clodinafop-propargyl (ISO),600-662-6,105512-06-9,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H373:0;H400:0;H302:0
129769,4-(trifluoromethoxy)aniline,207-317-5,461-82-5,Acute Tox. 3;Acute Tox. 1;Eye Irrit. 2;Acute Tox. 2;Aquatic Chronic 3,REACH registration C&L,55,H301:55;H319:6;H310:52;H412:6;H330:6;H373:45;H318:48;H315:48;H311:3;H331:1
129776,Potassium tetraoxoruthenate,250-473-4,31111-21-4,Not Classified,Notified C&L,9,Not classified:9
129777,"1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene",236-948-9,13560-89-9,Not Classified,REACH registration C&L,283,Not classified:184;H332:99
129778,Polydimethyldiphenylsiloxane,614-272-9,68083-14-7,Not Classified,Notified C&L,149,Not classified:96;H319:52;H332:52;H302:1
129780,"2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate",402-490-5,106359-93-7,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H319:0;H400:0;H410:0
129787,4-(trifluoromethyl)phenylglycolic acid,206-900-1,395-35-7,,Notified C&L,6,H319:6;H315:6;H335:6
129788,"Resin acids and Rosin acids, zinc salts",232-723-4,9010-69-9,Not Classified,Notified C&L,15,Not classified:14;H228:1
129793,C.I. Direct Black 62,602-177-5,12221-89-5,Not Classified,Notified C&L,2,Not classified:2
129795,Ammonium 2-amino-5-nitrobenzenesulphonate,224-408-5,4346-51-4,Not Classified,Notified C&L,1,Not classified:1
129799,3-bromo-α-methylbenzyl alcohol,258-177-7,52780-14-0,Flam. Liq. 3,Notified C&L,40,H226:39;Not classified:1
129803,Praseodymium phosphate,238-231-6,14298-31-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
129805,Diethyl phosphonate,212-091-6,762-04-9,Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,150,H317:111;H318:99;H319:51;H315:46;H335:40
129809,"Rosin, maleated, polymer with branched 4-nonylphenol, formaldehyde and pentaerythritol",606-063-6,185765-80-4,Not Classified,Notified C&L,13,Not classified:13
129813,"Quaternary ammonium compounds, coco alkylethyldimethyl, Et sulfates",269-662-8,68308-64-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,767,H400:615;H318:520;H314:586;H302:618;Not classified:149;H410:83;H315:32;H332:1;H413:1
129814,Octyl acetoacetate,240-491-0,16436-00-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
129817,"2-(3,4-dihydroxyphenyl)-3,5-bis(β-D-glucopyranosyloxy)-7-hydroxy-1-benzopyrylium chloride",220-034-1,2611-67-8,Not Classified,Notified C&L,2,Not classified:2
129818,p-[[4-(dimethylamino)phenyl]azo]benzenesulphonyl chloride,260-235-1,56512-49-3,Skin Corr. 1B,Notified C&L,46,H314:46;H290:1;H318:1
129819,"7H-dibenzo[c,g]carbazole",205-895-3,194-59-2,Acute Tox. 4;Eye Irrit. 2;Carc. 2,Notified C&L,55,H319:40;H351:40;H302:38;H350:12;Not classified:3;H315:2
129823,"Iron, compound with molybdenum (2:3)",304-589-8,94277-04-0,Not Classified,Notified C&L,3,Not classified:3
129830,Isopropylnaphthalene,249-535-3,29253-36-9,Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,24,H304:23;H411:23;Not classified:1;H400:1
129835,2-bromo-2-methylpropionic acid,218-139-2,2052-01-9,Skin Corr. 1B,Notified C&L,51,H314:51;H317:4;H302:1;H318:2;H341:1;H290:1
129839,"9,10-Anthracenedione, 1,4-diamino-, N,N'-mixed 2-ethylhexyl and 3-[(2-ethylhexyl)oxy]propyl and 3-methoxypropyl derivs.",290-505-4,90170-70-0,Aquatic Chronic 4,REACH registration C&L,148,H413:12;H319:132;H315:132;Not classified:4
129842,Ethyl 5-nitro-2-furoate,213-400-7,943-37-3,Eye Irrit. 2,Notified C&L,38,H319:38
129843,4-aminoazobenzene;4-phenylazoaniline,200-453-6,60-09-3,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H350:0
129844,"N-[2-[(2-cyano-4,6-dinitrophenyl)azo]-5-(diethylamino)phenyl]acetamide",246-058-2,24170-60-3,Flam. Sol. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,35,H317:2;H228:1;H410:2;H400:2;Not classified:33
129847,"Tricyclo[3.3.1.13,7]decan-1-aminium, N,N,N-trimethyl-, hydroxide (1:1)",610-954-5,53075-09-5,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,87,H290:87;H318:87;H302:87;H402:4;H412:87;H314:87
129849,"2,4-Imidazolidinedione, 5-[(3,4-dimethoxyphenyl)methyl]-",613-070-8,62682-18-2,Not Classified,REACH registration C&L,2,Not classified:2
129850,"6,6'-di-tert-butyl-2,2'-thiodi-p-cresol",202-009-7,90-66-4,Not Classified,REACH registration C&L,555,Not classified:2;H317:514;H412:514;H319:38;H413:39;H315:38;H335:38
129851,"Lead, isononanoate naphthenate complexes, basic",291-563-3,90431-40-6,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H373:3;H410:3;H360:3;H332:3;H400:3;H302:3
129857,"N-(phosphonomethyl)glycine, compound with 2-propylamine (1:1)",254-056-8,38641-94-0,Aquatic Chronic 2,Notified C&L,313,H411:309;H319:4;H318:1
129859,"2'-(2,3,4-trihydroxybenzyl)-DL-serinohydrazide monohydrochloride",238-991-9,14919-77-8,Eye Irrit. 2;STOT SE 3,Notified C&L,92,H319:87;H335:86;H315:40;H411:5
129860,Chondroitin,232-695-3,9007-27-6,,Notified C&L,0,No data
129861,5-methyl-3-phenyl-2-thioxoimidazolidin-4-one,224-373-6,4333-19-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H311:38;H301:39;H331:38
129864,"4,4'-Isopropylidenediphenol, polymer with 1-chloro-2,3-epoxypropane and acrylic acid",500-100-9,37625-93-7,Not Classified,Notified C&L,98,Not classified:77;H317:20;H314:19;H411:19;H319:1;H315:1
129865,"3'-Adenylic acid, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, mono(2-chlorophenyl) ester, compd. with N,N-diethylethanamine (1:1)",286-750-1,85381-22-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38;H332:38;H302:38
129868,Dimetindene hydrogen maleate,222-789-2,3614-69-5,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,3,H411:2;H302:2;Not classified:1
129869,"Butanedioic acid, sulfo-, 4-C12-14-alkyl esters, disodium salts",290-838-5,90268-37-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,20,H318:18;H315:14;H302:13;Not classified:2
129873,2-bromo-6-methylpyridine,226-173-4,5315-25-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:41;H312:5;H332:5;H302:5
129877,Ethyl diethylcarbamate,222-607-1,3553-80-8,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H227:1;H315:1;H335:1
129880,Indazol-6-ylamine,230-177-1,6967-12-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H302:41;H335:40;H312:1;H332:1
129881,"3,4,5,6-tetrabromo-o-benzoquinone",219-426-5,2435-54-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
129888,"Fatty acids, tallow, 2-[bis(2-hydroxyethyl)amino]ethyl esters, lactates (salts)",293-134-6,91051-79-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H400:1;H318:1;H315:1;H302:1
129890,2-methyl-1-(3-sulphonatopropyl)quinolinium,257-298-2,51583-69-8,Not Classified,Notified C&L,1,Not classified:1
129892,Tioconazole,265-973-8,65899-73-2,Acute Tox. 4;Skin Sens. 1;Repr. 2;Aquatic Chronic 1,Notified C&L,227,H317:185;H410:185;H361:185;H302:227;H360:1
129900,1-(1H-pyrrol-2-yl)propan-1-one,214-026-7,1073-26-3,Not Classified,Notified C&L,93,Not classified:88;H319:4;H315:4;H302:5;H335:4
129903,2-methylbenzimidazole monohydrochloride,216-728-9,1653-75-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
129905,Tantalum carbide,235-118-3,12070-06-3,Not Classified,REACH registration C&L,20,Not classified:14;H228:4;H413:2
129906,"4,7,7-trimethyl-4-(3-methyl-2-butenyl)bicyclo[4.1.0]heptan-3-one",277-896-7,74499-59-5,Not Classified,Notified C&L,389,Not classified:389
129907,"Octene, hydroformylation products, high-boiling",271-237-7,68526-89-6,Skin Sens. 1B,REACH registration C&L,113,H317:87;Not classified:26
129910,"Shellac, compds. with sodium tetraborate (Na2B4O7)",308-154-3,97863-03-1,Not Classified,Notified C&L,1,Not classified:1
129911,"2-Pyridinol, 5-methyl-",618-801-4,91914-06-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
129921,Disodium 2-[4-[[1-[[(2-methoxyphenyl)amino]carbonyl]-2-oxopropyl]azo]-3-sulphonatophenyl]-6-methylbenzothiazole-7-sulphonate,233-461-3,10190-68-8,Not Classified,Notified C&L,18,Not classified:18
129922,Aluminium yttrium trioxide,234-443-8,12003-86-0,Not Classified,Notified C&L,4,Not classified:4
129923,"carbophenothion (ISO);4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate",212-324-1,786-19-6,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H311:0;H400:0;H410:0;H301:0
129925,"Fatty acids, tallow, lithium salts",265-229-2,64755-02-8,Not Classified,Notified C&L,9,Not classified:9
129927,4-FLUORO-3-METHOXYBENZOIC ACID,617-395-6,82846-18-2,,Notified C&L,9,H319:9;H315:9;H335:8
129929,"2,3-dibromoallyl alcohol",230-629-8,7228-11-7,Acute Tox. 4,Notified C&L,38,H302:38
129931,Azure II eosinate,610-960-8,53092-85-6,Eye Dam. 1,Notified C&L,40,H318:40
129933,"2-Propenenitril Polymer mit 1,3-butadiene, 1-cyano-1-methyl-4-oxo-4-[[2-(1-piperazinyl)ethyl]amino]butyl-terminiert",614-706-7,68683-29-4,Skin Sens. 1,Notified C&L,360,H317:214;H413:128;H315:84;H332:16;H319:2;Not classified:2
129935,"β-Alanine, N-ethyl-N-[4-[2-(5-nitro-2,1-benzisothiazol-3-yl)diazenyl]phenyl]-, methyl ester",612-859-4,61968-29-4,Not Classified,Notified C&L,1,Not classified:1
129939,Tetrafluorosuccinyl chloride,206-598-1,356-15-0,Skin Corr. 1B,Notified C&L,2,H314:2
129941,"citric acid, nickel salt",245-119-0,22605-92-1,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H410:0;H360:0;H334:0;H400:0;H350:0;H372:0;H341:0
129944,"Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]-(2-isopropoxyphenylmethylene)ruthenium(II)",608-446-3,301224-40-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,33,H312:33;H319:33;H315:33;H332:33;H302:33;H413:33
129946,2-(2-methoxyethoxy)ethanol;diethylene glycol monomethyl ether,203-906-6,111-77-3,Repr. 2,Harmonised C&L,0,H361:0
129947,"1H-Pyrazole-4-carbonitrile, 5-amino-1-(2-hydroxyethyl)-",611-002-1,5346-53-2,Skin Corr. 1B,Notified C&L,1,H314:1
129949,1-iodo-3-methylbutane,208-773-8,541-28-6,Flam. Liq. 3;Acute Tox. 4,Notified C&L,45,H226:45;H302:45;H411:1
129950,Phthalazine,205-963-2,253-52-1,Muta. 2,Notified C&L,40,H341:40;H412:1
129955,Hexyloxirane,221-047-5,2984-50-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H226:44;H315:44;H335:43;Not classified:1
129956,"Benzoic acid, 4-chloro-, sodium salt (1:1)",609-302-2,3686-66-6,,Notified C&L,1,H319:1;H315:1;H335:1
129958,"4,6-dimethylheptan-2-one",243-148-3,19549-80-5,Not Classified,Notified C&L,378,Not classified:295;H226:83;H335:42;H332:7
129960,"N,2-dimethyl-N-phenylbutyramide",282-817-4,84434-18-4,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1632,H319:1632;H412:37;H410:1;H335:1;H318:1;H315:1;H302:1;H351:1
129968,"4-[[4-(dimethylamino)phenyl]imino]cyclohexa-2,5-dien-1-one",218-434-6,2150-58-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
129969,"Sodium 4,6-dihydroxynaphthalene-2-sulphonate",280-616-6,83732-66-5,Not Classified,Notified C&L,3,Not classified:2;H319:1;H315:1
129971,Quinolin-5-ol,209-428-4,578-67-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
129973,"3,4-dihydroxyphenylacetic acid",203-024-1,102-32-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
129977,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11-icosafluoroundecyl methacrylate",255-230-6,41123-44-8,,Notified C&L,4,H319:4;H315:4;H335:4
129978,2-methoxy-p-tolyl acetate,212-908-6,879-67-4,Not Classified,Notified C&L,88,Not classified:88
129979,cymoxanil (ISO);2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide,261-043-0,57966-95-7,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H317:0;H410:0;H373:0;H361:0;H400:0;H302:0
129980,2-(trifluoromethyl)benzenesulfonyl chloride,700-328-0,776-04-5,Flam. Liq. 3;Skin Corr. 1A,REACH registration C&L,80,H226:1;H314:80;H318:39;H317:33;H341:1;H290:1;H319:1;H335:1
129982,3-amino-1-phenyl-5-pyrazolone,223-974-0,4149-06-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40
129983,"Hydrocarbons, C",292-617-9,90640-95-2,Carc. 1B,Harmonised C&L,0,H350:0
129984,Berberine hydrogen sulphate,211-196-4,633-66-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:39;H312:39;H302:39
129986,"Residues (petroleum), catalytic reformer fractionator residue distn.;Heavy Fuel oil;[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 °C (750 °F).]",270-792-2,68478-13-7,Carc. 1B,Harmonised C&L,0,H350:0
129987,"3,5-dichlorobenzaldehyde",233-499-0,10203-08-4,Skin Corr. 1B,Notified C&L,46,H314:45;H319:1;H315:1;H335:1;H318:1
129988,"Amides, C8-18 and C18-unsatd., N,N-bis(hydroxyethyl)",268-935-9,68155-07-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,187,H411:137;H318:183;H315:183;H319:3;Not classified:1
129989,"N,N'-(2-nitro-1,4-phenylene)bis(acetamide)",226-297-9,5345-53-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
129990,"2-(2-hydroxypropyl)-9-methoxy-1H-xantheno[2,1,9-def]isoquinoline-1,3(2H)-dione",278-838-3,78108-20-0,Not Classified,Notified C&L,5,Not classified:5
129994,"Avermectin A1a, 5-O-demethyl-25-de(1-methylpropyl)-25-(1-methylethyl)-",265-611-9,65195-56-4,Acute Tox. 2;Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H332:1;H400:1;H300:1
129997,Aluminium silicate(3:2),238-509-7,14504-95-1,,Notified C&L,1,Not classified:1
130003,Methyl dimethyldithiocarbamate,223-105-5,3735-92-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
130008,"Methanone, (4-phenoxyphenyl)phenyl-",613-173-8,6317-73-3,,Notified C&L,4,H319:4;H315:4;H335:4
130010,Dipentylammonium dipentyldithiocarbamate,276-172-8,71902-20-0,Acute Tox. 4;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,37,H317:2;H400:2;H410:2;H302:2;Not classified:35
130012,"Methyl 2,2,2-trichloroacetimidate",219-796-8,2533-69-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
130013,"5-chloro-2,4-dimethoxyaniline",202-586-5,97-50-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38;H312:1;H332:1;H302:1
130014,Bis(hydroxymethanesulphonato)magnesium,280-474-5,83529-10-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H302:1
130016,"Gases (petroleum), hydrotreated sour kerosine flash drum;Refinery gas;[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]",272-776-0,68911-59-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
130017,"Benzyl [R-(R*,S*)]-(1-carbamoyl-2-hydroxypropyl)carbamate",256-436-9,49705-98-8,Not Classified,Notified C&L,1,Not classified:1
130019,"3-methyl-3-(2,2,3,3,3-pentafluoropropoxy)methyl oxetane",482-280-8,,Acute Tox. 3,Notified C&L,1,H301:1
130022,"4,7-dihydro-2-isopropyl-1,3-dioxepin",226-518-9,5417-35-6,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,1,H226:1;H302:1
130024,(2-ethylhexanoato-O)oxoaluminium,260-072-6,56237-73-1,Not Classified,REACH registration C&L,15,Not classified:15
130028,di(p-propylbenzylidene) alkyl sorbitol,473-780-7,,Not Classified,REACH registration C&L,1,Not classified:1
130034,"Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica and 3-(triethoxysilyl)-1-propanamine",606-414-3,199876-44-3,Not Classified,Notified C&L,2,Not classified:2
130035,benzyl (5-{[4-({5-[acetyl(hydroxy)amino]pentyl}amino)-4-oxobutanoyl](hydroxy)amino}pentyl)carbamate,619-167-1,95748-46-2,Eye Irrit. 2,Notified C&L,1,H319:1
130036,"Fatty acids, soya, compds. with diethanolamine",270-442-9,68440-21-1,,Notified C&L,60,H319:60;H315:60
130040,3-amino-4-chlorobenzenesulphonic acid,202-661-2,98-36-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
130041,"Tricyclo[3.3.1.13,7]decan-2-ol",211-846-7,700-57-2,Not Classified,Notified C&L,1,Not classified:1
130044,"4-amino-6-[[4-[[[4-[(2,4-dihydroxyphenyl)azo]phenyl]amino]sulphonyl]phenyl]azo]-5-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonic acid, potassium salt",284-407-0,84878-17-1,Eye Irrit. 2,Notified C&L,149,H319:139;Not classified:10;H317:8;H334:8
130045,3-(N-ethylanilino)propiononitrile,205-728-4,148-87-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H312:38;H335:38;H319:39;H315:39;H332:38;H302:1
130048,Ethyl palmitate,211-064-6,628-97-7,Not Classified,REACH registration C&L,1457,Not classified:1456;H413:1
130049,"Pregna-4,16-diene-3,20-dione",214-142-8,1096-38-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H332:38;H312:38;H351:38;H302:38
130054,Cobalt(2+) neononanoate,299-899-2,93918-18-4,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H317:1;H410:1;Not classified:1;H400:1;H332:1;H302:1
130056,"Siloxanes and silicones, Me 3,3,3-trifluoropropyl, hydroxy-terminated",614-652-4,68607-77-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,8,H319:8;H315:8;H335:8
130058,Ethyl trans-(±)-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate hydrochloride,248-226-0,27107-79-5,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,122,H319:84;H412:84;H302:122
130060,N-benzylideneisopropylamine,229-949-0,6852-56-8,Acute Tox. 4,Notified C&L,38,H302:38
130061,"Heparin, reaction products with N,N-didodecyl-N-methyl-1-dodecanaminium chloride",270-968-9,68512-38-9,Not Classified,Notified C&L,4,Not classified:4
130065,Hellebrin,236-303-1,13289-18-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Notified C&L,38,H310:38;H300:38;H330:38
130066,[5-chloro-3-(4-chlorobenzoyl)oxyoxolan-2-yl]methyl 4-chlorobenzoate,606-827-9,21740-23-8,Acute Tox. 4,REACH registration C&L,41,H302:2;H319:39;H315:39;H335:39
130072,"Aluminium, 7-hydroxy-8-[(4-sulfo-1-naphthalenyl)azo]-1,3-naphthalenedisulfonic acid complex",235-438-3,12227-64-4,Not Classified,Notified C&L,5,Not classified:5
130077,L-arabinose,226-214-6,5328-37-0,Not Classified,REACH registration C&L,121,Not classified:121
130079,"1,5-dibromopentane",203-849-7,111-24-0,Acute Tox. 4,REACH registration C&L,52,H302:6;H319:49;H315:49;H335:6;H341:1
130081,"2,3-diphenylpropiononitrile",222-064-0,3333-14-0,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H319:38;H400:38
130083,Potassium hydrogenperoxomonosulphate,233-187-4,10058-23-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,107,H314:64;H302:50;H271:38;H318:14;H301:14;H272:14;Not classified:5
130099,1-(4-(trans-4-heptylcyclohexyl)phenyl)ethanone,426-820-2,78531-60-9,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
130104,"(R)-2,2,3-trimethylcyclopent-3-ene-1-acetaldehyde",224-815-8,4501-58-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1532,H319:1531;H315:1531;H302:186;Not classified:1
130105,Tetraethyllead,201-075-4,78-00-2,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;Repr. 1A;STOT RE 2;STOT RE 2;Aquatic Acute 1,REACH registration C&L,74,H373:74;H360:74;H300:74;H400:74;H310:74;H330:74;H410:71
130107,3-nitrobenzonitrile,210-587-7,619-24-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46,H332:38;H312:42;H302:38;H301:7;H311:2;H300:1;H331:2;H319:1;H315:1
130110,"Methyl (1R,21S,24S)-21-tert--butyl-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1^4,7 .0. ^6,11] ]heptacosa-6,8,10-triene-24-carboxylate",618-840-7,923591-06-4,Not Classified,REACH registration C&L,1,Not classified:1
130114,Chloromethylphenylvinylsilane,241-333-3,17306-05-7,Skin Corr. 1B,Notified C&L,40,H314:40;H290:1;H318:1
130116,"1-Propene, 1,1,2,3,3,3-hexafluoro-, oxidized, polymd.",615-044-1,69991-67-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,6,H319:4;H315:4;H335:4;Not classified:2
130117,"Trisodium 1-amino-4-[[3-[[4-chloro-6-[(sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2,4,6-trimethyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",276-481-8,72214-18-7,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,52,H317:52;H319:12;H318:40
130119,4-(nitromethyl)-1-(2-phenylethyl)piperidin-4-ol;hydrochloride,928-867-9,,Acute Tox. 4,REACH registration C&L,2,H302:2
130121,"reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]",423-070-8,,Aquatic Chronic 4,Harmonised C&L,0,H413:0
130125,Tetrakis(1-piperidyl)phosphonium chloride,606-711-8,211385-45-4,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H301:2;H411:2;H319:2;H315:2;H310:2
130126,"Phenol, 2,4-dinonyl-, branched",284-323-4,84852-14-2,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,55,H317:55;H412:54;H315:55;H413:1
130130,"Hydrogen bis[1-[(5-chloro-2-hydroxyphenyl)azo]-2-naphtholato(2-)]chromate(1-), compound with 2,2'-(dodecylimino)diethanol (1:1)",282-387-8,84195-80-2,,Notified C&L,1,Not classified:1
130133,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyl acid, 7-amino-8-oxo-3-[(2S)-tetrahydro-2-furanil]-, (4-nitrophenyl) methyl ester, hydrochloride",613-812-0,655233-39-9,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
130136,"4-(Aminomethyl)piperidine, 4-BOC protected",619-591-7,135632-53-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,47,H319:39;H315:39;H314:8;H335:1;H318:1
130137,"1,3,5-TRIAZINE-2,4,6(1H,3H,5H)-TRIONE, 1-METHYL-3-[3-METHYL-4-[4-[(TRIFLUOROMETHYL)THIO]PHENOXY]PHENYL]-",614-893-5,69004-03-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,110,H400:107;H410:110;H373:35;H361:36;H302:27;H301:2;H330:3
130144,2-hydroxy-3-(oleoyloxy)propyl 5-oxo-L-prolinate,283-393-3,84608-82-2,Skin Sens. 1B,REACH registration C&L,8,H317:8
130145,"4-amino-5-hydroxy-6-[[2-methoxy-5-methyl-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-3-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonic acid",289-022-1,85959-30-4,Not Classified,Notified C&L,3,Not classified:2;H317:1;H318:1
130149,"Iron, complexes with diazotized 2-amino-5-nitrobenzenesulfonic acid coupled with diazotized 2-amino-4-nitrophenol and resorcinol",291-493-3,90412-13-8,Aquatic Chronic 3,REACH registration C&L,38,H412:2;H317:35;H334:35;H319:35;Not classified:1
130150,"2-hexyl-4,5-dimethyl-1,3-dioxolane",229-261-0,6454-22-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
130153,"reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];3,5-di-tert-butyl-salicylic acid",406-890-0,130296-87-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0
130155,2-(chloromethyl)thiophene,212-150-6,765-50-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
130158,4-bromotoluene,203-391-8,106-38-7,Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,60,H319:18;H315:57;H302:47;H335:7;H332:4;H411:4;Not classified:1
130160,"Disodium 6,6'-dihydroxy-3,3'-(4,5,6,7-tetrabromo-1,3-dihydro-3-oxoisobenzofuran-1-ylidene)dibenzenesulphonate",200-761-0,71-67-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,40,H317:40;H334:40
130161,2-bromo-1-ethylpyridinium tetrafluoroborate,212-900-2,878-23-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H311:1;H301:1;H331:1;H318:1;H314:1;H302:1
130164,Hexadecahydropyrene,219-429-1,2435-85-0,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38,H302:38;H413:38
130165,tert-pentyl peroxypivalate,249-530-6,29240-17-3,Org. Perox. C;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,31,H317:26;H410:10;H315:10;H400:10;H242:26;H304:10;Not classified:5
130167,Tin titanium zinc oxide,618-845-4,923954-49-8,Not Classified,Notified C&L,49,Not classified:33;H412:16
130172,"N,N',N''-tris(methoxymethyl)-1,3,5-triazine-2,4,6-triamine",219-341-3,2420-27-1,Skin Sens. 1,Notified C&L,2,H317:1;Not classified:1
130173,"N-nitroso-N-phenylhydroxylamine, ammonium salt",205-183-2,135-20-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,49,H301:48;H335:43;H319:49;H315:48;H351:46;H317:4;H350:3;Not classified:1;H341:1;H228:1;H302:1
130174,Tris(acrylato-O)(propan-2-olato)titanium,262-790-5,61436-49-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
130179,Trimethoxysilane,219-637-2,2487-90-3,Flam. Liq. 2;Water-react. 3;Skin Corr. 1C;Acute Tox. 1;STOT SE 3,REACH registration C&L,81,H335:41;H225:81;H261:41;H314:42;H330:80;H319:38;H318:1;H302:1
130180,"Linseed oil compound with 2,5-furandione, 2-propenoic acid, 2-methyl-, 2-hydroxyethyl ester and ethanol, 2-(dimethylamino)- salt",924-725-5,,Not Classified,Notified C&L,71,Not classified:71
130183,"Phthalic acid, sodium salt",233-493-8,10197-71-4,,Notified C&L,35,Not classified:35
130184,Sodium hydrogen L-aspartate,223-264-0,3792-50-5,Not Classified,REACH registration C&L,12,Not classified:12
130185,"(trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide",404-670-9,89797-01-3,Skin Sens. 1,Harmonised C&L,0,H317:0
130192,1-(2-bromoethyl)-4-methoxybenzene,238-393-8,14425-64-0,Acute Tox. 4,Notified C&L,38,H302:38
130199,Chromium (VI),606-053-1,18540-29-9,Not Classified,Notified C&L,68,Not classified:33;H317:35;H400:35;H410:35;H350:35
130203,2-(4-chlorophenoxy)propionic acid,221-991-8,3307-39-9,Acute Tox. 3,Notified C&L,71,H301:71
130207,"reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)",407-900-6,111381-12-5,Aquatic Chronic 4,Harmonised C&L,0,H413:0
130208,4-chloro-2-fluoro-1-nitrobenzene,211-842-5,700-37-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H315:3;H335:3;H312:2;H332:2;H302:2
130215,"Methanesulfonamide, N-[4-(2-chloroacetyl)phenyl]-",613-606-0,64488-52-4,Eye Dam. 1,REACH registration C&L,3,H319:2;H318:1;H315:1;H302:1;H335:1
130216,4-bromo-2-fluorotoluene,257-201-3,51436-99-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H302:40;H335:46;H312:1;H332:1
130217,"2,2,3,3,4,4,5,5-octafluoropentan-1-ol",206-593-4,355-80-6,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,REACH registration C&L,62,H319:62;H302:4;H335:61;H315:58
130218,"Phenol, 4-(9H-carbazol-3-yl-amino)-, reaction products with sodium sulfide (Na2(Sx))",215-499-2,1327-79-3,Not Classified,Notified C&L,10,Not classified:10
130223,3-methylcyclopentene,214-315-8,1120-62-3,Not Classified,Notified C&L,4,Not classified:3;H312:1;H335:1;H225:1;H332:1;H304:1;H412:1
130224,"3,6,9,12,15-pentaoxanonadecan-1-ol",217-246-1,1786-94-3,,Notified C&L,40,Not classified:40
130225,C.I. SOLVENT ORANGE 99,600-955-9,110342-29-5,Acute Tox. 4,Notified C&L,19,H302:19
130227,Barium bis[o(or p)-heptylphenolate],309-472-5,100348-34-3,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,566,H332:441;H319:441;H302:441;Not classified:125
130233,"Propanamide, 2-hydroxy-N,N-dimethyl-",609-066-0,35123-06-9,Not Classified,REACH registration C&L,140,Not classified:118;H319:22;H315:22
130236,"5-benzyloxy-N,N-dimethylamino-3-methylindole",215-927-8,1453-97-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
130247,Magnesium diethyl difumarate,281-295-5,83918-60-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
130251,oxygen,231-956-9,7782-44-7,Press. Gas;Ox. Gas 1,Harmonised C&L,0,H270:0;Not classified:0
130254,"trans-cyclohexane-1,2-dinitrilotetraacetic acid",236-308-9,13291-61-7,Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,51,H319:49;H332:2;H315:47;H335:44;Not classified:2
130257,Quinazoline,205-965-3,253-82-7,,Notified C&L,1,H319:1;H315:1;H335:1
130262,β-alanine,203-536-5,107-95-9,Not Classified,REACH registration C&L,313,Not classified:310;H319:2;H315:3;H335:2
130266,"Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αR)-, sulfate (1:1)",601-681-2,120202-71-3,Skin Corr. 1B,Notified C&L,40,H314:39;H302:1
130267,"m,m'-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)diimino]bis[2,4,6-trimethylbenzenesulphonic] acid, compound with hexane-1,6-diamine (1:1)",279-213-8,79665-26-2,Aquatic Chronic 3,REACH registration C&L,137,H412:54;Not classified:83
130270,2-chloro-4-fluorobenzonitrile,262-384-8,60702-69-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:38;H335:39;H319:44;H315:44;H332:42;H302:42;H311:6;H301:3;H331:2
130271,"2-nitro-4,5-xylidine",230-211-5,6972-71-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H312:42;H335:42;H319:42;H315:42;H332:42;H302:42
130282,Methyl 4-[2-[4-(5-methyl-2-benzoxazolyl)phenyl]vinyl]benzoate,241-949-2,18039-18-4,Not Classified,REACH registration C&L,39,Not classified:39
130284,"Amides, coco",263-039-4,61789-19-3,Not Classified,Notified C&L,12,Not classified:12
130285,"Fatty acids, vegetable-oil, zinc salts",296-277-2,92456-98-9,Not Classified,Notified C&L,6,Not classified:6
130287,"Fatty acids, soya, reaction products with diethanolamine",270-599-3,68457-09-0,Skin Sens. 1;Eye Dam. 1,Notified C&L,2,H317:1;H318:1;Not classified:1
130289,Betamethasone 17-benzoate,244-897-9,22298-29-9,Repr. 1B;STOT RE 2,Notified C&L,2,H373:1;H360:1;H361:1
130290,"(+)-13-Ethylgon-4-ene-3,17-dione",606-833-1,21800-83-9,Acute Tox. 5;Eye Irrit. 2B;STOT RE 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,4,H320:2;H372:2;H411:3;H303:2;H401:2;H360:1
130292,"Residues (petroleum), heavy coker gas oil and vacuum gas oil;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C",270-796-4,68478-17-1,Carc. 1B,Harmonised C&L,0,H350:0
130293,hexamethylene-di-isocyanate,212-485-8,822-06-0,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H317:0;H335:0;H319:0;H334:0;H315:0;H331:0
130294,"Benzene, C14-26-alkyl derivs.",274-583-7,70356-32-0,Aquatic Chronic 4,Notified C&L,34,H413:33;H304:1
130295,"1H,3H-Prrolo[12,-c][1,3,2]oxazaborole, tetrahydro-1-methyl-3,3-diphenyl,-, (3aR)",601-151-0,112022-83-0,,Notified C&L,8,H373:5;H361:5;H315:6;H332:4;H304:5;H224:4;H336:5;Not classified:1;H318:2;H302:2;H319:1;H335:1;H225:1
130296,"Disodium 4,4'-diazidostilbene-2,2'-disulphonate",220-316-4,2718-90-3,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H228:2;H312:2;H302:2
130303,"Sodium 3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonate",227-973-6,6054-86-0,Not Classified,REACH registration C&L,2,Not classified:2
130304,"Tetrahydro-α,α,5-trimethyl-5-(4-methyl-3-cyclohexen-1-yl)furan-2-methanol",259-624-9,55399-12-7,Not Classified,Notified C&L,2,Not classified:2
130305,"Benzeneacetic acid,alpha-amino-4-chloro-",612-944-6,6212-33-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H315:40;H302:38;H335:39;Not classified:1
130307,m-chlorothiophenol,218-010-0,2037-31-2,Skin Corr. 1B,Notified C&L,44,H314:44;H302:5;H318:1
130310,"4-hydroxy-3,5-dimethoxybenzyl alcohol",208-485-2,530-56-3,,Notified C&L,4,H319:4;H315:4;H335:4
130311,Zaprinast,253-655-1,37762-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
130312,"Dihydrogen (ethyl)[4-[4-[ethyl(3-sulphonatobenzyl)]amino]-2'-sulphonatobenzhydrylidene]cyclohexa-2,5-dien-1-ylidene](3-sulphonatobenzyl)ammonium, disodium salt",223-339-8,3844-45-9,Not Classified,REACH registration C&L,2807,Not classified:2628;H319:130;H315:127;H373:43;H412:6;H341:5
130313,S-ethyl propanethioate,219-405-0,2432-42-0,Flam. Liq. 3,Notified C&L,44,H226:44;H319:1;H315:1;H335:1
130318,Tetraamminepalladium(II) chloride monohydrate,604-126-2,13933-31-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:42;H335:42;H317:1;H410:1;H290:1;H400:1;H302:1;H412:1
130322,(S)-5-(amidinoamino)-2-amino-N-2-naphthylvaleramide monohydrochloride,242-654-1,18905-73-2,Carc. 2,Notified C&L,39,H351:38;H350:1
130323,3-sulfinobenzoic acid,416-000-2,,Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H317:1;H314:1
130325,"Sodium [6R-[6α,7β(Z)]]-3-[[(aminocarbonyl)oxy]methyl]-7-[2-furyl(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",260-073-1,56238-63-2,Skin Sens. 1,Notified C&L,52,H317:52;H334:11;H335:1;H319:1;H315:1
130327,"2-[(dichloroacetyl)amino]-3-hydroxy-3-[4-(methylsulphonyl)phenyl]propyl [R-(R*,R*)]aminoacetate monohydrochloride",220-033-6,2611-61-2,Acute Tox. 4,Notified C&L,1,H302:1
130329,lysophospholipaseIUBMB 3.1.1.5,618-333-0,9001-85-8,Resp. Sens. 1,REACH registration C&L,9,H334:9
130334,"1,8-bis(phenylthio)anthraquinone",237-167-6,13676-91-0,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,256,H317:198;H411:191;Not classified:58
130335,"Alchemilla vulgaris, ext.",283-614-3,84695-94-3,Flam. Liq. 3,Notified C&L,4,H226:3;Not classified:1
130341,Lithium hypochlorite,237-558-1,13840-33-0,Ox. Sol. 2;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,39,H400:39;H314:39;H302:38;H272:39
130344,Dimethylamine--borane (1:1),200-823-7,74-94-2,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,286,H301:284;H311:260;H319:185;H331:83;H411:156;H332:71;H228:102;H314:6;H330:5;H335:5;H315:6;H318:3;H317:3;H302:1;H412:2;H300:1
130345,"Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",292-616-3,90640-94-1,Carc. 1B,Harmonised C&L,0,H350:0
130350,1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone,427-320-7,83626-30-6,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
130354,"1,5-dimethylbicyclo[3.2.1]octan-8-one",244-662-0,21922-58-7,Not Classified,Notified C&L,1,Not classified:1
130355,4-methylvaleraldehyde,214-273-0,1119-16-0,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H225:1;H315:1;H302:1
130357,"2-chloropyrimidine-4,5-diamine",238-672-4,14631-08-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,66,H312:66;H335:66;H319:66;H315:66;H332:66;H302:66
130358,"2-Propenoic Acid, Polymer",920-377-3,,Not Classified,Notified C&L,441,Not classified:441
130361,"(9β,11β,16β)-9,11-Epoxy-16-methyl-17,21-bis(1-oxopropoxy)-pregna-1,4-diene-3,20-dione",614-000-9,66917-44-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,Notified C&L,1,H312:1;H361:1;H335:1;H319:1;H315:1;H332:1;H302:1
130362,"Bis(pentane-2,4-dionato-O,O')platinum",239-223-5,15170-57-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,Notified C&L,52,H312:51;H361:49;H335:49;H319:51;H315:50;H332:51;H302:52;H413:1
130363,Zinc sulphide,215-251-3,1314-98-3,Not Classified,REACH registration C&L,872,Not classified:798;H317:26;H334:26;H410:26;H319:20;H400:21;H335:20;H332:7;H331:1
130366,"Aluminium, 3-hydroxy-4-[(4-sulfo-1-naphthalenyl)azo]-2,7-naphthalenedisulfonic acid complex",235-437-8,12227-62-2,Not Classified,REACH registration C&L,9,Not classified:9
130367,"C10-14 ethoxylated fatty alcohol, 6 EO",923-894-2,66455-15-0,Eye Dam. 1,Notified C&L,441,H318:441
130368,"7,11b-dihydrobenz[b]indeno[1,2-d]pyran-3,6a,9,10(6H)-tetrol",207-477-6,474-07-7,Not Classified,Notified C&L,1,Not classified:1
130373,Mandelonitrile,208-532-7,532-28-5,Acute Tox. 1;Acute Tox. 1;Eye Dam. 1;Acute Tox. 1;Aquatic Chronic 1,REACH registration C&L,100,H410:6;H300:2;H318:45;H310:2;H330:2;H311:93;H301:98;H331:93;H315:5;H400:4
130379,Dinonylnaphthalenesulphonic acid,246-841-9,25322-17-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,725,H318:684;H315:685;H317:32;H319:33;Not classified:5;H411:2;H302:1;H314:1
130383,(3He)helium,238-822-9,14762-55-1,Press. Gas (Comp.),Notified C&L,83,H280:83;H281:44
130385,(E)-p-methoxycinnamic acid,213-405-4,943-89-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:52;H315:52;H335:52
130390,dodecachloropentacyclo[5.2.1.0,219-196-6,2385-85-5,Acute Tox. 4;Acute Tox. 4;Carc. 2;Lact.;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H410:0;H312:0;H361:0;H362:0;H400:0;H302:0;H351:0
130393,"(Z)-5-Amino-.alpha.-(methoxyimino)-1,2,4-thiadiazole-3-acetic acid",456-150-6,,Eye Irrit. 2,Notified C&L,1,H319:1
130395,6-chloro-2-nitrobenzonitrile,229-496-9,6575-07-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42,H312:38;H335:42;H319:42;H315:42;H332:38;H302:42
130396,"Geranium maculatum, ext.",283-491-6,84650-10-2,Not Classified,Notified C&L,37,Not classified:37
130398,"Benzenebutanoic acid, ethyl ester",600-062-4,10031-93-3,,Notified C&L,1,H319:1;H315:1;H335:1
130404,Propyl valerate,205-452-4,141-06-0,Flam. Liq. 3,Notified C&L,40,H226:40
130407,"endosulfan (ISO);1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite;1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite",204-079-4,115-29-7,Acute Tox. 2;Acute Tox. 4;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H312:0;H300:0;H400:0;H330:0
130411,Methyl pyrazinecarboxylate,228-198-6,6164-79-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
130413,"2-methylnaphth[2,1-d]oxazole",243-971-8,20686-65-1,Not Classified,Notified C&L,1,Not classified:1
130414,"N-(dimethylphenylsilyl)-1,1-dimethyl-1-phenylsilylamine",222-372-5,3449-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
130421,Dioctanoyl peroxide,212-094-2,762-16-3,Org. Perox. C;Skin Irrit. 2;Skin Sens. 1A,REACH registration C&L,2,H317:2;H242:2;H315:2
130422,"2,3,7,8-tetrachlorodibenzo[b,e][1,4]dioxin",217-122-7,1746-01-6,Acute Tox. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H400:38;H410:38;H300:38
130424,Pent-4-ynylbenzene,217-352-8,1823-14-9,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H319:39;H400:38;H410:38;H226:4;H315:1;H335:1
130425,3-Chloro-4-iodoaniline,603-892-5,135050-44-1,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H312:42;H301:39;H335:42;H319:43;H315:43;H332:42;H302:5;H311:1;H331:1
130428,"1,2,3-Trifluoro-5-[4-(trans-4-methylcyclohexyl)-1-cyclohexen-1-yl]benzene",924-628-8,,Not Classified,Notified C&L,1,Not classified:1
130429,3-(propan-2-yl)-7-oxabicyclo[4.1.0]heptane,605-005-7,15536-71-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H315:2;H335:2
130431,maneb (ISO);manganese ethylenebis(dithiocarbamate) (polymeric),235-654-8,12427-38-2,Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H317:0;H410:0;H361:0;H319:0;H400:0;H332:0
130442,Cobalt(2+) hydrogen citrate,242-538-0,18727-04-3,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Resp. Sens. 1;Muta. 2;Carc. 1B;Repr. 1B;Aquatic Chronic 2,REACH registration C&L,6,H317:5;H360:5;H334:5;H318:5;H350:5;H302:5;H411:5;H341:5;Not classified:1
130443,3-amino-4-hydroxybenzenesulphonic acid,202-662-8,98-37-3,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,95,H319:6;H315:6;H314:76;H318:37;Not classified:9;H332:4;H312:4;H302:3
130444,1H-indole-3-propylamine,228-361-1,6245-89-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
130445,"1,1,1-Tris(4-hydroxyphenyl)ethane",608-155-1,27955-94-8,Aquatic Chronic 2,Notified C&L,417,H411:417
130447,"Dinonylphenol Ethoxylates, Branched",614-755-4,68891-21-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,136,H319:57;H412:57;H315:57;H318:50;Not classified:28;H411:14;H302:14;H413:1
130452,nickel dibenzoate,209-046-8,553-71-9,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H410:0;H360:0;H334:0;H400:0;H350:0;H372:0;H341:0
130453,"3-Penten-2-ol, (3E)-",609-603-9,3899-34-1,Flam. Liq. 3,Notified C&L,38,H226:38
130454,6-nitro-m-cresol,211-843-0,700-38-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H312:6;H332:6;H302:7
130455,1-(Mercaptomethyl)cyclopropaneacetic Acid,605-290-8,162515-68-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,74,H317:74;H312:39;H302:74;H411:39;H314:74;H318:35
130456,"4-[(4-amino-m-tolyl)(4-imino-3-methylcyclohexa-2,5-dien-1-ylidene)methyl]-o-toluidine monohydrochloride",221-831-7,3248-91-7,Eye Dam. 1,REACH registration C&L,118,H318:69;H410:53;H335:53;H319:46;H315:54;H400:40;H351:44;H373:37;H350:14;H412:6;H341:6;Not classified:3;H411:1
130462,5-(2-aminobutyl)o-cresol hydrochloride,249-627-3,29440-91-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
130473,"Hexanedioic acid, ester with 2,2'-[oxybis(methylene)]bis[2-(hydroxymethyl)-1,3-propanediol]",260-232-5,56509-15-0,Eye Irrit. 2,Notified C&L,1,H319:1
130474,3'-ethoxyacetanilide,209-713-3,591-33-3,,Notified C&L,4,H302:4
130475,Tetra-n-butylammonium tribromide,609-598-3,38932-80-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H319:44;H315:44;H335:44;H314:7;H318:2
130480,"Distillates (coal), solvent extn., hydrocracked;[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30°C to 300°C (86°F to 572°F). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C",302-689-6,94114-53-1,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
130482,1-methyl-4-(1-methylvinyl)cyclohexyl acetate,233-494-3,10198-23-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,23,H319:23;H315:23;H335:23
130484,"Bis(5-oxo-L-prolinato-N1,O2)zinc",239-473-5,15454-75-8,Eye Dam. 1,REACH registration C&L,6,H318:4;H319:1;Not classified:1
130487,"(1S,3'R,4'S,5'S,6'R)-6-(4-ethylbenzyl)-6'-(hydroxymethyl)-3',4',5',6'-tetrahydro-3H-spiro[2-benzofuran-1,2'-pyran]-3',4',5'-triol",619-989-0,903565-83-3,,,0,No data
130488,"Phenol, 4-ethenyl-, homopolymer, 1-(2-cyclohexylethoxy)ethyl ethers",484-300-0,,Flam. Sol. 2,Notified C&L,1,H228:1
130489,"Nickel, dichloro[[]1,1'-(1,3-propanediyl)bis[[]1,1-diphenylphosphine-[?]P]]-",605-052-3,15629-92-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Carc. 1A,Notified C&L,115,H317:115;H335:113;H319:114;H334:40;H315:114;H350:107;H351:8;H371:1;H301:1
130490,4-hexylaniline,251-409-8,33228-45-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H302:44;H335:39
130492,Methylsulphamic acid,223-895-1,4112-03-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,39,H318:39;H314:39
130494,Bis(methylphenyl) phenyl phosphate,247-708-8,26446-73-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,204,H400:117;H410:117;H411:81;H317:16;H312:16;H302:16;H340:16;H330:16;Not classified:6
130497,3'-aminoacetanilide,203-021-5,102-28-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:44;H315:44;H335:43;H302:12
130499,2-(2-hydroxy-4-methoxybenzoyl)benzoic acid,225-290-8,4756-45-0,Skin Sens. 1B;Aquatic Acute 1,Notified C&L,38,H317:38;H400:38
130503,"1-(1,2,3,4-tetrahydro-4,4-dimethyl-1-naphthyl)propan-1-one",277-897-2,74499-60-8,Not Classified,Notified C&L,88,Not classified:88
130508,chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane,410-270-5,770722-46-8,Skin Corr. 1A,Harmonised C&L,0,H314:0
130514,Phenaceturic acid,207-916-1,500-98-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:39;H315:1;H335:1
130515,"furathiocarb (ISO);2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate",265-974-3,65907-30-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H373:0;H410:0;H301:0;H319:0;H315:0;H400:0;H330:0
130516,"2,4,5-trichlorobenzenesulphonyl chloride",240-079-0,15945-07-0,Skin Corr. 1B,Notified C&L,43,H314:43;H290:1;H318:1
130518,"1,3-dichlorobutan-2-one",240-767-0,16714-77-5,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H319:1;H302:1
130525,"2-amino-3,5-dinitrobenzonitrile",245-116-4,22603-53-8,Acute Tox. 3,Notified C&L,38,H301:38
130526,"reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]",420-850-1,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
130534,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 3-aminomethyl-3,5,5-trimethylcyclohexylamine",500-101-4,38294-64-3,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,432,H317:175;H412:102;H318:95;H314:128;Not classified:258;H312:79;H311:46;H302:80;H411:72
130535,o-(phenylazo)benzenesulphenyl bromide,220-654-2,2849-62-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38,H311:38;H301:38;H331:38
130536,"10-ethyl 7-methyl 1,4-dioxa-7-azaspiro[4.5]decane-7,10-dicarboxylate",265-616-6,65202-60-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
130537,"Guanidine, cyano-polymer with N-(2-aminoethyl)-1-2ethanediamine and ammonium chloride",615-786-6,72645-72-8,Not Classified,Notified C&L,4,Not classified:3;H319:1;H411:1;H315:1;H302:1
130538,"Sulfuric acid, mono-C12-14-alkyl esters, sodium salts",287-809-4,85586-07-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,673,H412:580;H318:673;H315:673;H302:629;H335:204;H332:203;H228:203
130545,"1-Ethoxy-2,3-difluorbenzol",601-758-0,121219-07-6,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;Not classified:1
130547,3-methyl-4-oxo-4-(3-nitro-4-chlorophenyl)butanoic acid,440-860-8,,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H317:2;H412:2;H318:2
130550,Sodium [[4-(aminosulphonyl)phenyl]amino]methanesulphonate,205-330-0,138-43-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
130551,Methyl octyl sulphide,223-029-2,3698-95-1,Not Classified,Notified C&L,1,Not classified:1
130553,3-ethoxypropionaldehyde,220-546-5,2806-85-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H226:2;H315:2;H335:2
130556,"reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;1,4-diamino-2,3-bis-phenoxyanthraquinone",423-220-2,12223-77-7,Aquatic Chronic 4,Harmonised C&L,0,H413:0
130559,"1-Hexanol, 3-mercapto-3-methyl-",608-525-2,307964-23-4,Not Classified,Notified C&L,1,Not classified:1
130561,Bis(phenylseleninic) anhydride,241-701-3,17697-12-0,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,43,H373:43;H410:43;H301:43;H331:43;H400:43
130562,"1,2-dibromocyclohexane",226-449-4,5401-62-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
130564,"Eucalyptus dives, ext.",289-839-3,90028-48-1,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Repr. 2;Aquatic Chronic 2,REACH registration C&L,1373,H317:1373;H411:1373;H361:2;H304:1373;H226:1362;H315:72;H319:1
130565,"(2-bromo-1,1,2,2-tetrafluoroethoxy)trifluoroethylene",288-516-4,85737-06-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
130567,"2,2,3,3,3-pentafluoropropanol",207-012-7,422-05-9,Acute Tox. 4;STOT RE 2,REACH registration C&L,50,H373:3;H302:48;H319:47;H315:47;H335:46;H332:2;H226:1
130575,Gallium tribromide,236-609-5,13450-88-9,Skin Corr. 1B,Notified C&L,42,H314:42
130576,Cobalt dioctanoate,216-452-9,1588-79-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,Notified C&L,2,H317:2;H315:2;H302:2
130579,"1H-1,2,4-Triazole-5-carbonitrile",609-243-2,3641-10-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H301:2;H335:2;H311:1;H319:2;H315:2;H331:1
130581,acrylic polymer,924-135-8,9065-11-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H319:1;H315:1;H332:1;H302:1
130582,p-allyltoluene,222-063-5,3333-13-9,Flam. Liq. 3;Acute Tox. 4,Notified C&L,63,H226:38;H302:38;H304:25
130585,"1,4-dibromobenzene",203-390-2,106-37-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,REACH registration C&L,65,H319:64;H400:45;H315:64;H335:62;H411:13;Not classified:3;H302:1;H412:1
130588,Sodium 2-amino-5-nitrobenzenesulphonate,250-299-9,30693-53-9,Not Classified,REACH registration C&L,48,Not classified:47;H319:1;H315:1
130591,Isopropyl nitrite,208-779-0,541-42-4,Flam. Liq. 2;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Muta. 2,REACH registration C&L,50,H317:10;H225:50;H318:10;H341:10;H314:10;H330:50;H301:40;H335:40;H311:40;H319:40;H315:40
130593,Propylidynetrimethanol,201-074-9,77-99-6,Repr. 2,REACH registration C&L,5028,H361:165;Not classified:4853;H311:8;H400:1;H410:2;H301:2;H331:2
130595,"Benzenesulfonic acid, 2,4-dimethyl-, polymer with formaldehy de and 4,4'-sulfonylbis(phenol), ammonium sodium salt",614-559-9,68516-87-0,Aquatic Chronic 3,Notified C&L,31,H412:31
130602,2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid,604-138-8,139481-59-7,Repr. 2,REACH registration C&L,4,H361:3;H332:1;H411:1
130603,"[R-(R*,S*)]-benzyldimethyl(α-methylphenacyl)ammonium bromide",261-375-6,58648-09-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
130606,"Dodecene, branched",306-479-5,97280-83-6,Asp. Tox. 1;Skin Irrit. 2,REACH registration C&L,90,H304:7;H315:88
130607,"Lubricating oils (petroleum), hydrotreated solvent-refined bright stock-based",295-426-9,92045-45-9,Not Classified,Notified C&L,1,Not classified:1
130611,"1,4-phenylenebis[dimethylsilane]",219-638-8,2488-01-9,Acute Tox. 4,Notified C&L,44,H302:44;H319:6;H315:6;H335:5
130613,"3,7-dihydro-3-isobutyl-1-methyl-1H-purine-2,6-dione",249-259-3,28822-58-4,Acute Tox. 4,Notified C&L,130,H302:130;H361:1
130614,2-amino-6H-purin-6-one 3-oxide,242-653-6,18905-29-8,Carc. 2,Notified C&L,38,H351:38
130619,N6-Benzoyladenosine,610-251-3,4546-55-8,Acute Tox. 4,REACH registration C&L,40,H302:40
130621,Procaine penicillin,200-205-7,54-35-3,,Notified C&L,42,Not classified:37;H334:4;H317:3
130622,N-{(1R)-1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl}-4-[(trifluoromethyl)thio]benzamide,639-778-7,887148-70-1,,Notified C&L,34,Not classified:34
130623,"(R)-(+)-1,2-Epoxytetradecane",601-440-1,116619-64-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
130624,"Ammonium, (6-bromohexyl)trimethyl-, bromide",608-782-0,32765-81-4,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H317:1;H335:1;H319:1;H302:1;H314:1
130626,"Sulfite liquors and Cooking liquors, pink",270-710-5,68477-10-1,Not Classified,Notified C&L,1,Not classified:1
130627,"Oxirane, 2-methyl-, polymer with oxirane, tridecyl ether",612-360-1,61725-89-1,Not Classified,Notified C&L,1,Not classified:1
130630,"reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium",451-440-9,586372-44-3,Eye Dam. 1,Harmonised C&L,0,H318:0
130631,Daunorubicin hydrochloride,245-723-4,23541-50-6,Acute Tox. 3;Resp. Sens. 1;Carc. 2,Notified C&L,75,H334:41;H351:74;H301:44;H341:33;H360:34;H302:31;H317:2;H311:1;H331:1;H350:1;H340:2;H335:1;H319:1;H315:1;H361:1
130632,"2,6-dimethyl-6-(4-methyl-3-pentenyl)bicyclo[3.1.1]hept-2-ene",241-702-9,17699-05-7,Not Classified,Notified C&L,1,Not classified:1
130633,Asulam,222-077-1,3337-71-1,Acute Tox. 4,Notified C&L,130,H302:127;Not classified:3
130634,"Champac, ext.",305-079-8,94333-99-0,Skin Sens. 1;Acute Tox. 3,Notified C&L,1313,H317:1313;H331:1286;H412:26;H319:26;H315:25;H332:1
130636,(3-fluorophenyl)acetonitrile,207-918-2,501-00-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,48,H312:46;H335:41;H319:47;H315:47;H332:46;H302:46;H301:2;H311:2;H330:1;H331:1
130637,"5'-Uridylic acid, 5-bromo-2'-deoxy-, disodium salt",257-200-8,51432-32-7,Carc. 2,Notified C&L,38,H351:38
130640,"Tetrasodium 4-amino-5-hydroxy-6-[[2-methoxy-5-methyl-4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]-3-[[4-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonate",289-021-6,85959-29-1,Not Classified,Notified C&L,1,Not classified:1
130645,Oxprenolol hydrochloride,229-260-5,6452-73-9,,Notified C&L,4,H301:2;H412:1;H302:1;Not classified:1
130649,Divinylbenzene,215-325-5,1321-74-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,570,H319:346;H411:222;H315:445;H302:238;H335:346;H410:65;H361:103;H317:83;H373:24;H400:9;H372:6;Not classified:8;H371:4;H341:5;H314:4;H336:5;H318:3;H412:2
130651,"3-diazo-3,4-dihydro-4-oxonaphthalene-1-sulfonyl chloride",253-042-9,36451-09-9,Flam. Sol. 1;Self-react. B;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,43,H317:1;H241:2;H319:3;H228:2;H412:1;H314:39;H335:1;H311:1;H315:2;H242:1
130655,2-bromo-5-methylthiophene,212-151-1,765-58-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,3,H319:3;H315:3;H302:3;H335:3;H312:1;H332:1;H227:1
130656,Metaphosphoric acid,253-433-4,37267-86-0,Skin Corr. 1B,Notified C&L,47,H314:47;H318:1
130658,digitoxin,200-760-5,71-63-6,Acute Tox. 3;Acute Tox. 3;STOT RE 2,Harmonised C&L,0,H373:0;H301:0;H331:0
130660,3-(N-ethyl-m-toluidino)propiononitrile,205-721-6,148-69-6,Acute Tox. 3,Notified C&L,39,H301:38;H332:1;H312:1;H319:1;H315:1
130662,Sucrose palmitate,247-706-7,26446-38-8,Not Classified,Notified C&L,41,Not classified:40;H400:1
130663,3-nitrobenzyl alcohol,210-588-2,619-25-0,,Notified C&L,6,H319:5;H315:5;H335:5;H332:1;H312:1;H302:1
130669,"Disodium [[[[3-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]phenyl]amino]sulphonyl]sulphamoyl-29H,31H-phthalocyaninedisulphonato(4-)-N29,N30,N31,N32]cuprate(2-)",276-480-2,72214-17-6,Not Classified,Notified C&L,37,Not classified:37
130678,Graphite,231-955-3,7782-42-5,Not Classified,REACH registration C&L,2502,Not classified:2311;H319:184;H335:166;H315:19;H372:8;H318:5;H228:5;H302:2;H373:2
130679,C.I. Direct Blue 262,612-853-1,61968-22-7,Not Classified,Notified C&L,1,Not classified:1
130681,"4,4'-biphthalic dianhydride",219-342-9,2420-87-3,Eye Irrit. 2,REACH registration C&L,105,H319:88;H315:52;H335:52;Not classified:17
130689,1-(methylsulphonyl)imidazolidin-2-one,255-523-9,41730-79-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
130690,"Disodium 4-[(2,4-dihydroxyphenyl)azo]-5-hydroxynaphthalene-2,7-disulphonate, mono[(p-nitrophenyl)azo] mono[(2-hydroxy-3,5-dinitrophenyl)azo] derivative",282-386-2,84195-79-9,Eye Irrit. 2,Notified C&L,6,H319:6
130698,2-Chloropropiophenone,612-046-4,6084-17-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
130699,2-chloro-5-sec-hexadecylhydroquinone,407-750-1,137193-60-3,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H412:0;H317:0;H315:0
130707,Anthranilaldehyde phenylhydrazone,209-048-9,553-74-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
130708,2-(ethylamino)toluene-4-sulphonic acid,202-664-9,98-40-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
130710,Decafluorocyclohexene,206-592-9,355-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
130715,"Birch, Betula lenta, ext.",286-478-3,85251-66-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1404,H319:1286;H302:1404
130716,4-hexyloxybenzoyl chloride,254-561-3,39649-71-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42,H318:38;H314:42
130719,"3,4-Dimethylphenylhydrazine hydrochloride",611-983-6,60481-51-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,77,H319:44;H315:44;H335:43;Not classified:31;H302:6;H312:2;H341:1
130720,"trans-2-Butene-1,4-diol",617-300-8,821-11-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H302:1
130721,"2,5-Furandione, polymer with α-hydro-ω-hydroxypoly[oxy(methyl-1,2-ethanediyl)]",618-495-2,9016-60-8,Not Classified,Notified C&L,61,Not classified:61
130723,1-OCTYL-2-PYRROLIDONE,608-013-9,2687-94-7,Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,327,H411:327;H318:157;H314:327;H373:20
130724,"(2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentanamine monohydrobromide",618-308-4,898290-88-5,Acute Tox. 3;Eye Dam. 1,Notified C&L,7,H318:7;H301:7
130725,"3,5-dichlorobenzonitrile",229-495-3,6575-00-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,47,H312:45;H335:45;H319:46;H315:46;H332:45;H302:45;H301:2;H311:2;H331:1
130726,Diethyl phosphorochloridate,212-396-4,814-49-3,Acute Tox. 2;Acute Tox. 1;Skin Corr. 1B;Acute Tox. 3,REACH registration C&L,41,H310:41;H314:2;H300:41;H331:2;H330:38;H318:1
130727,"2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",612-189-2,61676-62-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,140,H319:56;H226:139;H315:56;H335:55;H228:1
130733,"Phosphorodithioic acid, mixed O,O-bis(1,3-dimethylbutyl and iso-Pr) esters, zinc salts",283-392-8,84605-29-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,682,H411:682;H318:682;H315:682
130735,"[R-(R*,S*)]-4-(2-amino-1-hydroxypropyl)pyrocatechol hydrochloride",233-853-4,10390-18-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,9,H312:9;H335:9;H319:9;H315:9;H332:9;H302:9
130741,sodium methanolate;sodium methoxide,204-699-5,124-41-4,Self-heat. 1;Skin Corr. 1B,Harmonised C&L,0,H314:0;H251:0
130745,Isonicotinamide,215-926-2,1453-82-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49,H319:49;H315:49;H335:48
130746,o-[[(2-mercaptophenyl)imino]methyl]phenol,222-370-4,3449-05-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H302:38;H335:38
130749,Methapyrilene hydrochloride,205-184-8,135-23-9,Acute Tox. 3,Notified C&L,41,H301:38;H302:3
130752,"3,5-dichloro-4-pyridone",241-267-5,17228-70-5,,Notified C&L,5,H319:5;H315:5;H302:4;H335:4
130757,9H-Carbazole-9-ethanol,604-632-3,1484-14-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
130758,1-(2-Bromoethoxy)-2-ethoxybenzene,608-759-5,3259-03-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,18,H319:16;H315:16;H335:15;H302:2;H317:1;H412:1
130759,2-(N-phenylcarbamoyl)-3-naphthyl acetate,214-608-0,1163-67-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
130760,Bentone LT,610-737-5,51811-28-0,Not Classified,Notified C&L,33,Not classified:33
130761,"2,3,5-trimethylpyridine",211-786-1,695-98-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:44;H312:5;H332:5;H302:5;H226:1
130763,4-nonyl-o-cresol,238-392-2,14417-90-4,Skin Corr. 1C;Aquatic Chronic 1,Notified C&L,3,H410:3;H314:3
130764,Anilinium bromide,208-801-9,542-11-0,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H317:38;H410:38;H351:38;H301:38;H311:38;H318:38;H331:38;H400:38;H372:38;H341:38;H319:1;H315:1
130765,"3,5-dimethylisoxazole",206-100-2,300-87-8,Flam. Liq. 3,Notified C&L,47,H226:47;H319:1;H315:1;H335:1
130775,Osmium,231-114-0,7440-04-2,Flam. Sol. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,47,H228:43;H318:41;H315:42;H335:42;H312:2;H332:2;H302:2;H319:1;H413:1
130777,"Amides, C10-16, N,N-bis(hydroxyethyl)",268-933-8,68155-05-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,460,H319:441;H315:459;H411:18;H318:18;Not classified:1
130779,"N,N-dimethyloctanamide",214-272-5,1118-92-9,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,390,H319:30;H315:390;H318:360;H335:239;H302:1
130791,"Schinopsis lorentzii, ext.",290-224-7,90106-04-0,Not Classified,Notified C&L,2,Not classified:2
130793,2-methyl-2-oxazoline,214-316-3,1120-64-5,Flam. Liq. 2,Notified C&L,46,H225:45;H319:2;H315:2;H335:2;H224:1
130799,1-Methyl-3-nitroguanidine,610-029-6,4245-76-5,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,134,H312:132;H335:131;H319:132;H315:132;H332:132;H228:132;H302:132;H410:4;H400:4;Not classified:2
130803,"Distillates (petroleum), light arom.;Low boiling point thermally cracked naphtha;[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C",267-565-5,67891-80-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
130804,"Residual oils (petroleum), deisobutanizer tower;Low boiling point naphtha - unspecified;[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C",270-795-9,68478-16-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
130808,4-bromophenyl phenyl ether,202-952-4,101-55-3,Aquatic Acute 1,Notified C&L,172,H400:167;H411:4;H317:5;H410:6;H318:5;H302:5;H319:2;H315:2;Not classified:1;H412:1
130815,Diisobutylaluminium hydride,214-729-9,1191-15-7,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,144,H260:132;H314:144;H250:140;H318:116;H225:14;H261:12;H373:4;H361:4;H411:4;H304:4;H224:4;H336:4;H252:2
130825,2-(4-aminophenyl)butanoic acid,608-388-9,29644-97-1,Not Classified,REACH registration C&L,1,Not classified:1
130827,Sodium 2-(1-carboxylatoethoxy)-1-methyl-2-oxoethyl laurate,236-942-6,13557-75-0,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,78,H318:2;H314:2;Not classified:73;H319:3;H315:2
130828,Ethyl 3-(5-bromo-1H-indol-3-yl)-2-cyanoacrylate,301-250-6,93982-61-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H315:38;H335:38
130831,"4-hydroxy-3,5-dimethoxybenzoic acid",208-486-8,530-57-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H319:73;H315:73;H335:72
130833,"4,4'-(1,3-Phenylenediisopropylidene)bisphenol",603-937-9,13595-25-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
130837,"2-methyl-1,3-dithiane",227-859-6,6007-26-7,Not Classified,Notified C&L,1,Not classified:1
130840,2-bromo-5-chlorophenol,603-968-8,13659-23-9,,Notified C&L,2,H319:2;H315:2;H302:2;H335:2
130841,"Orthoboric acid, calcium salt",237-559-7,13840-55-6,Not Classified,Notified C&L,129,Not classified:129
130842,"N,N'-[iminobis(ethyleneiminoethylene)]distearamide diacetate",268-481-1,68109-66-0,Not Classified,Notified C&L,4,Not classified:4
130844,Sodium surfactin,444-240-8,,Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,1,H319:1;H332:1
130857,"Butane-1,4-dithiol",214-728-3,1191-08-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38;H312:1;H332:1;H302:1
130861,"1-Hexanol, 2-ethyl-, reaction products with 1,6-diisocyanatohexane",606-366-3,197393-84-3,Skin Irrit. 2,Notified C&L,83,H315:83
130863,"Fatty acids, rape-oil, hydrogenated, reaction products with diethylenetriamine, di-Me sulfate-quaternized",306-529-6,97281-29-3,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,33,H400:2;H410:2;H412:31
130864,"4,4'-isopropylidenebis[2-allylphenol]",217-121-1,1745-89-7,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,146,H317:127;H410:88;H318:74;H400:88;H314:142;H335:14;Not classified:4;H361:1
130865,"chlorthiophos (ISO);[isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O,O-diethyl phosphorothioate predominates]",244-663-6,21923-23-9,Acute Tox. 2;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H311:0;H400:0;H410:0;H300:0
130866,di-n-butyl ether;dibutyl ether,205-575-3,142-96-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H319:0;H335:0;H315:0;H226:0
130869,S-(4-methylphenyl) ethanethioate,233-921-3,10436-83-6,Acute Tox. 4,Notified C&L,38,H302:38
130870,2-chloroacetophenone,208-531-1,532-27-4,Acute Tox. 2;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,53,H300:53;H335:53;H311:39;H334:45;H318:49;H315:50;H331:40;H317:10;H330:7;H319:4
130872,Tin disulphide,215-252-9,1315-01-1,Not Classified,REACH registration C&L,35,Not classified:34;H319:1;H315:1;H335:1
130873,"Residues (petroleum), C",270-794-3,68478-15-9,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
130875,(3-chloro-4-methylphenyl)hydrazine monohydrochloride,259-357-8,54812-56-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H312:39;H335:43;H319:44;H315:44;H332:39;H302:39
130876,Dodecylnaphthalene,254-054-7,38641-16-6,,Notified C&L,1,Not classified:1
130877,"2,3-dichloro-6-methoxypyridine",280-618-7,83732-68-7,Acute Tox. 3,Notified C&L,1,H301:1
130878,"2,6-dibromo-p-cresol",219-404-5,2432-14-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
130880,2-ethylvaleric acid,243-608-3,20225-24-5,,Notified C&L,2,H302:1;H314:1
130881,Molybdenum oxide,234-321-4,11098-99-0,Not Classified,Notified C&L,3,Not classified:3
130885,1-[bis(dimethylamino)methylene]-1H-benzotriazol-1-ium 3-oxide tetrafluoroborate,603-087-9,125700-67-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,174,H317:116;H319:174;H315:174;H335:174;H228:52;Not classified:2;H350:1
130889,Ethyl vanillate,210-503-9,617-05-0,Not Classified,Notified C&L,127,Not classified:89;H319:38;H315:38;H302:38;H335:38
130891,(2-ethylhexanoato-O)(neodecanoato-O)nickel,285-698-7,85135-77-9,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H410:0;H360:0;H334:0;H400:0;H350:0;H372:0;H341:0
130894,Niobium,231-113-5,7440-03-1,Not Classified,REACH registration C&L,477,Not classified:258;H228:179;H250:40;H319:2;H315:2;H335:2
130896,4-dodecyloxy-2-hydroxybenzophenone,221-049-6,2985-59-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H315:38;H335:38;Not classified:5
130898,YELLOW RN 1329,426-670-8,,Not Classified,Notified C&L,37,Not classified:37
130899,Undecamethylenediamine,212-486-3,822-08-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
130902,"2,5-Pyrrolidinedione, 1-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]-, monopolyisobutenyl derivs.",614-117-5,67762-72-5,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
130903,"Methyl N,S-diacetyl-L-cysteinate",243-146-2,19547-88-7,Eye Irrit. 2,Notified C&L,2,H319:1;Not classified:1
130906,4-(dibutylamino)butyronitrile,226-516-8,5417-24-3,Acute Tox. 4,Notified C&L,38,H302:38
130907,Diethyl maleate,205-451-9,141-05-9,Skin Sens. 1,REACH registration C&L,208,H317:201;H412:130;H319:151;Not classified:7;H410:1;H315:2;H400:1;H372:1;H335:2
130908,"4,5-diphenyl-4-oxazoline-2-thione",229-707-4,6670-13-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45,H332:41;H312:41;H302:41;H319:5;H315:5;H335:4
130919,[No public or meaningful name is available],695-658-4,143722-25-2,Flam. Sol. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,11,H319:11;H228:11;H302:11;H335:11
130920,"3,3'-(oxydimethanediyl)bis(3-ethyloxetane)",620-240-5,18934-00-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,22,H319:17;H412:19;H302:19;Not classified:3;H373:1;H371:1
130926,"Distillates (petroleum), highly refined middle;Gasoil - unspecified;[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",292-615-8,90640-93-0,Carc. 1B,Harmonised C&L,0,H350:0
130929,"2-methylnaphtho[2,1-d]thiazole",243-970-2,20686-62-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,39,H335:39;H319:39;H315:39;H302:39;H413:38
130931,1-phenyl-3H-indol-2-one,441-020-3,,Aquatic Chronic 2,REACH registration C&L,2,H411:2
130932,Cobaltocenium hexafluorophosphate(1-),235-655-3,12427-42-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H312:38;H335:39;H319:40;H315:40;H332:38;H302:38;H351:1
130933,"3,3'-(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bispropylamine",219-588-7,2469-55-8,Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,106,H402:1;H412:33;H318:36;H314:83;H319:22;H411:22;H315:23
130936,2-Butyl-1H-imidazole-5-carboxaldehyde,614-393-7,68282-49-5,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,12,H317:11;H412:11;H319:1;H315:1
130937,4-fluorobenzoic acid,207-259-0,456-22-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,50,H318:40;H302:40;H319:7;H315:7;H335:6;Not classified:3
130938,Ethylene diacetoacetate,226-724-9,5459-04-1,Eye Irrit. 2,REACH registration C&L,35,H319:33;Not classified:2;H315:1;H335:1
130941,"Solanidan-3-ol, (3β,5α)-",207-478-1,474-08-8,Acute Tox. 4;Carc. 2,Notified C&L,40,H351:38;H302:38;H301:2
130942,"Sulfuric acid, mono-C16-18-alkyl esters, sodium salts",273-258-7,68955-20-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,296,H412:252;H318:252;H315:254;H335:132;H228:49;Not classified:42;H319:2
130944,"benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate",432-590-4,243869-48-9,Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0,H319:0;H412:0
130946,Di-tert-butylphenyl phenyl phosphate,265-859-8,65652-41-7,Not Classified,Notified C&L,99,Not classified:98;H317:1;H335:1;H319:1;H315:1;H330:1
130947,"Proteinase, Bacillus polymyxa neutral",255-914-4,42613-33-2,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,40,H319:40;H334:40;H315:40;H335:40
130948,"4',4'''-azobis[N-(9,10-dihydro-9,10-dioxo-1-anthryl)[1,1'-biphenyl]-4-carboxamide]",235-436-2,12227-50-8,Skin Sens. 1,REACH registration C&L,16,H317:3;Not classified:13
130949,Methadone hydrochloride,214-140-7,1095-90-5,Acute Tox. 2,Notified C&L,111,H300:105;H317:16;H361:17;H311:16;H334:16;H331:16;H341:17;H411:7;H301:6;H360:1;H319:2;H362:1;H315:2;H336:2;H332:1
130952,C.I. Disperse Yellow 201,617-166-0,80748-21-6,Not Classified,Notified C&L,88,Not classified:88
130954,6-methoxysalicylaldehyde,211-844-6,700-44-7,,Notified C&L,4,H319:4;H315:4;H335:4
130957,"7-chloro-1,8-naphthyridin-2-amine",240-078-5,15944-33-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
130958,"Stereoisomers of 4-[[4-[(2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]-5-hydroxy-5-oxopentanoate",603-809-2,134-35-0,Skin Sens. 1,REACH registration C&L,4,H317:4
130962,"Sodium [[4-[[4-(anilino)phenyl][4-(phenylimino)-2,5-cyclohexadien-1-ylidene]methyl]phenyl]amino]benzenesulphonate",232-331-3,8004-90-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
130964,"2-(4,6-diamino-m-tolylazo)-4,6-dinitrophenol",228-362-7,6247-27-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
130968,"Pelargonium crispum, ext.",290-134-8,90082-46-5,Asp. Tox. 1,Notified C&L,112,H304:87;H317:25;H412:25;H318:25;H315:25
130971,"Benzene, 1,2-difluoro-3-[(trans,trans)-4'-propyl[1,1'-bicyclohexyl]-4-yl]-",603-124-9,126162-37-6,Not Classified,Notified C&L,1,Not classified:1
130973,"Fatty acids, C18-unsatd., dimers, reaction products with butane-1,4-diol, 1-chloro-2,3-epoxypropane and cyclohexane-1,2-dicarboxylic anhydride",500-483-2,161025-26-9,Not Classified,Notified C&L,9,Not classified:9
130974,"2,4-dimethylpyrrol-3-yl methyl ketone",219-197-1,2386-25-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39;H302:1
130975,Zinc dibenzoate,209-047-3,553-72-0,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,129,H400:30;H318:30;H411:106;H319:76;Not classified:23;H315:1
130976,"2-Hydroxyethyl acrylate, polypropylene glycol, isophorone diisocyanate polymer",641-072-9,73297-27-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,95,H319:95;H315:94;H335:22
130977,Undecylbenzenesulphonic acid,256-805-4,50854-94-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H317:38;H319:38;H315:38;H302:38
130978,"(2R*,3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate",427-100-0,,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0;H318:0;H302:0
130979,Allyltriethylammonium bromide,249-628-9,29443-23-0,,Notified C&L,4,H319:4;H315:4;H335:4
130983,"N-(8-benzyl-8-azabicyclo[3,2,1]oct-3-yl)-2-methylpropanamide",924-537-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2,H332:2;H312:2;H302:2
130986,"3,5-dimethoxyphenol",207-917-7,500-99-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,160,H319:160;H315:160;H335:159
130987,"3,4-DIFLUOROBENZOTRIFLUORIDE",608-708-7,32137-19-2,,Notified C&L,9,H319:6;H226:6;H315:6;H335:5;H225:3
130992,diisohexyl phthalate,276-090-2,71850-09-4,Repr. 1B,Harmonised C&L,0,H360:0
130996,Condensation products of oil shale alkylresorcinols and formaldehyde,447-830-3,,Acute Tox. 4;Acute Tox. 3;Skin Sens. 1;STOT SE 3,Notified C&L,2,H311:1;H317:2;H302:1;H335:1
131000,Iron chloride oxide,260-233-0,56509-17-2,Not Classified,Notified C&L,1,Not classified:1
131008,"6-bromo-2,3-dihydro-1,4-benzodioxin",257-817-2,52287-51-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;H332:1;H312:1;H302:1
131010,sodium chloro[(4-methylphenyl)sulfonyl]azanide hydrate (1:1:3),615-172-8,7080-50-4,Acute Tox. 4;Skin Corr. 1B;Resp. Sens. 1,Notified C&L,94,H334:93;H314:89;H302:93;H318:6;H335:4;H319:4;H315:4;Not classified:1
131015,Lithium dicyclohexylamide,223-894-6,4111-55-1,Pyr. Sol. 1;Water-react. 2;Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H261:38;H314:38;H250:38
131019,3-hydroxyphenyl acetate,203-022-0,102-29-4,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,73,H317:39;H318:39;H302:40;Not classified:33;H312:1;H319:1;H315:1;H332:1
131021,"2,3,4,5-tetrafluoronitrobenzene",226-972-8,5580-79-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:40
131023,"reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate",411-310-4,,Eye Dam. 1,Harmonised C&L,0,H318:0
131026,"[4-[4-(diethylamino)benzhydrylene]cyclohexa-2,5-dien-1-ylidene]diethylammonium hydrogen sulphate",211-190-1,633-03-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,135,H317:35;H410:43;H318:57;H315:14;H400:41;H302:108;H319:88;H314:32;H301:20;Not classified:7;H335:4;H332:1;H312:2;H361:1
131034,"Propanenitrile, 3-[[2-(benzoyloxy)ethyl][4-[2-(4-nitrophenyl)diazenyl]phenyl]amino]-",616-679-7,79300-11-1,Not Classified,Notified C&L,8,Not classified:8
131035,"1,5-dimethylpyrrolidin-2-one",225-783-8,5075-92-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
131038,"1'-[3-(10,11-dihydro-5H-dibenz(b,f)azepin-5-yl)propyl][1,4'-bipiperidine]-4'-carboxamide dihydrochloride",230-372-1,7075-03-8,Acute Tox. 4,Notified C&L,1,H302:1
131039,"3,4-dimethylbenzyl alcohol",230-175-0,6966-10-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
131040,"4-chloro-1,1-dimethoxybutane",249-924-8,29882-07-3,Skin Sens. 1,Notified C&L,3,H317:2;H319:1;H226:2;H315:2;H335:1;H318:1;H302:1
131042,"1,1-diethoxyhex-2-ene",259-086-5,54306-00-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
131046,"Benzoic acid, 2-[(3S)-3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]-, methyl ester",604-294-7,142569-69-5,Not Classified,Notified C&L,2,Not classified:2
131052,"1H-Indeno[5,4-f]quinoline-7-carboxylic acid, 2,3,4,4a,4b,5,6,6a,7,8,9,9a,9b,10-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS)-",600-423-6,103335-54-2,Aquatic Chronic 4,Notified C&L,27,H413:26;Not classified:1
131056,3-methoxybenzaldehyde,209-712-8,591-31-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H319:49;H315:49;H335:43;Not classified:5
131058,"7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2-oxo-2H-1,4-benzodiazepin-3-yl acetate",220-653-7,2848-96-6,Self-heat. 2;Repr. 2;Lact.,REACH registration C&L,46,H362:4;H361:5;H252:4;Not classified:2;H400:38;H410:38;H302:39;H341:1;H335:1
131061,dibromomethane,200-824-2,74-95-3,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H332:0;H412:0
131062,"Butanedioic acid, sulfo-, 1-C12-18-alkyl esters, disodium salts",290-836-4,90268-36-3,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,105,H318:103;H302:100;H315:4;H319:1;Not classified:1
131066,Bis(trimethylsilyl)acetylene,238-671-9,14630-40-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:41;H225:40;H315:41;H335:40;H226:5;H228:1
131069,"benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate",479-100-5,577705-90-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
131074,"1-Brom-3,4,5-trifluorbenzol",604-081-9,138526-69-9,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;Carc. 2;Aquatic Chronic 2,Notified C&L,45,H318:45;H315:45;H411:45;H226:45;H351:45;Not classified:1
131077,Tetraethylammonium hydroxide,201-073-3,77-98-5,Met. Corr. 1;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;STOT SE 1;STOT RE 1,REACH registration C&L,250,H290:17;H311:95;H318:147;H370:101;H302:96;H372:97;H314:250;H410:126;H301:4;H224:4;H330:4;H411:1;H300:1
131078,"Phenol, methylstyrenated",270-966-8,68512-30-1,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 3,Notified C&L,196,H317:150;H412:150;H315:150;H302:20;Not classified:26
131081,Potassium N-methylalaninate,249-849-0,29782-73-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;Not classified:1
131082,"Phosphoric acid, C12-14-alkyl esters, compds. with ethanolamine",291-884-9,90506-25-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:2;H315:3;H319:1
131084,10-(chloroacetyl)-10H-phenothiazine,212-326-2,786-50-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H302:1;H335:1
131092,N-propylbenzylamine,217-987-0,2032-33-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H302:1;H335:1
131094,"5'α(S)-sec-butyl-9,10α-dihydro-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate",265-975-9,65914-79-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
131100,"Alcohols, coco, ethoxylated (>2EO)",612-394-7,61791-13-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,338,H412:208;H318:305;H302:283;H400:75;Not classified:33
131101,"4-[difluoro(3,4,5-trifluorophenoxy)methyl]-2',3,5-trifluoro-4''-propyl-1,1':4',1''-terphenyl",619-490-8,303186-36-9,Not Classified,REACH registration C&L,2,Not classified:2
131103,Pentafluoropropiononitrile,207-011-1,422-04-8,,Notified C&L,1,H311:1;H280:1;H330:1
131104,"Benzoic acid, 4-nitro-, 2-ethylhexyl ester",605-350-3,16397-70-9,Muta. 2,Notified C&L,85,H341:85;H400:1;H410:1
131108,"4,4-methylenebis-3-(chloro-2,6-diethyl)-aniline",402-130-7,106246-33-7,Aquatic Chronic 4,REACH registration C&L,48,H413:48
131110,"1-(2-bromoethyl)-4-ethyl-1,4-dihydro-5H-tetrazol-5-one",282-986-4,84501-67-7,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Muta. 2,Notified C&L,1,H317:1;H341:1;H318:1;H302:1
131111,"Phosphoric acid, hexyl ester, potassium salt",253-422-4,37242-45-8,Not Classified,Notified C&L,18,Not classified:18
131113,Disodium 6-amino-5-[[4-[(2-bromo-1-oxoallyl)amino]-2-[(4-methyl-3-sulphonatophenyl)sulphonyl]phenyl]azo]naphthalene-2-sulphonate,286-122-7,85187-33-3,Skin Sens. 1B,REACH registration C&L,22,H317:6;H319:12;H315:12;Not classified:4
131114,"Alcohols, C12-18, ethoxylated, sulfates, sodium salts",500-189-4,68081-91-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,106,H412:84;H318:84;H315:106;H319:22
131115,"8,9,10,11-tetrachloro-12H-phthaloperin-12-one",244-007-9,20749-68-2,Not Classified,REACH registration C&L,2339,Not classified:2294;H413:45
131119,Dibutyltin maleate,201-077-5,78-04-6,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Muta. 2;Repr. 1B;STOT SE 1;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,180,H317:178;H410:141;H360:178;H318:140;H370:140;H302:179;H372:178;H341:178;H314:178;H330:180;H411:38;H301:1;H335:1;H311:1;H319:2;H315:2;H400:2;H310:1
131123,4-diethylamino-o-toluidine,205-722-1,148-71-0,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 4,Notified C&L,1,H317:1;H301:1;H311:1;H331:1;H413:1
131125,benzo[e]pyrene,205-892-7,192-97-2,Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H350:0
131127,Butyl 2-butenoate,230-742-2,7299-91-4,,Notified C&L,1,H319:1;H226:1
131135,"Sodium [6R-[6α,7β(R*)]]-7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",255-877-4,42540-40-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,44,H317:44;H335:42;H319:42;H334:44;H315:42
131136,Lithium tert-amoxide,700-269-0,53535-81-2,Water-react. 1;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Notified C&L,71,H260:38;H332:38;H314:71;H302:38
131138,Fluorodiisobutylaluminium,211-621-3,675-15-0,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,38,H260:38;H314:38;H250:38
131141,"Tyrosine, N-carboxy-, N-benzyl methyl ester, L- (8CI)",603-895-1,13512-31-7,Not Classified,REACH registration C&L,3,Not classified:3
131142,fluorine,231-954-8,7782-41-4,Press. Gas;Ox. Gas 1;Skin Corr. 1A;Acute Tox. 2,Harmonised C&L,0,H330:0;H270:0;H314:0;Not classified:0
131143,Methyl 3-(Trifluoromethyl)benzoate,607-745-6,2557-13-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H226:40;H315:44;H335:43;H411:1;H302:1
131144,2-(1-Octadecenyl)succinic anhydride,606-205-7,19024-74-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
131146,"2,2-dimethylaziridine",220-191-6,2658-24-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H301:1;H335:1;H319:1;H225:1;H315:1;H314:1
131150,"1,6-dioxecane-2,5-dione",250-516-7,31218-69-6,Eye Irrit. 2,Notified C&L,39,H319:39
131154,platinum(IV) nitrate/nitric acid solution,432-400-1,,Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H314:0
131159,"3-methoxy-2-phenyl-4H-furo[2,3-h][1]benzopyran-4-one",208-319-9,521-88-0,,Notified C&L,2,H312:2;H335:2;H319:2;H315:2;H332:2;H302:2
131160,"5(or 6)-carboxy-4-hexylcyclohex-2-ene-1-octanoic acid, compound with 2,2'-iminodiethanol",282-385-7,84195-78-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
131167,Cassia,616-916-4,8007-80-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,Notified C&L,261,H317:221;H312:217;H315:259;H311:42;H319:53;H335:1;Not classified:1
131170,3-chloropropionyl chloride,210-890-4,625-36-5,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 1,REACH registration C&L,143,H290:88;H318:88;H302:142;H314:143;H330:141;H226:15;H341:1
131174,Zinc bromide,231-718-4,7699-45-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,306,H317:154;H411:131;H314:273;H302:188;H400:68;H410:66;H318:36;Not classified:2;H290:2;H335:1
131178,"(Reaction product of Soybean Oil, (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2, 5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol and propane-1,2,3-triol), propoxylated",922-995-9,,Not Classified,Notified C&L,25,Not classified:25
131180,"2-(3,4-epoxycyclohexyl)ethyltriethoxy silane",425-050-4,10217-34-2,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
131181,Disodium C-octadecyl sulphonatosuccinate,247-705-1,26446-37-7,,Notified C&L,59,Not classified:33;H318:26;H302:23
131186,"[1,1'-biphenyl]-4,4'-dicarboxylic acid",212-328-3,787-70-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
131188,tert-butoxycarbonyl-L-methionine,219-639-3,2488-15-5,Not Classified,Notified C&L,5,Not classified:2;H318:2;H319:1;H315:1;H335:1
131191,5-methylpyrazine-2-carboxylic acid,413-260-9,5521-55-1,Eye Dam. 1,Harmonised C&L,0,H318:0
131193,"Naphtha (petroleum), polymn.",613-683-0,64741-72-6,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,12,H411:12;H225:6;H315:12;H304:12;H336:12;H224:6;H361:3;H350:3;H340:3
131195,"N-[4-[[(2-amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid",205-181-1,135-16-0,Self-heat. 2;Skin Sens. 1,REACH registration C&L,2,H317:2;H252:2
131202,3-(hydroxymethyl)heptan-2-one,265-739-5,65405-68-7,Not Classified,Notified C&L,88,Not classified:88
131211,"N,N-diphenylhydrazine",208-483-1,530-50-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H319:1;H315:1;H332:1;H302:1
131212,"9,10-Anthracenedione, 1,4-bis[(4-butylphenyl)amino]-5,8-dihydroxy-",615-613-4,71839-01-5,Not Classified,Notified C&L,22,Not classified:22
131216,"3-[Benzylmethylamino]-1-phenyl-1-propanone, Hydrochloride",611-098-5,5409-62-1,Eye Dam. 1,Notified C&L,1,H318:1
131220,"D-Gluconic acid, 6-(dihydrogen phosphate), trisodium salt",258-543-6,53411-70-4,Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1
131221,2-(propyloxy)ethanol;EGPE,220-548-6,2807-30-9,Acute Tox. 4;Eye Irrit. 2,Harmonised C&L,0,H319:0;H312:0
131229,"Tris(2,2,3,3,4,4,5,5-octafluoropentyl) phosphate",206-595-5,355-86-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H315:1
131232,"2,3,5,6-tetrafluoroaniline",211-840-4,700-17-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:40;H312:6;H332:6;H302:6
131233,Palladium,231-115-6,7440-05-3,Not Classified,REACH registration C&L,534,Not classified:137;H228:204;H413:166;H319:165;H315:163;H335:97;H334:26;H251:15;H317:19;H250:11;H224:7;H272:5;H252:6;H360:2;H301:1;H361:1;H370:1;H280:1;H271:1
131238,4-ethoxyphenoxyacetic acid,226-212-5,5327-91-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
131242,Ethyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride,215-929-9,1454-53-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
131244,"N-(4-ethoxyphenyl)-3-hydroxy-4-[(2,4,5-trichlorophenyl)azo]naphthalene-2-carboxamide",225-691-8,5012-29-3,Not Classified,REACH registration C&L,41,Not classified:40;H317:1
131249,Acryloyl chloride,212-399-0,814-68-6,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 1,REACH registration C&L,50,H225:50;H314:50;H302:10;H330:50;H290:1;H318:1
131250,3-formylbenzoic acid,210-585-6,619-21-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
131251,"[1,4-phenylenebis(methylene)]bis[triphenylphosphonium] dibromide",255-092-7,40817-03-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
131253,"2-methylnaphtho[1,2-d]oxazole",201-589-9,85-15-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H302:38;H335:38
131254,"1,3-propanesultone;1,2-oxathiolane 2,2-dioxide",214-317-9,1120-71-4,Acute Tox. 4;Acute Tox. 4;Carc. 1B,Harmonised C&L,0,H312:0;H350:0;H302:0
131255,Dihydrogen tetrachloropalladate(2-),241-047-9,16970-55-1,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,189,H317:189;H410:189;H290:189;H318:189;H400:189;H302:189;H314:189
131257,"Hexahydro-4,7-methano-1H-indenol",253-436-0,37275-49-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
131263,"Sulfonyl chlorides, C12-15, reaction products with ammonia",295-887-6,92129-85-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
131265,Flupirtine,260-503-8,56995-20-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
131268,"Ethyl 3,5-dichloro-4-hydroxybenzoate",241-331-2,17302-82-8,,Notified C&L,6,H319:6;H315:6;H335:4;H312:2;H332:2;H302:2
131271,Carbon dioxide,204-696-9,124-38-9,Press. Gas (Comp.),Notified C&L,1433,H280:1103;H281:320;Not classified:126;H332:14;H335:4
131273,2-(2-nitro-4-trifluoromethylphenylamino)ethanol,443-760-2,10442-83-8,Aquatic Chronic 2,Notified C&L,36,H411:36
131276,lead(II) bis(methanesulfonate),605-758-1,17570-76-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Repr. 1A;STOT RE 2,Notified C&L,116,H373:116;H360:116;H318:116;H315:116;H332:116;H302:116
131278,C-C1,481-970-6,,Eye Dam. 1,Notified C&L,2,H318:2
131279,P16513,,,Not Classified,Notified C&L,1,Not classified:1
131285,Sodium butylnaphthalenesulphonate,247-150-5,25638-17-9,Not Classified,Notified C&L,53,Not classified:43;H318:7;H315:8;H319:3;H412:1;H335:1
131287,Sarcosine,203-538-6,107-97-1,Not Classified,REACH registration C&L,126,Not classified:126
131290,"3,3,4,4,5,5,6,6,7,7,8,8,9,10,10,10-hexadecafluoro-9-(trifluoromethyl)decyl methacrylate",239-221-4,15166-00-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39;H312:1;H332:1;H302:1
131291,(1-benzylindazol-3-yl)methanol,603-485-2,131427-21-9,Not Classified,REACH registration C&L,1,Not classified:1
131295,"4,4,5,5,6,6,7,7,8,8,9,9,10,11,11,11-hexadecafluoro-2-hydroxy-10-(trifluoromethyl)undecyl acrylate",246-231-2,24407-09-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
131296,"N,N'-(2,5-dimethyl-1,4-phenylene)bis[4-[(5-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide",279-211-7,79665-24-0,Not Classified,REACH registration C&L,37,Not classified:37
131297,Methyl 5-oxo-DL-prolinate,259-233-3,54571-66-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
131298,potassium cyanate,209-676-3,590-28-3,Acute Tox. 4,Harmonised C&L,0,H302:0
131299,"3-methyl-1,1-diphenylurea",236-039-7,13114-72-2,Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,43,H373:1;H412:1;H302:1;H319:39;Not classified:3
131300,"Alcohols, C14-18 and C16-18-unsatd.",268-930-1,68155-00-0,Skin Sens. 1B,REACH registration C&L,3,H317:3;H319:1
131302,"2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;metaldehyde",203-600-2,108-62-3,Flam. Sol. 2;Acute Tox. 3;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H228:0;H301:0;H361:0;H412:0
131306,"Alcohols, C6-12, ethoxylated, sulfates, sodium salts",500-485-3,161025-28-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:1;H315:2;H319:1;Not classified:1
131309,"Fatty acids, C8-10, mixed esters with adipic acid and trimethylolpropane",306-085-3,95912-89-3,Not Classified,REACH registration C&L,64,Not classified:64
131314,(Z)-non-2-enal,262-428-6,60784-31-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
131317,"Amidase, N-carbamoyl-D-amino acid",615-345-8,71768-08-6,Resp. Sens. 1,Notified C&L,2,H334:2
131319,"Fats, pork",305-195-9,94349-77-6,Not Classified,Notified C&L,1,Not classified:1
131320,Magnesium digluconate,222-848-2,3632-91-5,Not Classified,REACH registration C&L,17,Not classified:17
131326,Methyl 3-aminothiophene-2-carboxylate,244-895-8,22288-78-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,52,H319:51;H315:50;H335:49;H302:4;H412:3;H301:1
131328,4-(2-methoxyethyl)morpholine,233-531-3,10220-23-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:8;H315:8
131329,"Copper, 5-(acetylamino)-4-hydroxy-3-[[2-hydroxy-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-2,7-naphthalenedisulfonic acid complex",235-434-1,12226-38-9,Not Classified,Notified C&L,108,Not classified:102;H319:2;H334:6;H317:4
131332,"2,4-dihydro-4,5-dimethyl-3H-1,2,4-triazole-3-thione",254-202-0,38942-50-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
131333,"Disodium 5,5'-azodisalicylate",227-975-7,6054-98-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
131334,"Distillates (petroleum), solvent-refined hydrogenated heavy;Baseoil - unspecified;[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",307-011-2,97488-74-9,Carc. 1B,Harmonised C&L,0,H350:0
131336,6-amino-6-deoxy-D-glucose hydrochloride,259-591-0,55324-97-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
131337,m-toluohydrazide,235-926-6,13050-47-0,,Notified C&L,6,H319:6;H315:6;H335:6
131340,(S)-(-)-2-Methyl-CBS-oxazaborolidine,601-150-5,112022-81-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,127,H318:84;H302:84;H319:39;H315:43;H335:39;H373:4;H361:4;H332:4;H304:4;H224:4;H336:4
131341,Isotridecyl palmitate,274-585-8,70364-64-6,Not Classified,Notified C&L,5,Not classified:5
131342,"diphenyl ether, pentabromo derivative pentabromodiphenyl ether",251-084-2,32534-81-9,Lact.;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H400:0;H410:0;H362:0
131345,"Benzoic acid, 5-bromo-2-chloro-, methyl ester",607-552-7,251085-87-7,Not Classified,Notified C&L,1,Not classified:1
131346,"Sulfuric acid, mono-C12-18-alkyl esters, sodium salts",273-257-1,68955-19-1,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,613,H412:303;H318:588;H315:605;H335:131;H228:96;H319:17;Not classified:8;H302:2
131351,Diphenylmethyl (6R)-3-hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylate,610-726-5,51762-51-7,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1,H317:1;H334:1
131354,Camylofin,200-202-0,54-30-8,Acute Tox. 4,Notified C&L,38,H302:38
131360,Methyl (R)-amino(4-hydroxyphenyl)acetate,253-657-2,37763-23-8,Not Classified,REACH registration C&L,1,Not classified:1
131365,Prilocaine hydrochloride,217-244-0,1786-81-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,68,H312:52;H319:64;H315:64;H302:68;H412:66;H318:4;H332:1;H413:1
131369,"Tallow, lithium salt",271-784-1,68608-50-4,Not Classified,REACH registration C&L,20,Not classified:20
131373,2-chloroveratraldehyde,226-515-2,5417-17-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
131375,Dimethyldi(octadecyl)ammonium methyl sulphate,223-336-1,3843-16-1,Eye Irrit. 2,Notified C&L,1,H319:1
131376,Dihydrogen hexachloroosmate(2-),248-192-7,27057-71-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,42,H301:38;H311:38;H318:38;H331:38;H314:42
131378,Cyclohex-3-enylmethyl cyclohex-3-enecarboxylate,220-031-5,2611-00-9,Not Classified,Notified C&L,70,Not classified:57;H302:13
131381,"Bis(5-oxo-L-prolinato-N1,O2)copper",239-471-4,15454-74-7,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H400:2;H410:2;H318:3;H302:3
131382,"[6R-[6α,7β(R*)]]-3-(acetoxymethyl)-7-(hydroxyphenylacetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",257-448-7,51818-85-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1
131384,"Ledum groenlandicum, ext.",297-236-1,93384-25-9,,Notified C&L,3,H317:3;H410:2;H315:3;H304:3;H226:3;H400:1
131388,"Distillates (petroleum), complex dewaxed light paraffinic;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",292-614-2,90640-92-9,Carc. 1B,Harmonised C&L,0,H350:0
131391,"4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine",604-750-5,150728-13-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,6,H317:2;H319:4;H315:4;H314:1;Not classified:1;H335:1
131393,hydrogen cyanide ...%;hydrocyanic acid ...%,200-821-6,74-90-8,,,0,H224:0;H400:0;H410:0;H330:0
131396,"(E)-3,7-dimethyl-2,6-octadienyl acetoacetate",233-101-5,10032-00-5,Not Classified,Notified C&L,88,Not classified:88
131404,Hydroxyaluminium distearate,206-101-8,300-92-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,459,H319:44;H315:2;Not classified:412;H411:3
131405,2-chloro-5-nitrotoluene,236-306-8,13290-74-9,Acute Tox. 4,REACH registration C&L,52,H302:51;H373:5;H312:7;H319:7;H315:7;H332:7;H411:5;H412:5;H311:1;H301:1;H331:1
131407,Lithium diisopropylamide,223-893-0,4111-54-0,Flam. Sol. 1;Pyr. Sol. 1;Skin Corr. 1B,REACH registration C&L,74,H228:32;H314:74;H250:46;H224:2
131408,Tropinone,208-530-6,532-24-1,,Notified C&L,8,H319:7;H315:7;H302:8;H314:1;H312:1;H335:1;H332:1
131411,"Sodium 1,4-diisopentyl sulphonatosuccinate",248-229-7,27115-04-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,36,H319:36;H315:36
131413,Triphenylstibine oxide,225-292-9,4756-75-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H301:1;H331:1
131414,"Drosera ramentacea, ext.",305-194-3,94349-76-5,Flam. Liq. 3,Notified C&L,1,H226:1
131415,2-Octyn-1-ol,606-616-1,20739-58-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
131416,"3,3'-difluoro-1,1'-biphenyl",206-905-9,396-64-5,,Notified C&L,8,H412:5;H319:4;H315:4;H335:3;H312:1;H332:1;H302:1
131417,"Disodium 3-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-o-tolyl]azo]naphthalene-1,5-disulphonate",235-435-7,12226-45-8,,Notified C&L,1,Not classified:1
131418,"3-[(4-amino-2-sulfophenyl)diazenyl]-4,5-dihydroxy-6-[(4-nitro-2-sulfophenyl)diazenyl]naphthalene-2,7-disulfonic Acid",613-232-8,634584-76-2,Skin Corr. 1A,Notified C&L,1,H314:1
131420,"Glycine, N-methyl-, N-(C14-18 and C14-18-unsatd. acyl) derivs.",286-513-2,85251-99-6,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,25,H400:25;H318:25;H315:25
131421,"Reaction mass of 5-methylbenzene-1,3-diol and 2,5-dimethylbenzene-1,3-diol and 4,5-dimethylbenzene-1,3-diol and 4-methylbenzene-1,3-diol and 5-ethylbenzene-1,3-diol",447-750-9,,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,4,H317:4;H318:2;H302:4;H411:4;H314:4;H311:2;H341:2;H330:2;H071:1
131423,Sodium 5-oxo-DL-prolinate,259-234-9,54571-67-4,Not Classified,REACH registration C&L,87,Not classified:87
131424,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with fatty acids, C18-unsatd., dimers and diethylenetriamine",500-484-8,161025-27-0,Skin Sens. 1,Notified C&L,14,H317:14;H312:1;H314:1;H302:1
131425,L-homophenylalanine,213-403-3,943-73-7,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H335:1
131426,3-fluoropropionic acid,207-311-2,461-56-3,Acute Tox. 4;Skin Corr. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1;H302:1;H314:1
131432,"Guanidine, N-phenyl-, compd. with carbonic acid (2:1)",613-106-2,6291-89-0,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,239,H317:239;H318:239;H411:156
131436,Bis(pentabromophenyl) ether,214-604-9,1163-19-5,Not Classified,Notified C&L,354,Not classified:191;H332:89;H312:112;H302:116;H373:24;H341:25;H319:25;H413:27;H351:4;H318:4;H360:1;H315:1;H335:1
131437,"p-hydroxybenzoic acid, compound with p,p'-[hexane-1,6-diylbis(oxy)]bis(benzamidine) (2:1)",299-055-3,93841-83-9,Not Classified,Notified C&L,3,Not classified:3
131440,"1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride",204-077-3,115-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H315:0;H335:0
131442,Methyl non-2-ynoate,203-909-2,111-80-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1822,H317:1784;H315:1342;H400:1342;H302:1816;H412:1342;H319:60;H410:51
131444,"Benzenecarboximidamide, N-[5-(1,1-dimethylethyl)-1H-pyrazol-3-yl]-N'-hydroxy-4-nitro-",604-871-3,152828-23-4,Acute Tox. 4;STOT RE 1;Aquatic Chronic 3,Notified C&L,34,H412:34;H372:34;H302:34
131446,"2-heptadec-8-enyl-4,5-dihydro-1H-imidazole-1-ethylamine monoacetate",268-397-5,68083-47-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:3;H315:3;H302:3
131450,Disodium uridine-5'-monophosphate,222-211-9,3387-36-8,Not Classified,Notified C&L,17,Not classified:16;H332:1;H312:1;H302:1
131455,N-[(9H-fluoren-9-ylmethoxy)carbonyl]glycine,249-373-3,29022-11-5,Not Classified,Notified C&L,6,Not classified:4;H332:2;H312:1;H302:2;H335:2;H319:1;H315:1
131456,"Fatty acids, C16-18 and C18-unsatd., diesters with polyethylene glycol",614-878-3,68989-57-1,Not Classified,Notified C&L,51,Not classified:37;H319:14
131457,3-methyl-2-phenylpyridine,233-619-1,10273-90-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H315:39;H302:38;H335:38;H319:1
131458,[3-Methyl-4-(4-trifluoromethylsulfanyl-phenoxy)-phenyl]-carbamic acid ethyl ester,929-417-4,,Not Classified,REACH registration C&L,2,Not classified:2
131459,"N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide",424-550-1,84245-12-5,Muta. 1B;Carc. 1B;Repr. 1B,Harmonised C&L,0,H360:0;H340:0;H350:0
131461,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 4,4'-methylenebis(cyclohexylamine)",500-103-5,38294-67-6,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,54,H317:52;H410:5;H400:5;H302:54;H314:7;H411:49;H311:1;H331:1
131464,"4,4'-dioxo-4,4'-dioxydibutyric acid",204-611-5,123-23-9,Org. Perox. D;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,62,H242:10;H318:10;H314:62
131465,Octylammonium chloride,205-574-8,142-95-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
131466,Icos-1-ene,222-374-6,3452-07-1,Asp. Tox. 1,Notified C&L,14,H304:10;Not classified:4
131467,"5,9-dimethyl-4,8-decadienal",212-096-3,762-26-5,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,250,H317:26;H400:26;H410:26;Not classified:224
131468,"2,2'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2-methylphenyl)-3-oxobutyramide]",230-458-9,7147-42-4,Not Classified,Notified C&L,1,Not classified:1
131469,Ruthenium trinitrate,239-923-0,15825-24-8,Ox. Sol. 2;Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,83,H317:83;H318:83;H272:83;H302:83;H411:83
131475,3-phenylpropylamine,218-012-1,2038-57-5,Skin Corr. 1B,Notified C&L,136,H314:136;H332:3;H312:3;H302:3;H318:2
131476,1-tosylsemicarbazide,233-857-6,10396-10-8,Not Classified,Notified C&L,20,Not classified:16;H312:3;H335:3;H319:4;H332:3;H302:3
131479,6-benzylpyridin-2-amine,261-040-4,57963-09-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H302:1;H335:1
131483,"Urea, N,N'-bis(hydroxymethyl)-, reaction products with 2-(2-butoxyethoxy)ethanol, ethylene glycol and formaldehyde",292-348-7,90604-54-9,Not Classified,Notified C&L,55,Not classified:55
131484,Methyl α-D-mannopyranoside,210-502-3,617-04-9,Not Classified,REACH registration C&L,32,Not classified:32
131485,p-anilinobenzenesulphonic acid,202-955-0,101-57-5,Not Classified,Notified C&L,2077,Not classified:2039;H314:38;H302:38
131487,"Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91; Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52; Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348; Bacillus thuringiensis subsp. Tenebrionis strain NB 176 (TM 14 1)",614-245-1,68038-71-1,Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,104,H317:103;H334:100;H319:100;H335:100;Not classified:1
131490,2-chloro-6-methoxypyridine,241-264-9,17228-64-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:45;H335:43
131491,Sodium myristate,212-487-9,822-12-8,Not Classified,Notified C&L,15,Not classified:15
131496,"α,α-Dimethyl-ethyl ester benzeneacetic acid",608-307-7,2901-13-5,Aquatic Chronic 3,REACH registration C&L,1,H412:1
131497,Methyl 2-(acetylamino)benzoate,220-318-5,2719-08-6,Not Classified,Notified C&L,170,Not classified:170
131498,DRIMAREN RED X-KB 3613,403-400-7,,Not Classified,Notified C&L,37,Not classified:37
131510,"4,4'-diamino-5,5'-dimethylbiphenyl-2,2'-disulphonic acid",201-505-0,83-83-0,Eye Irrit. 2,Notified C&L,69,H319:38;Not classified:31
131511,N2-[(phenylmethoxy)carbonyl]-L-asparagine,218-969-5,2304-96-3,Not Classified,Notified C&L,2,Not classified:2
131512,"reaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)",423-580-0,,STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0,H373:0;H413:0
131513,"3-Pentenoic acid, 2-methyl-, hexyl ester, (E)-",611-721-0,58625-95-9,Not Classified,Notified C&L,41,Not classified:41
131514,4-methyl-γ-(1-methylethoxy)benzenebutyronitrile,230-174-5,6965-79-3,Acute Tox. 4,Notified C&L,38,H302:38
131515,"Fatty acids, C15-19, C11-15 sec-alkyl esters",273-949-3,69278-75-7,Not Classified,Notified C&L,1,Not classified:1
131517,"Sodium O,O-diethyl dithiophosphate",222-079-2,3338-24-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,19,H332:17;H318:17;H314:19;H302:17
131519,ethyl chloroformate,208-778-5,541-41-3,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 2,Harmonised C&L,0,H225:0;H314:0;H302:0;H330:0
131522,"p-mentha-1(6),8-dien-2-yl propionate",202-583-9,97-45-0,Not Classified,Notified C&L,88,Not classified:88
131530,Cropropamide,211-193-8,633-47-6,Not Classified,Notified C&L,1,Not classified:1
131534,m-aminobenzamidine dihydrochloride,253-355-0,37132-68-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H317:38;H319:38;H315:38;H335:38
131535,"4-chloro-7-nitrobenzo-2-oxa-1,3-diazole",233-496-4,10199-89-0,Acute Tox. 3,Notified C&L,163,H302:116;H301:38;H319:9;H315:9;H335:4;Not classified:1
131536,"N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide",414-740-0,96141-86-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
131538,"3,3-diethoxypropiononitrile",217-988-6,2032-34-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40;H312:1;H332:1;H302:1
131539,"Sulfuric acid, mono-C13-15-alkyl esters, ammonium salts",292-199-8,90552-74-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
131541,palladium(II) oxide hydrate,613-470-2,64109-12-2,Aquatic Chronic 4,Notified C&L,1,H413:1
131547,"Poly(1,1,2,2-tetrafluoro-1,2-ethanediyl), α-fluoro-ω-2-[3-((carboxylatomethyl) dimethylammonio)propylaminosulfonyl]ethyl-",500-631-6,161278-39-3,Aquatic Chronic 3,Notified C&L,2,H412:1;Not classified:1
131552,"4-CHLOROTHIENO[3,2,C]-PYRIDINE",608-127-9,27685-94-5,Acute Tox. 3;Eye Irrit. 2,Notified C&L,43,H319:43;H301:38;H315:5;H335:5
131553,"Fatty acids, coco, reaction products with polyethylenepolyamines",265-226-6,64754-98-9,Not Classified,Notified C&L,17,Not classified:17
131556,4-methyl-1H-benzotriazole,249-921-1,29878-31-7,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,73,H319:39;H412:39;H332:39;H302:40;Not classified:33
131558,tert-butyl (6-aminohexyl)carbamate monohydrochloride,265-976-4,65915-94-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
131559,Zirconium dichloride oxide,231-717-9,7699-43-6,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,150,H290:43;H318:38;H314:114;Not classified:37;H412:1;H302:2;H335:1
131566,"Yttrium oxide silicate (Y2O(SiO4)), cerium-doped",309-553-5,100403-12-1,Not Classified,Notified C&L,1,Not classified:1
131572,"cis-1-amino-2,3-dihydro-1H-inden-2-ol",422-660-2,7480-35-5,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0;H318:0
131579,Potassium pentachloronitrosyliridate,245-114-3,22594-86-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
131584,Diisobutyl adipate,205-450-3,141-04-8,Not Classified,REACH registration C&L,339,Not classified:338;H319:1
131587,"Polysiloxanes, di-Me, Me vinyl, vinyl group-terminated",614-273-4,68083-18-1,Not Classified,Notified C&L,9,Not classified:8;H319:1;H315:1;H335:1
131596,"2-[4-(1,3-benzodioxol-5-ylmethyl)piperazinyl]pyrimidinium methanesulphonate",257-818-8,52293-23-9,STOT SE 3;Lact.;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H373:1;H412:1;H362:1;H336:1
131599,"Ethanol, 2-amino-, reaction products with polyethylene-polypropylene glycol ether with trimethylolpropane (3:1) acrylate",601-599-7,119327-83-2,Aquatic Chronic 2,Notified C&L,115,H411:115
131602,Tetrabutylammonium periodate,265-614-5,65201-77-6,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H272:38
131606,4-(chloromethyl)pyridinium chloride,217-350-7,1822-51-1,Skin Corr. 1B,Notified C&L,48,H314:48;H317:4;H312:4;H302:8;H318:4;H290:1
131609,"Hydrocarbons, C11-C14, isoalkanes, cyclics, aromatics",927-285-2,,Asp. Tox. 1,REACH registration C&L,4,H304:4
131612,Phenyl Isonicotinate,679-756-4,94-00-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
131613,Diethoxyacetonitrile,228-111-1,6136-93-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H312:39;H335:39;H319:39;H315:39;H332:39;H302:39;H226:39
131614,"Formaldehyde, urea copolymer, methylolated",614-258-2,68071-45-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,77,H317:41;H335:40;H319:41;H315:40;H350:40;Not classified:36;H351:1
131615,Pilocarpine nitrate,205-723-7,148-72-1,Acute Tox. 2;Acute Tox. 2,Notified C&L,112,H300:111;H330:111;H319:1;H315:1;H302:1
131616,"1,8-dihydroxyanthracen-9(10H)-one",214-538-0,1143-38-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,58,H319:57;H315:57;H335:56;H410:1;H302:3;H312:1;H332:1;H351:1
131617,"2,2-Dimethylcyclopropyl Cyanide",605-108-7,157728-61-5,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1;H315:1;H302:1
131621,"Silicic acid (H4SiO4), tetramethyl ester, hydrolyzed",270-965-2,68512-28-7,Not Classified,Notified C&L,27,Not classified:27
131624,"Silicic acid, ethyl ester",234-324-0,11099-06-2,Flam. Liq. 3;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,149,H319:86;H226:86;H411:2;Not classified:63;H302:42;H335:81;H332:27
131626,"Guanosine 5'-(tetrahydrogen triphosphate), trilithium salt",288-514-3,85737-04-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
131632,Cocoalkylmethyl[polyoxyethylene] ammonium chloride,612-393-1,61791-10-4,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,318,H411:217;H318:216;H319:81;H410:54;H315:134;H302:69;H412:26;Not classified:5
131635,"2,2,3-trichlorobutane-1,1-diol",200-958-1,76-40-4,Acute Tox. 4,Notified C&L,38,H302:38
131636,"7-(2H-naphtho[1,2-d]triazol-2-yl)-3-phenyl-2-benzopyrone",222-067-7,3333-62-8,Not Classified,Notified C&L,2057,Not classified:2057
131639,"methyl 3,12-dioxoolean-9(11)-en-28-oate",606-849-9,218600-50-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H302:2;H335:2
131640,"Cyclosilazanes, di-Me, Me hydrogen, polymers with di-Me, Me hydrogen silazanes, reaction products with",640-361-7,475645-84-2,Skin Corr. 1B,Notified C&L,34,H314:34;H225:1;H318:1;H302:1;H412:1
131644,"2,3-diphenylpropionic acid",222-065-6,3333-15-1,Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,39,H319:39;H400:38;H301:38;H315:1
131645,"2,2'-[ethane-1,2-diylbis(oxy)]bisethyl diacetate",203-846-0,111-21-7,Not Classified,REACH registration C&L,37,Not classified:37
131649,SOLVENT RED 164 AZO DYE,615-510-4,71819-51-7,Not Classified,Notified C&L,534,Not classified:511;H226:23
131654,"(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate",420-560-3,79617-97-3,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H318:0
131655,"Sodium 2(or 5)-[(4-amino-3-bromo-9,10-dihydro-9,10-dioxo-1-anthryl)amino]-5(or 2)-methylbenzenesulphonate",280-166-0,83027-63-8,Not Classified,Notified C&L,2,Not classified:2
131656,"Amaranthus caudatus, ext.",607-014-1,223747-79-3,Not Classified,Notified C&L,5,Not classified:5
131660,Diytterbium trisulphate,236-727-7,13469-97-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:39;Not classified:1
131666,"1-(2',4',6'-triisopropylbenzenesulphonyl)imidazole",256-509-5,50257-40-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
131668,"Naphtho[1,2,3,4-def]chrysene",205-891-1,192-65-4,Eye Dam. 1;Carc. 2,Notified C&L,57,H351:38;H318:38;H341:12;H350:16;H400:4;H410:4;Not classified:3
131672,Bis(p-anilinophenyl)[4-[(3-methylphenyl)amino]phenyl]methylium sulphate (2:1),249-531-1,29243-26-3,Not Classified,Notified C&L,2064,Not classified:2064
131673,Diammonium zinc biscarbonate,255-118-7,40861-29-8,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,654,H318:443;H314:443;H302:444;Not classified:119;H319:92;H315:92;H335:91
131674,"(4-(3,4-dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-ylidene)-methyl-amide",455-240-2,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
131675,"2,4,6-trifluoro-1,3,5-triazine",211-620-8,675-14-9,,Notified C&L,5,H310:5;H314:5;H330:5
131677,Cyclopropyldiphenylsulphonium tetrafluoroborate,251-530-6,33462-81-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H315:39;H335:39;H318:1;H314:1;H302:1
131681,trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;propetamphos (ISO),250-517-2,31218-83-4,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H301:0
131685,Dipotassium octenylsuccinate,261-373-5,58641-28-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H319:7;H315:7;Not classified:1
131686,2-naphthol,205-182-7,135-19-3,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H332:0;H400:0;H302:0
131688,7-(ethylamino)-4-methyl-2-benzopyrone,249-257-2,28821-18-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
131690,5-iodouracil,211-788-2,696-07-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:41;H335:44;H319:45;H315:45;H332:41;H302:41
131691,Dodecyl isocyanate,224-111-0,4202-38-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,52,H312:41;H335:46;H318:42;H315:46;H332:45;H302:45;H317:7;H334:10;H319:10;H301:1;H331:1
131692,"1H-Imidazole-1-ethanamine, 4,5-dihydro-, 2-nortall-oil alkyl derivs.",270-500-3,68442-97-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,526,H318:499;H315:442;H411:57;H412:56;H314:81;H400:21;H410:24;H302:21;H317:4;Not classified:3
131700,4-methylcyclohexene,209-715-4,591-47-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H335:38;H319:39;H225:39;H315:39;H304:39
131701,"Formaldehyde, oligomeric reaction products with 1-chloro-2,3-epoxypropane and phenol, reaction products with triethylenetetramine",500-188-9,68072-39-9,,Notified C&L,2,H311:1;H412:1;H317:2;H314:2;H312:1;H411:1
131712,Bis(pentafluorophenyl) phenyl phosphite,225-780-1,5074-71-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:43;H315:43;H335:42;Not classified:3
131714,Sodium 4-methyl-2-oxovalerate,224-816-3,4502-00-5,Not Classified,Notified C&L,1,Not classified:1
131715,"Ethyl 1,3-dihydro-1,3-dioxo-2H-isoindole-2-carboxylate",245-048-5,22509-74-6,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,6,H317:2;H318:2;H315:4;H302:2;H319:2;H335:2
131716,"Quaternary ammonium compounds, coco alkyltrimethyl, chlorides",263-038-9,61789-18-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,216,H410:71;H312:98;H319:55;H315:56;H400:140;H302:128;Not classified:54;H314:104;H413:20;H301:14;H311:14;H318:15;H228:14;H225:1
131717,"Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;Cracked gasoil;[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",308-278-8,97926-59-5,Carc. 1B,Harmonised C&L,0,H350:0
131719,α-chloro-3-nitrotoluene,210-586-1,619-23-8,Skin Corr. 1B,Notified C&L,44,H314:44;H318:1
131722,Glycerol acetate,247-704-6,26446-35-5,Acute Tox. 4,Notified C&L,40,H302:39;Not classified:1
131723,1-naphthoyl chloride,212-903-9,879-18-5,Skin Corr. 1B,Notified C&L,47,H314:47;H290:1;H318:1;H335:2
131724,N-(2-hydroxyphenyl)-2-[(4-hydroxyphenyl)thio]acetamide,464-370-9,443965-81-9,Aquatic Chronic 3,Notified C&L,2,H412:2
131728,Diamond,231-953-2,7782-40-3,Not Classified,REACH registration C&L,104,Not classified:104
131730,"reaction product of boric acid, 2-aminoethanol and 2,2',2''-nitrilotriethanol",926-842-7,,Not Classified,Notified C&L,1,Not classified:1
131732,"2-Propanol, 1,1'-(tridecylimino)bis-",613-099-6,62889-66-1,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H400:83;H410:83;H318:83
131733,3-(2-carboxyethyl)benzothiazolium bromide,293-845-1,91626-39-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
131737,4-TERT-BUTYLCYCLOHEXANE-1-CARBOXYLIC ACID,611-163-8,5451-55-8,,Notified C&L,5,H319:5;H315:5;H335:4
131739,2-amino-4-bromo-5-chlorobenzoic acid,424-700-4,,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0
131741,"1-(3-trifluoromethylphenyl)-4-(2-hydroxyethyl)-piperazine, hydrochloride",611-190-5,54711-67-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
131742,"3,3,4-trimethylpyrrolidine-2,5-dione",262-956-7,61748-86-5,Acute Tox. 4,Notified C&L,39,H302:38;Not classified:1
131745,3-(4-aminophenoxy)aniline,220-190-0,2657-87-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:49;H315:49;H335:48;H317:6;H410:6;H301:6;H361:6;H311:6;H331:6;H350:6;H340:6
131748,"Methyl 3,5-dibromo-4-hydroxybenzoate",255-521-8,41727-47-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
131749,"5-[(5-amino-2-chlorophenyl)amino]-2,4-dihydro-2-(2,4,6-trichlorophenyl)-3H-pyrazol-3-one",258-542-0,53411-33-9,Aquatic Chronic 4,Notified C&L,1,H413:1
131752,"Copolymer of acetonoxime and 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate",600-028-9,1001254-87-0,Aquatic Chronic 4,REACH registration C&L,1,H413:1
131760,"2,6-dimethoxy-p-benzoquinone",208-484-7,530-55-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43;H351:1
131771,2-[2-[2-(tetradecyloxy)ethoxy]ethoxy]ethyl laurate,283-390-7,84605-13-0,Not Classified,Notified C&L,441,Not classified:441
131774,Heptyl methacrylate,226-727-5,5459-37-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,281,H319:281;H315:281;H335:281
131775,"2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)",400-270-3,40278-59-9,Aquatic Chronic 2,Harmonised C&L,0,H411:0
131777,Trimetazidine,225-690-2,5011-34-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,3,H412:2;H318:2;H302:2;H226:2;H314:2;H319:1;H315:1;H335:1
131778,"Propane-1,2-dithiol",212-398-5,814-67-5,Acute Tox. 4,Notified C&L,234,H302:233;H335:10;H319:10;H315:10;H226:11;H301:1
131780,1-DODECYL-2-PYRROLIDONE,682-760-9,2687-96-9,Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,149,H317:149;H400:149;H410:149;H314:149;H373:20
131785,Methyl 2-((tert-butoxycarbonyl)amino)-3-nitrobenzoate,611-470-7,57113-90-3,Not Classified,REACH registration C&L,4,Not classified:4
131787,di-methylamine;di-methylamine ... %,204-697-4,124-40-3,,,0,Not classified:0;H335:0;H318:0;H315:0;H332:0;H220:0
131793,2-chloro-4-pyridone,241-265-4,17228-67-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H302:39;H335:39
131798,4-biphenylyl-3-methoxy-4-(4-(4-oxiranylbutoxy)benzoyloxy)benzoate,926-242-5,,Not Classified,Notified C&L,1,Not classified:1
131799,"2-ethylhexanoic acid, compound with dodecylamine (1:1)",285-327-9,85068-69-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H315:1
131804,"2,3-dichloro-5-trifluoromethyl-pyridine",410-340-5,69045-84-7,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H318:0;H332:0;H302:0;H411:0
131806,Furosemide,200-203-6,54-31-9,Repr. 1B,Notified C&L,360,H360:313;H361:35;H335:27;H319:25;H315:27;H351:30;H301:11;H302:5;H350:2;Not classified:1;H373:3;H341:5;H412:1;H362:2;H312:1
131810,2-morpholinoethylamine,218-011-6,2038-03-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,57,H311:17;H318:5;H314:57;H302:55;H317:47
131811,"Carbonic acid, compound with (S)-2,6-diamino-N-2-naphthylhexanamide (1:1)",242-655-7,18905-74-3,Carc. 1A,Notified C&L,1,H350:1
131814,"Ammi visnaga, ext.",283-616-4,84695-96-5,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,4,H317:3;H226:2;H315:3;H412:3;Not classified:1
131816,"3,4,5,6-tetrabromophthalimide",246-232-8,24407-32-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
131821,Hydantoin,207-313-3,461-72-3,Not Classified,REACH registration C&L,69,Not classified:68;H319:1;H315:1;H335:1
131822,Potassium formate,209-677-9,590-29-4,Not Classified,REACH registration C&L,853,Not classified:346;H319:506;H315:63;H335:63;H314:1
131823,Bis(1-methylheptyl) adipate,203-601-8,108-63-4,Not Classified,REACH registration C&L,7,Not classified:7
131827,1-(2-hydroxy-1-naphthyl)ethan-1-one,209-369-4,574-19-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
131828,"Distillates (petroleum), complex dewaxed heavy paraffinci;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",292-613-7,90640-91-8,Carc. 1B,Harmonised C&L,0,H350:0
131829,"Ethylenediamine-N,N'-di(acetic acid)",227-105-6,5657-17-0,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,41,H411:2;H302:2;H319:39;H315:39;H335:38
131831,Teicoplanin,612-067-9,61036-64-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H317:1;H319:1;H315:1;H335:1
131837,Platinum,231-116-1,7440-06-4,Not Classified,REACH registration C&L,438,Not classified:303;H317:69;H228:108;H270:63;H334:13;H225:7;H251:5;H272:3
131839,Diethyl L-glutamate hydrochloride,214-270-4,1118-89-4,Aquatic Acute 1,Notified C&L,14,H400:9;Not classified:4;H319:1;H315:1;H335:1
131840,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with ethyl 2-propenoate and N-(hydroxymethyl)-2-propenamide",607-494-2,25035-74-9,Not Classified,Notified C&L,22,Not classified:22
131842,TCA-sodium (ISO);sodium trichloroacetate,211-479-2,650-51-1,STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H335:0
131850,(dodecylbenzyl)trimethylammonium chloride,215-551-4,1330-85-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
131853,"Sulfonic acids, C12- and C16-2-alkene, sodium salts",272-002-1,68648-72-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,55,H319:55;H315:55
131862,Indium hydroxide,259-592-6,55326-87-9,Not Classified,Notified C&L,2,Not classified:2
131864,Propyl aminoacetate hydrochloride,235-925-0,13049-01-9,,Notified C&L,4,H319:4;H315:4;H335:4
131866,trans-4-Propylcyclohexancarbonic acid-(4-heptylphenylester),619-745-3,81288-16-6,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
131868,"Cellulose, 2-hydroxyethyl ether, reaction products with ethenylphosphonic acid",604-588-5,147515-57-9,,Notified C&L,1,Not classified:1
131869,"4'-pentyl[1,1'-biphenyl]-4-carbonitrile",255-093-2,40817-08-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:44;H335:39;H319:39;H315:39;H332:44;H302:44;H317:1;Not classified:1
131870,Disodium 5-(p-sulphophenylazo)salicylate,227-976-2,6054-99-5,Not Classified,Notified C&L,13,Not classified:13
131871,"Neodecanoic acid, iron salt",257-446-6,51818-55-4,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,26,H315:5;H302:26;H412:21
131875,"5-(4-hydroxyphenyl)imidazolidine-2,4-dione",219-340-8,2420-17-9,Aquatic Chronic 1,REACH registration C&L,2,H410:2
131876,Silver methanesulphonate,219-199-2,2386-52-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,123,H317:64;H314:79;H302:80;H319:40;H315:44;H335:60;H312:16;H318:20;H332:15;H411:6;H400:5;H290:1
131889,"tembotrione (ISO);2-{2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)methyl]benzoyl}cyclohexane-1,3-dione",608-879-8,335104-84-2,Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H317:0;H410:0;H373:0;H361:0;H400:0
131890,2-methylphenanthrene,219-791-0,2531-84-2,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,41,H400:38;H410:38;H318:38;H302:38;Not classified:3
131894,"N,N-diallyldichloroacetamide",253-658-8,37764-25-3,Skin Irrit. 2,Notified C&L,190,H315:146;H332:39;H302:44;H330:3;H312:2;H331:3
131896,2-phenoxyethyl acrylate,256-360-6,48145-04-6,Skin Sens. 1A;Repr. 2;Aquatic Chronic 2,REACH registration C&L,871,H317:613;H411:694;H361:118;H319:646;Not classified:69;H413:63;H315:178;H335:109;H334:14;H312:3
131897,Sodium 2-(4-isobutylphenyl)propionate,250-477-6,31121-93-4,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,Notified C&L,189,H319:135;H302:187;H335:187;H312:52;H360:52;H318:52;Not classified:2;H315:1;H411:1
131898,"3,6-diamino-9-(2-carboxyphenyl)xanthylium chloride",236-944-7,13558-31-1,Acute Tox. 4,Notified C&L,1,H302:1
131899,1-[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium hydroxide,306-317-3,97043-68-0,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,2,H412:2;H318:2
131901,3-mercaptopropionic acid,203-537-0,107-96-0,Met. Corr. 1;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,398,H290:140;H301:279;H318:141;H332:150;H314:279;Not classified:121;H311:51;H330:53;H370:4
131904,Protopine hydrochloride,228-196-5,6164-47-2,Acute Tox. 3,Notified C&L,39,H301:39
131906,Dimethyl 5-nitroisophthalate,236-307-3,13290-96-5,Not Classified,REACH registration C&L,5,Not classified:4;H319:1;H315:1
131911,Mefenidramium metilsulfate,225-459-6,4858-60-0,Acute Tox. 4;Eye Dam. 1;Acute Tox. 2,Notified C&L,1,H318:1;H302:1;H330:1
131918,(2R)-2-{[(tert-butoxy)carbonyl]amino}hexanoic acid,611-299-8,55674-63-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
131924,2-bromo-6-chlorobenzonitrile,229-497-4,6575-08-2,,Notified C&L,1,H301:1;H335:1;H311:1;H319:1;H315:1;H331:1
131925,"triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)",442-960-7,332350-93-3,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H318:0;H301:0
131928,5-(4-nitrophenyl)-2-furaldehyde,230-459-4,7147-77-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H302:40;H335:40
131929,4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine,605-600-1,171054-89-0,Eye Dam. 1,Notified C&L,27,H318:27
131931,"2-isobutyl-4-methyl-1,3-dioxolane",242-309-5,18433-93-7,Flam. Liq. 3,Notified C&L,159,H226:159;H319:1;H315:1;H335:1;H317:1
131933,Phenyl vinyl sulphide,217-351-2,1822-73-7,Flam. Liq. 3,Notified C&L,41,H226:41
131934,(3-phenyloxiranyl)methanol,244-661-5,21915-53-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H302:1;H335:1
131937,2-bromostearic acid,205-573-2,142-94-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
131938,reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1),430-380-7,445409-27-8,Aquatic Chronic 2,Harmonised C&L,0,H411:0
131939,"neodecanoic acid, nickel salt",257-447-1,51818-56-5,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H410:0;H360:0;H334:0;H400:0;H350:0;H372:0;H341:0
131940,"Benzoic acid, 2,4-dichloro-3-methyl-",617-453-0,83277-23-0,Not Classified,Notified C&L,1,Not classified:1
131941,"[2,2'-Bipyrimidine]-4,6(1H,5H)-dione, 5-(2-methoxyphenoxy)-",604-748-4,150728-12-4,Not Classified,Notified C&L,1,Not classified:1
131943,"10-methoxy-4-(1-methylpiperidin-4-yl)-4H-benzo[4.5]cyclohepta[1,2-b]thiophene-4-ol",261-907-7,59743-88-3,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,2,H301:1;H413:1;H302:1
131947,Diethyl 2-butynedioate,212-095-8,762-21-0,Skin Corr. 1B,Notified C&L,45,H314:45;H318:1
131948,Hexamethylenediammonium dichloride,227-977-8,6055-52-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61,H319:60;H315:60;H335:59;H317:20;Not classified:1
131950,Bis(isopropyl)naphthalene,254-052-6,38640-62-9,Asp. Tox. 1;Aquatic Chronic 1,REACH registration C&L,835,H304:682;H410:197;H413:485;Not classified:150;H319:2;H315:2;H400:1;H411:1
131951,"2,6-dichloro-p-cresol",219-402-4,2432-12-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H318:38;H315:41;H302:39;H335:41;H319:3;H312:1
131953,Zymolyase,609-409-4,37340-57-1,Resp. Sens. 1,Notified C&L,39,H334:39
131954,nickel oxide,234-323-5,11099-02-8,Skin Sens. 1;STOT RE 1;Aquatic Chronic 4;Carc. 1A,Harmonised C&L,0,H317:0;H372:0;H350:0;H413:0
131955,"[(2,4-dibromophenoxy)methyl]oxirane",243-606-2,20217-01-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Muta. 2;Aquatic Chronic 2,REACH registration C&L,4,H317:3;H315:4;H302:2;H411:2;H341:2;H319:2
131956,2-hydroxy-2-methylbutyronitrile,223-892-5,4111-08-4,Acute Tox. 1;Acute Tox. 1;Eye Dam. 1;Acute Tox. 1;Aquatic Chronic 1,REACH registration C&L,107,H410:59;H300:69;H318:59;H310:69;H330:69;H400:55;H332:38;H312:38;H302:38
131959,2-(6-hydroxy-3-oxo-(3H)-xanthen-9-yl)benzoic acid,219-031-8,2321-07-5,Eye Irrit. 2,REACH registration C&L,354,H319:341;H302:51;Not classified:13;H315:1;H335:1
131963,"Methyl (9Z,12Z,15Z)-9,12,15-octadecatrienoate",206-102-3,301-00-8,Not Classified,Notified C&L,135,Not classified:119;H317:16;H400:16;H410:16;H319:16
131967,1-chlorotridecane,212-488-4,822-13-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
131969,"Oils, Callitris intratropica",606-110-0,187348-13-6,,Notified C&L,1,H412:1
131973,sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate,411-680-7,133167-77-8,Skin Sens. 1,Harmonised C&L,0,H317:0
131974,Decyl nonyl phthalate,306-154-8,96507-76-5,Not Classified,Notified C&L,1,Not classified:1
131975,Cyanoguanidine,207-312-8,461-58-5,Not Classified,REACH registration C&L,1100,Not classified:895;H332:181;H312:184;H302:181;H315:20;H319:4
131977,4-(4-methoxyphenyl)-3-buten-2-one,213-404-9,943-88-4,Eye Irrit. 2;STOT SE 3,REACH registration C&L,237,H319:4;H335:4;H317:233
131981,Clemizole hydrochloride,214-605-4,1163-36-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,65,H400:1;H410:1;H302:65
131982,2-methylcyclopentanone,214-318-4,1120-72-5,Flam. Liq. 3,REACH registration C&L,43,H226:43;H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
131986,"Stearic acid, monoester with oxybis(propanediol)",235-777-7,12694-22-3,Not Classified,Notified C&L,41,Not classified:41
131987,"Butan-2-one O-[[[[1,3,3-trimethyl-5-[[[[(1-methylpropylidene)amino]oxy]carbonyl]amino]cyclohexyl]methyl]amino]carbonyl]oxime",268-398-0,68083-48-7,Not Classified,Notified C&L,83,Not classified:83
131988,Thuj-4(10)-ene,222-212-4,3387-41-5,Acute Tox. 4,REACH registration C&L,199,H302:8;H304:128;H226:178;H319:41;H315:42;H335:41;H317:3;H411:3
131989,"Distillates (petroleum), heavy arom.;Low boiling point thermally cracked naphtha;[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C",267-563-4,67891-79-6,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
131992,"Fats and Glyceridic oils, Astrocaryum murumuru",609-150-7,356065-49-1,Not Classified,Notified C&L,2,Not classified:2
131993,"3H-Pyrazolo[1,5-b][1,2,4]triazole, 6-(1,1-dimethylethyl)-2-(4-nitrophenyl)-",604-872-9,152828-24-5,,Notified C&L,2,H317:2;H411:2
131995,"1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-ene-2,3-dicarboxylic acid",204-078-9,115-28-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B,Notified C&L,257,H319:213;H350:193;H315:193;H335:192;H351:41;H318:41;H331:20;H302:4
131996,"2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one",407-630-9,82633-79-2,Acute Tox. 3;Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H301:0;H318:0;H400:0
131999,methanethiol;methyl mercaptan,200-822-1,74-93-1,Press. Gas;Flam. Gas 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;Not classified:0;H331:0;H400:0;H220:0
132001,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with triethylenetetramine",500-104-0,38294-69-8,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,357,H317:249;H410:67;H318:69;H400:67;H302:244;H314:249;Not classified:66;H319:42;H315:42;H312:17;H412:5;H311:1
132013,"Fatty acids, coco, calcium salts",265-225-0,64754-97-8,Aquatic Chronic 4,Notified C&L,575,H413:569;Not classified:6
132014,3-Amino-2-methoxydibenzofuran,611-644-2,5834-17-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
132017,"2-bromo-1,1-diethoxyethane",217-989-1,2032-35-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 3,REACH registration C&L,96,H319:95;H301:83;H315:61;H331:4;H330:81;H226:13;H335:15;H302:2
132023,"Phosphoric acid, mono- and distearyl esters",291-946-5,90506-80-2,Skin Corr. 1B,Notified C&L,1,H314:1
132024,α-methylpyridine-2-methanol,242-539-6,18728-61-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2;H302:1
132028,N1-(3-Chloropyrazinyl)-sulfanilamide,604-402-2,14423-79-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H319:2;H315:2
132031,Magnesium dibenzoate,209-045-2,553-70-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:39;H315:38;H335:38;Not classified:6
132032,"Melia azedarach, ext.",290-052-2,90063-92-6,Not Classified,Notified C&L,36,Not classified:36
132037,"2,2'-oxybis[5,5-dimethyl-1,3,2-dioxaborinane]",259-477-0,55089-03-7,Not Classified,Notified C&L,1,Not classified:1
132038,Prothipendyl,608-469-9,303-69-5,Acute Tox. 4,Notified C&L,38,H302:38
132039,"Bacitracin F, 1-[N-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-4-thiazolyl]carbonyl]-l-leucine]-",245-115-9,22601-59-8,Not Classified,Notified C&L,1,Not classified:1
132047,"2-cyano-10-[3-(dimethylammonio)-2-methylpropyl]-10H-phenothiazinium [R-(R*,R*)]-tartrate",299-054-8,93841-82-8,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1;H302:1
132059,"Terpenes and Terpenoids, sinpine",272-842-9,68917-63-5,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,93,H317:16;H226:93;H411:16;H315:16;H304:87
132063,"Fatty acids, C16-18 and C18-unsatd., ethoxylated",614-879-9,68989-58-2,Not Classified,Notified C&L,1,Not classified:1
132067,Dithallium sulphide,215-250-8,1314-97-2,Acute Tox. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,38,H373:38;H300:38;H411:38;H330:38
132073,3-acetylbenzonitrile,228-110-6,6136-68-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:44;H335:44;H319:45;H315:45;H332:44;H302:44;H301:1
132075,1-(6-hydroxy-2-naphthyl)ethan-1-one,233-923-4,10441-41-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2;H302:1
132076,Isopropyl hydrogen maleate,213-109-5,924-83-4,,Notified C&L,2,Not classified:2
132077,"5,6-dihydro-6-pentyl-2H-pyran-2-one",259-359-9,54814-64-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1646,H317:1645;H319:1643;H315:1646
132078,α-hydroxy-o-tolyl β-D-glucopyranoside,205-331-6,138-52-3,Skin Sens. 1,Notified C&L,81,H317:55;Not classified:26;H411:1;H335:1
132082,2-(2-ethoxyethyl)pyridine,249-140-6,28672-54-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H335:38
132085,"1,4-dichlorobutan-2-one",240-768-6,16714-78-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H335:1
132087,"1,1'-binaphthyl-8,8'-dicarboxylic acid",249-922-7,29878-91-9,Eye Irrit. 2,REACH registration C&L,40,H319:2;H302:38;H413:38
132089,o-bromocumene,230-370-0,7073-94-1,,Notified C&L,7,H319:7;H411:5;H315:7;H335:1
132096,4-amino-3-nitrobenzoic acid,216-453-4,1588-83-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:47
132100,"3,5-dichlorophenol",209-714-9,591-35-5,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,51,H311:41;H411:42;H314:39;H302:41;H312:5;H335:6;H319:10;H315:10;H301:3;H331:3;Not classified:1;H410:1;H400:1
132106,7-hydroxy-2-phenyl-4-benzopyrone,229-705-3,6665-86-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
132111,Acetarsol,202-582-3,97-44-9,Acute Tox. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38;H301:38;H331:38
132114,"p-[4,5-dihydro-4-[[2-methoxy-5-methyl-4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonic acid, potassium sodium salt",287-720-0,85567-08-4,Not Classified,Notified C&L,1,Not classified:1
132116,"Tallow, mixed with tristearin, calcium sodium salts",271-783-6,68608-31-1,Not Classified,Notified C&L,1,Not classified:1
132119,DIMETHYL POLYSILOXANE (VINYL TERMINATED),614-275-5,68083-19-2,Not Classified,Notified C&L,190,Not classified:148;H319:42;H315:42
132124,Potassium pyruvate,223-978-2,4151-33-1,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H302:1
132125,"9-chloro-11β-hydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate",226-886-0,5534-09-8,Repr. 1B,Notified C&L,90,H360:82;H373:41;H361:8;H413:5;H317:2;H334:2;H302:1;H319:1;H315:2;H372:1
132129,Pentyl methacrylate,220-655-8,2849-98-1,,Notified C&L,1,H319:1;H315:1;H335:1
132130,Bis(triphenylphosphine)palladium chloride,233-495-9,10199-34-5,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,2,H317:1;H312:2;H334:1;H332:2;H302:2;H319:1;H315:1;H413:1
132134,Ethyl decanoate,203-761-9,110-38-3,Not Classified,REACH registration C&L,1640,Not classified:1640
132139,Cycloheptene,211-060-4,628-92-2,Flam. Liq. 2,Notified C&L,74,H225:74
132140,quinolin-6-ylmethanol,600-106-2,100516-88-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H315:1;H335:1
132142,"3-hydroxynaphthalene-2,7-disulphonic acid",205-724-2,148-75-4,Not Classified,Notified C&L,1,Not classified:1
132145,"4,4'-ethylidenediphenyl dicyanate",405-740-1,47073-92-7,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H410:0;H318:0;H332:0;H400:0;H302:0
132146,5-CHLOROTHIOPHENE-2-CARBOXYLIC ACID,607-311-6,24065-33-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,63,H317:53;H319:63;H315:20;H335:20;H301:1
132153,"Tetrasodium [3-[(3-chloro-2-hydroxy-5-sulphophenyl)azo]-5-[[4-chloro-6-(3-sulphoanilino)-1,3,5-triazin-2-yl]amino]-4-hydroxynaphthalene-2,7-disulphonato(6-)]cuprate(4-)",274-977-9,70880-03-4,Skin Sens. 1B,REACH registration C&L,12,H317:1;Not classified:10;H412:1
132155,Oxymorphone,200-959-7,76-41-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,REACH registration C&L,47,H310:43;H300:42;H330:43;Not classified:1;H317:1;H334:1;H332:1;H302:2;H301:2;H311:1;H331:1
132159,"4-[[4-(acetylamino)phenyl]amino]-1-amino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",228-364-8,6247-34-3,Not Classified,Notified C&L,11,Not classified:11
132160,Triamterene,206-904-3,396-01-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:45;H315:45;H302:43;H335:44;H301:4;H312:1;H332:1
132161,"2,-5-furandione, dihydro-, monpolyisobutylene derivs.",614-118-0,67762-77-0,,Notified C&L,709,Not classified:447;H319:253;H413:9;H335:1
132162,"phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide",423-340-5,162881-26-7,Skin Sens. 1A;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
132164,Bicyclo[3.3.1]nonan-9-one,241-868-2,17931-55-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
132167,4-(phenyl)thiosemicarbazide,226-329-1,5351-69-9,Acute Tox. 2,Notified C&L,45,H300:42;H301:2;H311:1;H332:1;H312:1;H302:1
132168,"Cottonseed oil, hydrogenated",269-804-9,68334-00-9,Not Classified,Notified C&L,113,Not classified:113
132169,"6-[(2,4-diaminophenyl)azo]-3-[[4-[[4-[[7-[(2,4-diaminophenyl)azo]-1-hydroxy-3-sulpho-2-naphthyl]azo]phenyl]amino]-3-sulphophenyl]azo]-4-hydroxynaphthalene-2-sulphonic acid",278-387-2,76186-07-7,Not Classified,REACH registration C&L,2,Not classified:2
132173,"9H-Xanthen-9-one, 2-β-D-glucopyranosyl-7-(β-D-glucopyranosyloxy)-1,3,6-trihydroxy-",613-694-0,64809-67-2,Acute Tox. 1,Notified C&L,1,H300:1
132175,Hexene,246-768-2,25264-93-1,Flam. Liq. 2;Asp. Tox. 1,REACH registration C&L,2,H304:2;H225:2
132177,"Chamaecyparis obtusa, ext.",294-769-1,91745-97-0,Asp. Tox. 1,Notified C&L,90,H304:90;H226:11;H317:2;H315:2
132178,Octyl butyrate,203-762-4,110-39-4,Not Classified,Notified C&L,239,Not classified:239
132179,"Silicic acid, titanium salt",255-911-8,42613-21-8,Not Classified,REACH registration C&L,88,Not classified:88
132181,"Tar acids, residues, distillates, first-cut;Distillate Phenols;[The residue from the distillation in the range of 235°C to 355°C (481°F to 697°F) of light carbolic oil.]",270-713-1,68477-23-6,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
132182,"9-Octadecenoic acid (Z)-, 1,2,3-propanetriyl ester, oxidized, sulfited, sodium salts",305-535-6,94624-11-0,Not Classified,Notified C&L,85,Not classified:85
132183,2-chloroethyl trityl ether,700-130-4,,Not Classified,Notified C&L,1,Not classified:1
132185,"(±)-N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-β-alanine",209-965-4,599-54-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
132188,"2,3-dimethylbuta-1,3-diene",208-172-0,513-81-5,Flam. Liq. 2,Notified C&L,43,H225:43;H304:4
132190,methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate,403-270-1,6386-39-6,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
132191,3-methylglutaric anhydride,224-020-6,4166-53-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
132195,1-(4-Chlorophenyl)-1-phenylethanol,611-881-1,59767-24-7,,,0,No data
132196,2'-bromoacetophenone,218-398-1,2142-69-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H315:45;H335:39;Not classified:1;H332:1;H312:1;H302:1
132204,"2-phenoxy-1,1'-biphenyl",229-793-3,6738-04-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H335:38;H318:38;H315:38;H400:38;H302:38
132205,"2-ethylhexyl 4-butyl-10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate",248-070-3,26864-37-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,122,H319:64;H412:63;H315:65;H302:122;H400:57;H413:2;H317:1;H410:1;H312:1
132209,"2,2-dibromo-1-(4-bromophenyl)ethan-1-one",236-161-0,13195-79-4,Skin Corr. 1B,Notified C&L,42,H314:42
132210,(2-(aminomethyl)phenyl)acetylchloride hydrochloride,417-410-4,61807-67-8,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1,Harmonised C&L,0,H317:0;H314:0;H302:0
132211,"2,2-dichloro-1-(2,4-dichlorophenyl)ethan-1-one",218-890-6,2274-66-0,Eye Irrit. 2,Notified C&L,38,H319:38
132212,"Alcohols, C12-16, ethoxylated",500-221-7,68551-12-2,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1271,H400:776;H318:1152;H315:640;H411:159;H302:450;H410:50;H319:70;H412:95;Not classified:12
132217,"Pentaerythritol, reaction product with fatty acids, C8 to 18 (even numbered) and/or branched and/or unsaturated",484-420-3,,Not Classified,Notified C&L,1,Not classified:1
132218,"Pear, ext.",290-131-1,90082-43-2,Flam. Liq. 3,Notified C&L,1348,H226:923;H304:389;Not classified:35;H225:1
132219,Heptyl octanoate,224-252-8,4265-97-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,114,H319:114;H315:114
132221,"Carbamic acid, [(1S,2R)-2-hydroxy-3-[(2-methylpropyl)[(4-nitrophenyl)sulfonyl]amino]-1-(phenylmethyl)propyl]-, 1,1-dimethylethyl ester",606-234-5,191226-98-9,Not Classified,Notified C&L,14,Not classified:12;H412:1;H271:1;H319:1;H315:1;H302:1;H335:1
132226,3-hydroxypropyl methacrylate,220-426-2,2761-09-3,Eye Irrit. 2;Skin Sens. 1,Harmonised C&L,0,H319:0;H317:0
132229,"Gadolinium oxide sulfide (Gd2O2S), praseodymium-doped",271-826-9,68609-42-7,Not Classified,REACH registration C&L,2,Not classified:2
132231,m-fluorobenzenethiol,219-876-2,2557-77-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H300:4;H331:4;H310:4;H226:6;H312:1;H332:1;H302:1
132232,"3,4-dihydro-2H-pyran-2-yl ethyl ether",203-141-8,103-75-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H319:39;H226:39;H315:38
132235,Phenoxazine,205-210-8,135-67-1,Not Classified,Notified C&L,33,Not classified:33
132238,1-phenylethyl propionate,204-397-3,120-45-6,Not Classified,Notified C&L,1580,Not classified:1580
132246,"4,4'-Methylenebis(2-methylphenol)",607-415-1,2467-25-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
132249,Ethyl 1-methyl-3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carboxylate,265-854-0,65652-28-0,Not Classified,Notified C&L,88,Not classified:88
132251,"N,N'-(2-chloro-5-methyl-1,4-phenylene)bis[3-oxobutyramide]",255-235-3,41131-65-1,Not Classified,REACH registration C&L,99,Not classified:98;H332:1;H312:1;H351:1;H302:1
132257,"1-bromo-2,2-dimethoxypropane",204-784-7,126-38-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H226:45;H315:45;H335:45
132260,"Fatty acids, C8-18, reaction products with 2-[(2-aminoethyl)amino]ethanol, acetates (salts)",293-011-7,91032-05-2,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,28,H411:28;H318:28
132262,Tetrahydropyran-2-ylmethanol,202-882-4,100-72-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,46,H319:46;H315:46;H335:5
132263,"Naphtha (petroleum), isomerization;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C",265-073-5,64741-70-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
132268,Tetramethyltin,209-833-6,594-27-4,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,94,H410:89;H300:89;H225:47;H400:64;H310:89;H330:94;H311:5;H301:5;Not classified:2
132269,"3,5,5-trimethylhexan-1-ol",222-376-7,3452-97-9,Skin Irrit. 2;Eye Irrit. 2;STOT RE 2,REACH registration C&L,741,H319:434;H315:443;H373:499;H412:267;H411:46;Not classified:24;H361:1;H302:1
132270,"Antimony, compound with zinc (1:1)",234-893-5,12039-35-9,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,38,H335:38;H311:38;H319:38;H315:38;H332:38;H302:38;H411:38
132271,4-phenylpiperidinium chloride,233-617-0,10272-49-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2;H302:1
132274,Chloro(triphenylphosphine)gold,238-117-6,14243-64-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:41;H228:1;H413:1;H302:1
132275,cumene,202-704-5,98-82-8,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H304:0;H226:0;H411:0;H335:0
132277,"1,1,1,3,3,5,5-heptamethyltrisiloxane",220-774-5,2895-07-0,,Notified C&L,2,H224:2;H319:2;H315:2;H335:2
132278,"2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-7-oxo-8-oxa-3,5-dithia-4-phosphatetradecanoate 4-oxide",280-479-2,83547-95-9,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H411:1;H315:1
132279,"Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, tetracosa-μ-oxododecaoxo[μ12-[phosphato(3-)-O:O:O:O':O':O':O'':O'':O'':O''':O''':O''']]dodecamolybdate(3-) (3:1)",268-391-2,68083-42-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
132284,Bis[p-(dimethylamino)phenyl][p-(dimethylammonio)phenyl]methylium,238-398-5,14426-25-6,Not Classified,Notified C&L,1,Not classified:1
132285,N-methylanilinium trifluoroacetate,249-927-4,29885-95-8,,Notified C&L,5,H373:4;H312:5;H332:5;H302:5;H411:4;H319:1;H315:1
132286,5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole,616-036-0,73963-42-5,Not Classified,REACH registration C&L,4,Not classified:3;H319:1;H228:1;H315:1
132287,"4,4'-thiodiphenol",220-197-9,2664-63-3,Skin Corr. 1B,Notified C&L,53,H314:43;H319:9;Not classified:2;H318:1;H315:1
132290,"2,6-difluorobenzyl alcohol",242-792-2,19064-18-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,46,H319:46;H312:5;H315:46;H302:37;H335:9;H332:1
132291,(E)-2-methylcrotonoyl chloride,252-659-0,35660-94-7,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,39,H301:38;H311:38;H225:38;H331:38;H314:39;H226:1;H290:1;H318:1
132292,"Starch, oxidized",613-862-3,65996-62-5,Not Classified,Notified C&L,73,Not classified:73
132293,"N-[2-[(2,6-dicyano-4-nitrophenyl)azo]-5-[[2-(2-ethoxyethoxy)ethyl]ethylamino]phenyl]acetamide",265-978-5,65916-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H317:1;H412:1
132298,"7,7'-(carbonyldiimino)bis[4-hydroxy-3-[(6-sulpho-2-naphthyl)azo]naphthalene-2-sulphonic] acid, compound with 2,2',2''-nitrilotriethanol (1:4)",253-122-3,36596-36-8,Not Classified,Notified C&L,1,Not classified:1
132302,5-chlorovaleronitrile,228-481-4,6280-87-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,45,H311:41;H301:41;H331:40;H312:4;H319:5;H315:5;H332:4;H302:4
132304,Tiamiprine,226-977-5,5581-52-2,Acute Tox. 4;Muta. 2;Carc. 2;Repr. 2;STOT RE 2,Notified C&L,1,H373:1;H351:1;H361:1;H302:1;H341:1
132307,Ethyl 2-methylpent-3-en-1-oate,216-572-1,1617-23-8,Flam. Liq. 3,Notified C&L,1376,H226:1375;Not classified:1
132308,butyric acid,203-532-3,107-92-6,Skin Corr. 1B,Harmonised C&L,0,H314:0
132309,"3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol",233-466-0,10191-41-0,Skin Sens. 1B,REACH registration C&L,2171,H317:1598;Not classified:564;H413:25;H315:7;H332:1;H312:1;H302:1
132310,"1,1-dimethoxyheptane",233-103-6,10032-05-0,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,151,H319:112;H226:150;H302:38;Not classified:1
132313,"4-aminobenzene-1,3-disulphonic acid",205-299-3,137-51-9,Eye Irrit. 2,REACH registration C&L,119,H319:35;H318:83;H314:1;H315:1;H335:1
132316,1-(4-nitrophenyl)-3-(3-pyridylmethyl)urea,258-626-7,53558-25-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H302:38;H335:38
132318,"7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid",405-050-0,86393-33-1,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
132322,1-methyl-4-(1-methylvinyl)-7-oxabicyclo[4.1.0]heptan-2-one,251-405-6,33204-74-9,Skin Sens. 1,Notified C&L,233,H317:233
132333,4'-cyanoacetophenone,215-885-0,1443-80-7,Acute Tox. 4,REACH registration C&L,50,H302:48;H312:5;H335:5;H319:6;H315:6;H332:5;H311:2;H301:2;H331:2
132334,diphenylether; octabromo derivate,251-087-9,32536-52-0,Repr. 1B,Harmonised C&L,0,H360:0
132337,"(2S,5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide",427-200-4,76646-91-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0;H315:0;H302:0
132339,4-bromobutyl phenyl ether,214-849-1,1200-03-9,,Notified C&L,6,H319:5;H315:5;H335:5;H332:1;H312:1;H302:1
132341,"Chromium, 3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonic acid complex",227-029-3,5610-64-0,Not Classified,REACH registration C&L,379,Not classified:21;H317:189;H410:177;H319:293;H400:177;H411:330;H226:84;H336:84;H412:23;H315:18;H335:1;H332:1;H302:1
132342,2-hydroxy-3-phenoxypropyl acrylate,241-045-8,16969-10-1,Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,189,H317:131;H318:95;H411:97;H302:87;H319:91;H315:91;H335:54;Not classified:1
132346,"(S)-(-)-1,2,3,4-Tetrahydro-3-isoquinolincarbonsäure",616-058-0,74163-81-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:40
132347,N-(2-hydroxyethyl)-N-(3-hydroxypropyl)-p-toluenesulphonamide,230-172-4,6965-77-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
132352,"Calcium 2,3-hydroxypropyl phosphate",204-813-3,126-95-4,Not Classified,Notified C&L,1,Not classified:1
132353,"2,3,4,5,6-pentafluorotoluene",212-233-7,771-56-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44,H312:39;H335:43;H319:44;H315:44;H332:39;H302:39;H226:44
132354,3-(benzoylamino)-2-methylpropionic acid,256-147-8,43218-35-5,,Notified C&L,1,Not classified:1
132357,"Carbonic acid, barium salt",246-600-8,25070-31-9,Not Classified,Notified C&L,566,Not classified:566
132358,3-methoxyphenyl isocyanate,242-658-3,18908-07-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,45,H312:39;H335:44;H319:44;H334:43;H315:44;H332:43;H302:43;H311:1;H301:2;H331:2
132359,"Disodium 1-amino-2,4-dihydroxy-9,10-dihydro-9,10-dioxoanthracene-3-sulphonate",229-088-0,6409-77-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:41;H315:41;H335:40;Not classified:1;H312:1;H332:1;H302:1
132360,bis(2-dimethylaminoethyl)(methyl)amine,221-201-1,3030-47-5,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0,H311:0;H314:0;H302:0
132363,4-nitrophenyl 2-(trimethylsilyl)ethyl carbonate,279-406-7,80149-80-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
132364,Sodium bis[N-(2-chlorophenyl)-2-[[2-hydroxy-5-(N-methylsulphamoyl)phenyl]azo]-3-oxobutyramidato(2-)]cobaltate(1-),274-503-0,70247-74-4,Aquatic Chronic 2,REACH registration C&L,14,H411:3;Not classified:10;H319:1;H412:1
132365,3-nitro-p-anisamide,233-859-7,10397-58-7,,Notified C&L,4,H319:4;H315:4;H335:4
132367,"tetrasodium 4-amino-3,6-bis[(2,5-dimethoxy-4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonate",445-810-9,536737-09-4,Not Classified,REACH registration C&L,1,Not classified:1
132368,Manganite (Mn(OH)O) (mineral),215-189-7,1310-98-1,Not Classified,Notified C&L,1,Not classified:1
132369,terpeneless lemon oil,614-688-0,68648-39-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,209,H317:209;H410:170;H315:209;H400:126;H304:171;H226:208;H319:47;H411:1
132371,"[3-(Hydroxy-kO)-4-{[2-(hydroxy-kO) carbopolycyl-1-yl]diazenyl-kN1}-6-substituted-carbopolycyle-1-sulfonato(3-)]chromium, reaction products with hydrogen amino-4-hydroxy carbopolycyle-2-sulfonate, sodium 2-[(aminophenyl)sulfonyl]ethyl sulfate, amino-5-substituted-phenol and 2,4,6-trichloro-1,3,5-triazine",454-620-5,854270-57-8,Aquatic Chronic 3,REACH registration C&L,2,H412:2
132373,"1,4-bis(methoxymethyl)benzene",229-828-2,6770-38-3,Skin Irrit. 2;Eye Irrit. 2;Repr. 2;STOT RE 2,REACH registration C&L,5,H319:2;H361:1;H315:2;H373:1;Not classified:3;H335:1
132377,2-chloro-3-methylpyridine,242-242-1,18368-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H312:5;H332:5;H302:5
132379,Hexyl acetate,205-572-7,142-92-7,Flam. Liq. 3,REACH registration C&L,1902,H226:1808;H411:1691;Not classified:8;H319:9;H315:9;H373:1;H410:1;H311:2;H400:1;H302:1;H225:1
132382,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(hydroxyphenylacetyl)amino]-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]disodium salt, [6R-[6,7(R*)]]-",612-109-6,61270-78-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H317:2;H334:2
132384,Di-tert-butyl phthalate,250-204-0,30448-43-2,Not Classified,Notified C&L,1,Not classified:1
132386,"2-Phenazinol, 8-amino-7-methyl-, reaction products with sodium sulfide (Na2(Sx)), leuco deriv.",287-805-2,85586-02-3,Not Classified,Notified C&L,1,Not classified:1
132394,"Pentane-1,3,5-tricarboxylic acid",230-087-2,6940-58-5,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1
132396,Tungsten dichloride dioxide,236-862-1,13520-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:38;H315:38;H335:38;H314:4
132398,2-methylisocrotonic acid,209-284-2,565-63-9,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H290:1;H318:1;H314:1
132399,"1,5-diaminoanthraquinone",204-947-2,129-44-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
132400,"2,2'-azobis[4-methoxy-2,4-dimethylvaleronitrile]",239-593-8,15545-97-8,Self-react. D;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H242:2
132405,"Cistus ladaniferus, ext.",289-711-7,89997-74-0,Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1219,H304:1030;H400:978;H317:1032;H410:1027;Not classified:184;H319:110;H226:117;H315:11;H411:5;H302:1;H412:1
132407,"3,7,11,15-tetramethylhexadec-1-en-3-ol",208-008-8,505-32-8,Skin Irrit. 2;Aquatic Chronic 1,REACH registration C&L,1780,H410:1780;H315:1779;H400:1735;H319:1;H361:1
132414,"Fatty acids, rape-oil, esters with triethanolamine",293-098-1,91051-45-5,Not Classified,Notified C&L,1,Not classified:1
132417,Ammonium trifluoroacetate,222-072-4,3336-58-1,Acute Tox. 2;Aquatic Acute 1,Notified C&L,53,H400:38;H300:41;H319:12;H315:12;H335:12
132424,"Chromate(1-), [6-amino-5-[(2-hydroxy-4-nitrophenyl)azo]-1-naphthalenesulfonato(2-)][2-[[(2-hydroxyethyl)imino]methyl]phenolato(2-)]-, sodium",284-039-0,84777-12-8,Not Classified,Notified C&L,2,Not classified:2
132427,4-ethyl-2-fluoro-4'-(2-(trans-4-pentylcyclohexyl)ethyl)biphenyl,433-390-1,95379-18-3,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
132429,"Bis(2-ethylhexyl) hydrogen phosphate, compound with 2,2',2''-nitrilotriethanol (1:1)",262-000-9,59965-28-5,Not Classified,Notified C&L,8,Not classified:3;H319:3;H318:2;H315:3
132432,Hexaboron dizinc undecaoxide,235-804-2,12767-90-7,Eye Irrit. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,800,H319:189;H400:785;H411:113;H361:116;H410:114;H335:32;H336:32;Not classified:13
132437,o-iodocumene,242-819-8,19099-54-8,,Notified C&L,5,H319:5;H315:5;H335:1
132438,BLUE E195,420-700-3,,Not Classified,Notified C&L,2,Not classified:2
132444,"2,2-dimethyl-1,3,6,9,12,15-hexaoxa-2-silacycloheptadecane",281-175-2,83890-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
132445,3-[3-hydroxypropyl(2-methylpropyl)phosphoryl]propan-1-ol,464-510-9,,Skin Mild Irrit. 3,Notified C&L,1,H316:1
132446,Sodium chlorite,231-836-6,7758-19-2,Ox. Sol. 1;Acute Tox. 3;Acute Tox. 2;Skin Corr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,944,H373:720;H410:165;H301:830;H271:353;H400:854;H310:772;H412:197;H314:846;H318:614;H272:523;H311:89;H332:55;Not classified:41;H330:102;H302:76;H335:21;H319:21;H315:38;H371:1;H331:1;H350:1;H290:1
132449,"(11β,17α)-11,17-dihydroxy-17-(1-oxopropyl)androst-4-en-3-one 17-butyrate",278-537-7,76738-96-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,16,H332:16;H312:16;H361:16;H302:16
132454,N-[2-hydroxy-3-(C,415-060-7,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
132457,N,218-130-3,2051-79-8,Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H301:0;H319:0;H400:0
132460,"4-amino-2,3,5,6-tetrafluorobenzoic acid",213-409-6,944-43-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
132461,"4-(2,4-dinitroanilino)phenol",204-300-4,119-15-3,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H228:39;H315:39;H335:39
132463,"1,3,2-Dioxaborolane, 2-butyl-4,4,5,5-tetramethyl-",614-932-6,69190-62-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
132471,4-nitroanthranilic acid,210-583-5,619-17-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:44;H335:44;H302:1
132474,"D-glucose pentakis[3,4-dihydroxy-5-[(trihydroxy-3,4,5-benzoyl)oxy]benzoate]",276-638-0,72401-53-7,Not Classified,Notified C&L,88,Not classified:88
132476,L-leucine,200-522-0,61-90-5,Not Classified,REACH registration C&L,200,Not classified:200
132477,Diantimony triselenide,215-256-0,1315-05-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H410:42;H301:42;H331:38;H400:42;H330:4
132481,"D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide Cyclic (2-7)-Disulfide Acetate",616-695-4,79517-01-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;H332:1
132482,Diethoxymethyl acetate,237-873-4,14036-06-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H226:40;H315:40;H335:38
132483,Sodium N-(2-aminoethyl)-β-alaninate,282-811-1,84434-12-8,Skin Sens. 1;Eye Dam. 1,Notified C&L,84,H317:83;H318:83;Not classified:1
132486,O-ethylhydroxylamine hydrochloride,222-060-9,3332-29-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:40;H302:1
132488,Trimethyl[(phenylseleno)methyl]silane,260-077-3,56253-60-2,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H410:38;H301:38;H331:38;H400:38
132490,Sebacic acid,203-845-5,111-20-6,Not Classified,REACH registration C&L,2757,Not classified:2742;H319:14;H315:15;H335:11;H332:1
132492,Rubidium iodate,236-604-8,13446-76-9,,Notified C&L,4,H317:4;H334:4;H272:4
132493,Lisuride hydrogen maleate,243-387-3,19875-60-6,Acute Tox. 2,Notified C&L,26,H300:26;H310:1;H330:1
132495,Nickel (II)sulphate hexahydrate,600-152-3,10101-97-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,245,H317:228;H410:242;H360:242;H334:242;H315:241;H332:241;H400:241;H350:242;H302:235;H372:241;H341:242;H373:16;H301:8;Not classified:2;H351:1
132497,"Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;Naphthalene Oil Extract Residue;[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]",292-612-1,90640-90-7,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
132499,"Benzenesulfonic acid, mono-C10-14-alkyl derivs., sodium salts",285-600-2,85117-50-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,317,H318:254;H315:278;H302:239;Not classified:39;H319:24;H412:1
132504,O-methylisourea hydrogen.sulphate,249-622-6,29427-58-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:38;H335:38;H341:1;H318:1;H302:1
132506,"Leek, ext.",283-496-3,84650-15-7,Flam. Liq. 3,Notified C&L,143,H226:133;Not classified:10
132507,"Poplar, Populus balsamifera, ext.",294-377-0,91721-76-5,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H410:1;H319:1;H400:1;H304:1;H226:1
132511,"acrylic acid, 3-(trimethoxysilyl)propyl ester",419-560-6,4369-14-6,Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0;H332:0;H314:0
132512,Triammonium tris[carbonato(2-)-O]hydroxyzirconate(3-),251-086-3,32535-84-5,Not Classified,Notified C&L,2,Not classified:2
132517,Ditungsten pentaboride,234-524-8,12007-98-6,Not Classified,Notified C&L,1,Not classified:1
132522,"(R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine",603-925-3,135616-40-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
132524,3-(ethylthio)propanol,242-534-9,18721-61-4,,Notified C&L,5,H319:5;H315:5;H335:5
132526,"Lubricating oils, used, distd.",295-421-1,92045-40-4,Flam. Liq. 2;Asp. Tox. 1;Skin Sens. 1;Muta. 1B;Carc. 1A;Repr. 2,REACH registration C&L,6,H317:4;H361:4;H225:4;H350:3;H304:5;H340:2;H351:2;H341:2
132532,"Linseed oil, ester with pentaerythritol",271-985-4,68648-28-2,Aquatic Chronic 3,REACH registration C&L,2,H412:2
132534,Octadecyl mercaptoacetate,233-533-4,10220-46-9,Eye Irrit. 2,Notified C&L,38,H319:38
132536,Aminomodified Polydimethylsiloxane,616-256-7,75718-16-0,Skin Irrit. 2,Notified C&L,116,H315:110;H319:9;H318:3;Not classified:1;H412:1
132540,"3,3'-iminodipropiononitrile",203-922-3,111-94-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H315:43;H335:42;H318:4
132541,Trichlorophenylstannane,214-393-3,1124-19-2,Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,46,H400:42;H318:39;H314:46;H410:4;H301:4;H311:4;H330:4;H290:1
132542,Benzimidazole,200-081-4,51-17-2,Acute Tox. 4,REACH registration C&L,103,H302:93;Not classified:6;H319:4;H315:4;H335:4
132543,Undec-10-enoyl chloride,253-951-0,38460-95-6,Skin Corr. 1B,REACH registration C&L,43,H314:43;H290:1;H318:1;H335:1
132544,Tamarind seed gum,254-442-6,39386-78-2,Not Classified,Notified C&L,91,Not classified:91
132545,"Acetic acid, ethenyl ester, polymer with ethene",607-457-0,24937-78-8,Not Classified,Notified C&L,263,Not classified:261;H317:2;H351:2
132546,"1,1,5,5-tetramethyl-3,3-diphenyl-1,5-divinyltrisiloxane",242-426-1,18586-22-6,Not Classified,Notified C&L,22,Not classified:22
132547,N-[3-(diethylamino)phenyl]acetamide,228-937-2,6375-46-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,41,H319:41;H315:41;H335:39;H302:1
132548,2-[(trifluoromethyl)thio]aniline,206-473-1,347-55-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
132552,Rhodinyl formate,205-456-6,141-09-3,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1398,H317:1373;H412:1373;H319:1286;Not classified:25
132555,3-amino-4-methoxybenzenesulphonic acid,202-667-5,98-42-0,Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,87,H317:40;H318:4;H314:75;Not classified:12;H372:1;H370:1
132558,"(2-butylbenzofuran-3-yl) (4-hydroxy-3,5-diiodophenyl) ketone",217-773-7,1951-26-4,Not Classified,REACH registration C&L,9,Not classified:8;H302:1
132560,(+)-3-methyladipic acid,210-816-0,623-82-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
132561,"Ethyl 4,4-difluoro-3-oxobutyrate",206-519-0,352-24-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,48,H319:47;H315:46;H226:7;H317:1;H318:1;H412:1;H225:1;H314:1;H335:1
132563,p-tert-butylstyrene,217-126-9,1746-23-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,64,H319:64;H315:64;H335:58;H411:2;H410:1;H361:1;H400:1;H332:1;H304:1
132567,fosetyl-aluminium (ISO);aluminium triethyl triphosphonate,254-320-2,39148-24-8,Eye Dam. 1,Harmonised C&L,0,H318:0
132568,"1,3-bis(ethenylsulfonyl)propan-2-ol",614-007-7,67006-32-0,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,2,H317:2;H318:2;H301:2
132571,"5H-dibenzo[a,d]cycloheptene",205-969-5,256-81-5,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,41,H302:40;H413:38;H319:2;H301:1;H315:2;H335:1;H412:1
132576,Dimethyl (2-oxopropyl)phosphonate,224-110-5,4202-14-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Muta. 2,Notified C&L,3,H319:3;H315:3;H332:2;H302:2;H341:2;H335:1
132579,"BUTANEDIAMIDE, N1,N4-BIS[3-[(9Z)-9-OCTADECEN-1-YLAMINO]PROPYL]-, POLYBUTENYL DERIVS.",618-220-6,88917-24-2,Aquatic Chronic 4,Notified C&L,33,H413:27;H412:6;H314:6
132582,(3-chloroprop-1-enyl)benzene,220-246-4,2687-12-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Repr. 2;STOT RE 2,REACH registration C&L,53,H317:7;H373:4;H361:4;H319:4;H315:4;H341:4;H334:39;H314:49;H302:42;H330:44;H290:1;H318:3
132583,"2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate",405-440-0,149172-69-0,Skin Sens. 1,Harmonised C&L,0,H317:0
132592,"1,3-diphenylpropane-1,3-dione",204-398-9,120-46-7,Skin Sens. 1,REACH registration C&L,150,H317:62;Not classified:84;H400:4;H410:4;H319:1;H315:1;H335:1;H312:1;H302:1
132593,1-(3-chloropropyl)-4-methylpiperazine dihydrochloride,217-981-8,2031-23-4,Acute Tox. 4,Notified C&L,38,H302:38
132595,"Diethyl 2,2'-azobis[2-methylpropionate]",223-409-8,3879-07-0,Flam. Liq. 3;Acute Tox. 4,Notified C&L,2,H311:2;H226:2;H302:2;H242:1
132596,Yttrium tribromide,236-728-2,13469-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43
132600,Lithium nitrate,232-218-9,7790-69-4,Ox. Sol. 3;Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,122,H319:49;H302:50;H272:101;H335:6;H315:6;H300:1;Not classified:2
132602,"Diethyl (3,3-dimethyl-2-oxobutyl)phosphonate",212-393-8,814-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
132605,"3,5-dibromo-2-hydroxybenzaldehyde",202-003-4,90-59-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,50,H317:1;H400:43;H410:1;H319:47;H315:47;H335:46;H302:2;H311:1;H301:1;H331:1;H312:1
132608,chromyl dichloride;chromic oxychloride,239-056-8,14977-61-8,Ox. Liq. 1;Skin Corr. 1A;Skin Sens. 1;Muta. 1B;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1B,Harmonised C&L,0,H317:0;H410:0;H271:0;H400:0;H350:0;H340:0;H314:0
132609,Pentacarbonylchlororhenium,237-948-1,14099-01-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,43,H301:42;H335:38;H311:38;H319:38;H315:38;H331:42;H332:1;H312:1;H302:1
132610,Methyl 2-bromopropionate,226-642-3,5445-17-0,Flam. Liq. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,48,H226:48;H314:47;H335:42;H319:3;H315:1;H302:1;H318:1
132611,"Trisodium 4-amino-3-[[4-[[4-[(2,4-diaminophenyl)azo]phenyl]amino]-3-sulphonatophenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate",276-990-5,72906-15-1,Not Classified,Notified C&L,9,Not classified:9
132615,1-(2-methoxy-1-methylethoxy)propan-2-ol,243-733-3,20324-32-7,Not Classified,Notified C&L,249,Not classified:249
132618,"Octahydro-4,7-methano-1H-indenedicarbaldehyde",247-319-3,25896-97-3,Aquatic Chronic 3,Notified C&L,1,H412:1
132621,"(3R,4S,5R)-3,4,5-trihydroxycyclohex-1-enecarboxylic acid",205-334-2,138-59-0,Not Classified,REACH registration C&L,7,Not classified:5;H319:1;H315:1;H318:1
132624,"Potassium 3,5,5-trimethylhexanoate",299-890-3,93918-10-6,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,29,H318:21;H314:2;H302:2;H319:8;H315:8
132625,"Phosphoric acid, dodecyl ester, compd. with 2,2'-iminobis[ethanol]",259-473-9,55078-28-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
132626,"2,2,6-trimethyl-α-propylcyclohexanepropanol",274-892-7,70788-30-6,Skin Sens. 1B,Notified C&L,1683,H317:1339;H315:342;H400:15;H410:15;H411:1;Not classified:2;H319:1
132627,2-carboxy-1-methylpyridinium chloride,223-025-0,3697-38-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1;H332:1;H302:1
132634,Heptachromium tricarbide,235-136-1,12075-40-0,Not Classified,Notified C&L,3,Not classified:3
132638,Antimony arsenic oxide,264-904-9,64475-90-7,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:2;H410:2;H301:2;H331:2
132639,"3-[(1,5-dihydroxy-2-naphthyl)azo]-4-hydroxybenzenesulphonic acid",247-236-2,25747-07-3,Not Classified,Notified C&L,13,Not classified:12;H412:1
132640,"Hydrocotyle asiatica, ext.",283-640-5,84696-21-9,Eye Irrit. 2,REACH registration C&L,46,H319:2;Not classified:43;H226:1
132644,"Benzoic acid, 2-(hexahydro-1-methyl-1H-azepin-4-yl)hydrazide, hydrochloride (1:1)",601-463-7,117078-69-0,,Notified C&L,1,H302:1
132649,"N,N'-ethylenebis(vinylsulfonylacetamide)",404-790-1,66710-66-5,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
132650,"Methanesulfonic acid, 1,1,1-trifluoro-, 2-fluoro-4-propylphenyl ester",605-749-2,175077-70-0,Not Classified,Notified C&L,1,Not classified:1
132653,"Vaccinium uliginosum, ext.",287-330-0,85480-50-8,Not Classified,Notified C&L,10,Not classified:10
132655,(2-nitro-4-trifluorobenzyl)acetic acid,217-081-5,1735-91-7,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1;H335:1
132659,"Lythrum salicaria, ext.",283-273-0,84603-74-7,Flam. Liq. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H225:1
132660,2-Propoxybenzoic Acid,606-685-8,2100-31-4,,Notified C&L,5,H319:5;H315:5;H335:4
132662,"3-dimethylaminopropane-1,2-diol",210-802-4,623-57-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,41,H318:41;H314:41
132664,Disodium phosphonate,237-249-1,13708-85-5,Not Classified,REACH registration C&L,170,Not classified:169;H412:1
132668,Iron tris(phosphinate),232-030-7,7783-84-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H319:2;H315:2
132669,Dimethyl(prop-2-ynyl)amine,230-620-9,7223-38-3,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,Notified C&L,44,H311:38;H225:44;H314:44;H302:42;H312:4;H318:2
132670,"1-{[(6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}pyridinium iodide hydrate (1:1:1)",606-216-7,190651-18-4,Skin Sens. 1;Muta. 2;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H341:1;H411:1
132674,Iodomethylmercury,205-600-8,143-36-2,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H410:42;H300:42;H400:42;H310:42;H330:42
132678,"[3β(S),4α,6α,7α,15α(R),16β]-4,9-epoxycevane-3,4,6,7,14,15,16,20-octol 6,7-diacetate 3-(2-hydroxy-2-methylbutyrate) 15-(2-methylbutyrate)",205-602-9,143-57-7,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,39,H310:39;H300:39;H330:39
132680,"Gadolinium oxide sulfide (Gd2O2S), terbium-doped",271-827-4,68609-43-8,Not Classified,Notified C&L,4,Not classified:4
132682,(+)-Methyloxirane,604-958-6,15448-47-2,Flam. Liq. 1;Acute Tox. 3,Notified C&L,47,H224:47;H301:39;H312:8;H335:8;H319:8;H315:7;H332:7;H350:7;H302:8;H340:7;H317:1;H361:1;H318:1;H314:1;H330:1;H311:1;H331:1
132684,C.I. Reactive Orange 69,612-917-9,61969-17-3,Not Classified,Notified C&L,1,Not classified:1
132685,"1,1,1,3,5,5,5-heptamethyl-3-[(trimethylsilyl)oxy]trisiloxane",241-867-7,17928-28-8,Flam. Liq. 3;STOT RE 2,REACH registration C&L,91,H373:2;H226:43;Not classified:47;H319:42;H315:42;H335:41
132686,2-piperazin-1-ylethanol,203-142-3,103-76-4,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,234,H318:171;H315:185;H319:50;H335:53;H314:11;H317:1;Not classified:1;H310:1;H300:1;H412:1
132687,"2-cyano-2-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-N-methylacetamide",278-388-8,76199-85-4,Not Classified,REACH registration C&L,176,Not classified:176
132689,bordeaux mixture; reaction products of copper sulphate with calcium dihydroxide,616-932-1,8011-63-0,Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H332:0;H400:0;H410:0;H318:0
132691,"trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a = 1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25",411-430-7,,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0
132692,Diflorasone,219-875-7,2557-49-5,Acute Tox. 4;Repr. 2,Notified C&L,4,H312:2;H361:3;H319:1;H371:1
132693,Ozone,233-069-2,10028-15-6,Ox. Gas 1;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,158,H410:12;H270:157;H318:11;H400:108;H372:11;H314:11;H330:157;H319:146;H373:56;H335:97;H315:97;H341:56
132695,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, aminosulfonyl sulfo derivs.",279-405-1,80146-12-9,Not Classified,Notified C&L,1,Not classified:1
132698,"Benzoyl chloride, 4-(dimethylamino)-",924-821-7,4755-50-4,,Notified C&L,5,H314:5
132699,Antimony sulphide,215-713-4,1345-04-6,Carc. 2;STOT RE 2,REACH registration C&L,266,H373:5;H351:5;H412:5;H360:1;H332:253;H411:229;H302:253;Not classified:3;H319:2;H315:2;H335:1;H301:1;H311:1;H331:1
132702,"(2Z)-(5-amino-1,2,4-thiadiazol-3-yl)(ethoxyimino)acetic acid",616-178-3,75028-24-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,REACH registration C&L,1,H319:1;H315:1;H335:1
132703,Chlorhexidine dihydrochloride,223-026-6,3697-42-5,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,229,H319:227;H400:72;H410:71;H315:131;H335:130;H373:60;H411:26;H302:2;H312:1;H332:1;Not classified:1
132704,Tetrabutylphosphonium Hydrogendifluoride,688-254-4,121240-56-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,35,H411:33;H314:33;H302:33;H312:2;H301:2;H335:2;H319:2;H315:2;H332:2
132706,"Tetrasodium 5,5'-[carbonylbis(imino-4,1-phenyleneazo)]bis[8-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate]",229-089-6,6409-83-2,,Notified C&L,42,Not classified:42
132707,"Oxirane, 2,2'-[ethylidenebis(4,1-phenyleneoxymethylene)]bis-",619-353-2,98460-24-3,Skin Sens. 1;Resp. Sens. 1;Muta. 2,Notified C&L,1,H317:1;H334:1;H341:1
132712,Isopropyl palmitate,205-571-1,142-91-6,Not Classified,REACH registration C&L,874,Not classified:863;H319:8;H315:11
132715,"Fatty acids, C9-19 and C9-19-unsatd., iron salts, basic",307-019-6,97488-81-8,Not Classified,Notified C&L,7,Not classified:7
132716,"(2S,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane",619-373-1,98737-29-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H400:39;H410:39
132719,3-(isononyloxy)propiononitrile,272-458-1,68845-31-8,Not Classified,Notified C&L,22,Not classified:22
132726,Diethyl (p-methoxybenzylidene)malonate,229-827-7,6768-23-6,Acute Tox. 4,Notified C&L,38,H302:38
132729,Aluminum titanium carbide (AlTi2C),603-064-3,12537-81-4,Not Classified,Notified C&L,1,Not classified:1
132730,Phenethyl 3-methylbut-2-enoate,255-649-4,42078-65-9,Not Classified,Notified C&L,1,Not classified:1
132731,"Methyl 3,5-dibromoanthranilate",400-990-8,606-00-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
132733,N-(2-carboxyethyl)-β-alanine,208-009-3,505-47-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
132737,"Octadecanoic acid, zinc salt, basic",257-363-5,51731-04-5,Not Classified,Notified C&L,1,Not classified:1
132745,"1-chloro-2,5-dimethoxy-4-nitrobenzene",230-086-7,6940-53-0,Aquatic Chronic 2,REACH registration C&L,74,H411:33;H319:39;H315:39;H335:38;H332:2;H412:2;H312:2;H302:2
132747,4-bromophenol,203-394-4,106-41-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56,H319:49;H315:53;H302:51;H335:48;H312:8;H301:5;H332:3;Not classified:3;H411:1
132748,"Trihydrogen [3-hydroxy-4-[(2-hydroxy-5-sulphophenyl)azo]naphthalene-2,7-disulphonato(5-)]chromate(3-)",288-811-8,85896-34-0,Not Classified,Notified C&L,2,Not classified:2
132749,"3,3'-[methylenebis(thio)]bispropionic acid",224-251-2,4265-57-0,,Notified C&L,4,H319:4;H315:4;H335:4
132750,"Pea, ext.",290-130-6,90082-41-0,Not Classified,Notified C&L,3,Not classified:3
132754,Sodium 3-aminobenzenesulphonate,214-419-3,1126-34-7,Not Classified,Notified C&L,1,Not classified:1
132758,N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine,425-300-2,186450-73-7,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
132759,"Disulfides, alkylaryl dialkyl diaryl, petroleum refinery spent caustic oxidn. products",269-805-4,68334-01-0,Not Classified,Notified C&L,88,Not classified:88
132762,"Sorbitan, monooctanoate",262-098-3,60177-36-8,Not Classified,Notified C&L,33,Not classified:33
132763,Dibismuth tritartrate,229-530-2,6591-56-6,Not Classified,Notified C&L,1,Not classified:1
132767,Tricalcium dicitrate,212-391-7,813-94-5,Not Classified,REACH registration C&L,95,Not classified:95
132769,"9-Octadecen-1-amine, (Z)-, sulfurized",294-008-3,91672-04-7,,Notified C&L,1,Not classified:1
132771,"Butane-2,3-diol",208-173-6,513-85-9,Not Classified,REACH registration C&L,196,Not classified:185;H319:11
132774,2-cyanoacetamide,203-531-8,107-91-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,60,H319:60;H315:60;H302:46;H335:49
132776,"Trisodium bis[amino[(2-hydroxy-3,5-dinitrophenyl)azo]naphthalenesulphonato(3-)]cobaltate(3-)",277-778-5,74220-71-6,Not Classified,Notified C&L,2070,Not classified:2070
132780,"Fatty acids, C14-18 and C14-18-unsatd., oleic acid-rich, compds. with triethanolamine",296-565-8,92797-29-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H319:5;H315:4;H335:1
132782,4-(ethylamino)-4-oxoisocrotonic acid,224-021-1,4166-67-0,Skin Corr. 1B,Notified C&L,42,H314:38;H319:4;H315:4;H335:4
132783,"[3aR-(3aα,5β,8aβ,9aα)]-3a,5,6,7,8,8a,9,9a-octahydro-5,8a-dimethyl-3-methylenenaphtho[2,3-b]furan-2(3H)-one",208-899-3,546-43-0,Skin Sens. 1,Notified C&L,40,H317:40
132786,"3,5-dimethoxyaniline",233-616-5,10272-07-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:43;H315:42;H302:47;H335:41;H311:4;H332:5;H373:4;H312:1
132787,"2,2-dichloropropane",209-832-0,594-20-7,Flam. Liq. 2,Notified C&L,10,H225:9;H332:4;H312:1;H302:1;Not classified:1;H319:1
132788,"tetrahydrothiophene-1,1-dioxide;sulpholane",204-783-1,126-33-0,Acute Tox. 4,Harmonised C&L,0,H302:0
132790,"Hydrogen (CL-methioninato-N,O,S)[sulphato(2-)-O]zincate(1-)",260-113-8,56329-42-1,,Notified C&L,1,H319:1;H315:1
132791,3-isobutoxycyclohex-2-en-1-one,245-414-4,23074-59-1,Skin Sens. 1,Notified C&L,38,H317:38
132793,Cadmium selenate,237-481-3,13814-62-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H373:1;H410:1;H301:1;H331:1;H400:1
132796,4'methoxy-2-methylcinnamaldehyde,265-737-4,65405-67-6,Not Classified,Notified C&L,88,Not classified:88
132797,"Distillates (petroleum), alkylate;Kerosine - unspecified;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C",265-074-0,64741-73-7,Asp. Tox. 1,Harmonised C&L,0,H304:0
132798,Bromo(triphenylphosphine)gold,238-118-1,14243-65-3,,Notified C&L,4,H319:4;H315:4;H335:4
132801,"Anthracene oil, anthracene paste, carbazole fraction;Anthracene Oil Fraction;[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350°C to 360°C (662°F to 680°F). It contains chiefly anthracene, carbazole and phenanthrene.]",295-276-4,91995-16-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
132802,"3,6,7-trimethyloct-6-en-1-yn-3-ol",258-011-3,52567-96-1,Acute Tox. 4,REACH registration C&L,2,H302:2;H317:1
132805,"1-[(2RS,4RS:2RS,4SR)-4-bromo-2-(2,4- dichlorophenyl)tetrahydrofurfuryl]-1H-1,2,4-triazole",601-417-6,116255-48-2,Acute Tox. 4;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,228,H400:228;H410:190;H361:157;H302:228
132806,Ethyl bicyclo[2.2.1]hept-2-ylacetate,252-658-5,35658-04-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
132808,Sodium hydrogen di(acetate),204-814-9,126-96-5,Eye Dam. 1,REACH registration C&L,1547,H318:1405;H319:94;H315:72;Not classified:28;H314:20;H335:4
132809,Peroxide~,619-206-2,96319-55-0,Skin Irrit. 2;Aquatic Chronic 2;Org. Perox. G,Notified C&L,13,H411:13;H315:13;Not classified:13
132810,"1,3-difluoro-2-nitrobenzene",242-793-8,19064-24-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42;H312:1;H332:1;H302:1
132812,4-Biphenylyl acetate,604-655-9,148-86-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
132817,Valeramide,210-974-0,626-97-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
132819,C.I. Solvent Yellow 83,602-766-7,12239-75-7,Not Classified,Notified C&L,5,Not classified:5
132820,"2-(4-methylphenyl)-1,3-dioxan-5-ol",225-295-5,4757-23-7,Not Classified,Notified C&L,88,Not classified:88
132821,Pyrochroite (Mn(OH)2),215-188-1,1310-97-0,Not Classified,Notified C&L,2,Not classified:2
132825,"2-({3-(octadecanoyloxy)-2,2-bis[[](octadecanoyloxy)methyl]propoxy}methyl)-2-[[](octadecanoyloxy)methyl]propane-1,3-diyl dioctadecanoate",615-229-7,70969-57-2,Not Classified,REACH registration C&L,8,Not classified:8
132828,Methyl 3-methyl-2-butenoate,213-107-4,924-50-5,Flam. Liq. 3,REACH registration C&L,66,H226:66;H319:1;H315:1;H335:2
132833,"(2,6-dimethylphenyl)boronic acid",600-084-4,100379-00-8,,Notified C&L,9,H319:9;H315:9;H335:8
132836,Geranyl hexanoate,233-102-0,10032-02-7,Not Classified,Notified C&L,89,Not classified:89
132838,Non-1-yne,222-375-1,3452-09-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H226:43;H315:39;H335:38;H304:5
132839,"6,10,14-trimethylpentadeca-5,9,13-trien-2-one",212-097-9,762-29-8,Not Classified,Notified C&L,89,Not classified:88;H411:1;H315:1
132841,"2-Propanol, 1,1',1''-nitrilotris-, compds. with ethanol 2-[2-(C12-14-alkyloxy)ethoxy] derivs. hydrogen sulfates",606-974-9,222975-06-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:4;H315:4
132843,"2-Hepten-4-one, 5-methyl-, (2E)-",600-299-3,102322-83-8,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A,REACH registration C&L,1,H317:1;H226:1;H315:1;H302:1
132847,"Guaiacum officinale, ext.",283-494-2,84650-13-5,Not Classified,Notified C&L,112,Not classified:61;H226:51
132855,1-hydroxyanthraquinone,204-946-7,129-43-1,Eye Irrit. 2;Carc. 2,Notified C&L,39,H319:39;H351:39
132856,N-ethylisopropylamine,243-442-1,19961-27-4,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,46,H225:46;H314:46;H318:1
132857,"Willow, Salix purpurea, ext.",283-301-1,84604-23-9,Not Classified,Notified C&L,1,Not classified:1
132860,Isonicotinaldehyde thiosemicarbazone,214-848-6,1200-00-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
132864,Diethyl bis(2-cyanoethyl)malonate,215-886-6,1444-05-9,,Notified C&L,4,H332:4;H312:4;H301:4
132867,6-tert-butyl-4-(morpholinomethyl)-o-cresol,284-250-8,84824-97-5,Eye Irrit. 2,Notified C&L,38,H319:38
132868,9-oxiranylnonyl methacrylate,607-258-9,23679-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
132871,"3,6-dihydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran",217-241-4,1786-08-9,Not Classified,Notified C&L,235,Not classified:234;H319:1;H411:1
132877,"1,6-dioxaspiro[2.5]octane",606-058-9,185-72-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H226:1;H315:1;H335:1
132881,m-anisidine,208-651-4,536-90-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,135,H410:134;H335:41;H319:42;H315:42;H400:134;H302:133;H373:93;H311:95;H332:93;H301:2;H371:1;H331:2
132882,"(E)-5-benzyl-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-N-nitro-1,3,5-triazinan-2-imine",606-753-7,213967-55-6,,Notified C&L,1,Not classified:1
132884,[No public or meaningful name is available],619-555-0,344413-67-8,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,3,H412:3;H302:3
132885,5-chloro-2-pyridylamine,214-020-4,1072-98-6,Acute Tox. 4,REACH registration C&L,60,H302:60;H312:6;H335:8;H319:11;H315:11;H332:7
132890,4-methyl-3-nitrobenzoyl chloride,233-858-1,10397-30-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
132895,C.I. Solvent Black 29,612-670-7,61901-87-9,Skin Sens. 1;Resp. Sens. 1,Notified C&L,601,H317:494;H334:494;H360:83;Not classified:21;H411:2;H400:1;H410:1
132897,"(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt",425-510-4,167944-94-7,Aquatic Chronic 3,Harmonised C&L,0,H412:0
132903,"Benzenesulfonic acid, hydroxy-, monosodium salt, polymer with formaldehyde and 4,4'-sulfonylbis[phenol]",615-559-1,71832-81-0,Not Classified,Notified C&L,42,Not classified:37;H412:4;H411:1
132904,6-chloro-2-methylpyridine,242-241-6,18368-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44;H312:6;H332:6;H302:6
132910,"2,4-dimethylanisole",229-794-9,6738-23-4,Not Classified,Notified C&L,126,Not classified:88;H318:38;H315:38;H302:38;H335:38
132912,"p-[(5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridyl)azo]-N-(2-ethylhexyl)benzamide",250-205-6,30449-81-1,Not Classified,REACH registration C&L,11,Not classified:11
132918,2-(methoxycarbonyl)-6-nitrobenzoic acid,606-804-3,21606-04-2,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,41,H319:3;H412:2;H302:38;H315:1
132919,"3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctan-1-ol",211-477-1,647-42-7,Acute Tox. 4;STOT RE 2,REACH registration C&L,167,H373:37;H302:93;H319:69;H315:68;H335:68;H411:24;Not classified:6;H372:1;H331:1
132920,DL-allo-isoleucine,207-139-8,443-79-8,Not Classified,Notified C&L,103,Not classified:103
132921,Tungsten tetrachloride oxide,236-863-7,13520-78-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39;H290:1;H318:1
132927,"chlorotoluron (ISO);3-(3-chloro-p-tolyl)-1,1-dimethylurea",239-592-2,15545-48-9,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H400:0;H410:0;H351:0;H361:0
132929,"2,3-dichloropropionic acid",209-285-8,565-64-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,42,H311:39;H301:39;H314:39;H302:3;H290:1;H318:1
132930,4-nitrophenyl formate,217-473-6,1865-01-6,,Notified C&L,4,H319:4;H315:4;H335:4
132932,4-[bis(p-tolyl)amino]benzaldehyde,255-996-1,42906-19-4,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H400:38;H410:38
132936,Disodium dihydrogenpyrophosphate,231-835-0,7758-16-9,Eye Irrit. 2,REACH registration C&L,435,H319:277;H318:88;H302:104;Not classified:70;H315:5;H335:2
132939,C.I. Solvent Red 132,612-357-5,61725-85-7,Not Classified,Notified C&L,1,Not classified:1
132943,Tridecylcyclohexane,227-854-9,6006-33-3,Asp. Tox. 1,Notified C&L,1,H304:1
132944,2-nitroso-1-naphthol,205-064-5,132-53-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42;H370:1
132948,sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate,425-460-3,,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
132950,hydroxylamine dihydrogenphosphate,242-818-2,19098-16-9,Expl. 1.1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H317:0;H373:0;H312:0;H319:0;H315:0;H400:0;H201:0;H302:0;H351:0
132951,"2,2'-(5-bromomethyl-1,3-phenylene)di(2-methylpropiononitrile)",601-717-7,120511-84-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,8,H332:7;H312:7;H302:7;Not classified:1
132955,Indol-3-ylacetonitrile,212-232-1,771-51-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,47,H332:45;H312:45;H302:45;H301:4;H311:2;H331:2
132956,"4-(4,6-Dichloro-2-pyrimidyl)morpholine",600-506-7,10397-13-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
132957,1-[4-(difluoromethoxy)phenyl]ethan-1-one,281-174-7,83882-67-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:1
132958,"(4R)-4-Benzyl-1,3-oxazolidin-2-one",600-264-2,102029-44-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H315:2;H335:2
132959,Aclarubicin,260-824-3,57576-44-0,Acute Tox. 3,Notified C&L,38,H301:38
132960,Tetrabutylammonium iodide,206-220-5,311-28-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,296,H411:2;H318:203;H315:255;H302:296;H335:252;H319:250;Not classified:2
132964,"Butanoic acid, 2-(methylthio)-, methyl ester",610-684-8,51534-66-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,89,H319:88;H315:88;H302:88;H335:88;Not classified:1
132968,"2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide monohydrochloride",256-148-3,43218-56-0,Acute Tox. 3,Notified C&L,2,H301:2;H317:1
132969,"17-hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dione 17-acetate",261-379-8,58652-20-3,Repr. 2;Aquatic Acute 1,Notified C&L,64,H400:39;H361:41;H410:18;H360:20;Not classified:2;H312:2;H332:2;H302:2;H411:2;H413:1;H351:2
132970,"Lubricating oils, used, vacuum distd.",295-422-7,92045-41-5,Skin Sens. 1B;Muta. 2;Carc. 1B,REACH registration C&L,7,H317:4;H341:4;H350:6;H304:2;Not classified:1
132972,Bis(2-methoxyethyl)amine,203-923-9,111-95-5,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,134,H226:134;H318:90;H314:134;H312:5;H302:1
132976,"2',4'-difluoro[1,1'-biphenyl]-4-yl acetate",261-598-9,59089-67-7,Not Classified,REACH registration C&L,2,Not classified:2
132978,Pyroligneous acids,232-450-0,8030-97-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,214,H319:180;H315:180;H312:48;H335:38;H226:38;Not classified:34;H302:10
132980,Poly(vinylidene fluoride),607-458-6,24937-79-9,,Notified C&L,47,Not classified:46;H319:1;H315:1;H335:1
132981,3'-amino-4'-methoxyacetanilide,228-938-8,6375-47-9,Not Classified,Notified C&L,11,Not classified:9;H319:2;H315:2;H302:2;H335:1
132984,"3-isopropenyl-1,2-dimethylcyclopentan-1-ol",276-639-6,72402-00-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,144,H319:144;H315:144
132988,"1,2,2,2-Tetrachloroethyl chloroformate",619-313-4,98015-53-3,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,38,H311:38;H301:38;H314:38;H331:38
132989,"Ethyl phenyl(2,4,6-trimethylbenzoyl)phosphinate",282-810-6,84434-11-7,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2400,H317:2287;H411:2284;H412:81;Not classified:32;H413:1;H373:1;H319:1;H315:1;H335:1;H400:1;H361:1
132990,"Alkenes, C6-10, hydroformylation products, high-boiling",271-230-9,68526-82-9,Not Classified,Notified C&L,1,Not classified:1
132996,Phenethyl methacrylate,222-969-0,3683-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,88,H319:88;H315:88;H335:88
132999,4-mercapto-4-methylpentan-2-one,243-386-8,19872-52-7,Not Classified,Notified C&L,160,Not classified:114;H319:44;H226:46;H315:39;H335:43
133000,Allyl phenyl ether,217-125-3,1746-13-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;Not classified:1
133002,Boron carbide,235-111-5,12069-32-8,Not Classified,REACH registration C&L,128,Not classified:122;H319:5;H332:6;H315:5;H335:5
133004,"S,S-dimethyl cyanoimidodithiocarbonate",233-467-6,10191-60-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,48,H314:48;H302:41;H317:5;H301:7;H311:7;H330:6;H331:1;H335:1;H318:1;H332:2;H312:2
133005,"8-methoxy-2,6-dimethyloct-2-ene",259-903-5,55915-70-3,Not Classified,Notified C&L,88,Not classified:88
133013,"Amines, C10-18-alkyldimethyl, N-oxides",287-010-0,85408-48-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,2,H400:2;H318:2;H315:2;H302:2
133016,TRANS-4-(4-CHLOROPHENYL)-1-CYCLOHEXANE CARBOXYLIC ACID,610-473-0,49708-81-8,,Notified C&L,7,H319:5;H315:5;H335:5;H373:2;H412:1;H411:1
133019,2-aminocyclopent-1-ene-1-carbonitrile,917-554-2,2941-23-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,5,H312:4;H335:5;H319:5;H315:5;H332:4;H302:4
133023,"Sodium 2,4,5-trichlorobenzenesulphonate",258-548-3,53423-65-7,Not Classified,REACH registration C&L,3,Not classified:3
133025,"reaction mass of:(3S)-3-(dodecylthio)-1-[(1S,2R)-2,6,6-trimethyl-3-cyclohexen-1-yl]-1-butanone and(3R)-3-(dodecylthio)-1-[(1S,2R)-2,6,6-trimethyl-3-cyclohexen-1-yl]-1-butanone and(3S)-3-(dodecylthio)-1-[(1R,2S)-2,6,6-trimethyl-3-cyclohexen-1-yl]-1-butanone and(3R)-3-(dodecylthio)-1-[(1R,2S)-2,6,6-trimethyl-3-cyclohexen-1-yl]-1-butanone",456-350-3,878665-13-5,Skin Sens. 1B,REACH registration C&L,1,H317:1
133027,(S)-[1-carboxy-2-(2-mercaptoimidazol-4-yl)ethyl]trimethylammonium hydroxide,207-843-5,497-30-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
133028,Calcium hexaboride,234-525-3,12007-99-7,Not Classified,REACH registration C&L,48,Not classified:6;H319:42;H315:42;H335:42
133030,Dimethyl butynedioate,212-098-4,762-42-5,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,53,H314:53;H302:50;H311:4;H332:3;H312:3;H335:1;H318:2
133031,Bis(2-hydroxyethyl)methyloctylammonium toluene-p-sulphonate,261-430-4,58767-50-3,Skin Corr. 1A,Notified C&L,25,H314:25
133033,Methyl 5-nitrosalicylate,241-330-7,17302-46-4,,Notified C&L,4,H319:4;H315:4;H335:4
133037,nickel(II) hydrogen citrate,242-533-3,18721-51-2,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H410:0;H360:0;H334:0;H400:0;H350:0;H372:0;H341:0
133043,(S)-α-(acetylthio)benzenepropanoic acid,430-300-0,76932-17-7,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0,H317:0;H318:0;H302:0
133044,Diphenyl[2-(triethoxysilyl)ethyl]phosphine,242-427-7,18586-39-5,,Notified C&L,3,H312:2;H335:3;H319:3;H315:3;H332:2;H302:3
133045,4-nitrosalicylic acid,210-584-0,619-19-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H315:42;H302:41;H335:41;Not classified:1
133049,"Acetic acid, chloro-, reaction products with 4,5-dihydro-2-nonyl-1H-imidazole-1-ethanol and sodium hydroxide",271-789-9,68608-61-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5,H319:5;H315:5
133052,"trans-cyclobutane-1,2-dicarboxylic acid",214-392-8,1124-13-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39;H302:1
133054,Tin selenide,215-257-6,1315-06-6,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H410:42;H301:42;H331:42;H400:42
133057,"Aspalathus linearis, ext.",616-481-0,776295-36-4,Not Classified,Notified C&L,26,Not classified:26
133065,Amiodarone,217-772-1,1951-25-3,Not Classified,Notified C&L,54,Not classified:53;H302:1
133066,"6-diazo-5-oxo-5,6-dihydronaphthalene-1-sulfonic acid ester mixture with 2-[bis-(2,3,5 trialkyl-4-substituted alkyl] substituted benzene",444-120-5,,Expl. 1.1;Flam. Sol. 1;Aquatic Chronic 4,Notified C&L,1,H228:1;H201:1;H413:1
133069,"2',4',6'-trihydroxyacetophenone",207-556-5,480-66-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
133073,"Distillates (coal tar), naphthalene oils, alk. exts.;Alkaline Extract;[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]",292-611-6,90640-89-4,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
133076,"3,6-dichloro-4-methylpyridazine",242-794-3,19064-64-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:48;H315:48;H335:47;H312:1;H332:1;H302:1
133080,"Cherry laurel, ext.",289-689-9,89997-54-6,Flam. Liq. 3,Notified C&L,87,H226:87
133083,Etretin,259-474-4,55079-83-9,Skin Irrit. 2;Eye Irrit. 2;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47,H410:47;H360:47;H319:47;H315:47;H400:47
133084,Bis(hydroxyethyl)ammonium chloride,238-396-4,14426-21-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,447,H319:447;H315:447
133085,1-fluoroheptane,211-545-0,661-11-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H225:38;H315:38;H335:38
133091,"1,1'-(ethylene)bis[5-oxopyrrolidine-3-carboxylic] acid",220-427-8,2761-13-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
133092,"3,4-dihydro-2H-pyran-2-carbaldehyde",202-884-5,100-73-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,73,H312:38;H335:40;H318:38;H315:40;H332:71;H226:73;H319:2
133097,"Ceramic materials and wares, chemicals",266-340-9,66402-68-4,Eye Dam. 1,REACH registration C&L,1003,H318:69;Not classified:700;H319:141;H315:225;H335:137;H350:37;H332:1;H302:1;H373:1
133098,2-aminoethyl dihydrogen phosphate,213-988-5,1071-23-4,Skin Corr. 1B,Notified C&L,50,H314:44;H302:3;Not classified:3;H300:1;H318:1
133100,"2-(2,4-dichlorophenoxy)aniline",247-603-7,26306-64-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H335:38;H318:38;H315:38;H400:38;H302:38
133106,"Benzenesulfonamide, N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-(2-methylpropyl)-4-nitro-, hydrochloride (1:1)",607-381-8,244634-31-9,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H318:1;H411:1
133107,"Hydrocarbons, C10-C13, n-alkanes",929-018-5,129813-66-7,Asp. Tox. 1,REACH registration C&L,11,H304:11
133109,"Benzenesulfonic acid, 2,4-diamino-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-5-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:4)",612-024-4,607724-40-3,Not Classified,Notified C&L,5,Not classified:5
133111,trans-4-Methyl cylclohexyl amine,607-658-3,2523-55-9,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H226:2;H318:2;H314:2
133112,"1-[(2,4,6-trimethylphenyl)sulphonyl]-1H-imidazole",256-507-4,50257-39-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
133115,Diethoxy(methyl)silane,217-982-3,2031-62-1,Flam. Liq. 2,REACH registration C&L,134,H225:126;H319:123;H315:123;H335:122;Not classified:7
133116,Ethyl 4-hydroxybenzoate,204-399-4,120-47-8,Not Classified,REACH registration C&L,1218,Not classified:695;H304:447;H317:454;H319:523;H315:516;H335:48;H302:4;H334:2
133117,Tristrontium dicitrate,212-392-2,813-97-8,Not Classified,Notified C&L,1,Not classified:1
133123,"1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino] hydrochloride",240-943-7,16899-81-3,Acute Tox. 4,Notified C&L,38,H302:38
133124,4-sulphoanthranilic acid,202-668-0,98-43-1,Not Classified,REACH registration C&L,10,Not classified:10
133128,Azidotri-n-butyltin(IV),605-822-9,17846-68-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H312:38;H301:38;H319:38;H315:38;H400:38;H372:38
133130,"(+)-(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)",430-460-1,133636-82-5,Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0;H314:0
133131,Diethyl sulphite,210-815-5,623-81-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H226:39;H315:39;H335:38
133133,N-(2-hydroxyethyl)-N-[2-[(1-oxooctyl)amino]ethyl]-β-alanine,264-761-2,64265-45-8,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,9,H317:2;H319:3;H411:2;Not classified:6;H315:1
133134,"(2,3-dimethylbut-2-yl)-trimethoxysilane",439-360-2,142877-45-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H318:0;H315:0
133139,"Manganese chloride (MnCl2), tetrahydrate",603-826-5,13446-34-9,Acute Tox. 4,Notified C&L,103,H302:98;H319:36;H411:39;Not classified:5;H332:1;H373:1;H318:1
133144,"Fatty acids, tall-oil, low-boiling",266-039-2,65997-03-7,Not Classified,REACH registration C&L,10,Not classified:10
133145,"[trans(trans)]-4'-butyl[1,1'-bicyclohexyl]-4-carbonitrile",274-891-1,70784-10-0,Not Classified,Notified C&L,1,Not classified:1
133146,Potassium isobutyrate,243-077-8,19455-20-0,Not Classified,REACH registration C&L,2,Not classified:2
133148,"Urea, N-methyl-N'-(1-methyl-1-phenylethyl)-N-phenyl-",610-043-2,42609-73-4,Eye Irrit. 2,Notified C&L,38,H319:38
133152,Di-μ-chlorodichlorobis(η2-ethylene)diplatinum,235-135-6,12073-36-8,,Notified C&L,4,H317:4;H335:4;H319:4;H334:4;H315:4
133153,S-methyl 2-methylbutanethioate,255-648-9,42075-45-6,Flam. Liq. 3,Notified C&L,1375,H226:1365;H335:88;H319:88;H315:88;H302:88
133157,D-glucosamine sulphate,249-379-6,29031-19-4,Not Classified,Notified C&L,58,Not classified:58
133158,2-benzyl-2-methyl-3-butenitrile,407-870-4,97384-48-0,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
133160,"1,4-Dioxaspiro[4.5]decan-8-one",610-352-2,4746-97-8,Not Classified,Notified C&L,5,Not classified:2;H319:3;H315:3;H335:3
133162,"2,4,6-triphenyl-1,3,5-triazine",207-779-8,493-77-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
133163,7-bromoheptanenitrile,244-128-7,20965-27-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:38;H312:4;H332:4;H302:4
133164,"2-Propenoic acid, reaction products with glycidyl tert-decanoate",305-533-5,94624-09-6,,Notified C&L,99,Not classified:73;H319:23;H315:21;H411:5
133166,[No public or meaningful name is available],619-914-1,1116495-86-3,Not Classified,Notified C&L,31,Not classified:31
133167,1-allyl-1H-imidazole,250-618-1,31410-01-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,45,H318:40;H314:45;H302:44;H311:4
133168,Methyl hydrogen succinate,223-408-2,3878-55-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:1
133172,"4,5-dihydro-5-oxo-4-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylic acid, sodium salt",287-722-1,85567-10-8,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,15,H317:1;H318:1;H411:1;Not classified:12;H412:2
133173,Calcium wolframate,232-219-4,7790-75-2,Not Classified,REACH registration C&L,7,Not classified:7
133175,Diisooctyl adipate,215-553-5,1330-86-5,Not Classified,REACH registration C&L,78,Not classified:78
133176,"p-mentha-1(6),8-dien-2-yl acetate",202-580-2,97-42-7,Not Classified,Notified C&L,1549,Not classified:1549
133178,1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol,432-890-5,72955-94-3,Aquatic Chronic 4,Harmonised C&L,0,H413:0
133179,2'-chloroacetophenone,218-397-6,2142-68-9,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,Notified C&L,79,H319:53;H302:74;H335:51;H315:11;H301:2;H311:2;H331:1;H330:1;Not classified:2
133181,"ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate",429-020-1,204254-96-6,Skin Sens. 1;STOT RE 2,Harmonised C&L,0,H317:0;H373:0
133182,"Laurus nobilis, ext.",283-272-5,84603-73-6,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Muta. 2;Carc. 2;Aquatic Chronic 2,REACH registration C&L,1680,H317:1678;H351:1676;H411:1493;H319:1636;H315:1636;H304:1678;H226:1678;H341:1676;H412:1
133184,2'-deoxy-5-iodocytidine,210-269-8,611-53-0,Acute Tox. 4,Notified C&L,40,H302:40
133187,"chlordecone (ISO);perchloropentacyclo[5,3,0,0",205-601-3,143-50-0,Acute Tox. 3;Acute Tox. 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H301:0;H311:0;H400:0;H351:0
133188,(S)-2-Oxiranylanisole,615-242-8,71031-03-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Carc. 1B,Notified C&L,39,H317:39;H312:39;H335:39;H318:38;H315:39;H332:38;H350:38;H361:1;H319:1;H372:1;H412:1;H351:1;H336:1
133189,2-ethylhexyl benzoate,226-641-8,5444-75-7,Repr. 1B,Notified C&L,213,H360:90;H413:74;Not classified:49
133193,"Dichlorotetrakis[N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide]manganese",278-301-3,75747-77-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,84,H400:84;H410:84;H302:84
133195,"(2R)-2-{[(5-bromo-2,3-difluorophenyl)oxy]methyl}oxirane",615-096-5,702687-42-1,Skin Sens. 1;Muta. 2,Notified C&L,1,H317:1;H341:1
133201,"4,4'-methylenebis(N,N'-dimethylcyclohexanamine",412-840-9,13474-64-1,Acute Tox. 4;Skin Corr. 1A;STOT RE 2;Aquatic Chronic 3,Harmonised C&L,0,H373:0;H412:0;H314:0;H302:0
133202,"4,5-dimethylthiazole-2(3H)-thione",226-327-0,5351-51-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
133203,"Bis(pentane-2,4-dionato-O,O')bis(propan-2-olato)titanium",241-866-1,17927-72-9,Eye Irrit. 2,REACH registration C&L,475,H319:237;H318:230;H335:111;H311:45;H225:52;H332:45;H336:101;H315:87;Not classified:8;H302:1;H226:2
133207,"Alcohols, C10-16, ethoxylated, sulfates, sodium salts",500-480-6,161025-23-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
133208,"3,3'-sulphonyldianiline",209-967-5,599-61-1,Acute Tox. 4;STOT SE 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,187,H373:102;H411:106;H371:102;H302:110;H319:63;H315:78;H335:61;H317:15;H410:15
133211,Acetoin,208-174-1,513-86-0,Flam. Liq. 3;Eye Dam. 1,REACH registration C&L,1765,H226:472;H318:95;H319:1494;H228:1297;H315:1580;H371:83;H331:83;H373:39;H314:4;H335:2
133215,Ethyl (E)-2-methylpent-2-en-1-oate,216-574-2,1617-40-9,Flam. Liq. 3,Notified C&L,88,H226:88
133225,"Sodium 6-[(2,4-diaminophenyl)azo]-3-[[4-[[4-[[7-[(2,4-diaminophenyl)azo]-1-hydroxy-3-sulpho-2-naphthyl]azo]phenyl]amino]-3-sulphophenyl]azo]-4-hydroxynaphthalene-2,7-disulphonate",280-246-5,83221-67-4,Not Classified,Notified C&L,8,Not classified:8
133229,"5-chloro-3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxybenzenesulphonic acid",247-233-6,25746-81-0,Not Classified,Notified C&L,1,Not classified:1
133234,"[3R-(3α,3aβ,7β,8aα)]-octahydro-3,8,8-trimethyl-6-methylene-1H-3a,7-methanoazulene",208-898-8,546-28-1,Not Classified,Notified C&L,216,Not classified:109;H400:74;H410:99;H304:68
133235,"Tricyclo[3.3.1.13,7]decane-1-carbonitrile",245-413-9,23074-42-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H332:42;H312:42;H302:42;H335:4;H319:5;H315:5;H301:2;H311:2;H331:2
133238,"Fatty acids, C14-22, C16-24-alkyl esters",296-566-3,92797-30-3,Not Classified,Notified C&L,52,Not classified:52
133240,2-butylbenzofuran,224-250-7,4265-27-4,Not Classified,REACH registration C&L,44,Not classified:6;H413:38
133245,"Alcohols, C10-16, ethoxylated, sulfates, sodium salts",500-223-8,68585-34-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1664,H319:1118;H315:1650;H318:498;H412:182;Not classified:13;H411:8;H302:4;H314:1
133248,"methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate",424-430-7,125778-19-0,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
133250,Dipotassium disulphate,232-216-8,7790-62-7,Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,163,H318:73;H314:160;H331:38;H335:4;Not classified:1
133251,"Reaction mass of tetrasodium 2-((1-(3-(6-fluoro-(4-((N-(2-(2-sulfatoethanesulfonyl)ethyl)-N-phenyl)amino)-1,3,5-triazin-2-ylamino)-2-hydroxy-5-sulfonatophenylazo)-1-phenylmethyl)azo)-4-sulfonatobenzoate cuprate (4-) and trisodium 2-((1-(3-((4-(N-(2-ethenesulfonylethyl)-N-phenyl)amino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-hydroxy-5-sulfonatophenylazo)-1-phenylmethyl)azo)-4-sulfonatobenzoate cuprate (4-)",419-480-1,,Not Classified,REACH registration C&L,1,Not classified:1
133253,3-amino-5-nitrosalicylic acid,212-602-2,831-51-6,Not Classified,REACH registration C&L,2051,Not classified:2051
133257,2-methyl-5-nitrobenzoxazole,250-904-6,32046-51-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H302:38;H335:38
133258,N-methylcaprolactam,219-874-1,2556-73-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46,H312:46;H335:45;H319:46;H315:46;H332:40;H302:46
133260,Trimethyloxirane,225-784-3,5076-19-7,Flam. Liq. 2,Notified C&L,39,H225:39
133262,"3-β,14-dihydroxy-5-β,14-β-card-20(22)-enolide",205-603-4,143-62-4,Acute Tox. 2,Notified C&L,41,H300:40;H301:1
133264,"Phosphoric acid, mono-C12-14-alkyl esters, compds. with diethanolamine (1:2)",291-949-1,90506-83-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H315:2
133265,(R) - (-) - 5-methoxy laudanosinium dibenzoil L-tartate,600-608-1,104832-01-1,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H411:1;H302:1
133267,Metrafenone,606-928-8,220899-03-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,266,H400:265;H410:228
133268,Sodium cyanotrihydroborate,247-317-2,25895-60-7,Flam. Sol. 1;Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,228,H410:172;H300:228;H400:169;H228:221;H310:228;H314:228;H330:228;H318:59;H261:6;H260:8;Not classified:1
133274,"Hydrocarbons, C9, aromatics",918-668-5,128601-23-0,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,80,H411:80;H335:80;H304:80;H226:80;H336:78;H400:1;H319:1;H315:1;H332:1
133277,"1,5-dichloro-2,4-dinitrobenzene",223-027-1,3698-83-7,Aquatic Acute 1,Notified C&L,44,H400:43;H410:5;H312:4;H335:5;H319:5;H315:5;H332:5;H302:5
133278,"Proteinase, serine",253-431-3,37259-58-8,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,39,H319:38;H334:39;H315:39;H335:38
133287,"1,2-dibromo-2-methylpropane",209-835-7,594-34-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,40,H312:39;H335:39;H319:39;H315:39;H332:39;H302:39;H351:39
133289,"Naphtha (petroleum), light hydrocracked;Low boiling naphtha - unspecified;[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C",265-071-4,64741-69-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
133290,Pyridine-2-carbonitrile,202-880-3,100-70-9,Acute Tox. 4;Acute Tox. 3,REACH registration C&L,174,H311:1;H302:170;H319:170;H315:141;H335:140;H332:6;H312:6;H301:1
133295,4-bromomandelic acid,230-085-1,6940-50-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43
133297,dodecyl methacrylate,205-570-6,142-90-5,STOT SE 3,Harmonised C&L,0,H335:0
133300,"2[3H]-Benzofuranone, 3,6-Dimethyl-",613-842-4,65817-24-5,Acute Tox. 4,Notified C&L,113,H302:88;H315:25
133301,2-methylpentan-3-ol,209-286-3,565-67-3,Flam. Liq. 3,Notified C&L,42,H226:42
133303,4-bromoaniline,203-393-9,106-40-1,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H335:40;H311:46;H319:46;H315:46;H302:49;H373:7;H332:7;H410:1;Not classified:1;H331:1;H400:1;H312:1
133304,"Oils, St.-John's-wort",614-798-9,68917-49-7,Not Classified,Notified C&L,1,Not classified:1
133306,Suramin sodium,204-949-3,129-46-4,Skin Sens. 1,Notified C&L,180,H317:180
133309,"Anthracene oil, anthracene paste, anthracene fraction;Anthracene Oil Fraction;[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330°C to 350°C (626°F to 662°F). It contains chiefly anthracene, carbazole and phenanthrene.]",295-275-9,91995-15-2,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
133311,Disilver tartrate,244-127-1,20963-87-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
133312,Neon,231-110-9,7440-01-9,Press. Gas (Comp.),Notified C&L,426,H280:265;H281:161
133313,"8,9,10-trinorbornan-2-one",207-846-1,497-38-1,Flam. Sol. 1,Notified C&L,43,H228:43
133320,m-tolylhydrazine,208-650-9,536-89-0,,Notified C&L,4,H319:4;H315:4;H302:4;H335:4
133321,"D-Ribonic acid, 2-C-methyl-, γ-lactone",610-448-4,492-30-8,Not Classified,Notified C&L,7,Not classified:7
133325,Amygdalin,249-925-3,29883-15-6,Acute Tox. 4,Notified C&L,58,H302:58;H319:5;H315:5;H335:5
133326,Hexyl cyanoacetate,236-426-0,13361-53-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
133329,"cyclohexadeca-1,9-diene",431-730-1,4277-06-9,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H315:0;H413:0
133332,"2-(2,5-dichlorophenoxy)propionic acid",230-170-3,6965-71-5,Acute Tox. 4,Notified C&L,38,H302:38
133336,3-hydroxy-4-nitrobenzoic acid,210-580-9,619-14-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,60,H319:51;H315:51;H335:44;H317:9;H400:9;H351:9;H302:9
133339,"Castor oil, hydrogenated, lithium salt",265-222-4,64754-95-6,Not Classified,REACH registration C&L,473,Not classified:471;H319:2
133340,(±)-4-amino-3-hydroxybutyric acid,213-106-9,924-49-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:40;H335:40
133341,"Phosphomolybdic acid, ammonium salt hydrate",611-191-0,54723-94-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:42;H315:42;H335:42;H314:1
133343,1-[[3-(dimethylamino)propyl]amino]-4-(methylamino)anthraquinone,246-766-1,25264-26-0,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H302:1;H413:1
133345,C.I. Solvent Red 124,602-765-1,12239-74-6,Not Classified,Notified C&L,9,Not classified:9
133346,4-chloro-2-nitrobenzoic acid,228-483-5,6280-88-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,47,H319:47;H315:47;H335:46
133348,3-chloropropionic acid,203-534-4,107-94-8,Skin Corr. 1B;Eye Dam. 1;Muta. 2;Carc. 2,REACH registration C&L,52,H341:2;H351:1;H318:2;H314:52;H302:11;H290:1
133351,Divanadium trisulphide,215-253-4,1315-03-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
133352,Diethyl sebacate,203-764-5,110-40-7,Aquatic Chronic 2,REACH registration C&L,1459,H411:1383;H315:38;Not classified:38
133353,Methyl (S)-3-hydroxybutyrate,258-628-8,53562-86-0,,Notified C&L,7,H318:5;H315:6;Not classified:1;H319:1;H335:1
133358,2-ethylhexyl decanoate,277-647-2,73947-30-5,Not Classified,Notified C&L,27,Not classified:27
133362,"Hydrogen [3-[(2,4-dihydroxyphenyl)azo]-4-hydroxybenzenesulphonato(3-)]cuprate(1-)",248-072-4,26864-44-8,Not Classified,Notified C&L,36,Not classified:36
133363,[No public or meaningful name is available],468-950-2,,Not Classified,Notified C&L,11,Not classified:11
133364,Prussian blue,237-875-5,14038-43-8,Not Classified,REACH registration C&L,329,Not classified:279;H332:36;H312:36;H302:13;H319:1;H315:1;H335:1
133366,4-chloro-3-nitro-N-phenylbenzenesulphonamide,205-297-2,137-49-5,Eye Irrit. 2,Notified C&L,38,H319:38
133367,Diammonium decaborate,234-521-1,12007-89-5,Repr. 2,REACH registration C&L,38,H361:12;Not classified:21;H319:4;H315:4;H302:4;H360:1
133370,Calcium(2+) 4-[(octadecylamino)carbonyl]benzoate,285-323-7,85068-65-1,Not Classified,Notified C&L,3,Not classified:3
133372,"O,o'-dinitrobibenzyl",241-043-7,16968-19-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,39,H319:39;H400:38;H315:39;H335:38
133374,"D-Glucose, 4-O-β-D-galactopyranosyl-, hydrate (1:1)",613-418-9,64044-51-5,,Notified C&L,43,Not classified:43
133377,"Persimmon, Diospyros kaki, ext.",294-374-4,91721-74-3,Not Classified,Notified C&L,2,Not classified:2
133378,"Benzenesulfonic acid, mono-C15-30-branched alkyl and di-C11-13-branched and linear alkyl derivs., calcium salts, overbased",615-296-2,71486-79-8,Not Classified,Notified C&L,128,Not classified:125;H413:3
133379,Perfluorooctanenitrile,211-476-6,647-12-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,2,H311:1;H301:1;H331:1;H312:1;H319:1;H315:1;H332:1;H302:1
133381,4-(acetylamino)-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide,227-027-2,5608-13-9,,Notified C&L,1,H302:1
133382,"Pelargonium capitatum, ext.",290-133-2,90082-45-4,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,37,H317:37;H411:37;H318:37;H315:37
133385,"phenkapton (ISO);S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate",218-892-7,2275-14-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H301:0;H311:0;H331:0;H400:0
133386,"3,4-dichloroisothiazole-5-carboxylic acid",619-518-9,18480-53-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,5,H312:3;H335:4;H319:4;H315:4;H332:3;H302:5;H411:1;H314:1;H412:1
133388,"Fatty acids, C7-16, mixed esters with neopentyl glycol and trimethylolpropane",295-355-3,91995-91-4,Not Classified,Notified C&L,1,Not classified:1
133389,"piperophos (ISO);S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate",607-329-4,24151-93-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0
133390,"4,6-dimethyl-5-formylpyran-2-one",207-554-4,480-65-9,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1;H302:1;H335:1
133392,Pentafluorophenol,212-235-8,771-61-9,Not Classified,REACH registration C&L,57,Not classified:4;H319:41;H315:40;H335:41;H312:13;H302:13;H314:8;H301:1;H311:1;H331:1;H332:2
133393,(2-hydroxyethyl)ammonium mercaptoacetate,204-815-4,126-97-6,Met. Corr. 1;Acute Tox. 3;Skin Sens. 1B,REACH registration C&L,50,H317:12;H290:12;H301:50;H319:38;H315:38
133397,2-Chloro-6-fluorophenol,606-545-6,2040-90-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:40;H315:40;H335:40;H317:5;H361:5;H302:5;H411:5;H340:5;H314:5;H301:1;H311:1
133398,Sodium bis[4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-N-(2-methoxyethyl)benzenesulphonamidato(2-)]cobaltate(1-),274-505-1,70247-76-6,Not Classified,Notified C&L,6,Not classified:6
133399,Naltrexone,240-649-9,16590-41-3,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,73,H318:4;H302:35;H400:38;H317:26;H312:17;H334:17;H332:19;H341:9;H361:2;Not classified:1;H336:2;H362:1
133400,"Benzenamin, N,N,4-trimethyl-, N-oxid",617-362-6,825-85-4,Skin Sens. 1;Muta. 2,Notified C&L,36,H317:36;H341:36
133401,Zinc di(benzimidazol-2-yl) disulphide,221-203-2,3030-80-6,Acute Tox. 3;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H317:2;H400:2;H410:2;H301:2
133405,"Pentane-1,4-diol",210-973-5,626-95-9,Not Classified,Notified C&L,3,Not classified:3
133411,2-phenylhexanenitrile,423-460-8,3508-98-3,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H302:0
133413,"2,3,4-trifluorobenzoic acid",612-077-3,61079-72-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H319:50;H315:50;H335:49
133418,Thiophene-2-carbohydrazide,219-107-0,2361-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:46;H315:46;H335:45;H332:1;H312:1;H302:2
133422,Bismut(III)methanesulfonate,439-650-9,,Skin Corr. 1B,Notified C&L,1,H314:1
133426,1-phenylethylamine,202-706-6,98-84-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H312:0;H314:0;H302:0
133430,"Fatty acids, vegetable-oil, satd.",271-983-3,68648-23-7,Not Classified,Notified C&L,6,Not classified:6
133432,"2,3-dihydro-9,10-dihydroxyanthracene-1,4-dione",241-631-3,17648-03-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H317:39;H319:39;H315:39;H335:39
133433,4-(4-Chlorobenzyl)-2-(1-methyl-4-azepanyl)-1(2H)-phthalazinone,611-699-2,58581-89-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H312:2;H335:2;H315:2;H332:2;H302:2;H413:1;H351:1
133434,"(1R,2S)-(+)-1-Amino-2-indanol",603-940-5,136030-00-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:42;H315:42;H335:41;H312:1;H332:1;H302:1;H311:1;H301:1;H331:1;Not classified:1
133437,"1,3-bis(methoxymethyl)urea",205-454-5,141-07-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
133439,Disodium glutarate,236-864-2,13521-83-0,Not Classified,Notified C&L,24,Not classified:24
133441,"Ginseng, Panax pseudoginseng, ext.",283-493-7,84650-12-4,Flam. Liq. 3,Notified C&L,1322,H226:1316;Not classified:4;H317:1;H302:1
133443,2-chloro-4'-fluoropropiophenone,206-475-2,347-93-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H302:38;H335:42
133448,Isotretinoin,225-296-0,4759-48-2,Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,131,H400:88;H410:89;H360:131;H319:47;H315:46;H335:45;H351:2;H372:1
133449,"mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate",411-270-8,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
133451,"2,2'-dichloroazoxybenzene",236-941-0,13556-84-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38,H400:38;H318:38;H315:38;H335:38
133454,"Isooctadecanoic acid, ester with 1,2,3-propanetriol",262-710-9,61332-02-3,Not Classified,Notified C&L,5,Not classified:5
133458,"N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline",413-380-1,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
133461,Dodecyl 4-hydroxybenzoate,220-195-8,2664-60-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
133462,"13-oxabicyclo[10.1.0]trideca-4,8-diene",213-407-5,943-93-1,Not Classified,REACH registration C&L,43,Not classified:4;H312:38;H335:38;H319:39;H315:39;H332:38;H302:38
133465,"4-Hydroxy-3,5-dimethylbenzonitrile",452-810-2,,Aquatic Chronic 3,REACH registration C&L,1,H412:1
133466,"17-hydroxy-6-methylene-19-norpregn-4-ene-3,20-dione 17-acetate",261-378-2,58652-19-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 1A,Notified C&L,2,H332:1;H312:1;H360:1;H302:1;H351:1;H361:1;H413:1
133467,(Z)-9-octadecenyl hydrogen maleate,275-851-6,71698-87-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1;H302:1
133469,Bis(2-hydroxypropyl)methyl(octadecyl)ammonium methyl sulphate,288-359-1,85712-01-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H410:83;H318:83;H315:83;H400:83;H302:83
133470,"4,4'-diamino[1,1'-biphenyl]-3-sulphonic acid",218-132-4,2051-89-0,Eye Dam. 1,Notified C&L,38,H318:38
133471,"ethyl trans-2,2,6-trimethylcyclohexanecarboxylate",412-540-8,22471-55-2,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H315:0
133474,"Hydrocarbons, C12-C15, n-alkanes, isoalkanes, cyclics, < 2% aromatics",920-107-4,,Asp. Tox. 1,REACH registration C&L,8,H304:8
133481,4-methylheptan-3-ol,239-058-9,14979-39-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H226:42;H315:42;H335:42
133483,"Ethane, 1,2-dichloro-, manuf. of, by-products from, distn. lights",271-788-3,68608-59-3,Not Classified,Notified C&L,1,Not classified:1
133488,"Distillates (coal tar), light oils, alk. exts.;Alkaline Extract;[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]",292-610-0,90640-88-3,Muta. 1B;Carc. 1B,Harmonised C&L,0,H340:0;H350:0
133489,"o-[(2'-hydroxy[1,1'-biphenyl]-4-yl)carbonyl]benzoic acid, compound with 1-[2-(4-chlorobenzhydryloxy)ethyl]piperidine (1:1)",286-126-9,85187-37-7,Aquatic Chronic 3,Notified C&L,2,H412:1;H302:1
133490,"Hexanedioic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol and (9Z)-9-octadecenoic acid",608-662-8,31727-13-6,Not Classified,Notified C&L,8,Not classified:8
133492,"1-Piperazineethanol, 4-[(4-chlorophenyl)phenylmethyl]-, hydrochloride (1:2)",605-374-4,164726-80-1,Acute Tox. 4,REACH registration C&L,4,H302:4
133493,2'-(o-chloro-α-piperidinobenzylidene)hexadecane-1-sulphohydrazide,242-009-4,18118-66-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
133495,"2-Imidazolidinone, 4,5-dihydroxy-1,3-dimethyl-, (4R,5R)-rel-",607-221-7,23349-82-8,Not Classified,Notified C&L,1,Not classified:1
133496,Hexyl isovalerate,233-105-7,10032-13-0,Not Classified,Notified C&L,93,Not classified:91;H319:2;H315:2
133497,Sebacoyl dichloride,203-843-4,111-19-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,49,H314:49;H302:49;H311:4;Not classified:2;H335:2;H290:1;H318:2;H310:3;H332:1
133502,"S,S-dimethyl-N-(p-tolylsulphonyl)sulphoximide",244-861-2,22236-45-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
133505,"1,1-dipropoxytrimethylamine",227-855-4,6006-65-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:39;H226:43;H315:39;H335:38
133509,Lithium methyl 12-oxidooctadecanoate,258-547-8,53422-16-5,Not Classified,Notified C&L,1,Not classified:1
133514,3-Chloro-bicyclo[3.2.1]oct-3-en-2-one,610-618-8,51145-45-0,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,156,H317:156;H318:156;H302:156;H411:156;H226:156
133517,"N,N-dimethyl-3,5-xylidine",225-539-0,4913-13-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT RE 2,Notified C&L,43,H373:42;H312:38;H335:38;H319:39;H315:39;H332:42;H302:42;H311:5;H301:1;H331:1
133520,"tert-butyl [[(1,1-dimethylethoxy)carbonyl]oxy]carbamate",285-055-0,85006-25-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
133522,Trihydro(triethylamine)aluminium,235-138-2,12076-08-3,Flam. Liq. 2;Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A,Notified C&L,38,H260:38;H225:38;H314:38;H250:38
133523,4-chloro-N-methyl-3-nitrobenzenesulphonamide,205-296-7,137-48-4,Eye Irrit. 2;STOT SE 3,Notified C&L,2039,H319:2039;H412:2039;H335:2039
133524,5-Bromo-2-iodopyridine,606-990-6,223463-13-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
133525,"N,N''-hexane-1,6-diylbis[N'-(2-hydroxyethyl)-N'-methylurea]",253-281-9,36938-15-5,,Notified C&L,25,Not classified:25
133526,Diethyl 4-nitrophenyl phosphate,206-221-0,311-45-5,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1,Notified C&L,41,H310:38;H400:38;H300:41;H330:38
133527,"Lubricating oils (petroleum), C",295-423-2,92045-42-6,Carc. 1B,Harmonised C&L,0,H350:0
133528,N-(4-aminophenyl)aniline,202-951-9,101-54-2,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 1,REACH registration C&L,567,H317:550;H410:522;H319:102;H302:548;H400:514;H412:16;H301:4;H335:7;H315:8;H411:4;H373:3;H332:3
133534,4-(1-phenylethyl)-o-cresol,254-171-3,38875-47-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
133535,2-(4-dimethylaminophenylazo)benzoic acid,207-776-1,493-52-7,Not Classified,Notified C&L,20,Not classified:14;H351:4;H411:2
133537,nickel isooctanoate,248-585-3,27637-46-3,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H410:0;H360:0;H334:0;H400:0;H350:0;H372:0;H341:0
133540,"3,6-diphenyl-1H,2H,4H,5H-pyrrolo[3,4-c]pyrrole-1,4-dione",402-400-4,,Not Classified,REACH registration C&L,139,Not classified:139
133542,"Dodecanoic acid, ester with 2,2-bis(hydroxymethyl)-1,3-propanediol",254-440-5,39385-67-6,,Notified C&L,1,Not classified:1
133544,"Fatty acids, tall-oil, reaction products with bisphenol A, epichlorohydrin, glycidyl tolyl ether and triethylenetetramine",606-078-8,186321-96-0,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,26,H317:4;H410:4;H318:4;H315:4;H400:4;Not classified:22
133546,"2,3,5,6-tetramethylpyrazine",214-391-2,1124-11-4,Acute Tox. 4,Notified C&L,1678,H302:1678;H318:41;H315:50;H335:49;H319:9
133548,bis(2-methoxyethyl) ether,203-924-4,111-96-6,Flam. Liq. 3;Repr. 1B,Harmonised C&L,0,H226:0;H360:0
133550,"Fatty acids, tall-oil, compds. with polyethylenepolyamine-tall-oil fatty acid reaction products",265-221-9,64754-94-5,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,9,H317:6;H410:5;H314:3;Not classified:3;H312:2;H335:2;H318:2;H315:3;H332:2;H400:2;H302:3;H319:1
133556,"2,3-dihydro-2-methylbenzofuran",217-124-8,1746-11-8,Skin Sens. 1,Notified C&L,1,H317:1
133557,Silver bromate,232-032-8,7783-89-3,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H272:38
133559,"Reaction mass of 2-(2-(2-butoxyethoxy)ethoxy)ethyl 5-isocyanato-2-methylphenylcarbamate, 2-(2-(2-butoxyethoxy)ethoxy)ethyl 3-isocyanato-4-methylphenylcarbamate and 2-(2-(2-butoxyethoxy)ethoxy)ethyl 3-isocyanato-2-methylphenylcarbamate",917-282-4,,Resp. Sens. 1,REACH registration C&L,1,H334:1;H335:1
133560,"Methylphosphonic acid, compound with amidinourea (1:1)",282-758-4,84402-58-4,Not Classified,REACH registration C&L,39,Not classified:5;H412:34
133563,Acenaphthene,201-469-6,83-32-9,Not Classified,REACH registration C&L,101,Not classified:5;H319:84;H400:88;H410:88;H411:8;H335:1;H315:1
133565,"N,N-dimethyl-1,3-dioxan-2-amine",243-076-2,19449-32-2,Flam. Liq. 3,Notified C&L,38,H226:38
133568,"Methyl 3,5-dichloro-4-hydroxybenzoate",222-074-5,3337-59-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
133569,Dipotassium hydrogenorthophosphate,231-834-5,7758-11-4,Not Classified,REACH registration C&L,1114,Not classified:515;H315:487;H318:104;H302:8;H319:5;H314:4;H335:1
133571,"1-(3,5-dimethoxyphenyl)ethan-1-one",254-322-3,39151-19-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
133576,"4-nonylphenol, branched",284-325-5,84852-15-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0,H410:0;H361:0;H400:0;H302:0;H314:0
133577,"5,6,11,12-tetraphenylnaphthacene",208-242-0,517-51-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
133580,"(S,S)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride",608-524-7,307926-51-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H302:38
133584,"2,5-Furandione, dihydro-, monopolybutenyl derivs.",614-119-6,67762-79-2,Not Classified,Notified C&L,26,Not classified:26
133593,2-chloro-2-methylbutane,209-836-2,594-36-5,Flam. Liq. 3;Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,46,H225:46;H226:2;H315:41;H412:2;H319:39;H335:38;H304:1
133597,Dichloro(2-cyanoethyl)methylsilane,213-985-9,1071-21-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H302:38;H335:38
133600,Chromium acetate,241-562-9,17593-70-3,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H411:1;H319:1;H315:1
133603,"α-d-Glucopyranoside, β-d-fructofuranosyl, dodecanoate",253-432-9,37266-93-6,Eye Irrit. 2,Notified C&L,58,H319:56;Not classified:1;H318:1;H413:1
133605,Barium zinc sulfate sulfide,215-715-5,1345-05-7,Not Classified,Notified C&L,79,Not classified:36;H332:43;H302:43
133611,"Fatty acids, tallow, reaction products with triethanolamine, di-Me sulfate-quaternized",297-088-8,93334-15-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,35,H319:20;H315:22;Not classified:13;H225:2;H318:2
133613,Triethoxy(methyl)silane,217-983-9,2031-67-6,Flam. Liq. 3,REACH registration C&L,709,H226:704;H319:21;Not classified:6;H335:5
133616,"Fatty acids, tall-oil, compds. with diethanolamine",263-157-6,61790-66-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,93,H319:62;H315:61;Not classified:31
133617,"L-glutamic acid, compound with 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine (1:1)",303-954-9,94232-28-7,Not Classified,Notified C&L,2,Not classified:1;H371:1;H302:1
133618,3'-bromoacetophenone,218-396-0,2142-63-4,,REACH registration C&L,56,H319:56;H315:56;H335:49
133619,(R)-2-Oxiranylanisole,615-241-2,71031-02-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Carc. 1B,Notified C&L,39,H317:39;H312:39;H335:39;H318:38;H315:39;H332:38;H350:38;H361:1;H319:1;H372:1;H412:1;H351:1;H336:1
133625,"2,6-dihydroxy-2,6-dimethylheptan-4-one",222-968-5,3682-91-5,Eye Irrit. 2,Notified C&L,38,H319:38
133629,"[trans(trans)]-4'-ethyl[1,1'-bicyclohexyl]-4-carbonitrile",274-890-6,70784-09-7,Not Classified,Notified C&L,1,Not classified:1
133631,"Cherry, sour, ext.",289-688-3,89997-53-5,Not Classified,Notified C&L,92,Not classified:39;H226:27;H224:25;H225:1
133632,"Amines, C12-16-alkyldimethyl, N-oxides",287-011-6,85408-49-7,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,111,H400:111;H318:111;H315:111;H302:31;H411:1
133635,"4,5-dihydro-4,4-dimethyloxazole",250-045-7,30093-99-3,,Notified C&L,5,H225:5
133638,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (101-68-8), Octylamine (111-86-4) and Cyclohexylamine (108-91-8)",926-119-6,,Flam. Sol. 1;Eye Dam. 1,REACH registration C&L,2,H228:2;H318:2
133641,"4,8-dichloroquinoline",244-480-1,21617-12-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
133643,O-ethyl S-(1-methoxycarbonylethyl)dithiocarbonate,435-410-2,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,2,H317:2;H410:2;H315:2;H302:2;H226:2;H400:1
133655,"1,1'-(1,3-Phenylenedicarbonyl)diazepan-2-one",616-020-3,7381-13-7,Not Classified,REACH registration C&L,2,Not classified:2
133658,Ibuprofen,239-784-6,15687-27-1,Acute Tox. 4;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,547,H319:393;H320:5;H302:547;H335:389;H410:42;H361:91;H373:38;H371:35;H360:52;H412:36;H315:26;H411:8;H316:1;H317:1;H332:1;Not classified:1;H312:2;H413:3
133663,"2,2,3,3,3-pentafluoropropylamine",207-010-6,422-03-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,202,H226:156;H314:202;H318:1
133667,"Amines, coco alkyl, ethoxylated, acetates (salts)",612-395-2,61791-15-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,47,H319:22;H411:22;H302:47;H400:19;H318:25;H315:25;H412:6
133670,"reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate;pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate;pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate;hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate",430-070-1,,Aquatic Chronic 2,Harmonised C&L,0,H411:0
133677,Ethyl mercaptoacetate,210-800-3,623-51-8,Flam. Liq. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,48,H319:43;H226:47;H301:48;H315:43;H317:1;H335:1;Not classified:1
133678,"2-aminobenzene-1,4-disulphonic acid",202-669-6,98-44-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,86,H319:85;H315:85;H335:10;Not classified:1
133680,(E)-3-formylbut-2-enyl acetate,247-825-4,26586-02-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,84,H318:84;H332:84;H302:84;H411:84;H314:84
133682,"3,3'-diazidodiphenyl sulphone",278-300-8,75742-13-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H335:38;H319:38;H315:38;H332:38;H302:38
133684,4-bromo-3-nitroanisole,226-290-0,5344-78-5,,Notified C&L,7,H319:7;H315:7;H335:6
133686,"BIS(2,4,6-TRIMETHYLBENZOYL)PHENYLPHOSPHINE OXIDE",605-307-9,162881-26-7,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,301,H317:300;H413:228;H411:72;H302:1;Not classified:1
133687,piperazine phosphate,217-775-8,1951-97-9,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3;Repr. 2,Harmonised C&L,0,H317:0;H361:0;H319:0;H334:0;H315:0;H412:0
133690,2-(aminothioxomethyl)benzohydrazide,226-328-6,5351-66-6,Acute Tox. 3,Notified C&L,38,H301:38
133691,2-(2-pyridyl)ethanol,203-140-2,103-74-2,Eye Irrit. 2,REACH registration C&L,92,H319:90;H315:46;H335:51;H302:1;H311:1;H332:1;H301:1;H412:1
133693,"Gadolinium oxide sulfide (Gd2O2S), europium-doped",271-825-3,68609-41-6,Not Classified,Notified C&L,1,Not classified:1
133694,Tetramethyloxirane,225-785-9,5076-20-0,Flam. Liq. 2;Acute Tox. 4,Notified C&L,39,H225:39;H302:39
133698,2-amino-5-chlorophenol,249-020-3,28443-50-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H319:72;H315:41;H335:40;H410:31;H312:32;H400:31;H332:32;H302:32
133701,"Hydrogen tetrakis(4,4,4-trifluoro-1-phenylbutane-1,3-dionato-O,O')europate(1-), compound with dimethylamine (1:1)",241-865-6,17926-15-7,Not Classified,Notified C&L,1,Not classified:1
133703,"Pentanol, branched and linear",305-536-1,94624-12-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1669,H335:1669;H319:1341;H315:1613;H332:1614;H226:1669;H318:272
133704,"4-(α,α-dimethylbenzyl)phenol",209-968-0,599-64-4,Acute Tox. 4;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,133,H373:8;H410:12;H318:12;H400:13;H302:14;H411:4;H319:119;H315:116;H335:115;Not classified:1;H312:1;H332:1
133705,Rubidium hydroxide,215-186-0,1310-82-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,73,H332:40;H312:40;H314:70;H302:72;H318:1
133706,(E)-pent-3-en-1-oic acid,216-573-7,1617-32-9,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H290:1;H318:1;H314:1
133708,Sodium methylsilanetriolate,240-648-3,16589-43-8,Skin Corr. 1A,Notified C&L,28,H314:23;Not classified:5
133709,2-Bromo-1-(2-chlorophenyl)ethanone,610-492-4,5000-66-8,Skin Corr. 1B,Notified C&L,46,H314:46;H318:1;H302:1;H225:1;H412:1
133710,Dodecyl methyl sulphide,223-028-7,3698-89-3,Asp. Tox. 1,REACH registration C&L,237,H304:34;H400:156;H410:156;H318:156;H315:156;H413:46;Not classified:1
133712,"Fatty acids, C12-20, reaction products with 2-[(2-aminoethyl)amino]ethanol",293-010-1,91032-04-1,Aquatic Chronic 2,Notified C&L,2,H411:2
133714,"Diphosphoric acid, tetrasodium salt, decahydrate",603-854-8,13472-36-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73,H319:73;H315:73;H335:73
133722,"4,5-dihydro-1H-triazolo(4,5-d)pyrimidin-4-ol",220-244-3,2683-90-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:1
133723,6-methoxynaphthalene-2-carbaldehyde,222-377-2,3453-33-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,47,H319:44;H315:44;H335:40;Not classified:3
133724,Heptadec-1-ene,229-825-6,6765-39-5,Not Classified,Notified C&L,4,Not classified:3;H304:1
133725,"[(3,5,6-trichloropyridin-2-yl)oxy]acetic acid",259-597-3,55335-06-3,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,105,H317:63;H373:56;H410:56;H319:64;H400:56;H302:105;H361:4;H413:4;H412:4;H371:1
133728,ethyl 2-(4-phenoxyphenyl)lactate,429-220-9,132584-17-9,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
133730,2-ethylpyridine,202-881-9,100-71-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 2;Repr. 2;STOT RE 2,REACH registration C&L,172,H373:1;H312:5;H361:2;H335:57;H319:58;H332:5;H302:16;H226:171;H315:57
133733,4-[3-(4-piperidyl)propyl]piperidine-1-ethanol,238-761-8,14712-23-3,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,39,H317:38;H318:38;H315:39;H335:38;H319:1
133737,"Glutens, wheat",297-233-5,93384-22-6,,Notified C&L,2,H317:1;Not classified:1
133740,"Methyl 4-hydroxy-2,6-dimethoxybenzoate",266-429-2,66625-19-2,Eye Irrit. 2,Notified C&L,38,H319:38
133744,3-bromophthalide,230-084-6,6940-49-4,Acute Tox. 4,Notified C&L,40,H302:38;H319:2;H315:2;H335:1
133746,Cinnamanilide,221-289-1,3056-73-3,Acute Tox. 4,Notified C&L,38,H302:38
133748,2-chloro-N-(1-methylethyl)acetamide,220-775-0,2895-21-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,161,H319:161;H315:161;H335:161
133750,"Hydrogen [4-[4-(diethylamino)-α-(3,6-disulphonato-1-naphthyl)benzylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium, sodium salt",222-142-4,3369-56-0,Aquatic Chronic 3,Notified C&L,2,H412:1;Not classified:1
133753,reaction mass of: trihexadecylmethylammonium chloride;dihexadecyldimethylammonium chloride,405-620-9,,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H318:0
133759,"Lotus corniculatus, ext.",283-643-1,84696-24-2,Not Classified,Notified C&L,1,Not classified:1
133760,"Sodium 2-amino-4,6-dinitrophenoxide",212-603-8,831-52-7,Acute Tox. 3;Skin Sens. 1,REACH registration C&L,104,H317:52;H301:43;H312:43;H332:43;H302:49;H373:36;H311:38;H331:36;H411:36;Not classified:12;H228:6;H412:3;H201:1;H413:1
133761,4'-chlorobiphenyl-4-ylamine,205-211-3,135-68-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:40;H315:40;H302:39;H335:2;H312:1;H332:1
133763,sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate,435-800-2,,Aquatic Chronic 3,Harmonised C&L,0,H412:0
133768,Sodium (cyano-C)[2H3]trihydroborate(1-),247-318-8,25895-62-9,Flam. Sol. 1;Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Acute Tox. 2,Notified C&L,38,H300:38;H228:38;H310:38;H314:38;H330:38
133770,o-propoxyphenol,228-484-0,6280-96-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H335:1;H319:1;H315:1;H332:1;H302:1;H412:1
133774,"reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)",411-560-4,,Skin Sens. 1;STOT RE 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H372:0;H411:0
133776,"zeolite, phosphor containing, crystalline, synthetic, non fibrous",930-989-2,,STOT RE 2,REACH registration C&L,5,H373:5
133777,methyl 2-fluoroacrylate,607-233-2,2343-89-7,Flam. Liq. 2;Acute Tox. 3;Repr. 1B;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,41,H301:39;H360:3;H225:40;H411:3;H372:3;H311:36;H314:35;H330:36;H312:1;H335:1;H319:1;H315:1;H332:1;H302:1;Not classified:1
133779,2-(2-bromoethoxy)anisole,402-010-4,4463-59-6,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
133780,2-bromobut-1-ene,245-412-3,23074-36-4,,Notified C&L,4,H224:4
133782,BLUE UL 1071,440-200-9,,Eye Dam. 1,Notified C&L,1,H318:1
133785,1-(4-fluorophenyl)-4-oxocyclohexanecarbonitrile,260-111-7,56326-98-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,14,H312:14;H335:13;H319:13;H315:13;H332:14;H302:14
133786,Dichlorotriphenylantimony,209-834-1,594-31-0,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,39,H332:38;H411:38;H302:38;H301:1
133787,4-trans-(4-trans-Propylcyclohexyl)-1-cyclohexanole,617-390-9,82832-72-2,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
133788,Conessine,208-897-2,546-06-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
133789,3-chloro-5-methoxyaniline,233-614-4,10272-06-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
133790,"Cobalt(2+) potassium 2-hydroxypropane-1,2,3-tricarboxylate",304-421-3,94266-16-7,Skin Sens. 1;Carc. 2,Notified C&L,1,H317:1;H351:1
133795,"3-(2-hydroxyethyl)-5,5-dimethylimidazolidine-2,4-dione",249-411-9,29071-93-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
133796,γ-methylaziridine-1-propylamine,278-047-3,74993-03-6,Flam. Liq. 3;Acute Tox. 4,REACH registration C&L,1,H226:1;H302:1
133797,Glycerol dimyristate,258-629-3,53563-63-6,Not Classified,Notified C&L,1,Not classified:1
133798,3-[(4-nitrophenyl)formamido]propanoic acid,611-856-5,59642-21-6,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H335:1
133799,"Dehydrogenase, glutamate (nicotinamide adenine dinucleotide (phosphate))",232-848-4,9029-12-3,Not Classified,Notified C&L,3,Not classified:3
133800,"4-hydroxy-2,2,6,6-tetramethylpiperidine-4-carboxylic acid",265-735-3,65402-65-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
133801,"2-heptadec-8-enyl-4,5-dihydro-1H-imidazole-1-ethylamine monocitrate",268-394-9,68083-45-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,63,H319:60;H315:60;Not classified:3
133804,2-amino-4-chloro-6-methoxypyrimidine,410-050-9,5734-64-5,Acute Tox. 4,Harmonised C&L,0,H302:0
133807,Phenyl formate,217-471-5,1864-94-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H302:38;H335:43
133809,"Anthracene oil, acid ext.;Anthracene Oil Extract Residue;[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 °C to 365 °C (617 °F to 689 °F). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]",295-274-3,91995-14-1,Carc. 1B,Harmonised C&L,0,H350:0
133810,4-methylpentyn-3-ol,209-287-9,565-68-4,,Notified C&L,4,H226:4
133815,Hexaphenoxycyclotriphosphazene,482-200-1,,Not Classified,REACH registration C&L,1,Not classified:1
133816,nickel;nickel powder;[particle diameter < 1 mm],231-111-4,7440-02-0,,,0,H317:0;H412:0;H351:0;H372:0
133817,Trimethyl-2-propynylsilane,236-427-6,13361-64-3,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H225:39;H315:39;H335:39
133819,Ethyl (dimethoxyphosphinoyl)acetate,206-222-6,311-46-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3
133822,"2,3,4,5,6-pentafluoroaniline",212-234-2,771-60-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H315:49;H335:46;H302:6;Not classified:2;H400:1;H412:1
133823,Stannous Chloride Dihydrate,600-045-1,10025-69-1,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,617,H400:225;H314:451;H302:439;H317:302;H318:220;H373:146;H361:127;H315:129;Not classified:36;H410:45;H335:70;H319:45;H332:63;H341:45;H412:38;H290:5
133825,"Trisodium 5-(acetylamino)-4-hydroxy-3-[[2-methoxy-5-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonate",287-270-5,85455-35-2,Not Classified,Notified C&L,3,Not classified:3
133828,"3,4-dimethoxy-β-methylphenethylamine",259-510-9,55174-61-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H302:1;H335:1
133830,Calcium dimethanolate,219-873-6,2556-53-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4,Notified C&L,38,H332:38;H318:38;H315:38;H302:38
133831,"3-(dimethylamino)-2,2-dimethylpropan-1-ol",242-791-7,19059-68-8,Flam. Liq. 3;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H226:1;H318:1;H314:1
133835,"D-Ornithine, N5-[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-",606-116-3,187618-60-6,,Notified C&L,2,Not classified:1;H317:1;H413:1
133837,"2,5-dinitrotoluene",210-581-4,619-15-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H373:0;H301:0;H361:0;H311:0;H331:0;H350:0;H411:0;H341:0
133839,3-(bromomethyl)heptane,242-659-9,18908-66-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,85,H319:52;H315:52;H302:4;H335:47;Not classified:33;H317:1;H226:1
133840,"9,9-bis(methoxymethyl)fluorene",424-650-3,,Not Classified,REACH registration C&L,2,Not classified:2
133841,"3,3'-thiodipropiononitrile",203-926-5,111-97-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
133844,"1-[2-[(5-chloro-2,1,3-benzothiadiazol-4-yl)amino]-4,5-dihydroimidazol-1-yl]ethanone",605-682-9,173532-15-5,Acute Tox. 4;Acute Tox. 4;Repr. 2,REACH registration C&L,3,H332:2;H361:2;H302:3
133851,Ethyl glyoxylate,213-105-3,924-44-7,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,40,H317:40;H315:40;H373:5;H225:7;H304:5;H336:5;H361:1
133852,Methyltripropoxysilane,226-978-0,5581-66-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H226:38;H315:38;H335:38
133858,Vinylphosphonic acid,217-123-2,1746-03-8,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,172,H290:18;H318:100;H314:172
133861,"reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate",415-430-8,86403-32-9,Eye Dam. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0;H318:0
133862,"4,6-diaminobenzene-1,3-disulphonic acid",205-298-8,137-50-8,Not Classified,REACH registration C&L,4,Not classified:4
133865,[2-(diphenylacetoxy)ethyl]diethylmethylammonium bromide,228-077-8,6113-04-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
133866,"N2,N4,N6-trichloro-2,4,6-triamino-s-triazine",231-648-4,7673-09-8,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H335:39;H319:40;H315:40;H272:40;H302:40
133868,Not known,618-583-0,9057-91-4,Resp. Sens. 1,Notified C&L,305,H334:157;H312:93;H335:110;H319:153;H315:127;H332:110;H302:93;Not classified:29;H317:94;H351:68;H331:17;H330:51
133869,"methyl 3-chloro-2-[(5-ethoxy-7-fluoro-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)sulfonylamino]benzoate",604-573-3,147150-35-4,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,130,H400:127;H410:127;H332:38;Not classified:3
133872,"Ethyl 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate",227-026-7,5606-55-3,Aquatic Chronic 3,REACH registration C&L,5,H412:4;H319:1;H315:1;H335:1
133878,"Poly(oxy-1,2-ethanediyl), α,α',α''-phosphinylidynetris[ω-(dodecyloxy)-",608-669-6,31800-90-5,Skin Irrit. 2,Notified C&L,13,H315:13
133879,Nafoxidine hydrochloride,606-036-9,1847-63-8,Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38,H312:38;H351:38;H302:38
133880,Tetradecyl oleate,244-949-0,22393-85-7,Not Classified,Notified C&L,1,Not classified:1
133881,β-methylenephenethyl alcohol,227-857-5,6006-81-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
133883,"tris(η5-2,4-cyclopentadien-1-yl)neodymium",215-057-9,1273-98-9,Flam. Sol. 2;Water-react. 2,Notified C&L,42,H228:42;H261:38
133888,"Fatty acids, C18-unsatd., dimers, hydrogenated, diisooctadecyl esters",500-481-1,161025-24-7,Not Classified,REACH registration C&L,21,Not classified:21
133889,"2,4,6-trimethylbenzoic acid",207-553-9,480-63-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
133895,2-cyclopentylphenol,216-179-5,1518-84-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39;H302:1
133901,2-methylundecanal,203-765-0,110-41-8,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1769,H317:1494;H400:1492;H410:1494;H315:1769;H319:215;H412:275;H332:1;H304:1
133907,"Curcuma aromatica, ext.",305-191-7,94349-73-2,,Notified C&L,26,Not classified:26
133910,4-nitrobenzoic acid,200-526-2,62-23-7,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,411,H319:275;H302:410;H351:23;H361:24;H315:9;H341:2;H332:116;H335:80;H312:40;Not classified:1;H318:1
133911,trans-crotonic acid,203-533-9,107-93-7,Eye Dam. 1,REACH registration C&L,106,H318:6;H312:93;H314:98;H302:100;H311:7;Not classified:3;H319:2;H315:2;H290:1
133917,L-born-2-yl acetate,227-101-4,5655-61-8,Not Classified,REACH registration C&L,1556,Not classified:1556
133919,"2-(3,4-dichlorophenyl)-2-methoxyacetyl chloride",281-009-9,83833-34-5,Not Classified,Notified C&L,2,Not classified:2
133920,Pentaboron sodium octaoxide,234-522-7,12007-92-0,Repr. 2,REACH registration C&L,14,H361:13;Not classified:1
133923,Quadrosilan,251-406-1,33204-76-1,Repr. 1B;STOT RE 1;Aquatic Chronic 4,Notified C&L,56,H372:36;H360:56;H413:56;H371:20
133925,"2,2-dimethylpropane-1,3-diol",204-781-0,126-30-7,Eye Dam. 1,REACH registration C&L,1012,H318:760;H319:222;H315:214;Not classified:18;H335:24
133931,"(E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime",406-100-4,94097-88-8,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
133934,"Anemone montana, ext.",289-557-0,89957-39-1,Flam. Liq. 3,Notified C&L,1,H226:1
133935,"Trilithium 6-[(2,4-diaminophenyl)azo]-3-[[4-[[4-[[7-[(2,4-diaminophenyl)azo]-1-hydroxy-3-sulphonato-2-naphthyl]azo]phenyl]amino]-3-sulphonatophenyl]azo]-4-hydroxynaphthalene-2-sulphonate",280-247-0,83221-68-5,Not Classified,Notified C&L,1,Not classified:1
133936,4-[2-(dimethylamino)ethoxy]benzonitrile,607-338-3,24197-95-3,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,84,H412:83;H318:83;H314:83;H302:84;H312:1;H335:1;H319:1;H315:1;H332:1
133937,2-phenylpropene;α-methylstyrene,202-705-0,98-83-9,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Harmonised C&L,0,H319:0;H226:0;H411:0;H335:0
133938,[3-(trimethoxysilyl)propyl]urea,245-904-8,23843-64-3,Not Classified,REACH registration C&L,592,Not classified:45;H318:546;H315:547;H335:546;H319:1
133939,"methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate",404-130-2,105560-93-8,Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0;H318:0
133940,"Whey, protein-free",271-787-8,68608-58-2,Eye Irrit. 2,Notified C&L,30,H319:20;Not classified:10
133941,"Alcohols, C16-18, ethoxylated, sulfates, sodium salts",500-224-3,68585-40-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,179,H319:156;H412:156;H315:179;H318:23
133943,"Propanoic acid, 2-hydroxy-, 2-(C10-16-alkyloxy)-1-methyl-2-oxoethyl ester",680-247-4,910661-93-7,Aquatic Acute 1,Notified C&L,1,H400:1
133945,"3,4,5-trihydroxybenzaldehyde",237-168-1,13677-79-7,,Notified C&L,5,H319:5;H315:5;H335:4
133949,"Diphosphoric acid, compound with 1,3,5-triazine-2,4,6-triamine",239-590-1,15541-60-3,Eye Irrit. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,61,H319:34;H412:34;H373:34;Not classified:27
133955,"Trifluoromethanesulphonic acid, compound with triethylamine (1:1)",211-475-0,646-58-2,,Notified C&L,1,Not classified:1
133956,6-ethyl-5-fluoro-4(3H)-pyrimidone,422-460-5,137234-87-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0
133958,"2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid",618-658-8,9082-07-9,Not Classified,Notified C&L,138,Not classified:135;H318:3;H315:3
133963,S-[2-(pyridin-4-yl)ethyl] ethanethioate,482-360-2,385398-71-0,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Aquatic Chronic 1,Notified C&L,57,H317:56;H410:56;H312:56;H301:56;H319:57;H315:57;H331:56;H335:1
133964,"N-methylbenzene-1,2-diamine",225-297-6,4760-34-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,39,H312:39;H319:39;H315:39;H332:39;H302:39;H335:1
133972,4-(phenylazo)resorcinol,218-131-9,2051-85-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,182,H319:93;H315:93;H335:93;Not classified:88;H302:1
133979,fonofos (ISO);O-ethyl phenyl ethylphosphonodithioate,213-408-0,944-22-9,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H310:0;H400:0;H410:0;H300:0
133980,"1,2-dihydro-2,2,4-trimethylquinoline",205-688-8,147-47-7,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,100,H411:47;H302:86;Not classified:14;H319:1;H315:1;H335:1
133993,"2',5'-dimethoxyacetoacetanilide",228-936-7,6375-27-5,Acute Tox. 4,Notified C&L,69,H302:69
133995,"5-(3-methylbut-2-enoxy)-5-oxo-2-[2-(phenylmethoxycarbonylamino)-1,3-thiazol-4-yl]pent-2-enoic acid",601-343-4,115065-79-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
133996,3-(3-fluoro-4-methoxybenzoyl)propionic acid,206-474-7,347-63-7,,Notified C&L,5,H319:5;H315:5;H335:5
133997,Dichloromethyltetradecylsilane,261-596-8,59086-80-5,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,25,H318:2;H314:2;Not classified:23
133998,"4,4'-trimethylenedipiperidine",240-941-6,16898-52-5,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,66,H412:8;H318:12;H314:7;H302:27;H319:54;H315:59;H335:55;H413:1
133999,"Fatty acids, vegetable-oil, unsatd.",271-984-9,68648-24-8,Not Classified,Notified C&L,20,Not classified:20
134001,Tetrakis(isobutyrato)zirconium,619-635-5,12567-73-6,Not Classified,Notified C&L,1,Not classified:1
134002,Ethyl 2-bromotetradecanoate,239-059-4,14980-92-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H315:39;H335:38;H410:1
134003,"[2-(3,4-dihydroxyphenyl)-2-oxoethyl]methylammonium chloride",200-525-7,62-13-5,Not Classified,Notified C&L,2,Not classified:1;H301:1
134004,Hex-3-enyl isovalerate,233-104-1,10032-11-8,Not Classified,Notified C&L,89,Not classified:89
134005,"D,L-4-amino-3-hydroxybutyric acid",206-518-5,352-21-6,,Notified C&L,1,H319:1;H315:1;H335:1
134008,"4-bromo-4'-fluoro-1,1'-biphenyl",206-909-0,398-21-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H400:38;H410:38;H318:38;H302:39;H319:1;H315:1;H335:1;H332:1;H312:1;H314:1
134009,"Esterification products of 4,4'-Isopropylidenediphenol, ethoxylated and prop-2-enoic acid and 3,5,5-trimethylhexanoic acid",919-846-5,,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1
134010,"1,3-bis(2,3-epoxypropoxy)butane",222-061-4,3332-48-7,Eye Irrit. 2;Resp. Sens. 1,Notified C&L,38,H319:38;H334:38
134012,Zinc 5-nitroisophthalate,262-309-9,60580-61-2,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,111,H400:20;H411:20;H319:52;H412:32;Not classified:7
134013,"N,N,N',N'-tetramethylhexamethylenediamine",203-842-9,111-18-2,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,233,H373:87;H301:155;H311:184;H318:115;H331:112;H411:154;H314:233;H302:78;H330:66
134016,Ammonium hydrogensulphite,233-469-7,10192-30-0,Eye Irrit. 2,REACH registration C&L,158,H319:148;H315:58;H335:57;Not classified:6;H302:4;H314:4;H312:1;H318:1;H332:1
134017,"Pimenta acris, ext.",294-376-5,91721-75-4,Not Classified,Notified C&L,118,Not classified:89;H317:28;H226:27;H411:27;H304:3;H302:3;H351:2;H319:2;H341:2;H315:1
134018,"4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-α-l-mannopyranosyl)-β-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-, hydrogen sulfate, sodium salt",235-805-8,12768-44-4,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H335:1
134019,"Tall oil, sodium salt",266-037-1,65997-01-5,Skin Corr. 1B;Skin Sens. 1B,REACH registration C&L,138,H317:77;H314:51;H318:25;H315:73;H319:61;Not classified:1
134023,4-chloro-3-nitrobenzyl alcohol,259-901-4,55912-20-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,38,H317:38;H335:38;H319:38;H315:38;H411:38
134030,Nonyl acrylate,220-194-2,2664-55-3,,Notified C&L,1,H335:1;H319:1;H315:1;H400:1;H302:1
134032,2-isopropoxyaniline,249-377-5,29026-74-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
134035,"Lauric acid, diester with glycerol",248-586-9,27638-00-2,Not Classified,Notified C&L,46,Not classified:46
134036,3-METHYLENEQUINUCLIDINE,928-892-5,22207-84-7,Not Classified,Notified C&L,1,Not classified:1
134039,Triethyldialuminium trichloride,235-137-7,12075-68-2,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A,REACH registration C&L,162,H260:162;H314:162;H250:162;H318:116;H225:71
134040,3-Fluorobenzal Bromide,610-260-2,455-34-5,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:39;H314:39;H335:38;H312:1;H332:1;H302:1
134042,4-benzylphenol,202-950-3,101-53-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
134044,"5-bromopyridine-2,3-diamine",254-172-9,38875-53-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45;H312:4;H332:4;H302:5
134049,Diantimony pentasulphide,215-255-5,1315-04-4,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,52,H332:40;H228:52;H411:40;H302:47;H319:5;H315:5;H335:5
134050,5-amino-6-cyanopyrazin-2-yl acetate,259-354-1,54798-28-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H302:38
134054,"Fatty acids, tall-oil, reaction products with polyethylenepolyamines, acetates",265-220-3,64754-93-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,84,H319:62;H315:62;H318:22
134055,6-amino-4-hydroxynaphthalene-2-sulphonic acid,202-000-8,90-51-7,Not Classified,REACH registration C&L,2190,Not classified:92;H412:4;H314:2088;H332:2;H312:2;H302:2;H319:2;H315:4;H318:1
134056,"Benzothiazole-2(3H)-thione, compound with diethylamine (1:1)",253-950-5,38456-45-0,Not Classified,Notified C&L,35,Not classified:35
134060,sec-butyl nitrite,213-104-8,924-43-6,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H225:0;H302:0
134069,"6-nitro-2,4-xylenol",238-436-0,14452-34-7,,Notified C&L,5,H319:5;H315:5;H335:4
134070,Nickel sulfate heptahydrate,600-153-9,10101-98-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H317:39;H410:39;H360:39;H334:39;H315:39;H332:39;H400:39;H350:39;H302:39;H372:39;H341:39
134072,"2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-(2-sulfophenyl)diazenyl]-, sodium salt (1:4)",607-222-2,23354-53-2,Not Classified,Notified C&L,1,Not classified:1
134074,"Tetrasodium 3,3'-[(4-methyl-1,2-phenylene)bis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino[2-(acetylamino)-5-methoxy-4,1-phenylene]azo]]bisnaphthalene-1,5-disulphonate",276-993-1,72906-25-3,Skin Sens. 1,Notified C&L,16,H317:10;Not classified:6
134076,"3,5-dibromo-4-hydroxybenzoic acid",222-075-0,3337-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
134079,2-(chloromethyl)benzoyl chloride,255-998-2,42908-86-1,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 3;Carc. 2,Notified C&L,39,H351:38;H314:39;H302:38;H331:38;H290:1;H318:1
134085,2-(chloromethyl)naphthalene,219-713-5,2506-41-4,Skin Corr. 1B,Notified C&L,42,H314:42;H312:4;H302:4
134086,"1,4-dihydro-4-oxopyridine-2,6-dicarboxylic acid",205-335-8,138-60-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49,H319:49;H315:49;H335:48
134088,"4-amino-3,5-dibromobenzenesulphonamide",254-321-8,39150-45-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
134089,1-Bromo-2-(1-methylethoxy)-benzene,615-067-7,701-07-5,Acute Tox. 4,Notified C&L,39,H302:39
134091,Triiron phosphide,234-682-8,12023-53-9,Not Classified,REACH registration C&L,176,Not classified:138;H319:38;H315:38;H335:38
134093,Diaminotoluene,246-910-3,25376-45-8,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 1B;Repr. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,170,H317:115;H373:93;H301:115;H361:93;H311:88;H319:115;H350:115;H411:115;H341:93;H400:83;Not classified:55;H312:27;H332:22
134098,DL-arginine hydrochloride,250-903-0,32042-43-6,Not Classified,Notified C&L,3,Not classified:3
134101,"β-D-Glucan, (1.fwdarw.3)-",618-576-2,9051-97-2,Not Classified,Notified C&L,2,Not classified:2
134103,2-(ethylthio)-1-phenylethan-1-one,233-613-9,10271-55-3,Acute Tox. 4,Notified C&L,38,H302:38
134104,"Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;Baseoil - unspecified",295-424-8,92045-43-7,Carc. 1B,Harmonised C&L,0,H350:0
134107,3-(trichlorosilyl)propiononitrile,213-986-4,1071-22-3,Skin Corr. 1A,REACH registration C&L,66,H314:28;H311:38;H318:39;H315:38;H302:39;H335:4;H290:1
134110,5-bromouracil,200-084-0,51-20-7,Acute Tox. 4,Notified C&L,43,H302:39;H341:4
134113,Triethoxypentylsilane,220-429-9,2761-24-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:39;H335:39
134116,Dibismuth trisulphide,215-716-0,1345-07-9,Not Classified,REACH registration C&L,72,Not classified:4;H319:68;H315:68;H335:68
134122,N-[3-(dipropylamino)phenyl]acetamide,257-365-6,51732-34-4,Acute Tox. 4,Notified C&L,38,H302:38
134123,Tributylphosphine oxide,212-394-3,814-29-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,44,H332:39;H312:39;H314:44;H302:39;H318:1
134128,Hexaethylcyclotrisiloxane,217-984-4,2031-79-0,,Notified C&L,1,H319:1;H315:1;H335:1
134131,"1-(4-{4-[(2R, 4S)-2Bromomthyl-2-(2,4-dichloro-phenyl)-[1,3]dioxolan-4-ylmethoxy]-phenyl}-piperazin-1-yl)-ethanone",604-274-8,142128-67-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
134134,1-bromo-4-chlorobenzene,203-392-3,106-39-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 2,REACH registration C&L,81,H319:78;H315:77;H335:76;H301:5;H332:5;H312:3;H302:2
134135,"2-Heptanone, oxime",610-969-7,5314-31-8,Not Classified,REACH registration C&L,40,Not classified:2;H317:38;H312:38;H335:38;H319:38;H315:38;H332:38;H302:38
134136,"Fatty acids, tallow, mixed esters with dipentaerythritol, glycerol and pentaerythritol",297-087-2,93334-14-6,Not Classified,Notified C&L,6,Not classified:6
134139,"O,S-diethyl dithiocarbonate",210-813-4,623-79-0,Flam. Liq. 4;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H227:1;H302:1;H412:1
134141,"Copper, [[2,2'-[1,2-ethanediylbis[(nitrilo-. kappa.N)methylidyne]]bis[phenolato-. kappa.O]](2-)]-, (SP-4-2)-",401-910-4,,Aquatic Chronic 2,REACH registration C&L,8,H411:2;Not classified:6
134142,"2-ethyl-2-[[3-(2-methylaziridin-1-yl)propionyl]methyl]propane-1,3-diyl bis(2-methylaziridine-1-propionate)",264-763-3,64265-57-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,308,H317:261;H318:259;H315:252;H302:95;H341:138;H335:46;H334:92;H351:27;H330:11;Not classified:5;H319:6;H373:2;H411:2;H336:1;H371:1
134144,Iron diiodide,232-031-2,7783-86-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 1B,Notified C&L,44,H312:39;H360:39;H335:39;H319:39;H315:39;H332:39;H302:43;H314:5
134145,N-prop-2-ynylphthalimide,230-621-4,7223-50-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,44,H319:44;H302:42;H315:6;H335:5
134147,"1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane",422-850-5,148757-89-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
134149,"1,1-dichloroacetone",208-175-7,513-88-2,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,74,H317:1;H301:46;H318:27;H332:1;H411:1;H314:27;H401:1;H226:72;H410:25;H400:25;H302:25;H335:7;H319:8;H315:5
134152,"N,N-dimethyl-1,3-dioxolan-2-amine",243-075-7,19449-26-4,Flam. Liq. 3,Notified C&L,38,H226:38
134153,p-tert-butylphenyl acetate,221-288-6,3056-64-2,Not Classified,Notified C&L,126,Not classified:88;H334:38
134158,Barium dodecairon nonadecaoxide,234-974-5,12047-11-9,STOT SE 2;STOT RE 2,REACH registration C&L,59,H373:48;H371:48;H332:38;H302:48;Not classified:1
134159,"Fatty acids, coco, diesters with polyethylene glycol",614-314-6,68139-91-3,Not Classified,Notified C&L,48,Not classified:48
134168,"Liatris odoratissima, ext.",271-627-7,68602-86-8,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,1419,H317:1376;H412:1287;H302:1376;H373:1352;Not classified:43;H361:7
134170,"(2-hydroxy-1,1-dimethylethyl)dimethylammonium toluene-p-sulphonate",233-066-6,10026-99-0,Not Classified,Notified C&L,74,Not classified:73;H317:1
134171,Sodium naphthalenesulphonate,215-323-4,1321-69-3,Not Classified,Notified C&L,104,Not classified:104
134175,5-methylhexan-3-one,210-801-9,623-56-3,Flam. Liq. 3,Notified C&L,39,H226:39
134177,"Formaldehyde, reaction products with bisphenol A and Bu alc.",614-845-3,68954-38-1,Not Classified,Notified C&L,12,Not classified:9;H317:3
134179,Di-p-tolyl sulphone,209-969-6,599-66-6,Not Classified,Notified C&L,33,Not classified:33
134182,Monosodium dihydrogen phosphate dihydrate,603-853-2,13472-35-0,,Notified C&L,51,Not classified:51
134186,"Propane-1,2-diol, monoacetate",215-555-6,1331-12-0,Not Classified,Notified C&L,8,Not classified:8
134187,6-Iodo-4-hydroxyquinazoline,605-218-5,16064-08-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
134188,"Pentane-2,4-dione, monolithium salt",242-008-9,18115-70-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,Notified C&L,39,H312:39;H361:38;H335:38;H319:39;H315:39;H332:39;H302:39
134189,N-benzylphthalimide,218-395-5,2142-01-0,Acute Tox. 4,Notified C&L,38,H302:38
134191,"Fatty acids, tallow, compds. with triethanolamine",263-158-1,61790-67-8,Not Classified,REACH registration C&L,7,Not classified:5;H319:2;H315:2
134196,4-hydroxybutane-1-sulfonic acid,928-903-3,,Skin Corr. 1B,Notified C&L,1,H314:1
134197,4-[2-(piperidyl)ethyl]pyridine,236-607-4,13450-67-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H335:38
134202,Methyl decanoate,203-766-6,110-42-9,Aquatic Chronic 2,REACH registration C&L,213,H411:92;Not classified:117;H315:6;H413:1
134205,Ambergris,232-454-2,8038-65-1,Not Classified,Notified C&L,88,Not classified:88
134207,"α,α',α''-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol",246-764-0,25254-50-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,445,H317:445;H319:445;H315:445;H302:445;H332:2
134211,Dodecyltrimethylammonium chloride,203-927-0,112-00-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,420,H319:89;H400:326;H315:137;H302:359;H410:190;H318:250;H314:261;H335:102;H411:47;Not classified:13;H301:5;H312:10;H332:3
134217,"Cotton, Gossypium herbaceum, ext.",607-034-0,223749-08-4,Not Classified,Notified C&L,1,Not classified:1
134218,"4-Methyl-2,6-bis[(4-methylphenyl)amino]-5-{[2-(trifluoromethyl)phenyl]azo}pyridine-3-carbonitrile",444-370-5,669005-94-1,Aquatic Chronic 4,Notified C&L,85,H413:85
134220,"Naphthalenesulfonic acid, diisononyl-, compd. with morpholine (1:1)",618-315-2,89921-55-1,,Notified C&L,1,Not classified:1
134221,"Trisodium 1-amino-4-[3-[[4-chloro-6-(3-sulphonatoanilino)-1,3,5-triazin-2-yl]amino]-4-sulphonatoanilino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",245-651-3,23422-12-0,Not Classified,Notified C&L,64,Not classified:64
134222,Dichloro(diphenyl)methane,218-134-5,2051-90-3,Skin Corr. 1B;STOT SE 3,Notified C&L,43,H314:43;H335:38;H318:1
134226,"2,6-Dichloro-4-methylnicotinamide",609-589-4,38841-54-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H317:1;H312:1;H335:1;H319:1;H334:1;H315:1;H332:1;H302:1
134230,"Bentonite, lime-activated",269-800-7,68333-91-5,Not Classified,Notified C&L,1,Not classified:1
134235,Aluminosilicate refractory ceramic fibres,604-314-4,142844-00-6,Carc. 1B,REACH registration C&L,115,H350:115;H315:1
134240,7-chloro-3-methylquinoline-8-carboxylic acid,402-790-6,90717-03-6,Aquatic Chronic 3,Notified C&L,119,H412:119
134241,"Alcohols, C9-11-iso-, C10-rich",271-234-0,68526-85-2,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,538,H412:117;H315:218;H319:247;Not classified:136;H335:22;H411:20
134242,"vamidothion (ISO);O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate",218-894-8,2275-23-2,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1,Harmonised C&L,0,H400:0;H312:0;H301:0
134246,Piperazin-1-ylpropanol,226-176-0,5317-32-8,Eye Irrit. 2,Notified C&L,43,H319:39;H318:4;H315:5;H335:5;H312:1;H332:1;H302:1
134249,"2-Propanoic acid, 2-methyl-, polymer with ethyl 2-propanoateand methyl 2-methyl-2-proponoate",607-559-5,25133-97-5,Not Classified,Notified C&L,14,Not classified:11;H319:3;H315:3;H413:3
134250,Tetracosane,211-474-5,646-31-1,Not Classified,Notified C&L,8,Not classified:8
134251,"3',6'-dihydroxy-4',5'-dinitrospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",246-308-0,24545-86-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
134252,"4-amino-2,5-dimethoxy-N-methylbenzenesulphonamide",256-435-3,49701-24-8,Not Classified,REACH registration C&L,37,Not classified:37
134256,"2,2'-(vinylenedi-p-phenylene)bis[5-methylbenzoxazole]",219-260-3,2397-00-4,Aquatic Chronic 4,REACH registration C&L,51,H413:3;Not classified:48
134259,"3,3'-thiodi(propionic acid)",203-841-3,111-17-1,Eye Dam. 1,REACH registration C&L,140,H318:92;H319:48;H315:4;H335:4;H317:2
134261,Penfluridol,248-074-5,26864-56-2,Acute Tox. 3,Notified C&L,39,H301:39
134264,Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight,926-771-1,,Carc. 2,REACH registration C&L,11,H351:11
134266,Molybdenum tribromide,236-600-6,13446-57-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
134267,"2-Naphthalenesulfonic acid, 5-[(4-amino-7-sulfo-1-naphthalenyl)azo]- 8-[[4-(4-acetylamino-3-sulfophenyl]azo]",919-027-2,,Not Classified,REACH registration C&L,2,Not classified:2
134269,3-methoxy-α-methyl-L-tyrosine,229-797-5,6739-31-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:39
134271,"2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate",260-828-5,57583-34-3,Repr. 2,Harmonised C&L,0,H361:0
134272,"Amines, tallow alkyl, dodecylbenzenesulfonates",268-766-0,68139-94-6,Not Classified,Notified C&L,17,Not classified:11;H318:6;H315:6
134277,"Fatty acids, vegetable-oil, esters with dipropylene glycol",305-769-9,95009-41-9,Not Classified,REACH registration C&L,3,Not classified:3
134281,3-(dimethylamino)propiophenone hydrochloride,212-909-1,879-72-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,44,H319:40;H301:44;H315:40;H335:1
134282,"(2,4-dichlorophenyl)acetyl chloride",610-950-3,53056-20-5,Skin Corr. 1A;Eye Dam. 1,Notified C&L,91,H318:89;H314:91
134286,"1,1'-bis(1-methylethyl)[3,3'-bianthra[1,9-cd]pyrazole]-6,6'(1H,1'H)-dione",298-413-6,93804-37-6,Not Classified,Notified C&L,1,Not classified:1
134290,"N,N-bis(2-hydroxyethyl)dodecanamide",204-393-1,120-40-1,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,834,H411:244;H318:785;H315:392;H319:48;H373:18;H302:17;H412:1
134293,Tris(perfluorobutyl)amine,206-223-1,311-89-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54,H319:51;H315:51;H335:50;Not classified:3
134298,"[5-benzyl-3-furyl]methyl [1R-[1α,3α(E)]]-3-[(dihydro-2-oxo-3(2H)-thienylidene)methyl]-2,2-dimethylcyclopropanecarboxylate",261-433-0,58769-20-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H410:38;H312:38;H332:38;H400:38;H302:38
134299,"N,N'-methanetetrayldi-o-toluidine",214-929-6,1215-57-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,72,H400:38;H410:38;H302:39;Not classified:33;H413:1
134300,"5,7-dihydroxy-2-(4-methoxyphenyl)-4-benzopyrone",207-552-3,480-44-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:45;H315:45;H335:44
134308,"2-chloro-3,4-dihydroquinazolin-4-one",612-021-8,607-69-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
134311,Toluene-4-thiol,203-399-1,106-45-6,,Notified C&L,16,H312:10;H335:8;H318:4;H315:9;H332:9;H302:10;H311:4;H319:10;H301:4;H330:3;Not classified:1;H331:2
134313,4-ethylpyrocatechol,214-397-5,1124-39-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H318:38;H315:42;H302:38;H335:42;H319:4
134314,(ethylthio)benzene,210-731-9,622-38-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
134316,2-fluoroiodobenzene,206-477-3,348-52-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,48,H318:38;H315:47;H302:41;H319:9;H335:7;H332:1;H312:1;H314:1
134319,Allyl octanoate,224-184-9,4230-97-1,Acute Tox. 4;Acute Tox. 3,Notified C&L,305,H311:263;H302:304;H319:40;H315:40;H335:40;H312:2;H301:1
134323,"phenol, dodecyl-, branched",310-154-3,121158-58-5,Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H410:0;H360:0;H318:0;H400:0;H314:0
134329,"2,4-dichloro-6-nitroaniline",220-241-7,2683-43-4,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,42,H373:38;H300:38;H411:38;H310:38;H330:38;H312:4;H335:4;H319:4;H315:4;H332:4;H302:4
134332,Isooctadecyl isooctadecanoate,255-485-3,41669-30-1,Not Classified,REACH registration C&L,173,Not classified:173
134335,1-aminocyclopentanemethanol,233-697-7,10316-79-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
134336,N-ethylacetamide,210-896-7,625-50-3,Acute Tox. 4,REACH registration C&L,40,H302:40
134338,3-(4-fluorophenyl)-2-methylpropionylchloride,426-370-7,1017183-70-8,Acute Tox. 4;Skin Corr. 1A;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H314:0;H302:0
134339,"1,2-Ethanediamine, N-{3-(trimethoxysilyl)propyl}-,N-{(ethenylphenyl)methyl}derivate,hydrochlorides",605-620-0,171869-89-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 3;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 3;STOT SE 1;Aquatic Chronic 3,REACH registration C&L,105,H317:104;H311:4;H225:4;H318:104;H331:4;H370:4;H302:82;H412:4;Not classified:1
134340,Lead bis(2-ethylhexanoate),206-107-0,301-08-6,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,249,H373:235;H410:235;H360:233;H332:217;H400:235;H302:233;H312:34;H362:48;H350:48;Not classified:14;H361:2
134341,Dibutyl (±)-malate,228-485-6,6280-99-5,Eye Irrit. 2,Notified C&L,22,H319:22
134344,Vincamine,216-576-3,1617-90-9,Acute Tox. 4,Notified C&L,45,H302:45
134347,"3-methoxy-5-methyl-4-oxohexa-2,5-dienoic acid",202-008-1,90-65-3,Acute Tox. 4,Notified C&L,39,H302:39
134351,[2-[[2-cyano-3-[4-[ethylbenzylamino]phenyl]-1-oxoallyl]oxy]ethyl]trimethylammonium chloride,275-604-2,71550-24-8,Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,16,H318:6;H314:4;H411:11;H412:1
134352,Ethyl 4-piperidinecarboxylate,214-416-7,1126-09-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,19,H319:19;H315:19;H335:18;H227:1
134359,"Poly[nitrilomethanetetraylnitrilo[2,4,6-tris(1-methylethyl)-1,3-phenylene]], α-[2,6-bis(1-methylethyl)phenyl]-ω-[[[2,6-bis(1-methylethyl)phenyl]carbonimidoyl]amino]-",617-275-3,81972-48-7,,Notified C&L,35,Not classified:35
134364,"1,3-diethylurea",210-811-3,623-76-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
134371,reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate,405-960-8,,Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0,H317:0;H411:0
134374,(Z)-pent-2-enyl hexanoate,277-808-7,74298-89-8,Not Classified,Notified C&L,88,Not classified:88
134375,Benzyltris(dimethylaminato)phosphorus(1+) tetrafluoroborate(1-),302-080-5,94088-77-4,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,16,H319:16;H412:2;H300:14;H335:14;H311:14;H315:14;H331:14
134376,"(1R-trans)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarbonyl chloride",263-318-0,61914-47-4,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H410:1;H301:1;H315:1;H400:1
134378,S-(3-(triethoxysilyl)propyl)octanethioate,436-690-9,220727-26-4,Skin Sens. 1,Harmonised C&L,0,H317:0
134379,Hexamethyldistannane,211-549-2,661-69-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,51,H410:47;H300:51;H400:46;H310:47;H330:41;H226:6;H311:4
134381,6-amino-m-xylene-4-sulphonic acid,228-878-2,6370-23-6,Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H314:38;H302:38
134387,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., potassium salts",284-669-6,84961-78-4,Acute Tox. 4,Notified C&L,41,H302:37;H412:7;H318:15;H315:15
134389,Ethyl 4-nitrophenylacetate,226-646-5,5445-26-1,Not Classified,Notified C&L,1,Not classified:1
134390,4-Iodophenetole,615-030-5,699-08-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
134396,C.I. Acid Red 131,602-541-3,12234-99-0,,Notified C&L,36,Not classified:36
134406,"[1,1'-biphenyl]-4-sulphonyl chloride",216-609-1,1623-93-4,Skin Corr. 1B,Notified C&L,44,H314:44;H290:1;H318:1
134411,"Iron, complexes with diazotized 3-amino-4-hydroxybenzenesulfonic acid monosodium salt coupled with diazotized 4-nitrobenzenamine and resorcinol, sodium salts",280-013-8,82707-46-8,Not Classified,Notified C&L,1,Not classified:1
134412,"Trisodium bis[5-chloro-3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxybenzenesulphonato(3-)]chromate(3-)",277-382-2,73324-05-7,Aquatic Chronic 4,Notified C&L,6,H413:2;Not classified:2;H319:1;H315:1;H335:1;H412:1
134413,sodium hydroxide;caustic soda,215-185-5,1310-73-2,Skin Corr. 1A,Harmonised C&L,0,H314:0
134417,Aluminium hexafluorosilicate,241-170-8,17099-70-6,Not Classified,Notified C&L,1,Not classified:1
134419,Sodium tetraphenylborate,205-605-5,143-66-8,Acute Tox. 3,Notified C&L,59,H301:57;H319:9;H315:9;H335:8;H302:2;Not classified:1;H310:1;H411:1
134421,Sucrose heptapalmitate,254-177-6,38884-66-1,Not Classified,Notified C&L,1,Not classified:1
134422,(R)-3-(1-methyl-2-pyrrolidinylmethyl)-5-[2-(phenylsulphonyl)ethyl]-1H-indole,921-685-0,,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,1,H402:1;H412:1;H318:1;H302:1
134423,"5,6-Dichloronicotinic Acid",609-951-1,41667-95-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,62,H319:62;H315:62;H335:61;H302:1
134424,"Margosa, ext. [cold-pressed oil of",283-644-7,84696-25-3,Aquatic Chronic 3,Harmonised C&L,0,H412:0
134425,Butan-1-[2H]ol,225-201-2,4712-38-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H335:38;H318:38;H315:38;H302:38;H226:38;H336:38
134427,1-bromo-3-fluorobenzene,214-023-0,1073-06-9,Not Classified,REACH registration C&L,78,Not classified:2;H319:74;H226:76;H315:75;H302:74;H335:3;H317:1;H332:1;H411:1
134428,2-amino-N-(isopropyl)benzamide,250-175-4,30391-89-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H302:42;H335:42
134429,Sodium metaphosphate,233-782-9,10361-03-2,Not Classified,Notified C&L,57,Not classified:56;H312:1
134431,Sodium 2-[(4-hydroxyphenyl)azo]benzoate,250-906-7,32050-78-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H302:38;H335:38
134432,methyl 3-(2-oxocyclohexyl)propanoate,600-517-7,10407-33-7,Not Classified,REACH registration C&L,2,Not classified:2
134434,"2,3,5,6-tetrafluorohydroquinone",212-237-9,771-63-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,46,H318:38;H302:40;H319:8;H315:8;H335:7
134435,Dichloro(ethylenediamine)platinum,237-943-4,14096-51-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:42
134436,"5H-Tetrazole-5-thione, 1-(3-aminophenyl)-1,2-dihydro-",607-213-3,23249-96-9,Flam. Sol. 2,Notified C&L,1,H228:1
134441,2-methylpentan-3-one,209-288-4,565-69-5,Flam. Liq. 2,Notified C&L,76,H225:76
134443,N-(2-bromoethyl)anilinium bromide,213-738-5,1005-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
134445,"bromelain, juice",232-572-4,9001-00-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0,H319:0;H334:0;H315:0;H335:0
134462,S-metolachlor;reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %),618-004-1,87392-12-9,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0
134468,"Fatty acids, palm kernel-oil, potassium salts",275-067-4,70969-43-6,Not Classified,Notified C&L,5,Not classified:5
134469,Zeins,232-722-9,9010-66-6,Not Classified,Notified C&L,90,Not classified:90
134473,2-iodo-2-methylbutane,209-838-3,594-38-7,Acute Tox. 4,Notified C&L,38,H302:38
134476,5-tert-butylisophthalic acid,219-100-2,2359-09-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
134477,2-phenylbutyramide,201-980-4,90-26-6,,Notified C&L,5,H319:4;H315:4;H335:4;H302:1
134483,"1-Propanesulfonic acid, 2-hydroxy-3-(sulfothio)-",610-225-1,45095-93-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
134485,Barium titanium trioxide,234-975-0,12047-27-7,Not Classified,REACH registration C&L,249,Not classified:87;H332:161;H302:161;H373:2;H319:1;H335:1
134488,potassium nitrite,231-832-4,7758-09-0,Ox. Sol. 2;Acute Tox. 3;Aquatic Acute 1,Harmonised C&L,0,H400:0;H301:0;H272:0
134489,"N-(9-acetyl-6,9-dihydro-6-oxo-1H-purin-2-yl)acetamide",221-287-0,3056-33-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H315:45;H335:44;H302:1
134497,reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy)but-2-ylamine,447-920-2,897393-42-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Repr. 2,Harmonised C&L,0,H361:0;H318:0;H314:0;H302:0
134499,2-chloro-4-methoxyphenol,242-007-3,18113-03-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:44;H335:43;H312:4;H302:4;H314:1
134502,"5-ethyl-2-phenyl-1,3-dioxane-5-methanol",244-867-5,22251-63-4,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,83,H317:83;H412:83
134503,"Sodium 1-amino-9,10-dihydro-9,10-dioxo-4-[[3-[(1-oxopropyl)amino]phenyl]amino]anthracene-2-sulphonate",289-550-2,89923-62-6,Eye Dam. 1,REACH registration C&L,8,H318:3;Not classified:5;H412:1
134507,Lead metaborate,238-762-3,14720-53-7,Acute Tox. 4;Acute Tox. 4;Repr. 2;STOT RE 2;Aquatic Chronic 1,Notified C&L,1,H410:1;H373:1;H361:1;H332:1;H302:1
134509,"N,N'-bis[3-(trimethoxysilyl)propyl]ethylenediamine",272-453-4,68845-16-9,Eye Dam. 1,Notified C&L,221,H318:99;H319:64;H315:79;H335:79;Not classified:58;H317:14;H334:1
134510,"9-Octadecenoic acid, 12-hydroxy-, [R-(Z)]-, mono- and diester with glycerol",294-606-4,91744-44-4,Not Classified,Notified C&L,24,Not classified:24
134513,4'-ethoxy-3-hydroxy-2-naphthanilide,225-200-7,4711-68-6,Skin Sens. 1,REACH registration C&L,34,H317:1;Not classified:33
134519,"Sodium 2(or 5)-[[1-amino-4-[[3-[[(chloroacetyl)amino]methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxo-2-anthryl]oxy]-5(or 2)-(tert-butyl)benzenesulphonate",276-634-9,72391-23-2,Aquatic Chronic 3,REACH registration C&L,5,H412:5
134521,drazoxolon (ISO);4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone,227-197-8,5707-69-7,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H301:0
134522,"methyl 7-chloro-6,7,8-trideoxy-3,4-O-isopropylidene-6-{[(4R)-1-methyl-4-propyl-L-propyl]amino}-1-thio-L-threo-α-D-galacto-octopyranoside",604-595-3,147650-54-2,Acute Tox. 4,REACH registration C&L,1,H302:1
134527,4-tert-pentylcyclohexanone,240-642-0,16587-71-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1628,H319:68;H411:27;H315:1366;Not classified:262;H335:42
134528,"Acetic acid, oxo-, sodium salt, reaction products with ethylenediamine and hydroxybenzenesulfonic acid monosodium salt, iron sodium salts",283-042-4,84539-54-8,Not Classified,REACH registration C&L,13,Not classified:12;H319:1;H412:1
134529,Di-L-arginine 2-oxoglutarate,226-059-4,5256-76-8,Not Classified,Notified C&L,20,Not classified:18;H319:2;H315:2;H335:2
134534,Methylcyclohexanone,215-556-1,1331-22-2,Flam. Liq. 3,Notified C&L,33,H226:33
134535,1-formyl-L-proline,236-165-2,13200-83-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H302:39;H335:39
134537,"3-(2-methylpiperidino)propyl 3,4-dichlorobenzoate",222-455-6,3478-94-2,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,127,H400:127;H410:127;H315:127
134539,2-methylheptan-3-ol,242-530-7,18720-62-2,,Notified C&L,4,H226:4
134540,"4,6- dimethyl-2-methylsulfonylpyrimidine",609-077-0,35144-22-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H315:3;H335:2;H317:1;H361:1;H334:1
134544,"Hydrocarbon waxes (petroleum), oxidized, Me esters",271-626-1,68602-85-7,Eye Irrit. 2,REACH registration C&L,469,H319:4;H318:446;Not classified:19
134547,"Ethyl 3,4,5-trihydroxybenzoate",212-608-5,831-61-8,Not Classified,Notified C&L,154,Not classified:154
134550,"2,4-dihydroxy-3-methylbenzaldehyde",228-369-5,6248-20-0,,Notified C&L,2,H319:2;H315:2;H335:2;H312:1;H332:1;H302:1
134552,"Lead, dross, bismuth-rich",273-792-0,69029-46-5,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4;Carc. 1A;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H410:5;H360:5;H318:5;H362:5;H332:5;H400:5;H350:5;H302:5;H372:5;H314:5
134557,5-[(4-methoxyphenyl)methylene]barbituric acid,256-365-3,49546-71-6,Acute Tox. 4,Notified C&L,38,H302:38
134560,1H-imidazole-4-carbonitrile,611-464-4,57090-88-7,,Notified C&L,3,H312:2;H335:3;H319:3;H315:3;H332:2;H302:2;H301:1;H311:1;H331:1
134565,"3,3,3-trifluoropropyne",211-548-7,661-54-1,Not Classified,Notified C&L,1,Not classified:1
134571,4-tert-butylbenzaldehyde,213-367-9,939-97-9,Acute Tox. 3;Skin Sens. 1;Repr. 2;Aquatic Acute 1,REACH registration C&L,132,H317:88;H400:130;H301:84;H361:84;H334:38;H410:47;H302:47
134577,"3,5-xylenol;3,5-dimethylphenol",203-606-5,108-68-9,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0,H311:0;H301:0;H314:0
134582,N-(4-fluorophenyl)acetamide,206-515-9,351-83-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
134583,Hydrazonodeoxybenzoin,226-292-1,5344-88-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
134584,1-(2-nitrophenyl)piperazine,261-593-1,59084-06-9,,Notified C&L,6,H319:6;H315:6;H335:5;H312:1;H332:1;H302:1
134585,vinyl acetate copolymer,925-954-3,,Not Classified,Notified C&L,1,Not classified:1
134586,"Amines, polyethylenepoly-, reaction products with diethanolamine, ethanolamine, tall oil and triethanolamine",295-272-2,91995-12-9,Not Classified,Notified C&L,1,Not classified:1
134589,(Z)-oct-5-en-1-ol,264-764-9,64275-73-6,Not Classified,Notified C&L,272,Not classified:234;H318:38;H315:38
134590,Butyl chloroacetate,209-670-0,590-02-3,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,40,H311:38;H318:38;H315:40;H302:38;H319:2;H335:1
134592,10-aminodecanoic acid,236-033-4,13108-19-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
134593,Pentacontane,229-534-4,6596-40-3,Not Classified,Notified C&L,3,Not classified:3
134596,Ethyl ethylcarbamate,210-812-9,623-78-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,38,H319:38;H351:38;H315:38;H335:38
134597,"2,2,6,6-tetramethyl-4-oxopiperidinooxy",220-778-7,2896-70-0,Acute Tox. 4;Skin Sens. 1A;Self-react. G,REACH registration C&L,84,H317:6;H302:7;Not classified:37;H400:40;H319:4;H315:4;H335:4;H412:2;H242:2;H318:1;H410:1
134598,"4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile",423-500-4,138401-24-8,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
134606,Pidolic acid,202-700-3,98-79-3,Eye Dam. 1,REACH registration C&L,141,H318:68;H319:68;H315:73;H335:72;H302:9;Not classified:5
134608,"5-β-pregnane-3-α,17-α,20-α-triol",214-148-0,1098-45-9,,Notified C&L,1,H302:1
134610,Pyridinium tribromide,254-446-8,39416-48-3,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,57,H314:57;H302:7;H312:1;H335:3;H319:1;H332:1;Not classified:1;H318:1
134614,Succinohydrazide,223-970-9,4146-43-4,Acute Tox. 4,Notified C&L,41,H302:39;H319:3;H315:3;H335:2
134617,N-sodiohexamethyldisilazane,213-983-8,1070-89-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,209,H312:125;H318:126;H332:124;H302:124;H412:125;H314:209;H261:5;H226:1;H228:1;H225:1;H351:1
134624,Quinuclidine,202-887-1,100-76-5,Acute Tox. 3;Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1,Notified C&L,41,H310:41;H318:41;H301:40;H315:41;H302:1
134630,reaction mass of: [1-(methoxymethyl)-2-(C,410-640-6,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H318:0;H315:0
134633,"7(S),20(R)-dihydroxy-16(R)-methyl-10-phenyl-24-oxa[14]cytochalasa-6(12),13(E)-diene-1,23-dione",254-324-4,39156-67-7,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Carc. 2,Notified C&L,38,H310:38;H351:38;H300:38;H330:38
134642,"Tetrafluoroethylene, oxidized, oligomers, reduced, methyl esters",500-550-6,161075-12-3,Not Classified,Notified C&L,1,Not classified:1
134643,nickel hexafluorosilicate,247-430-7,26043-11-8,Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0,H317:0;H410:0;H360:0;H334:0;H400:0;H350:0;H372:0;H341:0
134645,Reaction mass of trans-5-hexyldihydro-4-methylfuran-2(3H)-one and cis-5-hexyldihydro-4-methylfuran-2(3H)-one,922-963-4,,Skin Irrit. 2,REACH registration C&L,1,H315:1
134646,2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate,417-350-9,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H318:0;H315:0
134654,"Dec-1-ene, homopolymer, hydrogenated Dec-1-ene, oligomers, hydrogenated",500-183-1,68037-01-4,Asp. Tox. 1,REACH registration C&L,369,H304:188;Not classified:177;H335:4;H319:3;H332:3;H412:2;H373:2;H226:1;H314:1
134655,"1-(4-chloro-phenyl)-4,4-dimethyl-pentan-3-one",613-923-4,66346-01-8,Aquatic Chronic 2,Notified C&L,122,H411:122;H319:33;H315:33
134656,mixed linear and branched C,420-480-9,158570-99-1,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0;H315:0
134657,"4,4'-carbonimidoylbis[N-methyl-o-toluidine] monohydrochloride",218-436-7,2151-60-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
134660,"Boric acid (H3BO3), reaction products with ethanolamine",302-207-4,94095-04-2,Not Classified,Notified C&L,18,Not classified:18
134662,"Acetic acid, 2,2'-[(dioctylstannylene)bis(thio)]bis-, di-C12-22-alkyl esters",290-466-3,90170-34-6,Repr. 2;STOT RE 1;Aquatic Chronic 4,Notified C&L,1,H372:1;H361:1;H413:1
134666,Hept-1-en-4-ol,222-535-0,3521-91-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42,H318:38;H315:42;H335:42;H319:4;H226:4
134672,,213-103-2,924-42-5,Muta. 1B;Carc. 1B;STOT RE 1,Harmonised C&L,0,H372:0;H340:0;H350:0
134675,trans-1-ethyl-4-(4-propylcyclohexyl)benzene,280-085-0,82991-47-7,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
134681,2-methoxy-p-cresol,202-252-9,93-51-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1708,H317:1661;H319:1703;H315:1705;H302:1704;H335:43;Not classified:3
134684,"Ethanol, 2-amino-, polymer with 2-methyloxirane",609-082-8,35176-07-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,25,H319:25;H411:25;H302:25
134688,Isochromane,207-774-0,493-05-0,Not Classified,Notified C&L,10,Not classified:10
134689,"2-Propenoic acid, 3-(5-bromo-2-fluorophenyl)-",606-498-1,202865-71-2,,Notified C&L,5,H319:4;H315:4;H335:4;H311:1;H301:1;H331:1
134691,"(S)-(-)-1-(1-Naphthyl)ethylamine (2R,3R)-2,3-dihydroxybutanedioic salt",600-817-8,1073145-07-9,Not Classified,REACH registration C&L,2,Not classified:2
134692,"Hydrocarbon waxes (petroleum), clay-treated microcryst.",265-144-0,64742-42-3,Not Classified,REACH registration C&L,211,Not classified:209;H373:1;H319:1
134694,Bromocyclopentane,205-294-6,137-43-9,Flam. Liq. 3;Skin Irrit. 2,REACH registration C&L,80,H226:79;H315:2;Not classified:2;H341:1
134696,"β-([1,1'-biphenyl]-4-yloxy)-α-tert-butyl-1H-1,2,4-triazol-1-ethanol",259-513-5,55179-31-2,Acute Tox. 4;Skin Sens. 1,Notified C&L,136,H317:89;H302:131;H330:131;H411:1
134698,Sodium methylnaphthalenesulphonate,247-564-6,26264-58-4,Eye Irrit. 2,Notified C&L,309,H319:117;H318:89;H315:115;Not classified:103
134699,"N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]",429-380-1,133336-92-2,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
134700,C.I. Solvent Red 119,602-676-8,12237-27-3,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,87,H317:2;H400:2;H411:2;Not classified:84;H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
134702,(p-nitrophenyl)thiourea,223-021-9,3696-22-8,Acute Tox. 3,Notified C&L,44,H301:43;H319:2;H315:2;H335:1
134704,Potassium 4-aminobenzoate,205-338-4,138-84-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H315:41;H335:41
134707,"Alcohols, C12-13",278-306-0,75782-86-4,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1490,H400:1490;H411:96;H410:1286
134710,"1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone",401-470-3,93686-63-6,Aquatic Chronic 4,Harmonised C&L,0,H413:0
134711,8-benzyl-8-azabicyclo[3.2.1]octan-3-one oxime,616-314-1,76272-34-9,Acute Tox. 4,REACH registration C&L,3,H302:3
134712,ethyl 2-ethoxy-4-carboxymethylbenzoate,427-630-2,99469-99-5,Eye Dam. 1,Harmonised C&L,0,H318:0
134713,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.",287-494-3,85536-14-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,968,H412:543;H318:593;H314:960;H302:961;H290:23;Not classified:8
134714,(R)-(-)-1-methoxy-2-propylamine,620-037-1,99636-38-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,84,H312:83;H225:84;H318:83;H302:83;H412:83;H314:84;H303:1
134715,Silver chlorate,232-034-9,7783-92-8,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38;H272:38
134716,m-toluidinium chloride,211-314-4,638-03-9,Acute Tox. 4;STOT SE 1,Notified C&L,1,H302:1;H370:1
134718,2-acetylthiopropyltrimethylammonium iodide,217-476-2,1866-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
134723,Olean-12-en-3β-ol,209-204-6,559-70-6,Acute Tox. 4,Notified C&L,3,H302:2;Not classified:1
134728,"Valine, 3-methyl-",608-831-6,33105-81-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
134731,"Zanthoxylum, ext.",310-094-8,102242-62-6,Acute Tox. 4,REACH registration C&L,93,H302:2;Not classified:89;H317:1;H411:1;H226:1
134733,Perfluoroalkylether,611-940-1,60164-51-4,Eye Irrit. 2;STOT SE 3,Notified C&L,139,H319:100;H335:100;Not classified:39
134734,Trisodium bis[3-[[1-(anilinocarbonyl)-2-oxopropyl]azo]-5-chloro-2-hydroxybenzenesulphonato(3-)]cobaltate(3-),277-381-7,73324-01-3,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,18,H317:5;H412:5;Not classified:12;H319:1;H315:1;H335:1
134743,C.I. Solvent Red 89,612-352-8,61725-81-3,Not Classified,Notified C&L,33,Not classified:33
134744,Cetrimonium chloride,203-928-6,112-02-7,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1128,H410:343;H318:816;H400:1121;H302:569;H314:509;H315:554;H335:487;H225:156;H336:156;H311:255;H312:29;H411:18;H301:12;Not classified:6;H319:3;H304:1;H412:1
134746,"Oils, lard, Me esters, sulfated, sodium salts",270-320-5,68424-74-8,Not Classified,Notified C&L,1,Not classified:1
134747,(4-pyridylthio)acetyl chloride hydrochloride,248-348-4,27230-51-9,,Notified C&L,3,H332:2;H312:2;H302:2;Not classified:1
134749,Phenylacetyl chloride,203-146-5,103-80-0,Skin Corr. 1;STOT SE 3,REACH registration C&L,62,H314:62;H335:42;H290:2;H318:3
134752,4-chloro-o-anisidine,202-251-3,93-50-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
134754,Pentafluorothiophenol,212-236-3,771-62-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 3,Notified C&L,49,H312:40;H331:39;H302:45;H226:49;H314:49;H332:6;Not classified:1;H318:2
134755,N-tert-pentyl-2-benzothiazolesulfenamide,404-380-2,110799-28-5,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
134758,Vinblastine sulphate,205-606-0,143-67-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,96,H318:95;H315:95;H302:95;H335:94;H332:3;H360:2;H351:3;H340:1;H312:1;H361:2;H319:1;H371:2;H300:1
134759,(Z)-3-hexenyl octanoate,262-799-4,61444-41-5,Aquatic Chronic 4,Notified C&L,1,H413:1
134760,2-ethylhexyl cyanoacetate,236-425-5,13361-34-7,Not Classified,REACH registration C&L,148,Not classified:24;H290:84;H319:40;H315:40;H335:39;H302:1
134763,Bis(4-fluoro-3-nitrophenyl)sulphone,206-224-7,312-30-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
134764,"Tetrasodium [bis[[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]amino]sulphonyl]-29H,31H-phthalocyaninedisulphonato(6-)-N29,N30,N31,N32]cuprate(4-)",288-109-1,85650-98-2,Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,34,H334:13;H320:12;H335:13;Not classified:18;H412:2;H319:1;H317:1
134767,Azidobenzene,210-730-3,622-37-7,Self-react. B;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1,Notified C&L,39,H319:39;H372:38;H241:38;H315:39;H301:1
134768,p-cresol,203-398-6,106-44-5,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Harmonised C&L,0,H311:0;H301:0;H314:0
134776,"2,6-diethyl-p-toluidine",246-307-5,24544-08-9,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,235,H312:233;H302:233;Not classified:1;H335:1;H319:2;H315:2;H332:1
134777,1-chloro-2-fluorobenzene,206-476-8,348-51-6,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,50,H319:46;H226:47;H315:46;H335:5;H332:8;H225:3
134783,Pimelic acid,203-840-8,111-16-0,Eye Irrit. 2;STOT SE 3,REACH registration C&L,61,H319:54;H335:51;H315:49;Not classified:7
134786,Ethyl acrylate and 2-ethylhexyl acrylate copolymer,607-924-9,26376-86-3,Not Classified,Notified C&L,111,Not classified:100;H317:11
134788,Rescinnamine,246-471-8,24815-24-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H302:38
134789,"1,1'-(4-chlorobutylidene)bis[4-fluorobenzene]",221-998-6,3312-04-7,Not Classified,REACH registration C&L,5,Not classified:2;H302:3;H317:2;H335:1;H319:1;H315:1
134792,"Sodium 8-methoxy-6-nitrophenanthro[3,4-d]-1,3-dioxole-5-carboxylate",233-463-4,10190-99-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Notified C&L,40,H311:40;H351:40;H301:40;H331:40;H341:1
134798,(S)-benzyl [1-benzyl-3-chloro-2-oxopropyl]carbamate,247-432-8,26049-94-5,Skin Corr. 1B,Notified C&L,39,H314:39
134799,Pentalead tetraoxide sulphate,235-067-7,12065-90-6,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,36,H410:36;H360:36;H362:35;H332:36;H400:36;H302:36;H372:35;H351:35;H373:1
134806,"4,6-di-tert-butyl-m-cresol",207-847-7,497-39-2,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,45,H319:39;H411:38;H302:39;Not classified:6;H315:2
134807,"(S)-2,3-dihydro-5,7-dihydroxy-2-(4-methoxyphenyl)-4-benzopyrone",207-551-8,480-43-3,Not Classified,Notified C&L,2,Not classified:2
134808,1-phenylpropyl acetate,218-312-2,2114-29-6,Not Classified,Notified C&L,88,Not classified:88
134809,"Callitropsis araucarioides, ext.",305-070-9,94333-91-2,Not Classified,Notified C&L,1,Not classified:1
134810,"Alcohols, C11-14-iso-, C13-rich",271-235-6,68526-86-3,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1313,H400:870;H411:263;H315:286;H410:293;H319:208;Not classified:83
134811,C.I. Solvent Brown 22,612-582-9,61867-96-7,Not Classified,Notified C&L,36,Not classified:36
134817,Methyl tricosanoate,219-420-2,2433-97-8,Not Classified,Notified C&L,7,Not classified:5;H318:2
134821,"prothoate (ISO);O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate",218-893-2,2275-18-5,Acute Tox. 2;Acute Tox. 1;Aquatic Chronic 3,Harmonised C&L,0,H310:0;H412:0;H300:0
134824,Exo-2-bromonorbornane,219-798-9,2534-77-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H226:38;H315:38;H335:38
134831,"Naphtha (petroleum), heavy catalytic reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C",265-070-9,64741-68-0,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
134832,"Alcohols, C10-16, ethoxylated",500-182-6,68002-97-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1464,H400:1203;H318:1273;H315:669;H302:1148;H412:265;H410:83;H319:57;H335:42;H411:25;Not classified:3;H314:2;H225:1;H301:1
134833,"2-(2,6-diethyl-4-methyl-phenyl)-malononitrile",608-616-7,314020-53-6,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 3,Notified C&L,89,H317:89;H412:89;H302:89
134843,"2,2-bis[[(1-oxononyl)oxy]methyl]propane-1,3-diyl dinonan-1-oate",238-430-8,14450-05-6,Not Classified,REACH registration C&L,5,Not classified:5
134845,"Oils, persicaria odorata",442-310-2,,Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1,H317:1;H400:1;H319:1
134850,N-(2-aminoethyl)-N-(2-hydroxyethyl)stearamide,204-394-7,120-41-2,Not Classified,Notified C&L,35,Not classified:33;H319:2;H315:2
134851,Tin bis(2-ethylhexanoate),206-108-6,301-10-0,Aquatic Chronic 2,Notified C&L,903,H411:178;H317:665;H319:273;H315:250;H412:415;H318:448;H361:448;H335:54;Not classified:2;H413:1
134854,Sodium amidotrizoate,212-004-1,737-31-5,Skin Sens. 1;Resp. Sens. 1,Notified C&L,84,H317:84;H334:84
134857,"Sodium hydrogen 7,7'-(carbonyldiimino)bis(4-hydroxynaphthalene-2-sulphonate)",275-605-8,71550-28-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;Not classified:1
134858,"clothianidin (ISO);3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine",433-460-1,210880-92-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H302:0
134861,m-methoxyphenethylamine,218-017-9,2039-67-0,Skin Corr. 1B,Notified C&L,43,H314:42;H319:1;H315:1;H335:1;H318:2
134863,"Poly(oxy-1,2-ethanediyl), α-(methylphenyl)-ω-hydroxy-",609-383-4,37281-57-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:2;H315:3;H302:2;H319:1
134864,Ethoxyacetic acid,210-978-2,627-03-2,Skin Corr. 1B,Notified C&L,71,H314:46;H319:25;H315:25;H335:25;H318:3;H290:1
134865,"1-Propanol, 3-(2-propynyloxy)- (7CI,8CI,9CI)",611-823-5,5935-29-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,2,H318:1;H302:1;H319:1;H315:1;H335:1
134870,Mandelic acid,202-007-6,90-64-2,Eye Dam. 1,REACH registration C&L,140,H318:69;H315:61;H302:60;H335:60;Not classified:66;H319:3
134871,"2,2-dibromo-2-cyanoacetamide",233-539-7,10222-01-2,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1,Notified C&L,543,H317:519;H301:447;H318:493;H315:434;H400:504;H330:385;H412:151;H310:56;H314:101;H331:87;H410:93;H302:36;H300:20;H411:33;H372:13;H290:7;Not classified:5;H336:1;H335:1
134876,Ethyl diazoacetate,210-810-8,623-73-4,Flam. Liq. 3;Acute Tox. 4,Notified C&L,40,H226:40;H302:40;H351:2;H242:2;H315:1
134878,Dodec-4-en-1-al,250-174-9,30390-51-3,Not Classified,Notified C&L,88,Not classified:88
134881,"1,3,5-trichlorobenzene",203-608-6,108-70-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,49,H312:41;H335:40;H319:40;H315:40;H332:41;H302:45;H412:40;Not classified:4;H411:4
134885,"Fir, Abies pectinata, ext.",295-728-0,92128-34-2,Not Classified,Notified C&L,77,Not classified:77
134886,2-butylaminoethanol,203-904-5,111-75-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,905,H318:815;H315:224;H302:779;H335:759;H314:681;H336:125;H290:25
134887,"(2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenyl-chromen-7-yl)oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid",606-866-1,21967-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:43;H315:43;H335:42;H302:2
134888,"Phenol, 3-[1-(dimethylamino)ethyl]-",600-665-2,105601-04-5,Acute Tox. 3;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,40,H412:38;H318:38;H301:38;H319:1;H314:1;H335:1;Not classified:1
134889,"Trisodium bis[4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxynaphthalene-1-sulphonato(3-)]chromate(3-)",263-319-6,61916-41-4,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,124,H317:46;H412:62;H319:106;Not classified:6;H413:2;H315:1
134892,4-ethylresorcinol,220-777-1,2896-60-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
134899,"Benzeneacetic acid, alpha-(hydroxymethyl)-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, hydrobromide, trihydrate, (alphaS)-",613-776-6,6533-68-2,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2,Notified C&L,106,H310:103;H300:103;H330:103;H302:2;H301:1;H317:1
134901,2-amino-4-tert-butylphenol,214-844-4,1199-46-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:40;H335:44;H319:45;H315:45;H332:40;H302:45
134902,C.I. Acid Brown 425,601-617-3,119509-49-8,Not Classified,Notified C&L,5,Not classified:5
134913,didecyldimethylammonium chloride,230-525-2,7173-51-5,Acute Tox. 4;Skin Corr. 1B,Harmonised C&L,0,H314:0;H302:0
134916,"3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate",424-310-4,178452-66-9,Eye Dam. 1,Harmonised C&L,0,H318:0
134918,"Mesitylene-2-sulphonic acid, dihydrate",222-379-3,3453-83-6,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
134919,"3-methyl-1-(5-oxohexyl)-7-propyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",611-242-7,55242-55-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,93,H332:41;H312:41;H302:92;H373:35;Not classified:1
134920,Dodecylamine,204-690-6,124-22-1,Asp. Tox. 1;Skin Corr. 1B;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,746,H373:624;H410:603;H335:624;H400:694;H304:601;H314:714;H290:448;H302:90;Not classified:32;H411:13;H318:19;H311:1;H301:1;H331:1
134924,3-Cyano-4-methylpyridine,611-143-9,5444-01-9,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H335:40;H311:38;H319:45;H315:45;H332:39;H302:44
134925,Neocinchophen,207-615-5,485-34-7,Aquatic Chronic 4,Notified C&L,38,H413:38
134926,4-methylphthalic anhydride,243-073-6,19438-61-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H315:43;H335:42;Not classified:1
134931,White mineral oil (petroleum),232-455-8,8042-47-5,Not Classified,REACH registration C&L,3110,Not classified:1881;H304:1134;H413:89;H319:34;H371:33;H332:34;H372:33;H341:33;H373:5;H226:2;H317:2;H315:3;H312:3;H331:1;H302:1;H411:1
134938,(S)-methyl-2-chloropropionate,412-470-8,73246-45-4,Flam. Liq. 3;Eye Irrit. 2;STOT RE 2,Harmonised C&L,0,H319:0;H226:0;H373:0
134941,Dihydro-5-methyl-5-vinylfuran-2(3H)-one,214-024-6,1073-11-6,Not Classified,Notified C&L,88,Not classified:88
134944,"4-[2-(4-trans-Propyl-[1,1-bicyclohexyl]-4-trans-yl)-ethyl] -benzoicacidnitrile",601-407-1,116020-37-2,Aquatic Chronic 4,Notified C&L,1,Not classified:1;H413:1
134945,DL-bornan-2-one,244-350-4,21368-68-3,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,374,H335:62;H319:63;H315:63;H228:296;H302:94;H332:253;H371:271;H312:48;H226:37;H330:73;Not classified:33;H410:8;H351:8;H412:3;H317:2;H331:1;H360:1;H370:1
134954,Titanium tetra(2-hydroxyethanolate),238-829-7,14764-55-7,Acute Tox. 4,Notified C&L,1,H302:1
134959,"3-phenyl-1,3,4-thiadiazolidine-2,5-dithione",241-636-0,17654-88-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
134970,"7-acetamido-4-hydroxy-3-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2-sulphonic acid, sodium salt",287-574-8,85536-87-4,Not Classified,REACH registration C&L,72,Not classified:29;H318:41;H317:3
134978,"Dodecenylsuccinic acid, compound with 2,2',2''-nitrilotriethanol (1:2)",265-582-2,65166-21-4,,Notified C&L,1,Not classified:1
134979,6-tert-butylquinoline,268-835-5,68141-13-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H319:39;H315:39
134981,Methyl 2-[[[4-(4-hydroxy-4-methylpentyl)-3-cyclohexenyl]methylene]amino]benzoate,266-816-6,67634-12-2,Skin Sens. 1,Notified C&L,1525,H317:1298;Not classified:227;H319:1
134984,"Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-21-(phosphonooxy)-, dipotassium salt, (11β,16α)-",217-537-3,1881-20-5,Repr. 1A;STOT RE 1,Notified C&L,1,H372:1;H360:1
134987,"2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate",260-829-0,57583-35-4,Acute Tox. 4;Skin Sens. 1A;STOT RE 1;Repr. 2,Harmonised C&L,0,H317:0;H372:0;H361:0;H302:0
134990,2-(7-ethyl-1H-indol-3-yl)ethanol,431-020-1,41340-36-7,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0,H373:0;H411:0;H302:0
134992,4-hydroxybenzohydrazide,226-326-5,5351-23-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H315:47;H335:46;H302:1
134996,Benzylbromomagnesium,216-459-7,1589-82-8,Skin Corr. 1B,Notified C&L,38,H314:38
135001,Ammonium naphthalenesulphonate,264-208-5,63453-81-6,Not Classified,Notified C&L,83,Not classified:83
135002,Zirconium hydroxide,235-770-9,12688-15-2,Not Classified,Notified C&L,1,Not classified:1
135003,3-(1-ethoxyethoxy)but-1-yne,611-859-1,5967-11-3,Flam. Liq. 3;Skin Irrit. 2,Notified C&L,1,H226:1;H315:1
135004,(±)-4-(2-amino-1-hydroxyethyl)pyrocatechol,205-337-9,138-65-8,Acute Tox. 3,REACH registration C&L,42,H301:4;H318:38;H302:38
135005,"2,3,4,9-tetrahydro-1-methyl-1H-pyrido[3,4-b]indole",219-711-4,2506-10-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
135006,Potassium iodate,231-831-9,7758-05-6,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,372,H319:163;H335:155;H315:156;H272:307;H302:193;H318:22;H271:10;Not classified:2;H270:1;H360:1
135008,"Iron, compound with titanium (2:1)",234-680-7,12023-40-4,Not Classified,Notified C&L,2,Not classified:2
135016,"3,5-bis(β-D-glucopyranosyloxy)-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-benzopyrylium chloride",205-060-3,132-37-6,Not Classified,Notified C&L,2,Not classified:2
135021,"2-(2,6-dimethylhepta-1,5-dienyl)-4-methyl-1,3-dioxolane",233-929-7,10444-50-5,Skin Sens. 1,Notified C&L,25,H317:25
135022,4-chlorophenyl-2-thiourea,223-022-4,3696-23-9,,Notified C&L,7,H300:7;H310:1;H319:1;H315:1;H335:1
135023,"1,2-Dioxane, 3,3,6,6-tetramethyl-",607-075-4,22431-89-6,Flam. Liq. 3;Org. Perox. D;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H335:38;H319:38;H315:38;H242:38;H226:38;Not classified:5
135025,"(1R,2R,4S)- 1,3,3-trimethylbicyclo(2.2.1)heptan-2-ol",606-948-7,2217-02-9,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,9,H319:9;H315:9
135026,"Disodium 1-[[4-[[(6-methoxypyridazin-3-yl)amino]sulphonyl]phenyl]amino]-3-phenylpropane-1,3-disulphonate",303-951-2,94232-25-4,Not Classified,Notified C&L,2,Not classified:1;H302:1
135032,monolinuron (ISO);3-(4-chlorophenyl)-1-methoxy-1-methylurea,217-129-5,1746-81-2,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H373:0;H400:0;H410:0;H302:0
135033,Butyrophenone,207-799-7,495-40-9,Not Classified,Notified C&L,131,Not classified:88;H317:42;H318:41;H319:2;H315:2;H335:1
135037,"Oils, vegetable, reaction products with tetraethylenepentamine",307-972-8,97808-52-1,Not Classified,Notified C&L,1,Not classified:1
135038,"N,N'-dimethyloxamide",210-420-8,615-35-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
135039,Dimolybdenum carbide,235-115-7,12069-89-5,Not Classified,REACH registration C&L,4,Not classified:3;H413:1
135046,"Phosphoric acid, octyl ester",254-445-2,39407-03-9,Skin Corr. 1B,Notified C&L,39,H314:39;H302:1;H290:1
135047,"(2E)-But-2-enedisäure; Bis(2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol)",601-144-2,111974-72-2,Acute Tox. 4;Aquatic Acute 1,Notified C&L,94,H400:41;H302:74;H319:28;H361:16;H413:15;H332:11;H312:11;H410:5;H318:6;H412:9;H301:3;H331:2;Not classified:2;H336:4;H351:2;H362:2;H341:1;H370:1;H317:2;H373:1;H360:1;H335:1;H411:1
135048,3-[[4-[(2-chloro-4-nitrophenyl)azo]-3-methylphenyl]ethylamino]propiononitrile,240-641-5,16586-43-9,Not Classified,Notified C&L,23,Not classified:23
135050,Chloroselenobenzene,227-196-2,5707-04-0,Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44,H373:43;H410:44;H290:38;H301:44;H331:44;H400:44;H311:1;H318:2;H314:2
135053,"Sodium α-(chloroacetamido)[4-[[4-(cyclohexylamino)-9,10-dihydro-9,10-dioxo-1-anthryl]amino]phenoxy]xylenesulphonate",276-635-4,72391-24-3,Aquatic Chronic 2,Notified C&L,6,H411:6
135054,2-Bromo-4-chlorotoluene,608-052-1,27139-97-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:45;H315:45;H335:40;H332:1;H312:1;H302:1
135057,"Octasodium 7,7'-[(2,2'-disulphonato[1,1'-biphenyl]-4,4'-diyl)bis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino[2-(carbamoylamino)]-4,1-phenylene]azo]]bis(naphthalene-1,3,6-trisulphonate)",268-684-5,68133-40-4,Not Classified,REACH registration C&L,44,Not classified:35;H319:9
135058,1-acetylpiperidine-4-carbonyl chloride,261-594-7,59084-16-1,,Notified C&L,7,H314:7;H319:1;H335:1;H318:1
135060,Dicerium trioxide,215-718-1,1345-13-7,Not Classified,REACH registration C&L,125,Not classified:41;H400:84;H410:84
135062,"Euphrasia officinalis, ext.",283-410-4,84625-36-5,Not Classified,Notified C&L,1,Not classified:1
135064,"TETRASODIUM ETHYLENE 1,1-DIPHOSPHONATE",443-520-7,,Acute Tox. 4;Skin Sens. 1A;Eye Irrit. 2A,REACH registration C&L,0,No data
135068,"Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;Refinery gas;[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]",271-625-6,68602-84-6,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
135071,1-phenylpyrazole,214-415-1,1126-00-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,200,H319:200;H315:200;H335:199
135072,"Quaternary ammonium compounds, C12-14-alkyltrimethyl, Me sulfates",306-238-4,96690-44-7,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H410:1;H311:1;H319:1;H315:1;H400:2;H302:3;Not classified:1;H314:2;H318:1
135073,"Poly(oxymethylene), a-(1H,3H,5H-oxazolo[3,4-c]oxazol-7a(7H)-ylmethyl)-w-hydroxy-",611-414-1,56709-13-8,Not Classified,Notified C&L,56,Not classified:26;H319:30;H330:18;H312:12;H332:12;H302:12
135079,Cycloundecanecarboxylic acid,212-609-0,831-67-4,Acute Tox. 4,Notified C&L,38,H302:38
135082,bis(3-(trimethoxysilyl)propyl)amine,403-480-3,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0
135086,trans-2-phenylcyclopropanecarboxylic acid,213-366-3,939-90-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
135093,"3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxaoctatetracontan-1-ol",221-286-5,3056-00-6,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H318:1;H302:1
135097,[p-[[4-[ethyl[2-hydroxy-3-(trimethylammonio)propyl]amino]-o-tolyl]azo]-β-oxophenethyl]trimethylammonium bis[tetrafluoroborate(1-)],253-280-3,36936-37-5,Not Classified,Notified C&L,11,Not classified:9;H412:2
135098,Barium ditantalum hexaoxide,234-976-6,12047-34-6,,Notified C&L,4,H332:4;H302:4
135100,"7-chloro-2,3-dihydro-4-quinolone",244-481-7,21617-15-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
135102,"Amines, C12-14-tert-alkyl, mono(2-ethylhexyl) and bis(2-ethylhexyl) phosphates",287-014-2,85408-52-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H312:1;H315:1
135105,1-(2-chlorophenyl)-2-thiourea,226-291-6,5344-82-1,Acute Tox. 2;Skin Irrit. 2;Skin Sens. 1,Notified C&L,44,H317:39;H300:43;H315:40;H312:1;H335:1;H319:1;H332:1;H302:1
135108,"Sodium [3-[(4-chloro-2-hydroxy-5-methoxyphenyl)azo]-4-hydroxynaphthalene-2,7-disulphonato(4-)]chromate(1-)",289-551-8,89923-63-7,Skin Sens. 1,Notified C&L,3,H317:3;H412:1
135109,Diethyl[2-[2-(2-phenylbutyroyloxy)ethoxy]ethyl]ammonium dihydrogen citrate,242-006-8,18109-81-4,Not Classified,Notified C&L,2,Not classified:2
135113,1-bromopropene,209-671-6,590-14-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H225:39;H315:39;H335:38
135115,"3,5-xylidine",203-607-0,108-69-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 2,Notified C&L,83,H373:82;H301:83;H311:83;H331:83;H411:83
135122,Dore,273-793-6,69029-47-6,Not Classified,REACH registration C&L,12,Not classified:12
135128,Neryl acetate,205-459-2,141-12-8,Skin Sens. 1B,REACH registration C&L,1768,H317:1380;H412:1330;H315:1403;Not classified:299;H411:84;H319:5
135129,Triflupromazine hydrochloride,214-149-6,1098-60-8,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H312:38;H301:39
135136,"Benzenesulfonic acid, 2-amino-5-((2-(sulfooxy)ethyl)sulfonyl)-",610-097-7,42986-22-1,Acute Tox. 4;Acute Tox. 5;Acute Tox. 5;STOT SE 3,REACH registration C&L,3,H332:2;H313:2;H302:2;H335:2;Not classified:1
135138,Cobalt(2+) selenite,233-064-5,10026-23-0,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H373:1;H410:1;H301:1;H331:1;H400:1
135139,"1,2-dichloro-2-methylpropane",209-837-8,594-37-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H225:40;H315:40;H335:38
135143,(ethylthio)acetic acid,210-979-8,627-04-3,Eye Irrit. 2,Notified C&L,44,H319:39;H314:6;H315:1;H335:1
135144,1-hydroxy-1-phenylacetone,202-006-0,90-63-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
135145,"N,N'-(iminodiethane-1,2-diyl)distearamide",233-538-1,10220-90-3,Not Classified,Notified C&L,79,Not classified:77;H318:2;H315:2
135149,"4,4'-(dichlorosilylene)bis(butyronitrile)",213-984-3,1071-17-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H318:38;H314:38
135151,"2,2-dimethyl-1,3-dioxolan-4-ylmethanol",202-888-7,100-79-8,Eye Irrit. 2A,REACH registration C&L,259,H319:200;H411:52;H315:52;Not classified:7
135154,"Paraffin waxes (petroleum), clay-treated",265-145-6,64742-43-4,Not Classified,REACH registration C&L,686,Not classified:570;H413:83;H373:32;H319:1
135157,Poly (dipropyleneglycol) Phenyl phosphite,601-420-2,116265-68-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,62,H317:2;H373:2;H319:62;H315:62;H411:2;H335:38;H413:22
135159,Benzenehexacarboxylic acid,208-243-6,517-60-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:42;H315:42;H335:40;H302:1
135161,"2,4-diaminoanisole sulphate",254-323-9,39156-41-7,Acute Tox. 4;Muta. 2;Carc. 1B;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H341:0;H350:0;H302:0
135162,"2-[4-[[2-(cyanoimino)hexahydro-4,6-dioxo-5-pyrimidyl]azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1)",259-470-2,55067-15-7,Not Classified,REACH registration C&L,134,Not classified:134
135163,"2-[4-(benzyloxy)phenyl]-N,N-dimethylacetamide",619-603-0,919475-15-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H332:1;H312:1;H302:1
135167,DL-cysteine hydrochloride hydrate,233-698-2,10318-18-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,89,H319:86;H315:86;H335:79;H302:6;Not classified:3
135170,"m-phenoxybenzyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate",247-431-2,26046-85-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,21,H400:20;H410:20;Not classified:1
135171,β-(dimethylamino)-β-ethylphenethyl alcohol hydrochloride,262-307-8,60577-23-3,,Notified C&L,1,H302:1
135173,"5,11-dihydro-11-((4-methylpiperazin-1-yl)acetyl)-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one hydrochloride",918-816-9,,Not Classified,Notified C&L,1,Not classified:1
135175,5-methylquinoxaline,237-246-5,13708-12-8,Not Classified,Notified C&L,184,Not classified:140;H319:44;H315:44;H335:39
135177,α-chloro-4-fluorotoluene,206-516-4,352-11-4,Skin Corr. 1B,Notified C&L,58,H314:58;H226:12;H301:11;H302:8;H319:1;H412:1;H312:1;H290:1;H318:1
135178,Hexyl 2-methylbutyrate,233-106-2,10032-15-2,Not Classified,Notified C&L,159,Not classified:96;H411:38;H226:24;H413:1
135179,Silver chloride,232-033-3,7783-90-6,Met. Corr. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,291,H400:230;H410:152;H290:71;Not classified:50;H335:46
135181,2-[(4-methoxy-2-nitrophenyl)azo]-N-(2-methoxyphenyl)-3-oxobutyramide,229-419-9,6528-34-3,Not Classified,REACH registration C&L,425,Not classified:425
135182,"2-[methyl[(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)sulphonyl]amino]ethyl acrylate",256-503-2,49859-70-3,,Notified C&L,47,Not classified:47
135183,"1,1-diethoxyethane;acetal",203-310-6,105-57-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0,H319:0;H225:0;H315:0
135184,"Bisbenzimidazo[2,1-a:1',2'-b']anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-6,11-dione",611-221-2,55034-81-6,Not Classified,Notified C&L,83,Not classified:83
135188,4-(methylthio)benzoyl chloride,215-882-4,1442-06-4,Skin Corr. 1B;Skin Sens. 1,Notified C&L,38,H317:38;H314:38
135191,Perfluorocyclopentene,209-203-0,559-40-0,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,27,H319:27;H335:26;H315:26;H331:23;H330:1;H312:1;H332:1;H302:1;H373:1;H301:1;H311:1;H371:1
135193,Sodium diethyldihydroaluminate,241-795-6,17836-88-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
135194,"4-[2-((6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-ylsulfanyl)thiazole-4-yl]-1-methyl-pyridiniumchloride monohydrochloride",447-990-4,,Not Classified,REACH registration C&L,1,Not classified:1
135197,"1,4-benzodioxane",207-775-6,493-09-4,,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H315:1;H335:1
135198,"Dicarbonyl(η5-2,4-cyclopentadien-1-yl)cobalt",235-139-8,12078-25-0,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Resp. Sens. 1;Muta. 2;Carc. 2,Notified C&L,67,H351:62;H301:67;H311:40;H334:63;H331:40;H226:66;H341:67;H317:29;H412:22;H310:22;H330:23;H360:1;H350:1
135200,Bis(trimethoxysilylpropyl)amine,280-084-5,82985-35-1,Eye Dam. 1,REACH registration C&L,351,H318:351;H411:284;H332:38;H315:75;H335:38;H317:22
135202,"Oleic acid, compound with 2-(heptadec-8-enyl)-4,5-dihydro-1H-imidazole-1-ethylamine (1:1)",269-733-3,68310-76-9,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H317:3;H410:3;H314:3
135207,"Disodium hydrogen bis[2-[[6-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-1-hydroxy-3-sulpho-2-naphthyl]azo]benzoato(3-)]chromate(3-)",274-895-3,70788-63-5,Not Classified,Notified C&L,1,Not classified:1
135209,heptan-2-one;methyl amyl ketone,203-767-1,110-43-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4,Harmonised C&L,0,H332:0;H226:0;H302:0
135210,Lithium-2-methoxyethoxide,460-000-5,20246-63-3,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Repr. 1B,Notified C&L,1,H312:1;H360:1;H332:1;H228:1;H302:1;H314:1
135212,Hydroxyaluminium diformate,257-291-4,51575-25-8,Eye Dam. 1,Notified C&L,1,H318:1
135216,"Terpenes and Terpenoids, turpentine-oil, limonene fraction",266-035-0,65996-99-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,82,H317:39;H410:40;H315:40;H400:40;H304:67;H226:67;Not classified:15
135222,Rubidium chromate,236-601-1,13446-72-5,Ox. Sol. 2;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H317:38;H410:38;H272:38;H400:38;H350:38
135225,"2,5-dimethylthiophene",211-313-9,638-02-8,Flam. Liq. 3,Notified C&L,1425,H226:1425;H319:89;H332:6;H315:1;H335:1
135227,"Spiro[9,4-(epoxypentadeca[1,11,13]trienimino)-2H-furo[2',3':7,8]naphth[1,2-d]imidazole-2,4'-piperidine]-5,10,26(3H,9H)-trione, 16-(acetyloxy)-6,18,20-trihydroxy-14-methoxy-7,9,15,17,19,21,25-heptamethyl-1'-(2-methylpropyl)-, (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-",615-780-3,72559-06-9,Not Classified,Notified C&L,30,Not classified:30
135229,N-[3-(methylamino)propyl]oxolane-2-carboxamide,617-229-2,81403-67-0,Skin Corr. 1B;Skin Sens. 1,REACH registration C&L,3,H317:2;H314:2;H302:1
135232,"Benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1)",278-305-5,75768-65-9,Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,138,H373:7;H400:17;H410:17;H360:7;Not classified:81;H319:39;H318:11;H315:2;H335:2;H301:1
135237,"Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;Gasoil - unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 °C to 399 °C (650 °F to 750 °F).]",270-719-4,68477-29-2,Carc. 1B,Harmonised C&L,0,H350:0
135238,fuberidazole (ISO);2-(2-furyl)-1H-benzimidazole,223-404-0,3878-19-1,Acute Tox. 4;Skin Sens. 1;Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H373:0;H410:0;H400:0;H302:0;H351:0
135241,Iron(III) citrate,222-536-6,3522-50-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
135242,1-Penten-4-yn-3-ol,604-328-0,14304-27-9,Eye Dam. 1,Notified C&L,38,H318:38
135250,Allyl cinnamate,217-477-8,1866-31-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1610,H319:1561;H315:1561;H302:1610
135253,5-chloroanthranilic acid,211-230-8,635-21-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46
135256,"Hexa-1,5-dien-3-ol",213-102-7,924-41-4,Flam. Liq. 3,Notified C&L,42,H226:42
135258,"1,2-Cyclohexanediamine, reaction products with N-[4-(2-oxiranylmethoxy)phenyl]-N-(2-oxiranylmethyl)-2-oxiranemethanamine",601-523-2,118421-10-6,Not Classified,Notified C&L,9,Not classified:9
135260,"Lanolin, hydrogenated",232-452-1,8031-44-5,Not Classified,REACH registration C&L,25,Not classified:25
135261,"2-TERT-BUTYL-5-METHYL-2-PROPYL-2,5-DIHYDROFURAN",682-407-9,1092785-58-4,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1286,H317:1286;H411:1286
135263,(3-Aminopropyl)tris(trimethylsiloxy)silane,607-704-2,25357-81-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
135264,5-[(4-carboxybutanoyl)peroxy]-5-oxopentanoic acid,600-254-8,10195-54-7,Org. Perox. D;Acute Tox. 4;Eye Dam. 1,REACH registration C&L,2,H242:2;H318:2;H302:2
135272,Reactive Blue 160,615-670-5,71872-76-9,Eye Irrit. 2;Resp. Sens. 1,Notified C&L,41,H319:41;H334:41
135273,Benzyl lactate,218-136-6,2051-96-9,Not Classified,Notified C&L,101,Not classified:101
135275,3-[methoxy(dimethyl)silyl]propan-1-amine,608-570-8,31024-26-7,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,4,H226:3;H318:3;H315:3;H332:1;H312:1;H302:1
135276,N-(hydroxymethyl)stearamide,222-147-1,3370-35-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,8,H332:6;H312:6;H302:6;Not classified:2
135278,α-methylcinnamic acid,214-847-0,1199-77-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
135279,Ethyl dichlorophenylacetate,226-178-1,5317-66-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,39,H317:39;H319:39;H315:39
135280,"Piperazine, 1-methyl-4-(phenylmethyl)-, hydrochloride (1:1)",609-437-7,374898-00-7,,Notified C&L,5,H319:4;H315:4;H335:4;H302:1
135287,"3,7-bis(diethylamino)phenoxazin-5-ium chloride",251-403-5,33203-82-6,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,21,H400:8;H410:11;H318:11;H301:10;Not classified:4;H319:3;H302:7;H331:2;H312:1
135291,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with 2-methylimidazole",500-181-0,68002-42-6,Skin Sens. 1B,REACH registration C&L,276,H317:38;H318:198;H315:199;Not classified:39;H319:1
135292,trans-bicyclo[4.4.0]decane,207-771-4,493-02-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,43,H226:43;H314:43;H332:4;H410:1;H371:1;H318:1;H331:1;H400:1;H304:1;H411:1
135293,Cinnamyl acetoacetate,260-826-4,57582-46-4,Not Classified,Notified C&L,42,Not classified:42
135295,Dioleyl hydrogen phosphate,238-431-3,14450-07-8,,Notified C&L,25,Not classified:25
135302,O-methylbenzoin,222-538-7,3524-62-7,Acute Tox. 3,Notified C&L,46,H301:45;H311:2;H331:2;H302:1
135304,Bicyclo[2.2.1]hept-2-yl isothiocyanate,604-375-7,14370-23-1,Skin Corr. 1B,Notified C&L,39,H314:39
135305,Oleylamine hydrochloride,255-233-2,41130-29-4,Not Classified,Notified C&L,1,Not classified:1
135307,"Tetrasodium 7-[[2-[(aminocarbonyl)amino]-4-[[4-chloro-6-[[3-[[2-(sulphonatooxy)ethyl]sulphonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]phenyl]azo]naphthalene-1,3,6-trisulphonate",279-408-8,80157-00-2,Not Classified,REACH registration C&L,69,Not classified:56;H334:9;H320:3;H335:4;H319:4;H332:1;H312:1;H302:1
135309,"1,3-dihydro-1-(1-methylvinyl)-2H-benzimidazol-2-one",257-661-5,52099-72-6,Acute Tox. 3,REACH registration C&L,45,H301:40;H302:5
135311,"2,5-dimethylbenzylamine",202-250-8,93-48-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,41,H319:39;H315:39;H318:2;H314:2;H335:1
135316,1-fluoro-4-(phenylsulphonyl)benzene,206-225-2,312-31-2,Eye Irrit. 2,Notified C&L,38,H319:38
135319,Sodium 2-fluorobenzoate,610-444-2,490-97-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
135321,"Camellia sasanqua, ext.",305-073-5,94333-93-4,Not Classified,Notified C&L,37,Not classified:37
135322,Cyanocobalamin,200-680-0,68-19-9,Not Classified,REACH registration C&L,45,Not classified:44;H319:1;H315:1
135323,Fenbendazole,256-145-7,43210-67-9,Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,149,H400:112;H410:104;H361:101;H373:47;H412:33;H351:9;Not classified:2;H341:1
135327,Silver (II) fluoride,232-037-5,7783-95-1,Ox. Sol. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,46,H301:40;H311:40;H331:39;H272:43;H314:46;H312:5;H332:5;H400:4;H302:5;H330:1;H271:1
135328,2-Bromo-4-fluoro-1-iodobenzene,606-499-7,202865-73-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:38
135329,Benzylhydrazinium oxalate (1:1),250-908-8,32064-65-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H312:38;H302:38
135331,"Oxirane, methyl-, polymer with oxirane, nonylphenyl ether",618-656-7,9082-01-3,Aquatic Chronic 3,Notified C&L,143,H412:139;Not classified:4
135332,"Docosanoic acid, ester with 1,2,3-propanetriol",278-717-5,77538-19-3,Not Classified,REACH registration C&L,18,Not classified:18
135333,2-propylfuran,224-182-8,4229-91-8,,Notified C&L,10,H226:7;Not classified:3;H317:1;H334:1
135334,"N-[3-(dimethylamino)propyl]-3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-octane-1-sulfonamide",608-993-8,34455-22-6,Not Classified,REACH registration C&L,1,Not classified:1
135335,2-acetylthioethyltrimethylammonium iodide,217-474-1,1866-15-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H301:47;H335:46;H311:46;H319:47;H315:47;H312:1
135337,2-heptyltetrahydrofuran,219-423-9,2435-16-7,Skin Irrit. 2,Notified C&L,1411,H315:1411
135339,4-nitropyridine 1-oxide,214-395-4,1124-33-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48,H319:47;H301:44;H315:47;H335:44;H300:4;H341:4;H311:2;H331:2
135344,4-chlorotoluene,203-397-0,106-43-4,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0,H332:0;H411:0
135345,1-bromo-4-chlorobutane,230-089-3,6940-78-9,Acute Tox. 4,REACH registration C&L,57,H302:4;H226:52;H319:12;H315:12;H335:11;Not classified:2
135346,"2,4-dichloroanilinium chloride",249-416-6,29084-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
135351,"1,4-Butanediol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with acrylic acid",604-376-2,143708-49-0,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,83,H317:83;H318:83;H302:83
135357,Ethylurea,210-898-8,625-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
135358,Alcuronium chloride,239-229-8,15180-03-7,Flam. Sol. 2;Acute Tox. 3;Acute Tox. 2,Notified C&L,1,H228:1;H301:1;H330:1
135359,"m,m'-[carbonylbis[imino(3-methoxy-p-phenylene)azo]]bis(benzenesulphonic) acid, compound with 2,2'-iminodiethanol (1:2)",275-602-1,71550-21-5,Not Classified,REACH registration C&L,2,Not classified:2
135361,4-benzyloxybenzaldehyde,224-527-2,4397-53-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H315:2;H335:2
135365,Cyclopropylmagnesium bromide,472-500-0,,Flam. Liq. 2;Water-react. 1;Skin Corr. 1A,Notified C&L,1,H260:1;H225:1;H314:1
135366,"1,2,3-Propanetriol, homopolymer",607-759-2,25618-55-7,Not Classified,REACH registration C&L,203,Not classified:203
135368,Ethylenebis(trichlorosilane),219-710-9,2504-64-5,Skin Corr. 1A,Notified C&L,44,H314:40;Not classified:4;H318:2
135369,3-hydroxybutyraldehyde,203-530-2,107-89-1,Acute Tox. 2;Eye Irrit. 2,Notified C&L,59,H310:39;H319:39;H311:20
135371,"1,1'-methylenebis(2-naphthol)",214-145-4,1096-84-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
135373,Potassium bromide,231-830-3,7758-02-3,Eye Irrit. 2,REACH registration C&L,539,H319:414;Not classified:99;H315:69;H335:67;H336:38;H373:39;H318:20;H260:3;H412:5;H317:2;H371:1;H302:2
135374,"Hexahydro-1,3,5-tricyclohexyl-s-triazine",228-487-7,6281-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
135375,Trimethyloctadecylammonium chloride,203-929-1,112-03-8,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,265,H410:208;H311:93;H318:78;H400:189;H302:233;H314:208;H312:51;Not classified:10;H315:7;H335:2;H319:2;H332:2
135376,1-(2-Chlorobenzyl)-3-(1-methyl-1-phenylethyl)urea,619-438-4,99485-76-4,Aquatic Chronic 3,Notified C&L,39,H412:38;H302:1
135380,Trigermanium tetranitride,235-064-0,12065-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
135383,Pepstatin,247-600-0,26305-03-3,Not Classified,Notified C&L,3,Not classified:2;H300:1
135384,hexahydro-4-methylphthalic anhydride,243-072-0,19438-60-9,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0,H317:0;H334:0;H318:0
135389,Isobutyl cyanoacetate,236-422-9,13361-31-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H332:1;H312:1;H302:1
135391,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., lithium salts",284-667-5,84961-76-2,Not Classified,Notified C&L,3,Not classified:3
135396,Nonadecanoic acid,211-472-4,646-30-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:40;H315:40;H335:39;Not classified:1
135402,"1-Piperidinecarboxylic acid, 4-[2-[4-[(methylsulfonyl)oxy]-1-piperidinyl]-2-oxoethyl]-, 1,1-dimethylethyl ester",610-165-6,440634-25-3,Acute Tox. 4,Notified C&L,10,H302:10
135413,(2R)-acetoxy(phenyl)acetic acid,610-598-0,51019-43-3,Eye Irrit. 2,REACH registration C&L,2,H319:2;H315:1
135414,2-chloro-5-methoxyanilinium chloride,285-050-3,85006-21-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:44;H335:39;H373:4;H301:5;H311:5;H332:1;H312:1;H302:1;H331:1
135416,Bismuth citrate,212-390-1,813-93-4,Not Classified,REACH registration C&L,25,Not classified:25
135418,"TRISODIUM 1-[[[[4-[4-[BIS-(2-HYDROXYETHYL)AMINO]-6- [(2-SULFONATOETHYL)AMINO]]-1,3,5-TRIAZIN-2-YL]AMINO]-2-SULPHONATOPHENYL]AZO]-2-AMINO-8-HYDROXY-6-NAPHTHALENE SULFONATE",419-720-5,182061-89-8,Not Classified,REACH registration C&L,2045,Not classified:2045
135420,5-chlorovaleric acid,214-279-3,1119-46-6,Skin Corr. 1B,REACH registration C&L,44,H314:3;H319:41;H315:41;H335:41
135423,Methyl alpha-Bromo-2-chlorophenylacetate,617-693-6,85259-19-4,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H290:1;H318:1;H314:2
135426,Methyl 2-bromooctanoate,226-644-4,5445-22-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
135427,Triglycerol,259-986-8,56090-54-1,Not Classified,Notified C&L,36,Not classified:36
135428,1-ETHOXY-3-METHYL-2-BUTENE,606-931-4,22094-00-4,Flam. Liq. 2,Notified C&L,1377,H225:1376;H224:1
135430,4-chloro-3-nitrobenzaldehyde,240-645-7,16588-34-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H317:40;H319:44;H315:44;H335:43
135432,"Formaldehyde, polymer with 4-(1,1,3,3-tetramethylbutyl)phenol",607-986-7,26678-93-3,Not Classified,Notified C&L,45,Not classified:34;H412:8;H317:3
135434,Methyl 2-amino-3-chlorobenzoate,620-109-2,77820-58-7,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,5,H317:3;H411:3;Not classified:1;H302:1
135437,Lithium hydroxide,215-183-4,1310-65-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,956,H318:701;H314:869;H302:733;H412:101;Not classified:83;H411:26;H312:9;H301:16;H331:11;H290:1;H362:1
135439,"Oleic acid, monoester with oxybis(propanediol)",256-367-4,49553-76-6,Aquatic Chronic 2,REACH registration C&L,46,H411:36;Not classified:10
135442,Isopropyl dihydrogen phosphate,216-607-0,1623-24-1,Not Classified,Notified C&L,1,Not classified:1
135446,"(4R)-4-Isopropyl-1,3-oxazolidin-2-one",619-146-7,95530-58-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
135450,4-chlorobutyric acid,210-977-7,627-00-9,Acute Tox. 4;Skin Corr. 1B,Notified C&L,41,H314:41;H302:40;H290:1;H318:1
135451,"Sulfuric acid magnesium salt (1:1), hydrate",606-949-2,22189-08-8,,Notified C&L,38,Not classified:38
135452,Ethyl piperazine-1-carboxylate,204-395-2,120-43-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,52,H319:12;H315:12;H302:45;H335:10;H312:2;H332:2;H301:1
135456,12-Glycidylölsäureglycerinester,616-085-8,74398-71-3,Skin Irrit. 2;Skin Sens. 1,Notified C&L,220,H317:213;H315:147;H319:24;H335:24;Not classified:7
135457,Magnesium 8-(phenylamino)naphthalene-1-sulphonate,242-004-7,18108-68-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
135458,Tricarbonylnitrosylcobalt,237-945-5,14096-82-3,Flam. Liq. 2;Acute Tox. 3;Skin Sens. 1;Acute Tox. 2;Carc. 2,Notified C&L,42,H317:42;H301:42;H225:42;H351:42;H330:42
135460,Cyclohexylacetone,203-143-9,103-78-6,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H335:1;H319:1;H315:1;H227:1;H302:1
135461,"(S)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone",207-550-2,480-41-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,433,H319:431;H315:431;H302:3;H335:2
135462,"1,2,3-Trideoxy-4,6:5,7-bis-O-((4-propylphenyl)methylene)-nonitol",618-128-6,882073-43-0,Not Classified,Notified C&L,52,Not classified:52
135464,2-amino-2-phenylacetamide,211-849-3,700-63-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H315:40;H335:39
135465,Embutramide,239-780-4,15687-14-6,Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,52,H336:51;H412:51;H302:51;Not classified:1
135466,1-METHYL-AZEPAN-4-ONE HYDROCHLORIDE,606-393-0,19869-42-2,Acute Tox. 4,Notified C&L,4,H302:4;H319:2;H335:2;H315:1
135472,"Glycerides, coco mono- and di-",294-603-8,91744-41-1,Not Classified,Notified C&L,61,Not classified:61
135477,"Diphosphoric acid, compound with 1,3,5-triazine-2,4,6-triamine (1:2)",236-860-0,13518-93-9,Acute Tox. 4,REACH registration C&L,7,H332:4;Not classified:3
135479,Phenyl thioxochloroformate,213-736-4,1005-56-7,Skin Corr. 1B,Notified C&L,46,H314:46;H290:2;H318:2
135481,"Poly(oxy-1,2-ethanediyl), α-methyl-ω-methoxy-",607-475-9,24991-55-7,Repr. 2,Notified C&L,157,H260:156;H360:156;Not classified:1
135484,"Carboxylic acids, di-, C4-6, potassium sodium salts",287-016-3,85408-55-5,Not Classified,Notified C&L,83,Not classified:83
135485,"1-bromo-2,4-difluorobenzene",206-479-4,348-57-2,Flam. Liq. 4;Acute Tox. 4;Eye Irrit. 2B;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,107,H227:4;H320:4;H302:4;H411:4;H401:4;H319:101;H226:102;H315:101;H335:100;Not classified:1
135486,"2,2'-methylenediphenyl diisocyanate;diphenylmethane-2,2'-diisocyanate",219-799-4,2536-05-2,Skin Irrit. 2;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Resp. Sens. 1;Carc. 2;STOT RE 2,Harmonised C&L,0,H317:0;H373:0;H335:0;H319:0;H334:0;H315:0;H332:0;H351:0
135490,"Naphtha (petroleum), light, sweetened;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C",272-206-0,68783-66-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
135491,α-bromostyrene,202-702-4,98-81-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
135492,"4,5-dihydro-2-(methylthio)thiazole",243-447-9,19975-56-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:1;H335:1
135494,3-ethyl-3-methylglutaric acid,226-294-2,5345-01-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
135497,Ethyl 6-methylpyridine-2-carboxylate,609-732-0,39640-51-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
135504,p-tolyl hexanoate,268-832-9,68141-11-7,Not Classified,Notified C&L,88,Not classified:88
135507,Ammonium molybdate(VI),236-031-3,13106-76-8,Acute Tox. 4,REACH registration C&L,174,H302:102;H319:107;H315:103;H335:103;Not classified:39;H412:26;H317:4;H334:4;H373:1;H351:1;H341:1
135509,"reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]",417-080-1,,Self-react. D;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0;H242:0
135510,Trisilver citrate,204-786-8,126-45-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:3;H315:4;H335:3;H400:1;H410:1
135514,"reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)",431-440-5,,Eye Dam. 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H318:0
135515,1-chloro-2-(chlorodiphenylmethyl)benzene,255-647-3,42074-68-0,Met. Corr. 1;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,42,H319:40;H290:39;H315:40;H335:2;H314:2;H318:1
135517,N-(cyclohex-1-en-1-yl)pyrrolidine,214-414-6,1125-99-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H226:40;H315:44;H335:43
135522,Diisobutyl hexahydrophthalate,275-069-5,70969-58-3,Skin Sens. 1,REACH registration C&L,6,H317:2;Not classified:4
135523,4-ethylmorpholine,202-885-0,100-74-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,456,H312:131;H318:152;H302:396;H226:451;H314:325;H311:193;H335:127;H319:126;H315:126;H332:74;Not classified:5;H361:1
135524,"N,N'-methylenebis[methacrylamide]",219-102-3,2359-15-1,Not Classified,REACH registration C&L,3,Not classified:2;H302:1
135525,3-diethylaminopropiononitrile,226-323-9,5351-04-2,Acute Tox. 4;Eye Irrit. 2A,REACH registration C&L,88,H319:87;H302:87;H317:2;H315:2;H350:2;H300:1;H318:1;H310:1;H314:1;H330:1
135528,"binapacryl (ISO);2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate",207-612-9,485-31-4,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0,H410:0;H312:0;H360:0;H400:0;H302:0
135530,2-phenylbenzimidazole,211-939-2,716-79-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H318:38;H315:38;H302:38;H335:38;H413:1;Not classified:1
135532,Tribarium dinitride,234-977-1,12047-79-9,Acute Tox. 4,Notified C&L,39,H332:38;H300:38;Not classified:1
135533,Quinuclidin-3-ol,216-578-4,1619-34-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50,H319:3;H315:3;H335:3;H314:47;H228:1
135534,"Hydrocarbons, C7, n-alkanes, isoalkanes, cyclics",927-510-4,64742-49-0,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,53,H411:53;H225:53;H315:52;H304:53;H336:53;H224:1
135535,"Hexafluoropropene, oxidized, oligomers, reduced and hydrolyzed",500-552-7,161075-14-5,Eye Irrit. 2,Notified C&L,58,H319:58;H315:3
135536,"3-(p-ethylphenyl)-2,2-dimethylpropionaldehyde",266-819-2,67634-15-5,Not Classified,Notified C&L,1215,Not classified:986;H319:177;H315:229;H317:50;H410:51;H400:51;H411:50
135537,hydrogen iodide,233-109-9,10034-85-2,Press. Gas;Skin Corr. 1A,Harmonised C&L,0,H314:0;Not classified:0
135539,"Glycerides, coco mono-, di- and tri-, hydrogenated",294-604-3,91744-42-2,Not Classified,Notified C&L,34,Not classified:34
135540,Tetrachlorvinphos,244-865-4,22248-79-9,Acute Tox. 4;Aquatic Acute 1,Notified C&L,74,H400:73;H302:73;H410:33;H312:34;H332:33;H341:33;Not classified:1;H319:1;H315:1;H411:1
135542,"Methyl tetrahydro-2,5-dimethoxyfuroate",254-568-1,39658-49-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
135547,Butamirate,242-005-2,18109-80-3,Not Classified,REACH registration C&L,4,Not classified:4
135548,[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium,237-946-0,14097-03-1,,Notified C&L,18,H412:11;H318:11;H302:9;Not classified:7
135550,"3,5-dichlorosalicylaldehyde",202-005-5,90-60-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
135551,"(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide",430-230-0,136522-17-3,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0,H412:0;H302:0
135557,Triphenylphosphine sulphide,223-407-7,3878-45-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,76,H312:43;H335:42;H319:43;H315:43;H302:43;Not classified:33;H332:4
135559,Phenyl (2-(phenylthio)phenyl)carbamate,601-145-8,111974-73-3,Aquatic Chronic 2,Notified C&L,3,H411:3
135560,4-chloro-3-nitrobenzamide,240-644-1,16588-06-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,43,H317:38;H319:43;H315:5;H335:4
135561,"Fatty acids, C16-18-unsatd., sulfited, sodium salts",308-829-2,98653-97-5,Not Classified,Notified C&L,2,Not classified:2
135567,"2,5-dibromoadipic acid",222-457-7,3479-85-4,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H314:38;H302:38;H335:38
135570,"Heptanoic acid, ester with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol pentanoate",267-029-0,67762-64-5,Asp. Tox. 1,REACH registration C&L,470,H304:4;Not classified:466
135571,"1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-5-oxo-1-(4-sulfophenyl)-4-[2-(4-sulfophenyl)diazenyl]-, sodium salt, compd. with 2-aminoethanol (1:?:?)",601-107-0,111636-30-7,Not Classified,Notified C&L,68,Not classified:68
135572,"Disodium benzene-1,3-disulphonate",212-606-4,831-59-4,Eye Irrit. 2,REACH registration C&L,45,H319:44;H315:40;H335:40;Not classified:3
135573,Potassium methyldithiocarbamate,205-292-5,137-41-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1,Notified C&L,4,H317:3;H312:2;H332:2;H400:4;H302:4;H314:4;H410:2
135576,"1,6-bis(4-butoxycarbonimidoyl phenoxy)hexane",917-531-7,,Not Classified,Notified C&L,1,Not classified:1
135577,Carboxymethyl cellulose sodium salt,618-378-6,9004-32-4,Not Classified,Notified C&L,1742,Not classified:1702;H412:36;H332:7;H315:3;H319:1;H372:1
135578,"5-(2-fluorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one",219-878-3,2558-30-7,,Notified C&L,1,H302:1
135579,6-methylheptan-3-ol,242-532-8,18720-66-6,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
135581,"p,p'-dinitrobibenzyl",212-001-5,736-30-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,78,H332:38;H312:38;H302:38;Not classified:32;H413:8
135583,"Cyclohexanemethanamine, 5-amino-1,3,3-trimethyl-, reaction products with [[4-(1,1-dimethylethyl)phenoxy]methyl]oxirane",291-128-8,90341-95-0,Not Classified,Notified C&L,55,Not classified:55
135584,"N,N'-but-2-enylidenebis(methylamine)",203-900-3,111-72-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
135586,Docosan-1-ol,211-546-6,661-19-8,Not Classified,REACH registration C&L,498,Not classified:427;H319:50;H412:20;H411:30;H400:30;H410:20;H312:10;H335:10;H225:10;H318:10;H302:11;H336:10
135588,"Tricyclo[5.2.1.02,6]decane",227-851-2,6004-38-2,Not Classified,Notified C&L,3,Not classified:1;H226:2;H335:1;H319:1;H315:1;H302:1;H304:1
135595,"Formaldehyde polymer with 4-(1,1-dimethylpropyl)phenol and oxirane",682-635-9,63428-93-3,Not Classified,Notified C&L,63,Not classified:62;H319:1;H315:1;H335:1
135596,"(+-)-3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2- methyl-4H-pyrido[1,2-a]pyrimidin-4-one",451-680-4,,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Muta. 2;STOT RE 2,REACH registration C&L,1,H317:1;H373:1;H319:1;H302:1;H341:1
135597,"Hexafluoropropene, trimer",633-258-3,6792-31-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H312:39;H335:43;H319:43;H315:43;H332:39;H302:39;H226:38;H225:1
135601,2-Chloro-5-methylbenzoic Acid,613-216-0,6342-60-5,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,45,H411:38;H318:38;H302:38;H319:7;H315:7;H335:6
135602,"(Z)-N-9-octadecenylpropane-1,3-diamine",230-528-9,7173-62-8,Acute Tox. 4;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1290,H410:1134;H400:1268;H302:723;H372:626;H314:743;H318:1192;H290:522;H301:542;H315:547;H411:1
135605,Hafnium carbide,235-114-1,12069-85-1,Flam. Sol. 2,Notified C&L,177,H228:175;Not classified:2
135608,D-histidine hydrochloride monohydrate,206-513-8,351-50-8,Not Classified,Notified C&L,4,Not classified:4
135611,Isooctadecanoic acid,250-178-0,30399-84-9,Not Classified,REACH registration C&L,198,Not classified:161;H315:37
135612,A mixture of: magnesium caprolactamate; 6-caprolactamate,454-340-3,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 2,Notified C&L,2,H361:1;H335:2;H319:2;H315:2;H332:2;H302:2
135622,2-methyl-4-oxo-4H-pyran-3-yl butyrate,267-435-8,67860-01-9,Not Classified,Notified C&L,1,Not classified:1
135627,"ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate",405-880-3,100501-62-0,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
135628,3-(2-bromoethyl)-1H-indole,222-219-2,3389-21-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:39;H315:39;H335:39;H318:1;H314:2
135629,"Octadecanoic acid, 12-hydroxy-, homopolymer",608-150-4,27924-99-8,Eye Irrit. 2,Notified C&L,58,H319:46;Not classified:8;H315:5;H335:1
135637,1-(3-methoxypropoxy)propyl acetate,618-219-0,88917-22-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,396,H319:358;H315:358;H302:177;H335:180;Not classified:38
135638,"2-(3,4-Dihydroxyphenyl)-3,5,7-trihydoxy-4-chromenon-2-Wasser",612-158-3,6151-25-3,Acute Tox. 3,Notified C&L,82,H301:79;H341:4;H302:2;H311:1;H331:1;Not classified:1
135639,"1,1,1,3-tetrachloropropane",213-981-7,1070-78-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H226:1;H315:2;H302:2;H332:1;H335:1
135641,"(S)-N-Boc-2,3-epoxypropylamine",605-257-8,161513-47-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
135642,"Proteins, soy",232-720-8,9010-10-0,Not Classified,Notified C&L,271,Not classified:270;H319:1;H335:1
135645,"Terpenes and Terpenoids, limonene fraction",266-034-5,65996-98-7,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,141,H317:133;H410:138;H315:138;H400:138;H304:138;H226:138;H319:6;Not classified:3
135646,"reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;inert biomass from Aspergillus terreus",415-840-7,,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0,H317:0;H412:0
135647,Thulium(3+) acetate,254-326-5,39156-80-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
135650,Iotalamic acid,218-897-4,2276-90-6,Not Classified,REACH registration C&L,1,Not classified:1
135653,"Hexa-2,4-dienoic acid",203-768-7,110-44-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2214,H319:2100;H315:1890;H335:611;Not classified:63;H314:51;H317:3;H411:3;H410:1;H400:1;H302:1;H312:1
135654,Epoxysuccinic acid,221-900-1,3272-11-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H302:38;H335:38
135658,N-methylhydroxylamine hydrochloride,224-181-2,4229-44-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
135662,"1,8-dihydroxy-2,4,5,7-tetranitroanthraquinone",208-246-2,517-92-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
135663,"4-amino-N,N-diethylaniline hydrochloride",240-760-2,16713-15-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
135668,2-(2-hydroxy-5-(2-(methacryloyloxy)ethyl)phenyl)-2H-benzotriazole,424-240-4,96478-09-0,Not Classified,REACH registration C&L,7,Not classified:5;H413:1;H319:1;H315:1
135672,4-chlorophenyl 2-chloro-4-nitrophenyl ketone,256-514-2,50274-64-1,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,38,H319:38;H400:38
135674,"Alcohols, C7-9-iso-, C8-rich",271-231-4,68526-83-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,549,H319:90;H412:94;H315:101;H318:441;H302:441;H336:10;Not classified:5
135677,Methyl 3-[4-[bis[2-(acetoxy)ethyl]amino]-2-methylphenyl]-2-cyanoacrylate,258-624-6,53554-75-9,Not Classified,Notified C&L,11,Not classified:11
135681,Bis(2-hydroxyethyl)ammonium heptanoate,271-492-4,68568-51-4,Eye Dam. 1,Notified C&L,1,H318:1
135683,"3-Butyn-1-ol, 4-(triethylsilyl)-",605-201-2,160194-29-6,,Notified C&L,5,H319:5;H315:5;H335:5
135685,N-nitrosodibutylamine,213-101-1,924-16-3,Acute Tox. 4;Carc. 2,Notified C&L,48,H351:44;H302:47;Not classified:1
135686,"Hydrogen 9-(2,4-dicarboxylatophenyl)-3,6-bis(diethylamino)xanthylium, sodium salt",265-730-6,65392-81-6,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
135689,"[2-ethyl-2-[[2-[(1-oxoallyl)oxy]ethoxy]methyl]-1,3-propanediyl]bis(oxy-2,1-ethanediyl) diacrylate",278-260-1,75577-70-7,Eye Irrit. 2,Notified C&L,1,H319:1
135690,"2,2,5-trimethylhexane",222-537-1,3522-94-9,Flam. Liq. 2,Notified C&L,47,H225:47;H411:8;H315:8;H304:9;H336:8
135691,"N-cyclopropyl-1,3,5-triazine-2,4,6-triamine",266-257-8,66215-27-8,Aquatic Chronic 2,Notified C&L,204,H411:160;H319:43;H315:44;H335:42;H302:2;H373:1
135694,N-benzyl-N-phenylhydrazinium(1+) chloride,227-195-7,5705-15-7,,Notified C&L,6,H319:6;H315:6;H335:5;H312:1;H332:1;H302:1
135695,"Anthra[2,1,9-mna]naphth[2,3-h]acridine-5,10,15(16H)-trione, 3-[(9,10-dihydro-9,10-dioxo-1-anthracenyl)amino]-, chlorinated",283-302-7,84604-24-0,Not Classified,Notified C&L,9,Not classified:9
135696,penthachloronaphthalene,215-320-8,1321-64-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H312:0;H319:0;H315:0;H400:0;H302:0
135697,Strontium selenide,215-258-1,1315-07-7,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H410:42;H301:42;H331:42;H400:42
135702,Diethyl carbonate,203-311-1,105-58-8,Flam. Liq. 3,REACH registration C&L,411,H226:400;H319:54;H315:53;H335:53;Not classified:12;H351:4;H361:4
135705,Pemoline,218-438-8,2152-34-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:39;H312:39;H302:39
135707,"2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride",414-670-0,141890-30-4,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0;H318:0;H302:0
135709,"Oils, mustard, oxidized",270-322-6,68424-78-2,Not Classified,Notified C&L,1,Not classified:1
135714,"Sodium 1,4-diisotridecyl sulphonatosuccinate",259-515-6,55184-72-0,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,28,H411:18;H318:26;H315:28;H226:8;H319:2
135716,"Gases (petroleum), C1-5, wet;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",271-624-0,68602-83-5,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
135719,Oil of Origanum,616-905-4,8007-11-2,Acute Tox. 4;Asp. Tox. 1;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,86,H317:45;H312:43;H411:45;H315:84;H302:85;H304:45;H311:39;H319:41;H314:1;H361:1;Not classified:1
135723,7-(α-D-glucopyranosyloxy)-4-methyl-2H-1-benzopyran-2-one,241-794-0,17833-43-1,Not Classified,Notified C&L,1,Not classified:1
135726,Cerium hexaboride,234-526-9,12008-02-5,Not Classified,Notified C&L,1,Not classified:1
135733,"N,N-bis[3-(dimethylamino)propyl]formamide",279-477-4,80459-59-2,Skin Corr. 1B,Notified C&L,8,H314:8
135735,3-carboxy-1-methylpyridinium chloride,228-119-5,6138-41-6,Not Classified,Notified C&L,2,Not classified:2
135737,Lanthanum(III) chloride hydrate,606-464-6,20211-76-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:43;H315:43;H335:43;H317:2;H290:2;H318:2;H411:2
135740,"Disodium hydrogen bis[2-[[6-[(4-chloro-6-methoxy-1,3,5-triazin-2-yl)amino]-1-hydroxy-3-sulpho-2-naphthyl]azo]benzoato(3-)]chromate(3-)",274-894-8,70788-62-4,Not Classified,Notified C&L,1,Not classified:1
135744,"coriandrol; (S)-3,7-dimethyl-1,6-octadien-3-ol; d-linalool",204-810-7,126-90-9,Skin Sens. 1B,Harmonised C&L,0,H317:0
135745,"Fatty acids, tall-oil, reaction products with ethanolamine, ethoxylated",612-396-8,61791-19-3,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,85,H317:85;H412:85;H319:85
135747,Terbium trifluoride,237-247-0,13708-63-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43,H312:43;H335:43;H319:43;H315:43;H332:42;H302:43;H331:1
135748,"2,4-dimethylthiophene",211-312-3,638-00-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H315:1;H335:1;H332:1;H225:1;H312:1;H302:1
135749,3-chlorobutyric acid,217-771-6,1951-12-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H318:39;H315:38;H302:38;H335:38;H290:1;H314:2
135751,"cyclobutane-1,1-dicarboxamide",608-895-5,33582-68-2,Flam. Sol. 2;Self-heat. 2,REACH registration C&L,2,H228:2;H252:2
135752,2-ethyl-3-(methylthio)pyrazine,277-191-4,72987-62-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H318:38;H315:39;H335:39;H319:1
135757,Rhodinyl acetate,205-458-7,141-11-7,,Notified C&L,1437,H319:1286;H411:1399;H315:1399;H226:38
135758,Cyclopentaneethanol,212-156-9,766-00-7,Flam. Liq. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H227:1;H315:1;H335:1
135761,Salbutamol,242-424-0,18559-94-9,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,52,H332:5;H302:52;H317:4;H412:4;H319:4
135766,"3-(3,4-dimethoxyphenyl)-2-hydrazinyl-2-methylpropanoic acid",618-965-7,937203-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2,REACH registration C&L,1,H319:1;H341:1;H315:1;H335:1
135771,Cobalt difluoride,233-061-9,10026-17-2,Acute Tox. 3;Skin Corr. 1B,Notified C&L,45,H301:45;H314:45;H317:4;H351:4;H311:1;H331:1;H350:1
135772,Bis(trifluoromethane)sulfonimide lithium salt,618-438-1,90076-65-6,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1B;Eye Dam. 1;STOT RE 1;Aquatic Chronic 3,Notified C&L,174,H301:173;H318:126;H310:126;H412:173;H372:126;H314:174;H373:45;H311:47;Not classified:1;H332:1;H312:1;H302:1;H331:1
135773,2-Fluoro-4-(trifluoromethyl)benzaldehyde,618-296-0,89763-93-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45,H319:44;H315:45;H335:44;H226:4;H412:1
135774,Sodium phosphate tribasic hexahydrate,605-134-9,15819-50-8,Skin Corr. 1B,Notified C&L,39,H314:39
135775,"3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, hydrochloride (1:1)",920-521-5,246852-07-3,Not Classified,Notified C&L,1,Not classified:1
135776,"Yucca schidigera, ext.",607-033-5,223749-05-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,65,H319:65;H315:65
135779,4-chloro-2-methylthiopyrimidine,256-500-6,49844-90-8,Skin Corr. 1B,Notified C&L,45,H314:45;H318:1
135780,"2,7-Naphthalenedisulfonic acid, 4-amino-6-[[5-[[4-chloro-6-[[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-3-[(4-sulfophenyl)azo]-, pentasodium salt",279-407-2,80156-94-1,Not Classified,Notified C&L,27,Not classified:24;H317:3
135784,Hydrocodone hydrogen tartrate,205-608-1,143-71-5,Acute Tox. 4,Notified C&L,7,H302:4;H317:3;H334:3;H301:2;H312:1;H300:1;Not classified:1;H336:1;H330:1;H331:1
135786,3-benzoylpropionic acid,218-135-0,2051-95-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H315:43;H335:42;Not classified:1
135787,(Z)-hex-3-enyl (Z)-hex-3-enoate,262-797-3,61444-38-0,Not Classified,REACH registration C&L,125,Not classified:123;H413:1;H411:1
135790,Phenylacetone,203-144-4,103-79-7,Not Classified,REACH registration C&L,46,Not classified:44;H319:2;H302:2
135792,[2-(aminomethyl)phenyl]acetic acid,255-110-3,40851-65-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H302:1;H335:1
135798,"Molybdate (MoO42-), sodium, hydrate (1:2:2), (T-4)-",600-158-6,10102-40-6,,Notified C&L,77,Not classified:59;H319:17;H315:17;H335:17;H332:13;H302:12;H412:8;H312:4
135799,Sodium etasulfate,204-812-8,126-92-1,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1293,H318:1058;H315:1189;H228:118;H335:119;H319:116;H302:68;Not classified:84;H330:18
135800,2-fluoroaniline,206-478-9,348-54-9,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 2;STOT RE 1;Aquatic Acute 1,REACH registration C&L,180,H317:123;H351:123;H301:124;H311:124;H318:166;H331:124;H400:123;H372:123;H341:123;H335:43;H315:56;H302:56;H226:55;H319:14;H411:7;H373:5;H312:8;H332:8
135802,6-ethyl-2-toluidine,246-309-6,24549-06-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,233,H332:186;H412:190;H312:190;H302:233;H331:39;H319:1;H315:1
135803,"Quaternary ammonium compounds, dimethylditallow alkyl, chlorides",272-207-6,68783-78-8,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,48,H410:48;H318:47;H302:37;H400:10;H315:10;H314:1
135807,"Acetic acid, 2,2',2''-[(butylstannylidyne)tris(thio)]tris-, tri-C12-22-alkyl esters",290-463-7,90170-31-3,Aquatic Chronic 4,Notified C&L,1,H413:1
135808,1-chloro-3-iodopropane,230-088-8,6940-76-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
135810,"reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, mixture reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers",401-740-0,,Acute Tox. 4,Harmonised C&L,0,H302:0
135812,"2,4-Dichloroquinazoline",612-020-2,607-68-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:5;H315:4;H335:5;H312:1;H332:1;H302:3
135813,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutyramide",247-820-7,26576-46-5,,REACH registration C&L,129,Not classified:129
135814,"1,3-dihydro-4(or 5)-methyl-2H-benzimidazole-2-thione, zinc salt",262-872-0,61617-00-3,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,141,H317:106;H373:64;H410:62;H360:4;H332:81;H302:108;H361:90;H411:46;H312:2;Not classified:1
135817,"Fatty acids, C14-18 and C16-18-unsatd., mixed esters with C18-unsatd. fatty acid dimers and trimethylolpropane",605-345-6,163879-67-2,Not Classified,REACH registration C&L,2,Not classified:2
135818,N-Phenyl-N-[(trimethoxysilyl)methyl]amine,616-531-1,77855-73-3,Acute Tox. 4;STOT RE 2;Aquatic Chronic 1,Notified C&L,1,H373:1;H410:1;H302:1
135820,Tris(2-hydroxyethyl)ammonium myristate,255-486-9,41669-40-3,Not Classified,Notified C&L,1,Not classified:1
135825,"2-(hydroxymethyl)-2-[[(2-methyl-1-oxoallyl)oxy]methyl]-1,3-propanediyl bismethacrylate",222-539-2,3524-66-1,,Notified C&L,1,H317:1;H319:1;H315:1
135826,"isopropyl (2E,4E,7S)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate; S-methoprene",613-834-0,65733-16-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
135827,2-[bis(2-hydroxyethyl)amino]ethanesulphonic acid,233-465-5,10191-18-1,Not Classified,REACH registration C&L,94,Not classified:25;H319:68;H315:69;H335:66;H317:1
135829,"1-(6-FLUORO-3,4-DIHYDRO-2H-CHROMEN-2-YL)ETHANONE",612-934-1,620176-90-1,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,1,H317:1;H412:1;H302:1
135832,Ligroine;Low boiling point naphtha;[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20°C to 135°C (58°F to 275°F).],232-453-7,8032-32-4,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0,H304:0;H340:0;H350:0
135838,"1,3,2-dioxathiane 2,2-dioxide",214-022-5,1073-05-8,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Muta. 2,REACH registration C&L,40,H317:1;H341:2;H318:2;H302:1;H351:39;H301:1;H311:1;H315:1;H332:1
135839,"Alcohols, C8-10-iso-, C9-rich",271-233-5,68526-84-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,147,H319:56;H412:1;H315:56;Not classified:89;H318:1;H400:1
135843,(2-hydroxyethyl)dimethyl(3-sulphopropyl)ammonium hydroxide,254-176-0,38880-58-9,Skin Corr. 1B,Notified C&L,39,H314:38;H319:1;H315:1
135849,Lead ditantalum hexaoxide,235-065-6,12065-68-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42,H373:42;H410:42;H360:42;H332:42;H400:42;H302:42
135851,1-Butylpyridinium heptachlorodialuminate,479-330-6,,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H318:2;H314:2;H302:2
135853,"m,α-dimethylstyrene",214-394-9,1124-20-5,,Notified C&L,4,H319:4;H226:4;H315:4;H335:4
135856,2-hydroxyiminomethyl-1-methylpyridinium chloride,200-080-9,51-15-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44,H332:38;H312:38;H302:39;H319:6;H315:6;H335:4
135857,"(R*,S*)-(±)-α-[4-[2-(dimethylamino)ethoxy]phenyl]-β-ethyl-α-phenylphenethyl alcohol",278-718-0,77542-06-4,Acute Tox. 4;Carc. 1A;Repr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H360:1;H400:1;H350:1;H302:1
135858,6-amino-1-methyluracil,219-422-3,2434-53-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H302:38;H335:42
135860,"Alcohols, C10-14, ethoxylated",613-933-9,66455-15-0,Eye Irrit. 2;STOT SE 3,Notified C&L,1178,H319:601;H335:599;H318:466;H400:98;H302:219;Not classified:64;H412:34;H410:14;H315:2
135862,5-aminophthalide,265-731-1,65399-05-5,,Notified C&L,2,H319:2;H315:2;H335:2
135863,3-(4-methyl-1-piperazine)propan-1-ol,226-177-6,5317-33-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H315:2;H335:2;H312:2;H332:2;H302:2
135864,methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate,416-240-8,155522-12-6,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0,H317:0;H413:0
135868,(propylcarbonylthioethyl)trimethylammonium iodide,217-475-7,1866-16-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46,H319:46;H315:46;H335:45
135872,ammonium perfluorooctane sulfonate;ammonium heptadecafluorooctanesulfonate,249-415-0,29081-56-9,Acute Tox. 4;Acute Tox. 4;Carc. 2;Lact.;STOT RE 1;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0,H351:0;H360:0;H362:0;H332:0;H302:0;H411:0;H372:0
135874,"Citric acid, lead salt",238-432-9,14450-60-3,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H373:1;H410:1;H360:1;H332:1;H400:1;H302:1
135875,Ethyl-2-thiourea,210-899-3,625-53-6,Acute Tox. 3,Notified C&L,46,H301:46
135880,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with fatty acids, C18-unsatd., dimers",500-180-5,67989-52-0,Skin Sens. 1,REACH registration C&L,365,H317:172;Not classified:193;H411:99;H319:162;H315:140;H335:22
135887,"Sodium [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)",277-383-8,73324-06-8,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,83,H319:83;H411:83
135889,"2,4(or 2,5)-xylenol",276-245-4,71975-58-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0,H311:0;H301:0;H314:0;H411:0
135890,"Penta-2,4-dienoic acid",210-976-1,626-99-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
135898,"Chenopodium anthelminticum, ext.",289-683-6,89997-48-8,Acute Tox. 4;Asp. Tox. 1;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,2,H317:2;H312:2;H411:2;H315:2;H302:2;H304:2
135901,"(E)-6,10-dimethylundeca-5,9-dien-2-one",223-269-8,3796-70-1,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,474,H411:430;H315:474;H319:44;H335:44
135902,5-(chloromethyl)-2-furaldehyde,216-608-6,1623-88-7,Flam. Liq. 4;Skin Corr. 1B,Notified C&L,3,H227:2;H314:2;H351:1;H318:1;H302:1
135903,"trans-4,4'-dinitrostilbene",212-002-0,736-31-2,Not Classified,Notified C&L,31,Not classified:31
135904,"(+-)-2,3-Dihydro-9-methyl-3-((2-methylimidazol-1-yl)methyl)carbazol- 4(1H)-one monohydrochloride dihydrate",600-465-5,103639-04-9,Acute Tox. 3;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,115,H400:97;H410:96;H318:97;H301:115;H319:13;H315:10;H335:10;H411:5;H311:2;H331:2;H362:1;H312:1;H317:1;H334:1;H413:1;H361:1
135905,3-[(4-fluorophenyl)methylene]phthalide,219-877-8,2558-18-1,Not Classified,Notified C&L,1,Not classified:1
135906,2-Nitro-4-methylsulfonyltoluene,605-469-0,1671-49-4,Acute Tox. 4;Skin Sens. 1;Repr. 2;Aquatic Chronic 3,Notified C&L,199,H317:199;H412:199;H361:199;H302:199
135907,"2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol",617-303-4,82186-77-4,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1;H335:1
135908,Diethyl azodiformate,217-821-7,1972-28-7,Self-react. A;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H335:44;H319:44;H240:38;H315:44;H332:38;H312:5;H302:5;H301:2;H311:2;H331:2;H227:1
135909,"2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)",427-180-7,,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H400:0;H410:0;H302:0
135910,"Starch, acid-hydrolyzed",613-863-9,65996-63-6,Not Classified,Notified C&L,89,Not classified:89
135912,Allyl cyanoacetate,236-423-4,13361-32-5,Acute Tox. 3,REACH registration C&L,55,H301:55;H312:39;H335:39;H319:40;H315:40;H332:39;Not classified:2
135914,"2-Naphthalenecarboxylic acid, 3-hydroxy-4-[2-(1-sulfo-2-naphthalenyl)diazenyl]-, strontium salt (1:1)",605-115-5,15792-20-8,Not Classified,Notified C&L,7,Not classified:7
135915,"[[(phosphonomethyl)imino]bis[hexane-6,1-diylnitrilobis(methylene)]]tetrakisphosphonic acid, sodium salt",252-656-4,35657-77-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,3,H319:2;H412:2;H315:2;Not classified:1
135916,Norethisterone,200-681-6,68-22-4,Carc. 2;Repr. 1A;Lact.;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,65,H410:3;H360:21;H362:2;H400:2;H351:63;H332:18;H312:18;H361:1;H350:1;H317:1;H373:1;H335:1;H319:1;H315:1;H302:1
135918,Ketazolam,248-346-3,27223-35-4,,Notified C&L,2,Not classified:2
135919,Tin zinc oxide (SnZnO3),601-699-0,12036-37-2,Not Classified,Notified C&L,1,Not classified:1
135920,Difluorodiphenylsilane,206-226-8,312-40-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H315:38;H335:38
135922,"Benzoic acid, 4,5-difluoro-2-nitro-",922-203-1,20372-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
135923,"1,2,3-trifluoro-4-nitrobenzene",212-238-4,771-69-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,77,H312:44;H335:39;H319:43;H315:43;H332:44;H302:77;H311:33;H317:33;H373:33
135924,"Silsesquioxanes, Ph Pr",614-232-0,68037-90-1,Not Classified,Notified C&L,5,Not classified:5
135927,p-xylene,203-396-5,106-42-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Harmonised C&L,0,H332:0;H226:0;H312:0;H315:0
135928,"Aluminum, chloro formate hydroxy complexes",294-174-7,91696-20-7,Not Classified,Notified C&L,1,Not classified:1
135929,"Trisodium [N,N-bis[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]cuprate(3-)",235-361-5,12189-76-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
135931,(methyl-2-phenoxyethoxy)propanol,257-361-4,51730-94-0,Not Classified,Notified C&L,62,Not classified:62
135932,"Reaction products of alcohols, C8-22, distn. residues, maleic anhydride and sodium sulfite, sodium salt",924-650-8,,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,36,H319:36;H411:36
135933,"N,N'-diethylethylenediamine",203-902-4,111-74-0,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,45,H226:45;H314:45;H318:2
135934,"Lead(2+) 4,6-dinitro-o-cresolate",265-460-9,65121-76-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H373:1;H410:1;H360:1;H332:1;H400:1;H302:1
135935,propyl (2S)-2-hydroxypropanoate,611-025-7,53651-69-7,Eye Dam. 1,REACH registration C&L,3,H318:3
135936,"Euphorbia hirta, ext.",283-412-5,84625-37-6,Not Classified,Notified C&L,1,Not classified:1
135946,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3,8-bis[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-, trisodium salt",612-028-6,607724-47-0,Skin Sens. 1B,REACH registration C&L,2,H317:2
135950,"Methanone, bis(4-fluorophenyl)-, polymer with 1,4-benzenediol",608-392-0,29658-26-2,Not Classified,Notified C&L,1,Not classified:1
135954,1-acetyl-5-bromo-4-chloro-1H-indol-3-yl acetate,221-200-6,3030-06-6,Not Classified,Notified C&L,2,Not classified:2
135956,"Alpinia galanga, ext.",283-399-6,84625-26-3,Flam. Liq. 3;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1311,H317:1311;H226:1286;H411:1286
135960,"Estra-1,3,5,7,9-pentaene-3,17-diol, 3-(hydrogen sulfate), monosodium salt, (17α)-",259-985-2,56086-66-9,Carc. 2;Repr. 1B,Notified C&L,17,H351:16;H360:17;H373:1;H319:1;H362:1;H315:1;H350:1
135961,"1,2-benzenedicarboxylic acid, dipentylester, branched and linear",284-032-2,84777-06-0,Aquatic Acute 1;Repr. 1B,Harmonised C&L,0,H400:0;H360:0
135962,Methyl 3-hydroxybenzoate,243-071-5,19438-10-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55,H319:55;H315:55;H302:49;H335:54
135965,p-[[(4-chlorobutyl)sulphonyl]amino]benzenesulphonamide,277-776-4,74220-53-4,Acute Tox. 4,REACH registration C&L,3,H302:2;Not classified:1
135966,"2-naphthalenesulfonic acid, 5(or 8)-amino-8(or 5)-[(4-hydroxyphenyl)amino]-, reaction products with sodium sulfide (Na2(Sx))",215-491-9,1327-69-1,Not Classified,Notified C&L,2,Not classified:2
135972,4-phenylpiperidine-4-carboxamide monohydrochloride,261-591-0,59083-35-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
135977,Isononyl acrylate,257-544-9,51952-49-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
135978,"Glycerides, C16-18 mono-, di- and tri-, lactates",294-602-2,91744-40-0,Not Classified,Notified C&L,2,Not classified:2
135979,Ammonium dodecylbenzenesulphonate,215-559-8,1331-61-9,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,312,H319:85;H315:204;Not classified:88;H318:139;H302:119;H335:20;H412:20;H314:20
135980,"Zinc sulfide (ZnS), aluminum and copper-doped",271-902-1,68611-68-7,Skin Sens. 1;Resp. Sens. 1;Aquatic Acute 1,Notified C&L,1,H317:1;H334:1;H410:1;H400:1
135983,Carbohydrase,232-575-0,9001-02-9,Resp. Sens. 1,Notified C&L,8,H334:8
135984,Decamethylenediamine,211-471-9,646-25-3,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,82,H314:82;H302:41;H318:34;H312:1;H335:2
135985,Fluorooxobismuthine,236-861-6,13520-72-4,Met. Corr. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H290:1;H315:1;H335:1
135989,Ferrocholinate,215-649-7,1336-80-7,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,1,H317:1;H319:1
135991,Dihydroxy(phenyl)borane,202-701-9,98-80-6,Acute Tox. 4,Notified C&L,100,H302:93;H300:5;H319:15;H315:15;H335:15;Not classified:2;H332:2;H312:2
135995,"2-(1H-BENZOTRIAZOLE-1-YL)-1,1,3,3-TETRAMETHYLURONIUM HEXAFLUOROPHOSPHATE",619-076-7,94790-37-1,STOT SE 3,Notified C&L,172,H317:119;H315:172;H335:170;H319:56;H312:3;H332:3;H302:3;H228:3;Not classified:2;H334:3
135996,"D-Glucopyranose, oligomers, decyl octyl glycosides",500-220-1,68515-73-1,Eye Dam. 1,REACH registration C&L,1001,H318:823;Not classified:107;H319:70;H315:54;H412:2
135997,2-aminobenzyl alcohol,226-293-7,5344-90-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,75,H319:48;H315:48;H335:47;H302:27
135998,4-tert-butylpiperidine,217-539-4,1882-42-4,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H335:1;H318:1;H315:1;H227:1;H302:1
136000,"1-(2,5-dimethylphenyl)ethan-1-one",218-399-7,2142-73-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
136002,"2-ethyl-2-methyl-1,3-dioxolane",204-785-2,126-39-6,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,42,H319:42;H225:42;H315:41;H335:41;H332:39
136003,Hept-3-en-2-one,214-278-8,1119-44-4,Flam. Liq. 3,Notified C&L,1443,H226:1433;H319:39;H315:39;H335:39;Not classified:10
136014,"Fatty acids, C16-18, reaction products with diethanolamine",293-014-3,91032-08-5,Not Classified,REACH registration C&L,147,Not classified:140;H319:4;H315:5;H318:2;H317:1;H412:1
136015,"3-(o-ethylphenyl)-2,2-dimethylpropionaldehyde",266-818-7,67634-14-4,Not Classified,Notified C&L,529,Not classified:472;H319:42;H315:58;H317:13;H410:14;H400:14;H411:13
136016,"δ-2:2'-bis(1,3-dithiazole)",250-593-7,31366-25-3,,Notified C&L,4,H317:4
136017,1-nitrosopiperidine,202-886-6,100-75-4,Acute Tox. 3;Carc. 2,Notified C&L,46,H351:42;H301:45;Not classified:1
136020,"Fatty acids, C12-20, reaction products with diethylenetriamine",293-015-9,91032-09-6,Not Classified,Notified C&L,7,Not classified:5;H317:2;H315:2
136022,4-aminobenzohydrazide,226-324-4,5351-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:44;H315:44;H335:43
136025,"Ferrate(4-), hexakis(cyano-κC)-, lead(2+) (1:2), (OC-6-11)-",604-391-4,14402-61-0,,Notified C&L,5,H373:5;H410:5;H360:5;H332:5;H400:4;H302:5;H312:1
136026,2-(triethoxysilyl)propiononitrile,241-869-8,17932-62-6,Not Classified,Notified C&L,5,Not classified:5
136027,"5,6-dihydro-2-(2,6-xylidino)-4H-1,3-thiazine monohydrochloride",245-417-0,23076-35-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,78,H319:45;H301:74;H315:46;H335:45;H412:24;H318:24;Not classified:1;H314:1;H312:1;H332:1;H302:2;H311:1;H331:1;H300:1
136031,1-oxa-4-azaspiro[4.5]decan-4-ethanol,219-101-8,2359-11-7,Skin Corr. 1C,REACH registration C&L,1,H314:1
136032,"4,4-Difluoropiperidine hydrochloride",604-401-7,144230-52-4,Eye Irrit. 2,Notified C&L,46,H319:46;H315:8;H335:8
136035,"3,4-diethoxytoluene",220-039-9,2612-56-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
136036,Dipyrithione,223-024-5,3696-28-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,101,H319:68;H315:39;H302:67;H335:68;Not classified:33;H400:29
136039,"7,11-Dichloro-6-Methylene Oxytetracycline NaphtalenSulphonate",923-240-6,,Not Classified,Notified C&L,1,Not classified:1
136040,tetramethylammonium hydrogen phthalate,416-900-5,79723-02-7,Acute Tox. 3;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0,H373:0;H400:0;H301:0
136041,[No public or meaningful name is available],469-330-4,,Not Classified,Notified C&L,1,Not classified:1
136043,"D-(-)threo-2-amino-1-(p-nitrophenyl)propane-1,3-diol",211-938-7,716-61-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,43,H319:43;H315:43;H302:41;H335:42
136044,Tetramethylammonium tetrafluoroborate,211-547-1,661-36-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44,H319:43;H315:43;H335:43;H318:1;H314:1;H302:1
136045,"2,4-dithiapentane",216-577-9,1618-26-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1456,H319:1444;H226:170;H315:1443;H412:30;H335:1413;H311:10;H331:10;Not classified:1
136047,Potassium hydrogensulphide,215-182-9,1310-61-8,Not Classified,Notified C&L,2,Not classified:1;H317:1;H373:1;H251:1;H332:1;H228:1;H302:1;H351:1
136048,2-[(3-methyl-4-nitropyridin-2-yl)methylsulfanyl]-1H-benzimidazole,460-440-8,,Not Classified,Notified C&L,1,Not classified:1
136055,Magnesium perchlorate,233-108-3,10034-81-8,Ox. Sol. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,61,H319:60;H271:10;H315:60;H302:9;H335:52;H272:51;Not classified:2
136058,"2,3,5,6,8,9,11,12-octahydro-1,4,7,10,13-benzopentaoxacyclopentadecin",237-947-6,14098-44-3,,Notified C&L,7,H319:7;H315:7;H335:6
136060,4-isohexylpyridine,244-864-9,22241-38-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H302:1;H335:1
136061,3-fluoro-p-anisaldehyde,206-514-3,351-54-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2;Aquatic Chronic 4,REACH registration C&L,11,H335:10;H319:11;H315:11;H413:2;H351:2;H302:1
136064,Disodium phosphate dihydrate,600-053-5,10028-24-7,Eye Irrit. 2,Notified C&L,61,H319:55;Not classified:6
136066,"3-ethyl-4-methyl-1,5-dihydro-2H-pyrrol-2-one",616-364-4,766-36-9,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,10,H318:6;H302:6;Not classified:1;H319:3;H315:3;H335:2
136068,"Benzene, mono-C10-13-alkyl derivs.",603-362-3,129813-58-7,Not Classified,Notified C&L,41,Not classified:41
136072,(Benzhydrylthio)acetic Acid,613-245-9,63547-22-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
136073,"amitrole (ISO);1,2,4-triazol-3-ylamine",200-521-5,61-82-5,STOT RE 2;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0,H373:0;H361:0;H411:0
136074,2-chloro-5-nitrobenzonitrile,240-643-6,16588-02-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45,H312:39;H335:44;H319:45;H315:45;H332:39;H302:1
136075,(1-cyclopenten-1-yloxy)trimethylsilane,243-448-4,19980-43-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H226:40;H315:40;H335:39
136083,Teclothiazide,224-253-3,4267-05-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H332:1;H312:1;H302:1
136089,"Alpha,alpha-dimethoxytoluene",214-413-0,1125-88-8,Acute Tox. 4,Notified C&L,316,H302:315;H319:42;H315:65;H335:41;H317:24;H411:24;H312:2;H332:2
136095,5-methylheptan-3-ol,242-531-2,18720-65-5,Eye Irrit. 2,Notified C&L,38,H319:38
136098,(m-aminophenyl)metaboric acid hydrochloride,285-052-4,85006-23-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:39
136101,"Cyclohexanemethanamine, 5-amino-1,3,3-trimethyl-, reaction products with glycidyl Ph ether",291-129-3,90341-96-1,Not Classified,Notified C&L,22,Not classified:22
136103,"Fatty acids, tallow, hydrogenated, ammonium salts",293-139-3,91051-84-2,Not Classified,Notified C&L,1,Not classified:1
136104,"1H-Imidazolium, 1-ethenyl-3-methyl-, methyl sulfate, polymer with 1-ethenyl-2-pyrrolidinone",604-743-7,150599-70-5,Aquatic Chronic 2,Notified C&L,96,H411:83;H400:13;H410:13
136105,"Oxidase, galactose",232-843-7,9028-79-9,Resp. Sens. 1,Notified C&L,35,H334:35
136108,"Formaldehyde, polymer with 2-methyloxirane, 4-nonylphenol and oxirane",613-221-8,63428-92-2,Not Classified,Notified C&L,88,Not classified:85;H319:2;H412:1
136110,3-(5-nitro-2-furyl)acrylic acid,228-488-2,6281-23-8,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1
136112,"3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)propanal",700-133-0,2436-29-5,Not Classified,Notified C&L,5,Not classified:4;H312:1;H335:1;H319:1;H315:1;H332:1;H302:1
136113,Ethyl cyclobutanecarboxylate,238-995-0,14924-53-9,Flam. Liq. 3,Notified C&L,39,H226:39
136114,Methyl 2-bromohexanoate,226-643-9,5445-19-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,60,H317:4;H315:7;H302:4;H314:53;H301:1;H335:2;H318:1;H412:1;H319:2
136118,"Lead, dross, antimony-rich",273-791-5,69029-45-4,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Carc. 2;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,8,H410:8;H360:8;H319:8;H332:8;H400:8;H302:8;H372:8;H351:8
136121,"(3,5-dimethylphenyl)boronic acid",605-655-1,172975-69-8,,Notified C&L,8,H319:7;H315:7;H335:6;H302:2
136125,"9-fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-valerate",218-439-3,2152-44-5,STOT RE 2,Notified C&L,143,H373:64;H410:51;H372:77;H360:83;H330:51;H411:6;H362:3;H361:5;H302:2;H412:1;H317:1;H312:2;H332:2;H335:1;H319:1;H315:1
136127,Zinc selenide,215-259-7,1315-09-9,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,339,H373:338;H410:338;H301:339;H331:339;H400:338;H372:1;H261:1
136131,Dodecyl(2-hydroxy-3-sulphonatopropyl)dimethylammonium,236-164-7,13197-76-7,Eye Dam. 1;Aquatic Acute 2;Aquatic Chronic 3,REACH registration C&L,500,H412:2;H318:23;H401:2;H319:477;H411:20;H400:1
136132,"Oils, bergamot, psoralen-free",614-687-5,68648-33-9,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,147,H317:147;H410:147;H315:147;H400:110;H304:147;H226:147
136134,"5,6,7,7a-Tetrahydrothieno[3,2-c]pyridin-2(4H)-one Hydrochloride",601-365-4,115473-15-9,,Notified C&L,3,H319:3;H315:3;H335:2
136135,tert-pentylamine,209-839-9,594-39-8,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1B,Notified C&L,44,H225:44;H301:39;H314:44;H312:4;H332:4;H302:4;H318:1
136140,"2-chloro-N,N-dimethylthioxanthene-δ9,γ-propylamine citrate",238-116-0,14241-35-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H301:1;H315:1;H335:1
136142,"Residual oils (petroleum), clay-treated;Baseoil - unspecified;[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C",265-143-5,64742-41-2,Carc. 1B,Harmonised C&L,0,H350:0
136146,metam-sodium (ISO);sodium methyldithiocarbamate,205-293-0,137-42-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H317:0;H410:0;H400:0;H302:0;H314:0
136153,"3,3-dimethylbutyric acid",213-982-2,1070-83-3,Skin Corr. 1B,Notified C&L,46,H314:46;H290:1;H318:1
136154,Sodium 4-(1-methylethyl)naphthalene-1-sulphonate,259-514-0,55184-48-0,Acute Tox. 4;Eye Dam. 1;STOT SE 3,Notified C&L,1,H332:1;H318:1;H302:1;H335:1
136156,Isosteareth-10,641-057-7,52292-17-8,Not Classified,Notified C&L,38,Not classified:37;H319:1;H302:1
136157,"Hexahydro-3,6-methanophthalic anhydride",227-852-8,6004-79-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
136158,2-(formylamino)-3-thiophenecarboxylic acid,610-100-1,43028-69-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,194,H317:194;H302:194
136168,"3,5-dichloro-4-hydroxybenzoic acid",222-071-9,3336-41-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
136172,5'-BROMO-2'-HYDROXYACETOPHENONE,604-457-2,1450-75-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:42
136173,2-[2-(piperazin-1-yl)ethoxy]ethanol dihydrochloride,286-638-2,85293-16-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
136174,2-(2-methoxyphenoxy)ethyl 4-toluenesulfonate,403-930-9,,Acute Tox. 4;Muta. 2,Notified C&L,1,H341:1;H302:1
136176,"tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;dimethyl propyleneurea",230-625-6,7226-23-5,Acute Tox. 4;Eye Dam. 1;Repr. 2,Harmonised C&L,0,H361:0;H318:0;H302:0
136177,Isopropyl carbamate,217-127-4,1746-77-6,Acute Tox. 4,Notified C&L,39,H302:39;H332:1;H312:1
136178,copper(II) carbonate--copper(II) hydroxide (1:1),235-113-6,12069-69-1,Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H410:0;H319:0;H400:0;H332:0;H302:0
136181,Silver perchlorate,232-035-4,7783-93-9,Ox. Sol. 2;Skin Corr. 1B,Notified C&L,45,H314:45;H272:45;H400:4;H318:1
136182,"[3R-(3α,3aβ,6β,7β,8aα)]-octahydro-6-methoxy-3,6,8,8-tetramethyl-1H-3a,7-methanoazulene",243-384-7,19870-74-7,Not Classified,Notified C&L,1646,Not classified:1604;H317:42;H400:42;H410:42
136183,"Fatty acids, rape-oil, mixed esters with 1,4:3,6-dianhydro-d-glucitol, sorbitan and sorbitol",297-083-0,93334-10-2,Not Classified,REACH registration C&L,3,Not classified:3
136188,"2,2'-(methylimino)diethanol;N-methyldiethanolamine",203-312-7,105-59-9,Eye Irrit. 2,Harmonised C&L,0,H319:0
136189,"η-1H-indol-3-yl-α,α,ε-trimethyl-1H-indole-3-heptanol",267-434-2,67860-00-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,42,H317:42;H319:42
136193,"Butanedioic acid, 1-[2-[(1-oxo-2-propen-1-yl)oxy]ethyl] ester",610-591-2,50940-49-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,60,H318:39;H315:40;H317:20;H373:20;H312:20;H335:20;H311:20;H302:21;H314:20;H319:1
136194,"2-Propenoic acid, 2-methyl-, polymer with 2-ethylhexyl 2-propenoate and methyl 2-methyl-2-propenoate",607-560-0,25133-98-6,Not Classified,Notified C&L,2,Not classified:2
136195,Ethylbis(2-hydroxyethyl)oleylammonium ethyl sulphate,273-940-4,69268-83-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1;H302:1
136202,1-chloro-1-ethoxyethane,230-378-4,7081-78-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,1,H312:1;H335:1;H319:1;H225:1;H315:1;H332:1;H302:1;H351:1
136203,"Disodium 6,13-dichloro-3,10-bis(phenylamino)triphenodioxazine-2,9-disulphonate",229-417-8,6527-70-4,Eye Irrit. 2,Notified C&L,42,H319:21;Not classified:20;H351:1
136204,Clofazimine,217-980-2,2030-63-9,,Notified C&L,1,H319:1;H413:1;H315:1;H335:1
136207,"4-hydroxy-3,5-dimethoxybenzoic acid",215-884-5,1443-76-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:43;H315:43;H335:43
136209,4-[3-hydroxy-3-phenyl-3-(2-thienyl)propyl]-4-methylmorpholinium methyl sulphate,229-386-0,6504-57-0,Acute Tox. 4,Notified C&L,3,H302:3;H360:1
136210,Zinc tetraethyl bis(phosphate),225-021-4,4615-25-2,Not Classified,Notified C&L,1,Not classified:1
136211,"Gases (petroleum), benzene unit hydrotreater depentanizer overheads;Refinery gas;[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]",271-623-5,68602-82-4,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0,H220:0;H340:0;H350:0;Not classified:0
136212,"2,7-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-6-[2-[3-[[[2-[[2-(sulfooxy)ethyl]sulfonyl]ethyl]amino]carbonyl]phenyl]diazenyl]-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:4)",601-455-3,116889-78-2,Not Classified,Notified C&L,1,Not classified:1
136218,4-(vinyloxy)butan-1-ol,241-793-5,17832-28-9,Acute Tox. 4;Eye Irrit. 2A;Aquatic Chronic 3,REACH registration C&L,154,H319:138;H412:129;H302:139;Not classified:7;H315:2;H335:1
136222,(E)-tetradec-11-enyl acetate,251-401-4,33189-72-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H319:38;H315:43;H335:38
136228,"8-Azabicyclo[3.2.1]octan-3-amine, 8-(phenylmethyl)-, (3-endo)-",616-315-7,76272-35-0,,Notified C&L,1,H332:1;H312:1;H302:1
136232,isopentyl formate,203-769-2,110-45-2,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0,H319:0;H225:0;H335:0
136233,"Madder (Rubia), R. tinctorum, ext.",283-497-9,84650-16-8,Not Classified,Notified C&L,2,Not classified:2
136238,Tidiacic,250-048-3,30097-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
136240,"3,6,9,12,15,18,21,24,27-nonaoxanonatriacontan-1-ol",221-284-4,3055-99-0,Eye Dam. 1,Notified C&L,9,H318:5;H302:4;H319:2;H315:2;H335:1;H400:1;H412:1
136242,2(or 4)-toluenesulphonic acid,274-893-2,70788-37-3,Not Classified,Notified C&L,84,Not classified:59;H319:25;H315:25;H335:25
136243,CYCLOPROPANEAMIDINE HYDROCHLORIDE,611-495-3,57297-29-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47,H319:47;H315:47;H335:46;H312:1;H332:1;H302:1
136247,Rubidium fluoride,236-603-2,13446-74-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,69,H332:39;H312:39;H351:39;H302:39;H301:30;H335:31;H311:30;H319:31;H315:31;H331:26;H330:4
136248,2-Fluoro-5-hydroxybenzoic acid,610-663-3,51446-30-1,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,48,H411:39;H318:39;H302:39;H319:9;H315:9;H335:9
136251,"licareol; (R)-3,7-dimethyl-1,6-octadien-3-ol; l-linalool",204-811-2,126-91-0,Skin Sens. 1B,Harmonised C&L,0,H317:0
136254,"(3-(C20-24-(even numbered)-alkyl-2-enyl)-dihydro-furan-2,5-dion",615-230-2,70983-53-8,Not Classified,Notified C&L,35,Not classified:33;H317:2;H318:1;H314:1
136256,(2-bromopropyl)benzene,218-315-9,2114-39-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H315:39;H335:38
136258,Sodium methanethiosulphonate,217-770-0,1950-85-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H315:38;H335:38
136265,triethyl[[4-(triethylsilyl)-3-butyn-1-yl]oxy]silane,605-200-7,160194-28-5,Flam. Liq. 2;Asp. Tox. 1;Skin Sens. 1B,Notified C&L,1,H304:1;H225:1;H317:1
136266,"4-(benzoylamino)-5-hydroxy-6-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-1,7-disulphonic acid, sodium salt",287-728-4,85567-16-4,Not Classified,Notified C&L,3,Not classified:3
136270,Cyclohexanecarbonitrile,212-157-4,766-05-2,Acute Tox. 3;Acute Tox. 3,Notified C&L,41,H311:41;H301:40;H302:1
136273,"6,10-dimethylundeca-3,5,9-trien-2-one",205-457-1,141-10-6,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,362,H317:362;H411:361;H315:362;H320:2;H401:2;H319:109;H410:1;H400:1
136275,Cobalt trifluoride,233-062-4,10026-18-3,Skin Corr. 1B,Notified C&L,43,H314:43;H317:5;H301:5;H272:4;H351:4;H341:1
136276,"Calendula officinalis, ext.",283-949-5,84776-23-8,Flam. Liq. 3,REACH registration C&L,138,H226:5;Not classified:125;H319:8;H315:7;H302:7;H317:1
136278,Triphenylphosphine selenide,223-406-1,3878-44-2,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H373:39;H410:40;H301:40;H331:40;H400:40
136287,"Reaction mass of 1,1,1-trifluoroethane and chlorodifluoromethane and pentafluoroethane",903-865-0,,Press. Gas (Comp.),Notified C&L,1,H280:1
136298,Reaction mass of 52408-84-1 and 55818-57-0,917-249-4,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H317:1;H319:1
136302,"1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta-2-benzopyran",904-816-6,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H400:3;H410:3
136313,"Diphenylmethane Diisocyanate, isomers and homologues",905-744-8,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,1,H317:1;H373:1;H335:1;H319:1;H334:1;H315:1;H332:1;H351:1
136340,Reaction mass of calcium carbonate and calcium sulfate and magnesium hydroxide,908-381-3,,Not Classified,Notified C&L,1,Not classified:1
136347,Reaction mass of biphenyl and diphenyl ether,905-106-9,,,Notified C&L,1,H319:1;H410:1;H315:1;H335:1
136350,"Reaction mass of (3S)-3,7-Dimethyl-7-octen-1,6-diol and (3S, 5E)-3,7-Dimethyl-5-octen-1,7-diol",917-940-0,,Not Classified,REACH registration C&L,2,Not classified:2
136353,Reaction mass of decamethylcyclopentasiloxane and octamethylcyclotetrasiloxane,908-718-4,,Flam. Liq. 3;Repr. 2;Aquatic Chronic 4,Notified C&L,2,H226:2;H361:2;H413:2
136359,"Reaction mass of Chromate(1-), [2-(3-chlorophenyl)-2,4-dihydro-4-[[2-hydroxy-5-(methylsulfonyl)phenyl]azo]-5-methyl-3H-pyrazol-3-onato(2-)][methyl [7-hydroxy-8-[[2-hydroxy-5-(methylsulfonyl)phenyl]azo]-1-naphthalenyl]carbamato(2-)]-, sodium and sodium bis[2-(3-chlorophenyl)-2,4-dihydro-4-[[2-hydroxy-5-mesylphenyl]azo]-5-methyl-3H-pyrazol-3-onato(2-)]chromate(1-) and sodium bis[methyl [7-hydroxy-8-[[2-hydroxy-5-mesylphenyl]azo]-1-naphthyl]carbamato(2-)]chromate(1-)",915-704-1,,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,85,H400:85;H410:85;H302:85
136372,Reaction mass of disodium carbonate and disodium sulfate and sodium chloride,908-570-0,,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,1,H319:1;H302:1
136383,Reaction mass of aluminium and iron and silicon,912-151-8,,Not Classified,Notified C&L,1,Not classified:1
136396,"Reaction mass of nitrilotriacetic acid and ammonia, aqueous solution and ammonium trioxovanadate",907-830-0,,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,1,H301:1;H335:1;H311:1;H319:1;H315:1;H330:1
136423,"Reaction mass of (3β,6Z)-9,10-secocholesta-5(10),6,8-trien-3-ol and colecalciferol",902-969-3,,,Notified C&L,0,No data
136439,Reaction mass of isopropylphenyl phosphate and triphenyl phosphate,907-393-6,,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,9,H332:8;H400:9;H410:9;H361:1
136457,"Reaction mass of N,N'-[(methylimino)diethylene]bis[dibenzylmethylammonium] dimethyl bis(sulphate) and N,N'-[[benzylimino]diethylene]bis[dibenzylmethylammonium] dimethyl bis(sulphate)",916-889-1,,Not Classified,Notified C&L,36,Not classified:36
136466,Reaction mass of carbon monoxide and carbon dioxide and hydrogen.,907-631-9,,Not Classified,Notified C&L,1,Not classified:1
136516,Reaction mass of manganese and nickel and silicon and silver and tin and copper and zinc,912-856-0,,Skin Sens. 1,Notified C&L,1,H317:1
136517,Reaction mass of fytic acid and water,904-794-8,,,Notified C&L,2,H319:2;H315:2;H335:2
136522,"Reaction mass of METHYL NONAFLUOROISOBUTYL ETHER and Butane, 1,1,1,2,2,3,3,4,4-nonafluoro-4-methoxy-",900-060-6,,Not Classified,Notified C&L,3,Not classified:2;H413:1
136528,"Reaction mass of 1,3-dichloropropene and 2-chloropropane and 2-chloropropene and 3-chloropropene",903-816-3,,Flam. Liq. 1;Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,1,H317:1;H312:1;H351:1;H411:1;H302:1;H224:1;H341:1
136530,Reaction mass of dicalcium silicate and hexacalcium hexaoxotris[sulphato(2-)]dialuminate(12-),914-915-6,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,1,H317:1;H318:1;H315:1;H335:1
136545,"Reaction mass of sebacic acid, compound with 2,2',2''-nitrilotriethanol and sebacic acid, compound with 2-aminoethanol and Boric acid, compd. with 2,2',2''-nitrilotris[ethanol] and orthoboric acid, compound with 2-aminoethanol",915-471-6,,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H335:1
136550,"Reaction mass of 4,4'-methylenediphenyl diisocyanate and Amines, soya alkyl",905-837-3,,Not Classified,REACH registration C&L,2,Not classified:2
136557,Reaction mass of butane and butene,903-812-1,,Flam. Gas 1;Press. Gas (Liq.),REACH registration C&L,255,H280:255;H220:255;H340:85;H350:85
136570,Reaction mass of diisobutyl adipate and diisobutyl glutarate and diisobutyl succinate,907-870-9,,Not Classified,REACH registration C&L,117,Not classified:117
136576,Reaction mass of 2-ethylhexan-1-ol and 2-ethylhexyl acetate (0650),905-975-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,56,H319:56;H315:56
136612,"Reaction mass of Fatty acids, montan-wax, ethylene esters and Glycerides, montan-wax and Montan wax",914-480-2,,Not Classified,Notified C&L,33,Not classified:33
136622,None,911-730-2,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,1,H317:1;H335:1;H319:1;H334:1;H315:1;H331:1
136625,"Reaction mass of Gibb-3-ene-1,10-dicarboxylic acid, 2,4a-dihydroxy-1-methyl-8-methylene-, 1,4a-lactone, (1α,2β,4aα,4bβ,10β)- and Gibbane-1,10-dicarboxylic acid, 2,4a-dihydroxy-1-methyl-8-methylene-, 1,4a-lactone, (1α,2β,4aα,4bβ,10β)-",908-290-9,,Not Classified,Notified C&L,1,Not classified:1
136686,Reaction mass of isopropyl dihydrogen phosphate and phosphoric acid and propan-2-ol,908-998-8,,Flam. Liq. 3;Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,34,H226:34;H290:1;H318:1;H314:34
136689,Reaction mass of aluminium oxide and europium(III) oxide and strontium oxide,909-818-0,,Not Classified,Notified C&L,1,Not classified:1
136692,Reaction mass of water and chloride,913-574-0,,,Notified C&L,5,H314:4;H335:5;H319:1;H315:1
136722,"Reaction mass of (24R)-ergost-5-en-3β-ol and ergosta-5,22(E)-dien-3β-ol and stigmast-5-en-3-β-ol and stigmasta-5,22-dien-3-β-ol",904-791-1,,Not Classified,Notified C&L,4,Not classified:4
136727,"Reaction mass of 2-aminopropane-1,3-diol and trometamol",904-038-7,,Not Classified,Notified C&L,55,Not classified:55
136755,"Reaction mass of piperazinium dihydrogen phosphate and 1,3,5-triazine-2,4,6-triamine monophosphate",915-227-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H335:1
136761,"Reaction mass of Montan wax acid, 1,3-butanediol diester and Montan wax carboxy acids, ethyleneesters and Montan wax and Fatty acids, montan-wax",914-471-3,,Not Classified,REACH registration C&L,40,Not classified:40
136786,Reaction mass of diiron trioxide and iron hydroxide oxide,909-975-5,,Not Classified,Notified C&L,2,Not classified:2
136814,Reaction mass of calcium disilicide and calcium silicide,915-037-6,,Not Classified,REACH registration C&L,20,Not classified:19;H261:1
136822,Reaction mass of aluminium nitrate and aluminium sulphate,914-919-8,,Met. Corr. 1;Eye Dam. 1,Notified C&L,1,H290:1;H318:1
136826,Reaction mass of 79-81-2 and 8001-21-6,904-554-2,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Repr. 2,Notified C&L,3,H319:2;H361:3;H315:2;H302:2
136835,Reaction mass of 2-methyldecan-1-al and undecanal,907-235-6,,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1
136843,"Reaction mass of 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol and [2R[2R*(4R*,8R*)]]-3,4-dihydro-2,7,8-trimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol and [2R[2R*(4R*,8R*)]]-3,4-dihydro-2,8-dimethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol",900-582-4,,Not Classified,Notified C&L,1,Not classified:1
136873,Reaction mass of 2-methylpropyl (Z)-2-methylbut-2-enoate and 2-methylpropyl (E)-2-methylbut-2-enoate,914-262-7,,Flam. Liq. 3,Notified C&L,2,H226:1;H411:1
136876,"Reaction mass of 2,2'-Oxydiethanol, propoxylated and Formaldehyde, polymer with benzenamine and 2-methyloxirane",917-215-9,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,3,H317:3;H411:3
136882,Reaction mass of disodium dihydrogen ethylenediaminetetraacetate and hexaammonium heptamolybdate,907-844-7,,Not Classified,Notified C&L,1,Not classified:1
136942,"Reaction mass of naphthalene and Solvent naphtha (petroleum), heavy arom.",905-089-8,,Asp. Tox. 1;Carc. 2;Aquatic Chronic 2,Notified C&L,1,H304:1;H351:1;H411:1
136955,Oligomerisation products of ethylene oxide with reaction products of rape oil and ethanolamine,932-164-2,,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,3,H412:3;H315:3
136964,"Acetone-Xylene, 1:1",902-944-7,,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H225:1;H315:1;H332:1;H336:1
136981,Reaction mass of 2-[2-(benzoyloxy)ethoxy]ethyl benzoate.and oxydipropyl dibenzoate,907-437-4,,Not Classified,REACH registration C&L,4,Not classified:2;H412:2
137000,Reaction mass of diiron trioxide and titanium dioxide and 12001-26-2,909-967-1,,STOT SE 3,Notified C&L,1,H335:1
137002,Byk-052,907-055-8,,Flam. Liq. 3;Aquatic Chronic 3,Notified C&L,1,H226:1;H412:1
137019,"Reaction mass of 1-vinyl-2-pyrrolidone and 4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane and Distillates (petroleum), hydrotreated heavy paraffinic and vinyl acetate",904-944-2,,Not Classified,Notified C&L,1,Not classified:1
137048,"1,2-xylene; 1,3-xylene; 1,4-xylene",905-215-1,1330-20-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H226:1;H312:1;H315:1
137074,Water solution of 108-95-2,906-651-5,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 3;Muta. 2,Notified C&L,2,H312:1;H331:1;H302:1;H341:1;H314:1;H311:1;H301:1
137088,"Reaction mass of Poly(oxy-1,2-ethanediyl),α-hydro-ω-hydroxy- Ethane-1,2-diol, ethoxylated and water",914-069-8,,Not Classified,Notified C&L,1,Not classified:1
137100,"Reaction mass of 7-azatridecane-1,13-diamine and hexamethylenediamine",907-605-7,68815-47-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,96,H317:96;H312:95;H335:95;H318:95;H302:96;H412:96;H314:96;H310:1
137104,Reaction mass of glyoxal and water,906-331-5,,,Notified C&L,1,H317:1;H319:1;H315:1;H331:1;H341:1
137108,"Reaction mass of 2,2'-(vinylenedi-p-phenylene)bis[5-methylbenzoxazole] and 2,2'-(vinylenedi-p- phenylene)bisbenzoxazole and 2-[4-[2-[4-(benzoxazol-2- yl)phenyl]vinyl]phenyl]-5-methylbenzoxazole",911-168-8,,Aquatic Chronic 4,REACH registration C&L,2,H413:2
137140,Reaction mass of bis(2-ethylhexyl) fumarate and bis(2-ethylhexyl) maleate,907-868-8,,STOT RE 2;Aquatic Acute 1,Notified C&L,1,H373:1;H410:1;Not classified:1
137147,Reaction mass of calcium(2+) 12-hydroxyoctadecanoate and dilithium azelate and dilithium tetraborate and lithium 12-hydroxystearate,911-517-4,,Not Classified,Notified C&L,1,Not classified:1
137169,"Reaction mass of 2-methylaminoethanol and 2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate",906-680-3,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2120,H317:2120;H412:2120;H319:2120
137179,Phenolic regin,900-320-9,,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Muta. 2;Carc. 1B;Aquatic Chronic 3,Notified C&L,1,H317:1;H311:1;H350:1;H302:1;H412:1;H341:1;H314:1
137218,"Reaction mass of [(3,7-dimethyloct-6-en-1-yl)oxy]acetaldehyde and [(3,7-dimethyloctyl)oxy]acetaldehyde",913-400-3,,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H317:1;H411:1;H319:1;H315:1
137234,"Reaction mass of edetic acid and ammonia, aqueous solution and [carbonato(2-)]tetrahydroxytrinickel",901-818-9,,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1
137241,Reaction mass of disodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-) and disodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-),916-848-8,,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,5,H319:5;H412:5
137260,Reaction mass of 5-ethyl-4-hydroxy-2-methylfuran-3(2H)-one and 2-ethyl-4-hydroxy-5-methylfuran-3(2H)-one,915-553-1,,Acute Tox. 4,Notified C&L,1,H302:1
137268,Reaction mass of toluene-2-sulphonamide and toluene-4-sulphonamide,903-036-3,,Not Classified,Notified C&L,1,Not classified:1
137275,"Reaction mass of disodium [2-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-5-nitrobenzene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-) and disodium [4-hydroxy-3-[(2-hydroxy-4-nitrophenyl)azo]naphthalene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-) and disodium [6-amino-5-[(2-hydroxy-4-nitrophenyl)azo]-N-methylnaphthalene-2-sulphonamidato(2-)][6-amino-5-[(2-hydroxy-4-nitrophenyl)azo]naphthalene-2-sulphonato(3-)]cobaltate(2-) and sodium bis[2-(3-chlorophenyl)-2,4-dihydro-4-[[2-hydroxy-5-mesylphenyl]azo]-5-methyl-3H-pyrazol-3-onato(2-)]chromate(1-)",915-702-0,,Not Classified,Notified C&L,1,Not classified:1
137305,"Reaction mass of propane-1,2-diol, monoacetate and propane-1,2-diyl diacetate",908-916-0,,Not Classified,Notified C&L,1,Not classified:1
137319,"Reaction mass of Fatty acids, montan-wax and Fatty acids, montan-wax, sodium salts and Montan wax",914-479-7,,Not Classified,REACH registration C&L,32,Not classified:32
137337,"Reaction mass of ethanol and Ethanol, lithium salt",902-004-6,,,Notified C&L,1,H224:1;H314:1
137341,Reaction mass of aluminium and cobalt,912-347-3,,,Notified C&L,1,H317:1;H334:1;H413:1
137360,"Reaction mass of 2-methylaminoethanol and Glycerol, propoxylated, esters with acrylic acid",906-684-5,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2120,H317:2120;H412:2120;H319:2120
137361,Reaction mass of copper oxide and manganese dioxide,910-356-7,,Acute Tox. 4;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H410:4;H373:4;H332:5;H400:4;H302:5;H318:1;H251:1
137376,Hex-3-en-1-yl acetate,911-593-9,,Flam. Liq. 3,REACH registration C&L,2,H226:2
137378,"Reaction mass of Fatty acids, montan-wax and Fatty acids, montan-wax, 1-methyl-1,3-propanediyl esters and Montan wax",914-470-8,,Not Classified,Notified C&L,1,Not classified:1
137386,"Reaction mass of 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol and Vitamin E and [2R*(4R*,8R*)]-(±)-3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol and α-tocopherol",901-775-6,,Not Classified,Notified C&L,1,Not classified:1
137397,Reaction mass of aluminium and chromium,912-344-7,,,Notified C&L,1,H317:1;H410:1;H319:1;H334:1;H315:1;H400:1;H351:1
137398,Reaction mass of dipotassium butyl phosphate and potassium dibutyl phosphate,915-430-2,,Not Classified,Notified C&L,1,Not classified:1
137401,Reaction mass of benzyldodecylbis(2-hydroxypropyl)ammonium chloride and benzylbis(2-hydroxypropyl)tetradecylammonium chloride,916-226-6,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 2;STOT SE 3;Carc. 1B;Aquatic Chronic 1,REACH registration C&L,1,H317:1;H410:1;H335:1;H318:1;H315:1;H350:1;H302:1;H330:1
137404,Reaction mass of calcium fluoride and calcium sulfate and calcium carbonate,910-697-1,,Not Classified,REACH registration C&L,2,Not classified:2
137406,"Acido 8,9-dideidro-6-metil-8-Erogolincarbossilico",904-781-7,,Skin Sens. 1,Notified C&L,1,H317:1
137412,Reaction mass of aluminium oxide and didysprosium trioxide and europium(III) oxide,909-814-9,,Not Classified,Notified C&L,1,Not classified:1
137423,"Reaction mass of 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl isobutyrate and 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl isobutyrate",916-331-7,,Aquatic Chronic 2,REACH registration C&L,5,H411:5
137431,Reaction mass of calcium dipalmitate and calcium distearate,908-726-8,,Not Classified,Notified C&L,11,Not classified:11
137450,Reaction mass of mullite and zirconium dioxide,909-252-4,,Not Classified,Notified C&L,1,Not classified:1
137501,"Reaction mass of Fatty acids, montan-wax and Fatty acids, montan-wax, esters with pentaerythritol and Montan wax",914-476-0,,Not Classified,Notified C&L,31,Not classified:31
137551,"Reaction mass of Fatty acids, montan-wax and Fatty acids, montan-wax, ethylene esters and Montan wax",914-475-5,,Not Classified,REACH registration C&L,47,Not classified:47
137562,"Reaction mass of ethane-1,2-diol and terephthalic acid",905-518-9,,Not Classified,Notified C&L,2,Not classified:1;H221:1
137583,"Reaction mass of (2E) 1-Bromo-6,6-dimethyl-2-hepten-4-yne and (2Z)- 1-Bromo-6,6-dimethyl-2-hepten-4-yne",900-137-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H332:1;H312:1;H301:1;H302:1
137686,DIETRICH'S FIXATIVE,900-245-1,,Flam. Liq. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Carc. 2,Notified C&L,1,H317:1;H319:1;H315:1;H224:1;H351:1
137690,Reaction mass of heptachromium tricarbide and trichromium dicarbide,915-035-5,,Not Classified,REACH registration C&L,15,Not classified:15
137719,Galvinoleum,906-603-3,,Flam. Liq. 2;Skin Irrit. 2;Acute Tox. 4;Repr. 2;STOT RE 2,Notified C&L,1,H373:1;H361:1;H225:1;H315:1;H332:1
137747,"Reaction mass of 1,1'-(dodecylimino)dipropan-2-ol and 1,1'-(hexadecylimino)dipropan-2-ol and 1,1'-(octadecylimino)dipropan-2-ol and 1,1'-(octylimino)dipropan-2-ol and 1,1'-(tetradecylimino)dipropan-2-ol and 1,1'-(decylimino)bispropan-2-ol",911-171-4,,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,1,H411:1;H314:1
137749,"Reaction mass of 1,1,3,3-tetrabutyl-1,3-bis[(1-oxododecyl)oxy]distannoxane and 1,1,3,3-tetrabutyl-1,3-bis[(1-oxohexadecyl)oxy]distannoxane and dibutylbis(myristoyloxy)stannane and dibutylbis(octadec-9(Z)-enoyloxy)stannane and dibutylbis(octadeca-9(Z),12(Z)-dienoyloxy)stannane and dibutylbis(palmitoyloxy)stannane and dibutylbis(stearoyloxy)stannane and dibutyltin dilaurate",904-013-0,,Not Classified,Notified C&L,55,Not classified:55
137759,Reaction mass of dipentyl hydrogen phosphate and pentyl dihydrogen phosphate,911-327-1,,Met. Corr. 1;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,1,H412:1;H290:1;H314:1
137769,Reaction mass of formaldehyde and DL-glyceraldehyde and glycollaldehyde and calcium diformate,900-175-1,,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 2,Notified C&L,1,H317:1;H301:1;H335:1;H311:1;H319:1;H315:1;H331:1;H351:1
137775,Reaction mass of dilithium azelate and lithium 12-hydroxystearate,913-449-0,,Not Classified,Notified C&L,30,Not classified:30
137784,"Reaction mass of 4,8-diamino-1,5-dihydroxy-2-(4-hydroxyphenyl)anthraquinone and 4,8-diamino-1,5-dihydroxy-2-(4-methoxyphenyl)anthraquinone",911-685-9,,Not Classified,Notified C&L,5,Not classified:5
137788,Reaction mass of 2-(phosphonooxy)ethyl acrylate and bis[2-(acryloyloxy)ethyl] hydrogen phosphate,915-618-4,,Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,2,H317:1;H318:2;H315:1
137867,"Reaction mass of dicyanamide and 1,1-dimethylurea",908-615-4,,,Notified C&L,2,H317:2;H335:2;H318:2;H315:2;H302:2;H351:2;H332:1
137876,Reaction mass of 2-hydroxyisopropyl 2-hydroxypropyl bicarbamate and 2-hydroxypropyl carbazate and propylene carbonate,906-521-8,,Eye Irrit. 2;Muta. 2,REACH registration C&L,2,H319:2;H341:2
137892,"Reaction mass of citric acid and ammonia, aqueous solution and copper(II) carbonate--copper(II) hydroxide (1:1)",904-086-9,,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
137907,water solution of 1310-73-2,910-286-7,,,Notified C&L,2,H314:2;H302:1
137975,"Reaction mass of bis(2-hydroxyethyl)ammonium hydrogentartrate and 2,2'-iminodiethanol and bis[2-hydroxyethyl]ammonium dihydrogen citrate",906-919-1,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2,Notified C&L,1,H373:1;H318:1;H315:1;H302:1
137993,"Reaction mass of 5-ethylidene-8,9,10-trinorborn-2-ene and 5,8-Methano-4H-1-benzopyran, 7-ethylidene-4a,5,6,7,8,8a-hexahydro-",915-287-6,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H317:1;H373:1;H411:1;H319:1;H315:1;H304:1;H226:1;H330:1
138055,Reaction mass of potassium and sodium,913-023-4,11135-81-2,Water-react. 1;Skin Corr. 1B,Notified C&L,2,H260:2;H314:2
138072,Reaction mass of 107-21-1 and 126-86-3,906-289-8,,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2,H319:1;H412:1;Not classified:1
138083,"Reaction mass of potassium;sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate;manganese, potassium;sodium;2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetate;manganese and potassium;sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetate;manganese",915-009-3,,Not Classified,REACH registration C&L,1,Not classified:1
138103,"Reaction mass of 2,2'-[methylenebis(oxymethylene)]bis[2-ethylpropane-1,3-diol] and 2,2'-[oxybis(methylene)]bis[2-ethylpropane-1,3-diol] and propylidynetrimethanol",904-155-3,,Not Classified,REACH registration C&L,3,Not classified:3
138115,"Reaction mass of 1-(2-methyl-4-(2-methylphenylazo)phenylazo)-2-naphthol and 1-[[2,5-dimethyl-4-[(2-methylphenyl)azo]phenyl]azo]-2-naphthol and 1-[[4-[(dimethylphenyl)azo]dimethylphenyl]azo]-2-naphthol",904-884-7,,Not Classified,Notified C&L,1,Not classified:1
138123,Phenolic resin,906-654-1,,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H302:1
138140,"Reaction mass of Fatty acids, montan-wax and Fatty acids, montan-wax, esters with trimethylolpropane and Montan wax",914-477-6,,Not Classified,Notified C&L,31,Not classified:31
138166,"Reaction mass of 2-ethylpropane-1,3-diol and 5-ethyl-1,3-dioxane-5-methanol and propylidynetrimethanol",904-153-2,,Eye Irrit. 2;Repr. 2,REACH registration C&L,2,H319:2;H361:1
138171,Reaction mass of calcium di(acetate) and magnesium di(acetate),901-895-9,,Not Classified,Notified C&L,1,Not classified:1
138253,Zwischenprodukt TPPTS 39.,915-935-8,,Not Classified,Notified C&L,1,Not classified:1
138264,"Reaction mass of disodium [1-[(2-hydroxy-3,5-dinitrophenyl)azo]-2-naphtholato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-) and hydrogen sodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-) and hydrogen sodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphtholato(2-)]chromate(2-)",916-667-4,,,Notified C&L,1,H319:1;H411:1;H315:1
138275,Reaction mass of isopropyl myristate and isopropyl palmitate,906-730-4,,Not Classified,Notified C&L,1,Not classified:1
138333,"6-benzyloctahydro-1H-pyrrolo[3,4-b]pyridine",929-459-3,,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H373:1;H332:1;H302:1;H411:1;H314:1
138339,"Reaction mass of 2-ethylhexyl dihydrogen phosphate, sodium salt and sodium bis(2-ethylhexyl) phosphate",907-924-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,31,H319:31;H315:31
138358,"Reaction mass of Lithium, 12-hydroxyoctadecanoate sebacate complexes and lithium 12-hydroxystearate and lithium stearate",911-653-4,,Not Classified,Notified C&L,17,Not classified:17
138373,Reaction mass of titanium dioxide and zinc oxide,910-490-6,,Not Classified,Notified C&L,1,Not classified:1
138391,"Reaction mass of 2-methylbutane and Styrene, oligomers and pentane",904-240-5,,Not Classified,Notified C&L,1,Not classified:1
138392,"Reaction mass of cyclohex-1,2-ylenediamine and hexamethylenediamine",907-609-9,,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 4;STOT SE 3,Notified C&L,5,H317:3;H335:5;H332:3;H302:5;H314:5;H312:2
138412,"Reaction mass of Matricaria recutita, ext. and glycerol and water",900-930-5,,Not Classified,Notified C&L,1,Not classified:1
138423,"Reaction mass of 2,4-xylenol and 2,5-xylenol",905-287-4,1638758-52-7,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,4,H317:3;H301:4;H311:4;H318:2;H411:4;H314:4
138435,"Reaction mass of 2-(2-butoxyethoxy)ethanol and Naphtha (petroleum), hydrotreated heavy and Fatty acids, C6-19-branched, cobalt(2+) salts",907-196-5,,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1;H319:1;H315:1;H302:1;H304:1
138446,"Reaction mass of 1,3,3-trimethylbicyclo[2.2.1]hept-2-yl acetate and (1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acetate",903-982-7,,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1,H304:1;H317:1;H411:1
138453,"Reaction mass of hydrogen tetrasodium bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonato(4-)]cobaltate(5-) and tetrasodium hydrogen bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonato(4-)]chromate(5-)",916-854-0,,Not Classified,Notified C&L,59,Not classified:59
138457,"Reaction mass of carbon tetrachloride and chloroform and 1,2-dichloroethane",900-600-0,,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 1B;Repr. 2;STOT RE 1;Aquatic Chronic 3;Ozone 1,REACH registration C&L,2,H317:2;H301:2;H361:2;H311:2;H319:2;H315:2;H331:2;H420:2;H350:2;H412:2;H372:2;H336:2
138466,"Reaction mass of 4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with glycerol, propoxylated and Glycerol, ethoxylated",917-238-4,,Not Classified,Notified C&L,1,Not classified:1
138473,Reaction mass of barium and iron and silicon,912-610-2,,Not Classified,Notified C&L,1,Not classified:1
138476,Reaction mass of (2E)-Tridec-2-enenitrile and (2Z)-Tridec-2-enenitrile and (3E)-Tridec-3-enenitrile and (3Z)-Tridec-3-enenitrile,919-489-5,,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H317:2;H400:2;H410:2
138495,Reaction mass of ethanol and propan-2-ol and water,902-098-9,,Not Classified,Notified C&L,1,Not classified:1
138519,"Reaction mass of 2-(3,4-dihydroxyphenyl)-2,3,4-trihydro-3,5,7-trihydroxychromene and C.I. Natural Brown 3 and Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl ester and 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R,3S)-rel- and Benzoic acid, 3,4,5-trihydroxy-, (2S,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester and 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R,3R)- and Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester",908-486-4,,Not Classified,Notified C&L,1,Not classified:1
138549,Reaction mass of ammonium dihydrogenorthophosphate and ammonium nitrate and ammonium sulphate and potassium chloride,911-865-7,,Not Classified,Notified C&L,1,Not classified:1
138554,"Reaction mass of 3,4-xylenol and 3,5-xylenol and 4-ethyl-o-cresol and 5-ethyl-o-cresol and p-isopropylphenol",905-276-4,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,2,H311:2;H301:2;H314:2;H411:2;H317:1
138555,Multi constituent substance,916-603-5,,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H410:2
138565,"Reaction mass of Montan wax and Fatty acids, montan-wax and Fatty acids, montan-wax, esters with trimethylolpropane and Fatty acids, montan-wax, mixed esters with adipic acid and trimethylolpropane",914-478-1,,Not Classified,REACH registration C&L,35,Not classified:35
138582,Reaction mass of 2-methylbutan-1-ol and 3-methylbutan-1-ol,907-525-2,,,Notified C&L,1,H226:1;H315:1;H302:1;H335:1
138629,Reaction mass of 2-aminoethanol and boric acid,907-907-9,,,Notified C&L,1,H315:1
138636,Reaction mass of iron and molybdenum,912-550-7,,Not Classified,Notified C&L,1,Not classified:1
138638,Reaction mass of cerium phosphate and lanthanum phosphate and terbium phosphate,915-152-1,,Not Classified,REACH registration C&L,4,Not classified:4
138641,"Reaction mass of 12-Hydroxy-N-[2-[(1-oxodecyl)amino]ethyl]octadecanamide and N,N'-1,2-Ethanediylbis(12-hydroxyoctadecanamide) and N,N'-1,2-Ethanediylbis[decanamide]",907-495-0,,Not Classified,REACH registration C&L,8,Not classified:6;H412:2
138646,Reaction mass of chromium nitride and dichromium nitride,915-072-7,,Not Classified,Notified C&L,1,Not classified:1
138674,"Reaction mass of Tallow, lithium salt and dilithium sebacate and lithium 12-hydroxystearate",913-448-5,,Not Classified,Notified C&L,3,Not classified:3
138675,Reaction mass of diiron trioxide and iron hydroxide oxide and triiron tetraoxide,909-901-1,,Not Classified,Notified C&L,1,Not classified:1
138685,Reaction mass of 1-O-α-D-glucopyranosyl-D-mannitol and 6-O-α-D-glucopyranosyl-D-glucitol,908-700-6,,Not Classified,REACH registration C&L,2,Not classified:2
138691,aluminium sulfate hydrated,913-979-2,,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H315:1;H335:1
138710,Reaction mass of potassium;sodium;2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetate;copper and potassium;sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetate;copper,915-008-8,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H319:2;H412:2;H315:2
138721,Reaction mass of Prussian blue and ammonium iron(3+) hexakis(cyano-C)ferrate(4-),915-214-8,,Not Classified,Notified C&L,1,Not classified:1
138730,Mixture of acrylic acid 4-[(chlorocarbonyl)oxy]butyl ester and 3-chloropropanoic acid 4-[(chlorocarbonyl)oxy]butyl ester,900-064-8,,Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 3,REACH registration C&L,86,H317:86;H402:2;H318:86;H315:86
138731,E-Cure 100 Plate Cleaner,902-792-1,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H312:2;H315:2
138771,Reaction mass of cerium phosphate and lanthanum phosphate,915-151-6,,Not Classified,Notified C&L,3,Not classified:3
138776,"Reaction mass of 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl methacrylate and 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl methacrylate and 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-henicosafluorododecyl methacrylate and 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,14-pentacosafluorotetradecyl methacrylate and 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-nonacosafluorohexadecyl methacrylate",911-270-2,,,Notified C&L,1,H319:1;H332:1;H315:1;H335:1
138785,"Reaction mass of 2,2'-iminodiethanol and Phosphoric acid, 2-ethylhexyl ester",906-918-6,,Not Classified,Notified C&L,1,Not classified:1
138860,"Reaction mass of 1-methyl-2-pyrrolidone and 2,2'-oxydiethanol",906-953-7,,Acute Tox. 4,Notified C&L,56,H302:56
138879,"Reaction mass of 2,4,6,8,10-pentamethylcyclopentasiloxane and 2,4,6,8-tetramethylcyclotetrasiloxane",911-325-0,,Not Classified,Notified C&L,1,Not classified:1
138896,"Reaction mass of lauric acid, compound with 2,2',2''-nitrilotriethanol (1:1) and stearic acid, compound with 2,2',2''-nitrilotriethanol (1:1) and tris(2-hydroxyethyl)ammonium palmitate",911-315-6,,Not Classified,Notified C&L,1,Not classified:1
138921,"copper sulfate;N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine",907-262-3,,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H317:2;H301:2;H318:2;H315:2;H411:2
138928,Reaction mass of calcium di(acetate) and calcium dodecylbenzenesulphonate and calcium phosphate and calcium tetraborate and calcium(2+) 12-hydroxyoctadecanoate and tricalcium bis(orthophosphate),901-906-7,,Not Classified,Notified C&L,2,Not classified:2
138950,Reaction mass of (Z)-octadec-9-enol and (Z)-9-Octadecen-1-ol ethoxylated,908-011-0,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H410:1;H315:1
138960,"Reaction mass of Boric acid, calcium salt and calcium di(acetate) and calcium(2+) 12-hydroxyoctadecanoate",901-913-5,,Not Classified,Notified C&L,1,Not classified:1
138983,Reaction mass of Fluorphlogopite (Mg3K[AlF2O(SiO3)3]) and titanium dioxide,915-021-9,,Not Classified,Notified C&L,2,Not classified:2
138997,Reaction mass of N-carboxymethyliminobis(ethylenenitrilo)tetra(acetic acid) and disodium molybdate,902-535-3,,Not Classified,Notified C&L,1,Not classified:1
139003,Reaction mass of aluminium and zinc,912-359-9,,,Notified C&L,3,H260:3;H410:3
139011,"Reaction mass of (2,4,6-trioxo-1,3,5-triazine-1,3,5(2H,4H,6H)-triyl)tri-2,1-ethanediyl triacrylate and 2-Propenoic acid, 1,1'-[[dihydro-5-(2-hydroxyethyl)-2,4,6-trioxo-1,3,5-triazine-1,3(2H,4H)-diyl]di-2,1-ethanediyl] ester",915-672-9,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H317:2;H412:2;H318:2;H315:2
139019,"Reaction mass of disodium L-glutamate and l-Glutamic acid, N-coco acyl derivs., disodium salts and sodium chloride",913-643-5,,Eye Irrit. 2,Notified C&L,2,H319:2
139050,reaction mass of cis 4-(3-methylbutyl)cyclohexanol and trans 4-(3-methylbutyl)cyclohexanol,930-389-0,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H318:1;H315:1
139055,Reaction mass of acetone and toluene,902-920-6,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Repr. 2;STOT RE 2,Notified C&L,2,H373:2;H361:2;H319:2;H225:2;H315:2;H304:2;H336:2
139057,"Reaction mass of Distillates (petroleum), solvent-dewaxed heavy paraffinic and Residual oils (petroleum), solvent-dewaxed",916-148-2,,Not Classified,Notified C&L,5,Not classified:5
139073,Reaction mass of 2-methyl-2H-isothiazol-3-one and 5-chloro-2-methyl-2H-isothiazol-3-one,911-418-6,55965-84-9,Acute Tox. 3;Acute Tox. 2;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,553,H317:553;H410:553;H301:553;H318:15;H400:553;H310:14;H314:553;H330:14;H311:539;H331:539
139075,"Reaction mass of 2-(3-ethylphenyl)oxirane and 2,2’-(1,3-phenylene)dioxirane and 2,2'-(1,4-phenylene)dioxirane",935-853-6,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1;H315:1
139083,Reaction Mass of LAURAMIDOPROPYL BETAINE and MYRISTAMIDOPROPYL BETAINE,911-636-1,,Eye Dam. 1,Notified C&L,2,H318:2
139094,"Reaction mass of Sulfonic acids, petroleum and sulphur dioxide and sulphuric acid",913-327-7,,Skin Corr. 1A,REACH registration C&L,1,H314:1
139104,"Reaction mass of 1,5-naphthylene diisocyanate and Amines, hydrogenated tallow alkyl",911-527-9,,Not Classified,REACH registration C&L,2,Not classified:2
139105,Reaction mass of dodecyldimethylamine and dimethyl(tetradecyl)amine,907-120-0,,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,2,H400:2;H314:2;H302:2
139109,Reaction mass of copper oxide and dicopper oxide,910-628-5,,Acute Tox. 4;Aquatic Chronic 1,REACH registration C&L,2,H410:2;H302:2
139118,"Reaction mass of 2-methylpenta-1,3-diene and 4-methylpenta-1,3-diene",909-068-4,,Flam. Liq. 2;Asp. Tox. 1,REACH registration C&L,3,H304:3;H225:3
139175,Reaction mass of calcium sulfate and tetracopper hexahydroxide sulphate,910-853-9,,Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,10,H332:10;H400:10;H410:10;H318:10
139184,2-EH-Gemsich aus Kopf Rückstandskolonne,906-020-4,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H317:1;H411:1;H335:1;H319:1;H315:1;H332:1;H302:1;H304:1;H226:1;H336:1
139187,"Reaction mass of 1,2,3,4,4a,5,6,7-octahydro-2,5,5-trimethyl-2-naphthol and 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)butan-2-one and 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)butan-2-one",915-318-3,,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H315:2
139199,Reaction mass of dithulium tricarbonate and diytterbium tricarbonate,911-787-3,,Not Classified,Notified C&L,1,Not classified:1
139200,"Reaction mass of tetra-, penta-, hexa, tri- and mono-ethylene glycols",906-259-4,,Eye Irrit. 2,Notified C&L,55,H319:55
139209,"Reaction mass of L-lysine, sodium salt and succinic anhydride",906-502-4,,Not Classified,Notified C&L,47,Not classified:47
139210,Reaction mass of 1-methyl-3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde and 1-methyl-4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,915-712-5,,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H400:2;H410:2;Not classified:4
139213,Reaction mass of lutetium oxide and ytterbium (III) oxide,910-567-4,,Not Classified,Notified C&L,1,Not classified:1
139229,"Reaction mass of lithium sodium 5-amino-3-{[4-(2-{4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)diazenyl]-2-sulfophenyl}vinyl)-3-sulfophenyl]diazenyl}-4-hydroxynaphthalene-2,7-disulfonate 2,2'-(methylimino)diethanol (1:1) and 3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[6-amino-4-hydroxynaphthalene-2-sulphonic] acid, lithium sodium salt, compound with 2,2'-(methylimino)diethanol and 3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, lithium sodium salt, compound with 2,2'-(methylimino)diethanol",916-916-7,,Not Classified,REACH registration C&L,5,Not classified:5
139252,"Reaction mass of 2,4,6,8,10-pentamethyl-2,4,6,8,10-pentavinylcyclopentasiloxane and 2,4,6,8-tetramethyl-2,4,6,8-tetravinylcyclotetrasiloxane",911-381-6,,Not Classified,REACH registration C&L,2,Not classified:2
139276,"Reaction mass of 3,6,10-trimethylundeca-3,5,9-trien-2-one and 7,11-dimethyldodeca-4,6,10-trien-3-one",909-122-7,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,84,H317:84;H320:1;H315:84;H319:83
139278,"Reaction mass of bis[3-[[4-[benzylmethylamino]phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium] tetrachlorozincate(2-) and bis[5-[[4-[benzylmethylamino]phenyl]azo]-1,4-dimethyl-1H-1,2,4-triazolium] tetrachlorozincate(2-)",916-918-8,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,6,H411:3;H318:6;H302:3;H412:3
139295,Reaction mass of isopropyl (E)-p-methoxycinnamate and methyl p-methoxycinnamate,909-035-4,,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H400:1;H410:1;H411:1
139297,"Reaction mass of 1,1,1,2,2,3,3,4,5,5,5-undecafluoro-4-(trifluoromethyl)pentane and tetradecafluorohexane",908-202-9,,Not Classified,Notified C&L,1,Not classified:1
139302,Reaction mass of adipic acid and hexamethylenediamine,907-579-7,,,Notified C&L,1,H221:1
139305,Reaction mass of sodium hydrogensulphide and sodium carbonate,908-593-6,,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H400:1;H318:1;H301:1;H314:1
139324,TEN ELEMENT ICPMS STANDARD,913-568-8,,Not Classified,Notified C&L,3,Not classified:3;H314:1;H336:1;H335:1
139327,Reaction mass of 50-00-0 and 67-56-1,900-234-1,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;Carc. 2,Notified C&L,3,H317:3;H301:2;H311:3;H331:3;H351:3;H314:3;H370:1;H302:1;H224:1
139335,"Reaction mass of N,N'-ethylenebis[N-methyl-2-[(1-oxo-9-octadecenyl)oxy]-N-[2-[(1-oxo-9-octadecenyl)oxy]propyl]propylammonium] dimethyl disulphate and [2-[bis(2-hydroxypropyl)amino]ethyl]bis(2-hydroxypropyl)(methyl)ammonium methyl sulphate, dioleate (ester)",916-222-4,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1;H318:1;H315:1
139353,"Reaction mass of N,N-dimethyltetradecylamine N-oxide and dodecyldimethylamine oxide",911-227-8,,,Notified C&L,1,H318:1
139367,TCD-Dial roh ex B6334 SOD,906-573-1,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H373:1;H361:1;H411:1;H319:1;H225:1;H315:1;H304:1;H336:1
139374,"Reaction mass of 2-methylaminoethanol and Propylidynetrimethanol, ethoxylated, esters with acrylic acid",906-682-4,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2120,H317:2120;H412:2120;H319:2120
139381,GLUTARALDEHYDE 8% EM GRADE,902-628-9,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,1,H317:1;H334:1;H318:1;H315:1;H302:1
139391,Aluminium doped Zinc oxide,910-448-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H335:1;H319:1;H315:1;H400:1
139413,Reaction mass of methanol and sodium methanolate,902-634-1,,Flam. Liq. 2,Notified C&L,2,H225:1;H311:1;H318:1;H370:1;H226:1;H314:1;H330:1
139428,"Reaction mass of 2-(2-butoxyethoxy)ethanol and Isotridecanol, ethoxylated",907-200-5,,Not Classified,Notified C&L,3,Not classified:3
139435,Reaction mass of undec-8-enal and undec-9-enal and undec-10-enal,907-237-7,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2,H317:1;H411:2;H319:1;H315:1
139440,Reaction mass of dipotassium sulfide (K2(Sx)) and potassium thiosulphate,914-988-4,,Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H400:1;H314:1
139477,Reaction mass of ethylenebis(oxyethylene) dibenzoate and oxydiethylene dibenzoate and oxydipropyl dibenzoate,907-434-8,,Not Classified,REACH registration C&L,2,Not classified:2
139494,Reaction mass of dihexadecyl hydrogen phosphate and hexadecyl dihydrogen phosphate,911-302-5,,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,5,H318:5;H315:5
139510,"Reaction mass of glycerol 1,3-di(acetate) and glycerol acetate and triacetin",905-964-4,,Not Classified,REACH registration C&L,6,Not classified:6
139516,Reaction mass of 7647-14-5 and 7778-54-3,913-624-1,,Ox. Sol. 2;Acute Tox. 4;Skin Corr. 1B;STOT SE 3;Aquatic Acute 1,Notified C&L,1,H335:1;H272:1;H400:1;H302:1;H314:1
139527,Copper(II) sulfate pentahydrate,913-732-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H411:1;H290:1;H318:1;H314:1
139529,"Reaction mass of bis(1,2,2,6,6-pentamethyl-4-piperidyl) sebacate and methyl 1,2,2,6,6-pentamethyl-4-piperidyl sebacate",915-687-0,1065336-91-5,Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,600,H317:600;H400:560;H410:592;H411:8
139532,"Reaction mass of 6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptane and rel-6,6-dimethylspiro[bicyclo[3.1.1]heptane-2,2'-oxirane]",907-728-6,,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1B;Aquatic Acute 1,REACH registration C&L,1,H304:1;H226:1;H317:1;H400:1
139536,"Reaction mass of 1-(2,6,6-trimethyl-1-cyclohexen-1-yl)pent-1-en-3-one and 3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one and [R-(E)]-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)pent-1-en-3-one",907-708-7,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,5,H317:3;H411:3;H315:2;H412:2
139572,Reaction mass of zinc oxide and calcium sulfate,910-475-4,,Aquatic Acute 1,Notified C&L,1,H400:1;H410:1
139631,Reaction mass of diisobutyl hydrogen phosphate and isobutyl dihydrogen phosphate,911-351-2,,Skin Corr. 1B,REACH registration C&L,6,H314:6;H290:1
139640,Reaction mass of methyl anthranilate and 4-(4-hydroxy-4-methylpentyl)cyclohex-3-enecarbaldehyde,907-774-7,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H317:1;H412:1;H319:1
139655,"A Mixture, with or without stabilising agents, of calcium hydroxide and copper (II) sulphate",909-472-0,8011-63-0,Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H332:1;H400:1;H318:1
139661,Reaction mass of acetic acid and ethane peroxoic acid,902-388-5,,Flam. Liq. 3;Org. Perox. D;Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H290:1;H312:1;H332:1;H400:1;H242:1;H302:1;H226:1;H314:1
139672,"Reaction mass of 4,4'-methylenediphenyl diisocyanate and 2,2'-methylenediphenyl diisocyanate and o-(p-isocyanatobenzyl)phenyl isocyanate",905-804-3,9016-87-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,3,H317:3;H373:3;H335:3;H319:3;H334:3;H315:3;H332:3;H351:3
139696,"Reaction mass of N,N-dimethyldecan-1-amide and N,N-dimethyloctanamide",909-125-3,,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,129,H318:129;H315:129;H335:90;H311:8;H302:8
139718,Reaction mass of 4-tert-butylphenol and phenol,905-392-5,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;STOT SE 3;Muta. 2;Repr. 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,1,H373:1;H410:1;H301:1;H361:1;H335:1;H311:1;H331:1;H341:1;H314:1
139730,[No public or meaningful name is available],930-449-6,,Skin Corr. 1B,Notified C&L,1,H314:1
139745,"Reaction mass of Magnesium bisulfite, Calcium bisulfite and Sulphur dioxide",913-331-9,,Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,1,H318:1;H315:1;H331:1
139771,Reaction mass of aluminium oxide and silicon carbide,908-245-3,,Not Classified,Notified C&L,1,Not classified:1
139784,"Reaction mass of 2-(1,1-dimethylpropyl)anthraquinone and 2-(1,2-dimethylpropyl)anthraquinone",915-623-1,,Acute Tox. 4;Carc. 1B;Aquatic Chronic 1,REACH registration C&L,8,H410:3;H350:2;H302:7;H373:4;H413:4;H412:1
139822,reaction mass of ethylbenzene and xylene,905-588-0,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,REACH registration C&L,227,H332:225;H226:227;H312:224;H315:225;H373:106;H335:106;H319:106;H304:106
139828,Reaction mass of lithium 12-hydroxystearate and lithium 4-[(octadecylamino)carbonyl]benzoate,913-460-0,,Not Classified,Notified C&L,1,Not classified:1
139835,Reaction mass of acetic acid and formic acid,902-308-9,,Flam. Liq. 3;Skin Corr. 1A;Eye Dam. 1,Notified C&L,2,H226:2;H318:2;H314:2
139877,"Reaction mass of N-[2-(2-heptadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]stearamide and N,N'-[[(2-cyanoethyl)imino]diethane-1,2-diyl]distearamide and N-[2-[(2-cyanoethyl)[2-[(2-cyanoethyl)amino]ethyl]amino]ethyl]stearamide",915-486-8,,Eye Irrit. 2,Notified C&L,1,H319:1
139911,"1,1'-(dodecylimino)dipropan-2-ol + 1,1'-(tetradecylimino)dipropan-2-ol",911-174-0,,Skin Corr. 1C,REACH registration C&L,1,H314:1
139928,Reaction mass of dipotassium dodecyl phosphate and potassium didodecyl phosphate,915-344-5,,Not Classified,Notified C&L,31,Not classified:31
139935,Reaction mass of 4-methyl-1H-benzotriazole and 6-methylbenzotriazole,907-796-7,,,Notified C&L,2,H411:1;H302:2
139940,disodium 2-methylpropan-1-ol [(2-methylpropoxy)methanethioyl]sulfanide hydroxide,904-290-8,,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,8,H312:8;H319:8;H315:8;H228:8;H302:8
139947,"Reaction mass of 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol and 3-(2,3-dihydroxypropoxy)propane-1,2-diol and 3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]propane-1,2-diol",915-741-3,,Not Classified,REACH registration C&L,60,Not classified:60
139968,"Reaction mass of 2,2',2''-nitrilotriethanol and 2,2'-iminodiethanol",905-890-2,,Skin Irrit. 2;Eye Dam. 1;STOT RE 2,Notified C&L,11,H373:9;H318:9;H315:10;H302:3
139975,Reaction mass of hydroxyethyl laurate and ethylenedilaurate,908-917-6,,Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2,H400:2;H412:2
139993,Reaction mass of nickel and niobium,912-947-5,,Not Classified,Notified C&L,9,Not classified:9
140007,"Reaction mass of 2-aminoethanol and 2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate",907-908-4,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2120,H317:2120;H412:2120;H319:2120
140028,"Reaction mass of 1,5-diamino-4,8-dihydroxy-2-(4-hydroxyphenyl)anthraquinone and 1,5-diamino-4,8-dihydroxy-2-(4-methoxyphenyl)anthraquinone",915-195-6,,Not Classified,Notified C&L,1,Not classified:1
140041,NCT 911,902-778-5,,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Repr. 1A;STOT SE 1;STOT RE 1,Notified C&L,1,H360:1;H319:1;H315:1;H370:1;H332:1;H372:1
140042,Reaction mass of xylene and ethylbenzene and toluene,905-579-1,,Flam. Liq. 3;Asp. Tox. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3;STOT RE 2,Notified C&L,1,H373:1;H312:1;H335:1;H319:1;H315:1;H332:1;H304:1;H226:1
140045,"Reaction mass of 2,2'-iminodiethanol and oleic acid",906-893-1,,Not Classified,Notified C&L,3,Not classified:3
140081,"Reaction mass of 1-phenyloctadecane-1,3-dione and phenylicosane-1,3-dione",915-316-2,,Not Classified,REACH registration C&L,7,Not classified:7
140105,potassium;2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetate;dicalcium,902-532-7,,Not Classified,REACH registration C&L,1,Not classified:1
140150,Reaction mass of cerium and lanthanum and neodymium,912-703-8,,Not Classified,Notified C&L,1,Not classified:1
140168,Reaction mass of europium(III) oxide and vanadium yttrium tetraoxide and yttrium phosphate and yttrium(3+) orthoborate,909-828-5,,Not Classified,Notified C&L,2,Not classified:2
140176,Iso-nonanal (roh) ex SAL Tank 55/56/75,908-714-2,,Flam. Liq. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Carc. 1B;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H315:1;H350:1;H302:1;H226:1
140189,"There no exists EC number for the mixture, as the mixture was not reported for EINECS. The substance was covered by the EINECS entries forthe constituents (231-908-7, 215-137-3).",909-475-7,,Ox. Sol. 2;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H400:1;H314:1;H302:1;H272:1
